<SEC-DOCUMENT>0001012477-22-000014.txt : 20221109
<SEC-HEADER>0001012477-22-000014.hdr.sgml : 20221109
<ACCEPTANCE-DATETIME>20221109092035
ACCESSION NUMBER:		0001012477-22-000014
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		72
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221109
DATE AS OF CHANGE:		20221109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		221370915

	BUSINESS ADDRESS:	
		STREET 1:		BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
		STREET 2:		BALLYCOOLIN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			15
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>avdl-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245,d:b6974235a8bb456c8a9779e6f98b5b6d--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:avdl="http://www.avadel.com/20220930" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avdl-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N18zLTEtMS0xLTU4NDMw_c1f670aa-20a0-4336-a7c6-a74df1f9465a">0001012477</ix:nonNumeric><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N180LTEtMS0xLTU4NDMw_f8273b6c-bd29-48a8-ad21-2566c06c2dd5">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N181LTEtMS0xLTU4NDMw_c2791915-f907-4c0f-acf2-6d29a9e3b00d">2022</ix:nonNumeric><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N182LTEtMS0xLTU4NDMw_2616e72e-ea5f-4837-97b4-f884123ed65d">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N183LTEtMS0xLTU4NDMw_5dd5e51e-4bce-4d84-9a5c-762f975958bc">false</ix:nonNumeric><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N184LTEtMS0xLTU4NDMw_de899252-ca24-4e29-a48c-90675679d410">&#9746;</ix:nonNumeric><ix:nonNumeric contextRef="ie3bf1ab4f00444c6ab2dda0c89d893b0_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0wLTEtMS01ODQzMA_6946dcf2-15ab-4f20-83ee-a51a11cce42f">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405" name="avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzc2Mg_386183ed-95c1-436b-a9e7-e1c14e3bde78">P5D</ix:nonNumeric><ix:nonNumeric contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405" name="avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzgwNw_508bcbe0-6ff0-45f0-850b-ee02e8547ae7">P5D</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avdl-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d88356afacb448386df09e27fc8201c_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i26afda82b1a54595b97eea252e8036f3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a91a73aa374140bd351a086c6c55a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f43b68471384987a8e508240d806954_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8cb34e98b804bc2a8b68791f13f017c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b1249cde8f3412792b6a31c6aea2f32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb305ae339da4b9e9da20b480077e5d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc69325a19a142a89fc302cf9e4c995e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f5b47363bca4f2d8091e56f790a6b0a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226c75787e2147c1b17dd3071938941f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i432dbcdc9aae432797d9078759a71608_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35d6eab9188e4c6ba7d964585d71fe15_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ed9d20b39a413c9890b8202a0e2d68_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf0dcb690e5547d78e784e45c6a81bf8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4406995bd3d645db88eae94e1a61ee22_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597de771574f44ecbf7bdca7363c74a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352fb45f049d4e20be6533e5330bed51_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i858c6029c86f470f8ea195b51df7fd90_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0235c181696c43e685632d5e23836a0a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf80f97883a4000a3b2582adeac9a34_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1c927f07094257b38758d27969490b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38e1032982cc4ef596e29fa5bd65b3d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406e727d4c7940eab3bce49cfe84a5b4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7333adc928c34207b1ae3ea0580e1a34_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fde74b73c43497f867e979065e4f089_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dcd418f53514c1bbf7914a6f2125336_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052fb6f4421c4d4f9984b955980c6583_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea88b7ed2ea84e5ab764b998327d144e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a1264cc8b9472daa169711675defb7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b3f5f57fc524b96b5cfe506a4c5fea0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a69202d1114ffc970a48ee40981389_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34a108c684b944f1949cff98177a2d4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b3fac2f2f8404794c0c0c3cb9dc2b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39750e42b8c4306aad61fee7e83a5eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0230fccabc48f5a6ef37bc48d526f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3c35d690609413bbeb5dca96b91b6b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3bf1ab4f00444c6ab2dda0c89d893b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a5be02a4754c908aea2eb24daf8a58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2113f33399c94c20b59358750f55db61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bd8f8d15554ccaa1b7314e61a0bda1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1daef32fcaaf4e3198268352bfe614c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5d3b32370a14fc9ac68416910db95b4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1abc68c06e44c02a69a0e3b81539a1b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i213fec939ca94d28a184d48147f2f980_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d53876fb534cecadcfeab8814f3dc8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229da85b4f654c07be3b461a8a726d99_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d09c1dffe3407b993cb0bf2c8894ab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1168117551d4a9a8647ed266ee1d21c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i441ab67fef8d46f69ad115a28d4e47b2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4916497bce934c388a6e76aef6e5f8b2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb5fe8401174459933a0141de1de360_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f8355061a09422faca4bfc446a9317f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a7bb9eb70c43868a690dbac0c7d90c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id909d7fef83b4684a532a146f36cc21e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c237b4e52b04e4190505ebcd87c3c0f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67aab025ab13460f81e69e191c346f26_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15da54ef7274b76b422a70b1c736327_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8f0906d79e940ad870b539d8791c365_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i858bb564a22c494cb368931091b853d9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e8617f6b8b4839961ae2d42367307e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i006e36115c06446280acc29186452555_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if21be33b2a2f4c259a0dc8988e8c8bbb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407de99cf96a455d8396a71ae495f64b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic846f79390da411baf672e11138d8640_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:AtTheMarketOfferingProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf727c0cbc0d4d77aecbe73f9e0c4cbb_I20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa1afa74539c4902922f142c1210083f_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65bfb99cbf2433ab28b9b155376252c_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2022ProspectusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4ca9e79bab4ceda5ce5f8750665f49_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b516ef9e5224745a478640fa35c9afe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2022ProspectusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9034e3eea5954251b56209f67d99c46b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d21dc155e64f37a446b0e84d4976b3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9be88a5186547af9bac2db96c0d314c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5b4e9bf4294ad3855eba74063db7bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b1fbf65244d44e5b30d39291b2fee91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7732fc52cd52433585e6e3881ca0de58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3773002d244c34aea4fe21b68c31f8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a16e746e11428a8a70889cb36973ac_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4659da3e5e6e4b81ac8a8c5d5408d5ed_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3636fc86bf4e418c691cc2e41b6d3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47dcccfa7c50438eb45d7d48956a6b42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie39a1b6970aa4db987b72e4f7b8b1e55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3a19c47255496184d2a49062a6a184_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if37b82ee9ff1453bb386fd75f1d28653_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f623a32e9c42a78b39d8b1336e8ed0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eadf013ec464baa8c05eace10107933_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a672b4236141ea87f8252cc44a0803_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83b8410c35f458bb9cc1c09bfed7f76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead5d1bc954d49df81b5bdb5758886e6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabde77903698481883f2e97de186f6c5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b1fb3c05c2d4391aac196e02ae0db2d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie64cc03ea55a4af785d07e9c36ed47f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ba686307084b878761e39792b65749_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c8ac8d5610497498f8d8ff97b74668_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43f7d3853b624df8b8d498a70765a7d3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b635783cf44814ab114c3ec2777bbc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33c84835d749403fad63d02da1c19f19_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008389be6902419a89fb4467f69d8cf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc7fd82afc824c2d809f04c9d1209c92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie24d32544eb3492583f742640967b39f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824eee128a3c45f7841f91d18b27b288_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib25efd41b0a8497088a128e71d6d5557_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25fb303f345248a9a4f13e49293b295b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f88e70592e4720b210f17465179f02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8be616cca445759476d602725c21af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a02dd313384743b867f33cd4c52454_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7728b1ad8844b9c8acb4b0a1e2a5eee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b46577c09a4108b4d6e3e1474da619_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5585700b61054faf8d529487860514d5_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ad36b5fcb3045a68356e8cc78da6a85_I20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c50635ba7df4b1f8f3cea8c28c4bd5b_I20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700854cc6b274bb6aa14c33e39284fc2_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f34651b6e804b898cbacfb584c9a8e9_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">avdl:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4289596c9445e5b6b589951af85b2f_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544add4877ba4985a689c57ae1698e30_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>avdl:day</xbrli:measure></xbrli:unit><xbrli:context id="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95fb7b72db174d1c930b80d69d55059e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb2365318f346929309ffb2b2636041_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b395e51b07443339e8545ddcb926fec_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6552bf81cec348cba10fdb3ad7a1af92_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68fd68b84e214afeb6ac688372c7b9b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef4b6bda88f459a829bd244521b420f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfec458cab2647ec9baffeb95d1d2718_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa65319a9bbf4a30919b395ad1dce174_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c144896d5e4e3a83ac70f08d710d09_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76ffebca8fd84c3e8cfc2a78874bfac7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91c2787e79e44ae873764654f563d0c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124b04c0e92f4d0fb431541e53c91932_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd2203e3e99413c90a5be54a528a206_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15d9478444524a59af93cc2f7ef2a1e8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0df7aa69fe43dbb346fad573194ef4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b75dc6dfac4a31922574bf257cd0d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cd7da939b0f43d5bf4ee7d265fa9078_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dd2ac44366649d6822cdcb681c75934_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i531c84d42a854c188abebdccb7a5cbb9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b6e419f0e784181bbd1f69a1ef3e998_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89275b0e02ad490a9cea278805a53efe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a81c1516d914bc5afcc186a3bb51380_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb2f5402fe644e0bce0169c6c82e87e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143ad04a470f4af39f1d8a4f532972a0_D20220601-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ccb82c6cb44edb9963e6452b789279_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5643a43d090c46a387889dbf7fcfb224_D20221104-20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-04</xbrli:startDate><xbrli:endDate>2022-11-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY3_e9935b73-4118-42d0-9e29-ed440e0d8968">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY4_0a7b6094-fa7e-4eb0-b208-a6c0f6de239f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yMzA_5a615a84-17c7-4cfa-983c-0d85ddd99d55">September&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU3_90eba5c0-87fe-42d2-9f45-a3e168db9b25">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission File Number: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6MzQ2YzcxYTU0NjhiNDQwN2JiM2Y4NjUzZTQ2ZGIxNjEvdGFibGVyYW5nZTozNDZjNzFhNTQ2OGI0NDA3YmIzZjg2NTNlNDZkYjE2MV8wLTAtMS0xLTYzODYwL3RleHRyZWdpb246ZWIwOWEzYmFiNGFlNGE5MzgwOGE3OTJmMzI1NzExM2NfOTM0NTg0ODgzNjE0Mg_44ed0d51-623a-4afa-a0cd-b327472e1218">001-37977</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYx_4cbf1165-8a4e-4e93-b8e2-87005b68eb34">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6Njc0NTI5NzViNDFkNDVhZTk4ZWFmZjZhZDRjNmE2ZjkvdGFibGVyYW5nZTo2NzQ1Mjk3NWI0MWQ0NWFlOThlYWZmNmFkNGM2YTZmOV8wLTAtMS0xLTU4NDMw_35994672-a20b-43e2-ba59-cd1028580916">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6Njc0NTI5NzViNDFkNDVhZTk4ZWFmZjZhZDRjNmE2ZjkvdGFibGVyYW5nZTo2NzQ1Mjk3NWI0MWQ0NWFlOThlYWZmNmFkNGM2YTZmOV8wLTItMS0xLTU4NDMw_2277f2a4-7e28-4dbe-a6a5-4cdf4141dbd6">98-1341933</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYy_3473b9f4-2da0-45d1-b830-7a21dcf52dd0">10 Earlsfort Terrace</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU5_bc464c76-66fe-4f34-9db8-861476ca46a7">Dublin 2</ix:nonNumeric> <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYw_7a9c145b-e3b2-4e8c-b5cc-b77f1bc18a2f">D02 T380</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU0_9c7ccda2-be47-4338-ad83-2ac4f179c738">Ireland</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Office and Zip Code)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYz_d398e860-970a-4b87-94b9-42c312a37c90">353</ix:nonNumeric>-<ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU4_fc1913a8-c094-4ea1-9a68-38501eb9364e">1</ix:nonNumeric>-<ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU1_b82bfabb-86c1-4051-b374-1693520b040d">901-5201</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTAtMS0xLTU4NDMw_e2d8444d-f91d-4a9d-a4c2-ab80b80f3b5a">American Depositary Shares*</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTEtMS0xLTU4NDMw_05f5dd1a-5f25-429a-8d09-4997503ac0d8">AVDL</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTItMS0xLTU4NDMw_78a1a9c8-2c22-406f-b67d-7bf412625534">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8yLTAtMS0xLTU4NDMw_080e74b4-aa66-4f6b-8b25-09841f139e3e">Ordinary Shares, nominal value $0.01 per share**</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*American Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) Ordinary Share.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Not for trading, but only in connection with the listing of American Depositary Shares on The Nasdaq Global Market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU2_eb313c03-bce1-4b98-a8d8-e5053c721277">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;<ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY0_d640d1cc-108a-406c-b803-9e14533790bb">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8xLTAtMS0xLTU4NDMw_f47ce54f-a455-4437-9bc9-dc6d75d244c5">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8xLTMtMS0xLTU4NDMw_9f7c8998-e4b9-4b74-b7fd-4df306de5154">&#254;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8yLTMtMS0xLTU4NDMw_a48a4b20-5ecd-4bbd-bcae-47fd6eb34f22">&#168;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY2_5590c6a6-98c0-4969-9971-7b88f2cbafbf">&#254;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At November&#160;7, 2022, <ix:nonFraction unitRef="shares" contextRef="i2d88356afacb448386df09e27fc8201c_I20221107" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNTc1_422fc479-b40d-4442-ad16-06a4f96883e0">61,778,732</ix:nonFraction> ordinary shares, nominal value $0.01 each, of the Company were outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_10">Cautionary Note Regarding Forward Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_10">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_13">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_16">Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_82">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_103">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_106">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_106">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_109">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_112">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_112">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_115">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_115">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_118">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_118">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_121">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_121">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_124">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_124">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_127">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_127">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_130">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib6974235a8bb456c8a9779e6f98b5b6d_130">40</a></span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NOTE REGARDING TRADEMARKS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own various trademark registrations and applications, and unregistered trademarks, including AVADEL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LUMRYZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,  and MICROPUMP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All other trade names, trademarks and service marks of other companies appearing in this Quarterly Report are the property of their respective holders. Solely for convenience, the trademarks and trade names in this Quarterly Report may be referred to without the &#174; and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may use our website, LinkedIn or our Twitter account (@AvadelPharma) to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at www.avadel.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website, our LinkedIn posts or our Twitter posts are not incorporated into, and does not form a part of, this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 2 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Disclosure Regarding Forward-Looking Statements</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;). Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar expressions, or the negative of these terms, or similar expressions. Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to differ materially from those expressed in them. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our reliance on a single lead product candidate, LUMRYZ, also known as FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain final regulatory approval and full authorization from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) to commercialize LUMRYZ, including any delays in a final approval and/or authorization to launch;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability of LUMRYZ, if granted final approval by the FDA, to be successfully commercialized and gain market acceptance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to enter into strategic partnerships for the commercialization, manufacturing and distribution of LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of suppliers for the manufacturing of LUMRYZ and certain raw materials used in LUMRYZ and any failure of such suppliers to deliver sufficient quantities of these raw materials, which could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to finance our operations on acceptable terms, either through the raising of capital, the incurrence of convertible or other indebtedness or through strategic financing or commercialization partnerships;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations about the potential market size and market participation for LUMRYZ, if granted final approval by the FDA;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding litigation related to LUMRYZ, including the potential delisting of U.S. Patent No. 8731963 from the Orange Book; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the timing and results of our cost structure optimization efforts, including the estimated charges and costs expected to be incurred and projected cost savings in connection with such cost structure optimization efforts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding our cash runway lasting to a potential final FDA approval of our New Drug Application (&#8220;NDA&#8221;) for LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to continue to service our exchangeable senior notes due February 2023 (the &#8220;February 2023 Notes&#8221;) and our exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;, together with the February 2023 Notes, the &#8220;2023 Notes&#8221;), including making the ongoing interest payments on the 2023 Notes, settling exchanges of the 2023 Notes in cash or completing any required repurchases of the 2023 Notes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impacts of COVID-19, inflation and rising interest rates on our business and future operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to hire and retain key members of our leadership team and other personnel; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition existing today or that will likely arise in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are neither promises nor guarantees of future performance due to a variety of risks and uncertainties and other factors more fully discussed in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 16, 2022 and the risk factors and cautionary statements described in our subsequent filings with the SEC. Given these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements to reflect events or developments occurring after the date of this Quarterly Report, even if new information becomes available in the future.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 3 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION&#160;</span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_16"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. &#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS&#160;</span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi0yLTEtMS01ODQzMA_ed3d4c16-a179-480f-b6a5-6971b51effaf">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi00LTEtMS01ODQzMA_b72c6a06-6062-48f2-8e84-95a855253c0f">4,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi02LTEtMS01ODQzMA_9d5a87d8-0fbf-4a67-84b4-3240797fbb89">14,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi04LTEtMS01ODQzMA_1bd25ef8-1cfb-4102-8083-92e40d25b47e">14,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy0yLTEtMS01ODQzMA_cca9d908-c14f-49b5-b551-18e201f358d9">14,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy00LTEtMS01ODQzMA_e359ce81-091e-466a-a662-f48cbc687ea6">21,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy02LTEtMS01ODQzMA_ccf09d59-1bec-47d3-b15c-98c5ee75589e">57,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy04LTEtMS01ODQzMA_c0326f93-cde3-403a-b097-4047e34dd6dd">47,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (income) expense </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC0yLTEtMS01ODQzMA_351c564b-e649-4795-aef2-38a6439924ff">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC00LTEtMS01ODQzMA_2f782438-a75c-48e2-9932-a6ccd5ce23ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC02LTEtMS01ODQzMA_86cc86d2-286c-440a-869e-ec949cac63fe">3,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC04LTEtMS01ODQzMA_cd9f1d6f-63fe-4641-a2b8-7d36c5c13edd">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS0yLTEtMS01ODQzMA_21153cfd-38e3-4c18-84ed-9c8d9438c35d">16,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS00LTEtMS01ODQzMA_c111c815-cb99-46aa-8ae1-3d22a72255de">25,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS02LTEtMS01ODQzMA_67ea13d7-7757-40b1-952f-b4d37bc53a8c">75,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS04LTEtMS01ODQzMA_567a3efe-437f-40f9-83a4-9335bcf79ea4">62,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtMi0xLTEtNTg0MzA_e911a61b-6280-4e49-9b18-3037393c663d">16,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtNC0xLTEtNTg0MzA_1dfd1ea2-20e8-4392-a0d9-506c1fe68505">25,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtNi0xLTEtNTg0MzA_c1b18afa-45bc-4f57-aa96-cf6b0576ff2d">75,523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtOC0xLTEtNTg0MzA_20b10da4-8d6d-4bc7-ad8f-fae278c50951">62,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtMi0xLTEtNTg0MzA_81ff3e9b-d888-4556-9b7e-1aedcc322b82">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtNC0xLTEtNTg0MzA_14c5b23e-3cac-43cf-ab34-d29f1424643c">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtNi0xLTEtNTg0MzA_465c1c74-712f-4308-a79e-1bcaf7201954">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtOC0xLTEtNTg0MzA_a50f7c7a-2712-4203-b767-f596ca0203f1">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItMi0xLTEtNTg0MzA_766a9d44-3453-452f-a0fa-444c5cbaea16">3,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItNC0xLTEtNTg0MzA_e84dc8b5-fdcb-4d1d-8633-41540dbeeca6">1,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItNi0xLTEtNTg0MzA_3af55798-d089-4397-b469-9dd4571d1b36">9,087</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItOC0xLTEtNTg0MzA_69fc2645-b9aa-4995-b4f9-6814016ec58b">5,788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtMi0xLTEtNTg0MzA_ce11fa99-832e-4496-b993-41412d97a33c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtNC0xLTEtNTg0MzA_fc779af2-6e8a-40f0-bce5-347f1378144a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtNi0xLTEtNTg0MzA_7a5e83f3-1b8d-48de-89f1-676520e11061">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtOC0xLTEtNTg0MzA_9ad6683e-cd7b-4146-a791-3bd33f05ef57">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtMi0xLTEtNTg0MzA_13d5cd17-ae82-4aa4-8a55-0fddabd4045e">20,076</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtNC0xLTEtNTg0MzA_3d41fb9f-9dd1-48b4-907a-d18b5134561b">27,103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtNi0xLTEtNTg0MzA_b0bbad5b-b4f8-45fa-98fa-1298002fc34d">84,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtOC0xLTEtNTg0MzA_a64d4656-f4c6-4d2f-854e-a6509cf1b9ea">66,501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtMi0xLTEtNTg0MzA_dba8bea4-e4a1-4309-a49b-6cdb9c71e061">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtNC0xLTEtNTg0MzA_905af191-07a2-4de6-9ee1-ce63a7463c80">5,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtNi0xLTEtNTg0MzA_93750112-5f66-4538-b3b9-4c50a03dfee4">25,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtOC0xLTEtNTg0MzA_1855921f-1b4c-4c65-94ed-30912df71709">11,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtMi0xLTEtNTg0MzA_903d5fb5-9beb-4051-b36a-90f776890e42">20,146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtNC0xLTEtNTg0MzA_19d713e7-4fa4-455d-8759-4d5ff9639e9d">22,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtNi0xLTEtNTg0MzA_e1f63364-a1f2-4302-ba07-5ff86e55c293">110,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtOC0xLTEtNTg0MzA_11a39f9c-9520-4507-9150-2cbc60dbd66f">55,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8211; basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtMi0xLTEtNTg0MzA_82690241-96d0-4b81-9712-7de7292652f3">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtNC0xLTEtNTg0MzA_c422033e-525a-4cc8-896c-93d48b8eb233">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtNi0xLTEtNTg0MzA_f757de9c-78e8-4697-8822-44b480e44327">1.85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtOC0xLTEtNTg0MzA_63486003-c2e1-4ba8-af24-d8b2ab7b172d">0.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8211; diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktMi0xLTEtNTg0MzA_0d221755-f5eb-4748-842f-15474be5b480">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktNC0xLTEtNTg0MzA_92651a70-cd01-416e-b57b-3bb97a982bd1">0.38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktNi0xLTEtNTg0MzA_4829d901-ffd9-4030-8436-1c8ac48d4db8">1.85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktOC0xLTEtNTg0MzA_2bdf75f7-8792-48d9-8a4c-ca899d4985e8">0.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtMi0xLTEtNTg0MzA_6d7996a3-e498-4727-a147-583f80ad582c">60,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtNC0xLTEtNTg0MzA_bcfefc46-a178-4b65-a665-35b82650a27f">58,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtNi0xLTEtNTg0MzA_dd0645d3-8967-4e1c-8e0e-127dc6c262f6">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtOC0xLTEtNTg0MzA_5f8762af-dc62-40fd-b0b5-5abb9589d062">58,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItMi0xLTEtNTg0MzA_3e8b95e6-ba0a-45c4-84c3-3063a437b849">60,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItNC0xLTEtNTg0MzA_27bc8362-3680-469f-9a5d-22856ab6148f">58,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItNi0xLTEtNTg0MzA_d8c84f23-eb7a-4e21-82c5-b80010113a57">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItOC0xLTEtNTg0MzA_47a3ea22-f367-419e-8a18-f3efc071e2ae">58,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 4 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy0yLTEtMS01ODQzMA_903d5fb5-9beb-4051-b36a-90f776890e42">20,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy00LTEtMS01ODQzMA_19d713e7-4fa4-455d-8759-4d5ff9639e9d">22,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy02LTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293">110,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy04LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f">55,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS0yLTEtMS01ODQzMA_b8b25f15-e641-4f94-b0f5-3ebaea30cc13">647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS00LTEtMS01ODQzMA_2cece5d6-1f63-4051-ae3a-7fd06d21fe6a">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS02LTEtMS01ODQzMA_9d7c6981-d85a-4236-9176-7ba94405cf01">1,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS04LTEtMS01ODQzMA_1e7f330c-87fa-4866-95a6-07eeea529c07">839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzYz_b201427a-793e-4a64-9171-366534267c91">&#8212;</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzY3_e39ccbc7-3d58-4131-8d8d-52d768c9f358">59</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzcx_1512047c-dacb-4f0b-9a6f-25657ff86c65">&#8212;</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzc4_c3456c5f-7771-4f1b-ab34-5a7389dfa6c8">220</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0yLTEtMS01ODQzMA_352c6d22-fd6d-44dd-b0f7-a27082344d40">934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi00LTEtMS01ODQzMA_7c49ef5c-256c-4b9c-ab70-39689b7c4518">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi02LTEtMS01ODQzMA_264826b8-76a8-4ee4-bbfc-a21f8dd92be3">2,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi04LTEtMS01ODQzMA_bacde1e9-e8f8-4078-8087-d407cfdc1300">854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy0yLTEtMS01ODQzMA_631b7037-f991-44cb-ba77-1a32e7ba7123">1,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy00LTEtMS01ODQzMA_6945a9ac-4038-439b-967d-10de72f3c069">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy02LTEtMS01ODQzMA_51c3c1a9-fc0d-438a-b61d-8cf842132c2e">3,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy04LTEtMS01ODQzMA_6bc3404e-ce8e-46ec-b5ba-c154a829b287">1,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC0yLTEtMS01ODQzMA_989918fb-de49-4576-a998-f76b0aeef66c">21,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC00LTEtMS01ODQzMA_710b1685-89bd-45f1-a5c3-8dc3089c940d">22,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC02LTEtMS01ODQzMA_22cdded2-4e15-4426-b3c7-cca96a594d60">113,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC04LTEtMS01ODQzMA_9fffbabf-62e2-4f09-b1be-4d4f86546fa4">56,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 5 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNC0yLTEtMS01ODQzMA_3a5c846d-ceea-44b0-bfe2-5c63ffa8e6c8">60,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNC00LTEtMS01ODQzMA_c3ae9ecf-fbac-4742-a5a3-d36105470090">50,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNS0yLTEtMS01ODQzMA_58b7c1e8-2ab9-4b11-83ec-81fda2930bb9">45,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNS00LTEtMS01ODQzMA_3280870e-13ba-4c61-a38d-1f8af278f11c">106,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOC0yLTEtMS01ODQzMA_2fb33d47-6bfa-425b-acf0-acf0be51e9c6">2,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOC00LTEtMS01ODQzMA_7bf4c56d-21c2-489d-9f32-28decadbddb5">2,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOS0yLTEtMS01ODQzMA_044c0afe-a239-4b3c-adf5-0331d36a4a18">4,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOS00LTEtMS01ODQzMA_bf9984f1-9b26-46ec-8bbb-b459bc4d21b5">32,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTAtMi0xLTEtNTg0MzA_263f5f3e-556c-49af-8628-8f19b8702e08">113,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTAtNC0xLTEtNTg0MzA_e516cb1c-6311-401b-be5e-b18514f2cb86">192,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTEtMi0xLTEtNTg0MzA_1cc72610-4f34-44ce-828b-397706ee44c0">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTEtNC0xLTEtNTg0MzA_292cf438-f33b-4fef-a831-68829098aeb8">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTItMi0xLTEtNTg0MzA_35e65504-75d0-4343-9e5a-fbf55753ccab">1,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTItNC0xLTEtNTg0MzA_1861b2c0-74d2-405e-b8e7-dd030524551c">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTMtMi0xLTEtNTg0MzA_d132e929-026f-4b5e-89cb-146258aa95a0">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTMtNC0xLTEtNTg0MzA_5f78c6aa-d047-4356-a62f-32668f7cac15">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTUtMi0xLTEtNTg0MzA_e2026978-6f4b-4352-8d63-633331034dff">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTUtNC0xLTEtNTg0MzA_a0806649-fdfe-4b5f-b1c0-4e6aa8c3d704">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTYtMi0xLTEtNTg0MzA_a0ee94e8-8890-4f3f-a5aa-3b3aa2d50c09">11,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTYtNC0xLTEtNTg0MzA_3f8a6277-bef3-47c6-8abc-3e9a23ed1e5d">33,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTctMi0xLTEtNTg0MzA_9d409163-5780-4c71-831c-a7e2e5a24a91">145,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTctNC0xLTEtNTg0MzA_67a21723-9ce3-4621-a8c0-d3f37d956282">247,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; (DEFICIT) EQUITY </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjEtMi0xLTEtNTg0MzA_8fca55c2-e6db-4b11-a1d3-e74d75dd3af3">26,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjEtNC0xLTEtNTg0MzA_c9f5a092-6f65-4d75-91b5-a5f836a6e74c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjItMi0xLTEtNTg0MzA_54715860-fe6b-4cc8-a590-b194c86f42df">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjItNC0xLTEtNTg0MzA_6297ad04-3610-4c8f-ac95-fdf7288c6f0a">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjMtMi0xLTEtNTg0MzA_6a5f8a09-6c88-4d9a-9a06-29b5d14eb87b">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjMtNC0xLTEtNTg0MzA_6799bb5b-6f60-4950-adbc-fc2c120ff535">7,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjQtMi0xLTEtNTg0MzA_b02c62f8-88ed-455f-a6bf-198cc02d9331">7,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjQtNC0xLTEtNTg0MzA_62dd8b40-bf09-4dd2-9025-1ea550f03e30">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjYtMi0xLTEtNTg0MzA_014f7f40-9c88-49f3-a65f-7e8d9f5975ee">3,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjYtNC0xLTEtNTg0MzA_a262c229-a9bf-4d2f-81d7-05caa31bbce5">5,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjctMi0xLTEtNTg0MzA_07653bb1-bc12-4fc4-9cc4-bac259708d40">41,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjctNC0xLTEtNTg0MzA_6cbb5a00-3f45-4da9-b81c-b384d8992b02">21,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjgtMi0xLTEtNTg0MzA_f62922af-1b3e-4376-a116-ba316b39ad2c">109,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjgtNC0xLTEtNTg0MzA_2f4c0b92-30f1-4e70-a81e-ba724e896f10">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzAtMi0xLTEtNTg0MzA_0db76a5b-1669-41c3-94cb-c16db2c23183">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzAtNC0xLTEtNTg0MzA_853f40b4-b202-4821-85b1-87258f5293e9">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzEtMi0xLTEtNTg0MzA_34d3c43d-6512-4573-bf1b-4b0775b0956c">5,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzEtNC0xLTEtNTg0MzA_1086a814-b892-4bca-a97d-1ae9fceeff11">3,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzItMi0xLTEtNTg0MzA_8884871b-13e3-43a9-b166-375856e0f56c">158,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzItNC0xLTEtNTg0MzA_1dbe956d-79d3-42fd-8f78-3a0c99371701">169,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; (deficit) equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8zOQ_d8c79000-0058-4243-a584-c10e9f76d57e"><ix:nonFraction unitRef="usdPerShare" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8zOQ_eeda4697-bc9f-4862-a3e0-44b96006d15d">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl81Mw_0ad17c2b-ce9e-4c04-8818-0febde6a5268"><ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl81Mw_b700340d-4a75-4890-8236-52dc844212be">50,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl83NQ_20c0f78c-2c98-4beb-8f20-d2e8c658fd07"><ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl83NQ_6b171e2e-8dbf-4a39-a3e2-5077daf1ad23">488</ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8xMTE_6e2d9803-31ce-4bbb-832f-22ea8c88ba82"><ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8xMTE_ede60972-a577-4e39-b24c-2818a9f5d3e0">488</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMi0xLTEtNTg0MzA_95bea75b-6003-4d99-ad74-460edb6e63a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtNC0xLTEtNTg0MzA_a55d2f5e-ac5b-4983-94e1-a503bfe4be67">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8zOA_857e75bd-9f1e-4596-9bce-c2c40417cd7f"><ix:nonFraction unitRef="usdPerShare" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8zOA_99c1214c-5f54-407c-bb4f-6744fa389960">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF81Mg_379a65ca-e398-45c0-94cb-9bd1ffd161e7"><ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF81Mg_6b108d25-c35c-43e2-9fbf-9148eb995f52">500,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF83NA_16c7f8fa-8446-4953-bd0a-fe37eaaf82f0"><ix:nonFraction unitRef="shares" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF83NA_1812fc92-dd20-4156-869b-3e2e46ca3d72">60,885</ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8xMTA_5100ed86-c1b1-4569-b1ff-9ea7eb860ffc"><ix:nonFraction unitRef="shares" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8xMTA_c266d3a8-3797-45ef-8233-dbe656087d35">58,620</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMi0xLTEtNTg0MzA_de117961-50ed-4123-b659-27f7db6c73b3">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtNC0xLTEtNTg0MzA_5fd92022-83dd-49b9-98b4-c01d13a140d5">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzctMi0xLTEtNTg0MzA_bc86b898-4f7e-45d7-b4b5-f7cd86473252">572,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzctNC0xLTEtNTg0MzA_d9bc4acd-3380-4836-b201-8b81daf16c78">549,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzgtMi0xLTEtNTg0MzA_6e5542cf-ddda-4ea7-a41a-dc6df822f012">557,770</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzgtNC0xLTEtNTg0MzA_0506a02b-e243-4b8f-87eb-d68512d1ca0d">447,756</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzktMi0xLTEtNTg0MzA_fa273ecf-99f8-4c34-af7d-58eb8262b9f8">27,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzktNC0xLTEtNTg0MzA_adc88539-9b35-4aea-b2a9-5c6333a41b69">23,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; (deficit) equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDAtMi0xLTEtNTg0MzA_c1ef058d-054a-466e-9eb4-9513a849edcf">12,440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDAtNC0xLTEtNTg0MzA_ece596a2-278a-4a89-ab38-192b57730fcd">78,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; (deficit) equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDEtMi0xLTEtNTg0MzA_2b6c650d-8614-43b5-b956-7d3345367929">145,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDEtNC0xLTEtNTg0MzA_033224c4-da73-4e04-9b43-b0a5b909f47b">247,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 6 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(deficit) equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f43b68471384987a8e508240d806954_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0yLTEtMS01ODQzMA_af3e2a59-2879-4ac7-a8fc-0d3d1ac4ecd4">58,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f43b68471384987a8e508240d806954_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi00LTEtMS01ODQzMA_b362858f-c42d-44ea-bddd-b0c00a67507f">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8cb34e98b804bc2a8b68791f13f017c_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi02LTEtMS01ODQzMA_3bddcbf9-dfe4-4b2d-973e-f09905350317">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8cb34e98b804bc2a8b68791f13f017c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi04LTEtMS01ODQzMA_65ef7ee6-179e-4db6-bf8b-96f4d68cef52">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b1249cde8f3412792b6a31c6aea2f32_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xMC0xLTEtNTg0MzA_0493e84b-304f-4646-ac64-8bfec5f4d309">549,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb305ae339da4b9e9da20b480077e5d5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xMi0xLTEtNTg0MzA_64ce5756-9f39-423b-90de-6cb3cfff7de3">447,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc69325a19a142a89fc302cf9e4c995e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xNC0xLTEtNTg0MzA_a52a51fa-4297-4d8a-95bc-b785cf898a35">23,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xNi0xLTEtNTg0MzA_38e10be4-4451-4002-ba05-0cd0536cbb78">78,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f5b47363bca4f2d8091e56f790a6b0a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMy0xMi0xLTEtNTg0MzA_d5faacd9-1bb4-4804-a04c-e2fa9baaccb3">26,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMy0xNi0xLTEtNTg0MzA_0dd133b0-8b7c-4e55-82c7-2d6e2aa364fc">26,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226c75787e2147c1b17dd3071938941f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNC0xNC0xLTEtNTg0MzA_2e4a21cb-d57e-4714-ba78-066947ccfae7">1,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNC0xNi0xLTEtNTg0MzA_472eac97-f4fb-485f-a24e-f7b915078130">1,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0yLTEtMS01ODQzMA_fee18769-f05a-4c14-a4bb-068497a059f9">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS00LTEtMS01ODQzMA_e136b878-77fd-41fc-b21d-91cbde39b21d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0xMC0xLTEtNTg0MzA_11b0cc14-01cd-417a-953b-aa34a4b361fe">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0xNi0xLTEtNTg0MzA_77cf30b8-370c-4138-b52d-88ab90dacde4">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0yLTEtMS01ODQzMA_3ab19343-afeb-45fa-b592-0b4163c0018d">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi00LTEtMS01ODQzMA_a7081b52-9072-4821-a445-1dcfec55d841">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0xMC0xLTEtNTg0MzA_ec33642b-68b2-4ab4-9e9b-8a03c8adb544">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0xNi0xLTEtNTg0MzA_8d5ade6b-e6f4-4830-9eca-490dce1ef0bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0yLTEtMS01ODQzMA_f97d1b6d-7536-48f7-b38c-9c4c8141457a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0xMC0xLTEtNTg0MzA_e87588fc-be24-43a6-860a-6dbf61ea32ce">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0xNi0xLTEtNTg0MzA_2477821c-3e88-4163-b883-2602c63dc62f">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOC0xMC0xLTEtNTg0MzA_a0b28142-474e-4f1b-b93d-57cc6c43a4a5">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOC0xNi0xLTEtNTg0MzA_2b8ae660-cc21-4f96-a9ee-804e21945dec">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35d6eab9188e4c6ba7d964585d71fe15_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0yLTEtMS01ODQzMA_b4050420-54ca-4844-93f8-97bfb8c439eb">59,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35d6eab9188e4c6ba7d964585d71fe15_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS00LTEtMS01ODQzMA_30d1a0df-7101-406e-acb7-141bbf470525">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS02LTEtMS01ODQzMA_c5e5a11e-2fdb-4156-b917-35dc9c2a23f4">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS04LTEtMS01ODQzMA_6ca8e629-4b39-4fc1-8a73-e00e57404ebf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ed9d20b39a413c9890b8202a0e2d68_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xMC0xLTEtNTg0MzA_a45ed289-3f59-4431-bffa-fbedf0ebf283">553,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf0dcb690e5547d78e784e45c6a81bf8_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xMi0xLTEtNTg0MzA_1bad55aa-059b-44aa-b931-51d33864205c">474,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4406995bd3d645db88eae94e1a61ee22_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xNC0xLTEtNTg0MzA_ae5149e0-9f4b-4d75-9a08-eb565fc0f87a">25,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i597de771574f44ecbf7bdca7363c74a3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xNi0xLTEtNTg0MzA_919ad3b0-32e8-4789-b2a8-da25c903f543">55,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i352fb45f049d4e20be6533e5330bed51_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTAtMTItMS0xLTU4NDMw_685cc4ab-a819-4042-9eea-f9e4a3364b20">63,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTAtMTYtMS0xLTU4NDMw_1b1cd9d0-18df-4268-9d6d-637c8b3f2882">63,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i858c6029c86f470f8ea195b51df7fd90_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTEtMTQtMS0xLTU4NDMw_d6bec324-54df-4414-89ed-83ac287e5fde">1,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTEtMTYtMS0xLTU4NDMw_3e3fd4e4-982f-4935-9943-f81059b49ae5">1,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0235c181696c43e685632d5e23836a0a_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTItMi0xLTEtNTg0MzA_7d615f47-91bb-4f35-981f-c442e8b06e71">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of October 2023 Notes conversion feature</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630" decimals="-3" name="avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTMtMTAtMS0xLTU4NDMw_0ed9ebc4-8da7-4c5e-a688-f90bbd37cf53">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630" decimals="-3" name="avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTMtMTYtMS0xLTU4NDMw_f85bfe12-e9ff-44ab-a100-cf6812e77fa4">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTQtMTAtMS0xLTU4NDMw_5762ca12-2c9a-46ab-b9bc-f5b39d4827f7">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTQtMTYtMS0xLTU4NDMw_81edb6c2-6102-45ce-acf6-cb53627d49d2">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, June 30, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bf80f97883a4000a3b2582adeac9a34_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMi0xLTEtNTg0MzA_0d58c91f-8bc8-491e-a479-a8a055208f01">59,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf80f97883a4000a3b2582adeac9a34_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtNC0xLTEtNTg0MzA_932b0ebc-0f6e-4ea7-a34a-1047ced17d38">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f1c927f07094257b38758d27969490b_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtNi0xLTEtNTg0MzA_901aee4c-523c-4e5e-8f6b-146a974e2b06">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1c927f07094257b38758d27969490b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtOC0xLTEtNTg0MzA_edc335bf-0362-4eb2-8c4a-f13eb5fa6f59">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38e1032982cc4ef596e29fa5bd65b3d9_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTAtMS0xLTU4NDMw_ac5865fb-9e25-4204-b4ae-2045f7880c0c">560,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i406e727d4c7940eab3bce49cfe84a5b4_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTItMS0xLTU4NDMw_e61bd89b-254a-4039-97d2-1490ebbe6c4f">537,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7333adc928c34207b1ae3ea0580e1a34_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTQtMS0xLTU4NDMw_dc28153e-7eee-495a-a778-46d18b7196cb">26,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fde74b73c43497f867e979065e4f089_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTYtMS0xLTU4NDMw_de0a3c1e-3e11-4a84-a6f9-ff7173b44c62">3,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTItMS0xLTU4NDMw_bc8c892a-c6e2-4e49-818f-58efa4357525"><ix:nonFraction unitRef="usd" contextRef="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTItMS0xLTU4NDMw_c815109f-d319-4ac2-916c-880804fd4f61">20,146</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTYtMS0xLTU4NDMw_bb9fdd5d-32dd-48e0-a67d-ce4c854db365">20,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dcd418f53514c1bbf7914a6f2125336_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTctMTQtMS0xLTU4NDMw_1dda69bb-4fa8-43dc-951f-606674e9a060">1,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTctMTYtMS0xLTU4NDMw_c2441024-5a5a-4a13-a42f-a5f421ed38b9">1,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMi0xLTEtNTg0MzA_0394a28d-e4fa-4ded-977a-ff84c06e21d1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMTAtMS0xLTU4NDMw_5917d262-1ccb-4171-8ca1-4e75f1fe7e94">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMTYtMS0xLTU4NDMw_1a078466-4e99-4219-a752-1eb90c01376f">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTktMi0xLTEtNTg0MzA_023b7bd8-ea5a-400e-ba3d-17d8c9bc4788">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTktMTYtMS0xLTU4NDMw_630cf886-5c7f-4496-bdb8-9b073201b1c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under at-the-market offering program, net of issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMi0xLTEtNTk5OTY_498016c8-a20e-4d3e-a977-05fb2f8eda25">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtNC0xLTEtNTk5OTY_68fa9f11-0f2d-40c8-a585-a7fca4497788">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTAtMS0xLTU5OTk2_4bce4ef5-8b89-430f-b77a-e3a59020a404">10,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTYtMS0xLTU5OTk2_1bf7bb6e-ade7-477b-8da3-830d38e96f68">10,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTAtMS0xLTU5OTk2_56634905-0b8e-45a6-bf2c-a11ce35bec9b">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTYtMS0xLTU5OTk2_96f79d6c-a77b-468b-bc1c-2f7c72e6e73d">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMi0xLTEtNTg0MzA_22633752-ff4f-4ad7-9576-c14e0f730251">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNC0xLTEtNTk5OTY_1892ec2b-52b5-44e8-9001-a7b6d74d0253">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTAtMS0xLTU4NDMw_252f8385-1ed4-480a-9e04-604db0ec1c2f">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTYtMS0xLTU4NDMw_293ce521-9879-4f33-b9e2-aa9cf37004c3">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTAtMS0xLTU4NDMw_c226e912-abdb-410c-a518-b689e024d01c">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTYtMS0xLTU4NDMw_043b2387-1bca-45ac-9c18-526c654c8bde">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i052fb6f4421c4d4f9984b955980c6583_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMi0xLTEtNTg0MzA_4b7d8c4e-562b-466a-981e-223683eb3489">60,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052fb6f4421c4d4f9984b955980c6583_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNC0xLTEtNTg0MzA_d3ec25c5-5add-45ba-809b-3c533863263c">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea88b7ed2ea84e5ab764b998327d144e_I20220930" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNi0xLTEtNTg0MzA_ac2df73d-c462-4af6-8721-b4e68f25f8f4">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea88b7ed2ea84e5ab764b998327d144e_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItOC0xLTEtNTg0MzA_6a9375ac-efa4-438f-a46e-0d484a9501a5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a1264cc8b9472daa169711675defb7_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTAtMS0xLTU4NDMw_fb959912-b4de-4d5c-a448-109cad95d8d8">572,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b3f5f57fc524b96b5cfe506a4c5fea0_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTItMS0xLTU4NDMw_902cff71-3692-4f09-b29d-c161483e8fba">557,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83a69202d1114ffc970a48ee40981389_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTQtMS0xLTU4NDMw_6673e493-19f8-421f-a22d-47b9c15e8359">27,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTYtMS0xLTU4NDMw_24fa64f9-7465-4faf-87ae-b3d3a16fc4ec">12,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 7 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217; </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">equity </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34a108c684b944f1949cff98177a2d4d_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0yLTEtMS01ODQzMA_be45cffe-972d-44b3-ba76-1715c5d119d7">58,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34a108c684b944f1949cff98177a2d4d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi00LTEtMS01ODQzMA_c5396975-3a57-4f2d-9008-5221d7377dec">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi02LTEtMS01ODQzMA_15e86e2f-1f96-4cef-8abf-c424ba1bc030">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi04LTEtMS01ODQzMA_f982784e-02d4-4d4a-b24b-47982163a51d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b3fac2f2f8404794c0c0c3cb9dc2b9_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xMC0xLTEtNTg0MzA_0bdc29bd-af22-47a0-ac7a-d555e0088dd7">566,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id39750e42b8c4306aad61fee7e83a5eb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xMi0xLTEtNTg0MzA_f3f57471-133b-4a14-b569-463d8b14fe9e">384,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief0230fccabc48f5a6ef37bc48d526f6_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xNC0xLTEtNTg0MzA_be1758ae-3da1-4b7c-9160-cf5df57689b2">21,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c35d690609413bbeb5dca96b91b6b7_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xNi0xLTEtNTg0MzA_9fd91b1c-7f67-4458-bebd-86f91bcf6c45">162,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0wLTEtMS01ODQzMA_6946dcf2-15ab-4f20-83ee-a51a11cce42f">Impact of the adoption of ASU 2020-06</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52a5be02a4754c908aea2eb24daf8a58_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xMC0xLTEtNTg0MzA_944524d5-e058-4eb0-aa50-290e4d038eb6">26,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2113f33399c94c20b59358750f55db61_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xMi0xLTEtNTg0MzA_6edff9cc-3463-4d42-a08e-826b7672602d">13,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bd8f8d15554ccaa1b7314e61a0bda1_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xNi0xLTEtNTg0MzA_e12156be-c8f7-42ed-be5e-212ac3267cec">12,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1daef32fcaaf4e3198268352bfe614c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNC0xMi0xLTEtNTg0MzA_b83f3e2e-de5b-49df-b0a2-e9e04798613f">13,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNC0xNi0xLTEtNTg0MzA_9249e1e0-6e1b-47ba-8dea-847cbf4aa2aa">13,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5d3b32370a14fc9ac68416910db95b4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNS0xNC0xLTEtNTg0MzA_c4a3518c-426e-46b7-bf84-572181372427">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNS0xNi0xLTEtNTg0MzA_196ed89f-b38f-4e1d-91f4-fd11e70debeb">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0yLTEtMS01ODQzMA_86442aa4-0bff-4cc1-b586-b128d31d1d13">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0xMC0xLTEtNTg0MzA_1f10466f-4d75-4d64-9f94-d5c3fee09a4c">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0xNi0xLTEtNTg0MzA_597f306c-c684-4890-8556-4539253ee0a5">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0yLTEtMS01ODQzMA_3597ace2-97c5-432e-9d78-397cc8057df3">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy00LTEtMS01ODQzMA_34fd7a87-73b0-486c-b41c-7301114afb84">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0xMC0xLTEtNTg0MzA_f199f54a-c8b2-4179-9d87-4b20ef8eb908">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0xNi0xLTEtNTg0MzA_a481e356-cc8c-475a-af7b-4b47e39f3060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0yLTEtMS01ODQzMA_1b36070d-a7ce-4b55-837e-e1d39b74c6ca">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0xMC0xLTEtNTg0MzA_0120d0d5-2a5e-41f5-925a-bea9dbee3a82">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0xNi0xLTEtNTg0MzA_f888cee3-9cb6-489a-af00-2f4263197abb">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOS0xMC0xLTEtNTg0MzA_3ba7e1d0-4c4e-4240-a248-98ca1813c4c9">1,728</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOS0xNi0xLTEtNTg0MzA_dad6b14e-1b98-470c-bd7f-916cddccbea5">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1abc68c06e44c02a69a0e3b81539a1b_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMi0xLTEtNTg0MzA_cd23a916-6105-4f8d-9d20-860314c1c9e0">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1abc68c06e44c02a69a0e3b81539a1b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtNC0xLTEtNTg0MzA_7030058f-46bd-40b2-86a5-316c28dca53b">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i213fec939ca94d28a184d48147f2f980_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtNi0xLTEtNTg0MzA_7c5c5b16-9d4c-47ca-a7ab-c7ec188a9ced">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213fec939ca94d28a184d48147f2f980_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtOC0xLTEtNTg0MzA_11699e07-ba11-4562-942c-b32d27d15a71">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d53876fb534cecadcfeab8814f3dc8_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTAtMS0xLTU4NDMw_1fc3ab27-9e8a-4888-a515-5aa1bc617813">542,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229da85b4f654c07be3b461a8a726d99_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTItMS0xLTU4NDMw_a2f4b0e5-05fc-47b2-9ad8-ed9be0e0d240">383,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58d09c1dffe3407b993cb0bf2c8894ab_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTQtMS0xLTU4NDMw_11cde0d4-7330-417c-9502-506f0b09d55b">22,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1168117551d4a9a8647ed266ee1d21c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTYtMS0xLTU4NDMw_b962ff0f-324d-41da-8c99-5c4f566b55d0">136,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i441ab67fef8d46f69ad115a28d4e47b2_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTEtMTItMS0xLTU4NDMw_06c95d2c-9d59-4d5e-8b71-fb31081dacd5">19,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTEtMTYtMS0xLTU4NDMw_46afd006-32fc-4785-9df1-806b48046ea6">19,581</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4916497bce934c388a6e76aef6e5f8b2_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTItMTQtMS0xLTU4NDMw_ac535442-a9d7-4a73-9856-a9fae5a12d69">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTItMTYtMS0xLTU4NDMw_af09e456-3485-4df6-8778-edf9970a33df">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb5fe8401174459933a0141de1de360_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTMtMTAtMS0xLTU4NDMw_aae81a1c-e520-4e9d-a76e-4596929cc7c7">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTMtMTYtMS0xLTU4NDMw_3bbc1f05-f3dd-4373-a239-5c98c4a5a181">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMi0xLTEtNTg0MzA_a9b878da-ccb4-4db2-809f-c746ed85e5b4">58,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtNC0xLTEtNTg0MzA_06e10c00-dad3-428b-b0e9-1e3944dcd1b5">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f8355061a09422faca4bfc446a9317f_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtNi0xLTEtNTg0MzA_a9691d7d-c7ee-471a-9483-0258bc0bd8ff">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8355061a09422faca4bfc446a9317f_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtOC0xLTEtNTg0MzA_b3cd09a3-7fbc-4196-afe5-4741679b7cf8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a7bb9eb70c43868a690dbac0c7d90c_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTAtMS0xLTU4NDMw_62fb8f1d-fd0f-4c81-ad50-e4a2b7031bf7">544,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id909d7fef83b4684a532a146f36cc21e_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTItMS0xLTU4NDMw_da49a035-eeed-4221-9c4a-5bbd39bcb795">403,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c237b4e52b04e4190505ebcd87c3c0f_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTQtMS0xLTU4NDMw_b4c4178d-9a2a-402a-933c-66f391db0f6a">22,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aab025ab13460f81e69e191c346f26_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTYtMS0xLTU4NDMw_ae1f8741-2911-4ca5-8f99-a803b915ab95">118,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie15da54ef7274b76b422a70b1c736327_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTUtMTItMS0xLTYwMDA3_b9a23a0f-cb79-4a10-a999-da7b16103e86">22,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTUtMTYtMS0xLTYwMDA3_afe2b98f-37d3-4345-ad61-0394bb45fed6">22,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8f0906d79e940ad870b539d8791c365_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTYtMTQtMS0xLTYwMDA3_05e19b65-49fc-4997-bcf8-bfd21de52972">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTYtMTYtMS0xLTYwMDA3_5be4fbdb-6d62-4dd4-8914-528eed7d896e">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMi0xLTEtNjAwMDc_8ba68f61-0f9a-41c3-9b61-fbf3946e008d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctNC0xLTEtNjAwMDc_17977fb8-2ced-46ab-8477-f806bcc2ce5f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMTAtMS0xLTYwMDA3_1c302f0b-06ca-4012-a50f-67c19bcf89e8">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMTYtMS0xLTYwMDA3_afe8cb33-a40c-4456-8166-36d7a2126769">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMi0xLTEtNjAwMDc_015e3a14-2d14-4629-a4af-b0f7abe9d869">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtNC0xLTEtNjAwMDc_b44b0f2f-9a6d-41bd-9a19-aa786a94f401">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMTAtMS0xLTYwMDA3_d326fcec-65f3-4854-8c28-7c46eb1e7b26">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMTYtMS0xLTYwMDA5_11838fbb-40c8-44bf-86ce-6c6d090adcb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMi0xLTEtNjAwMDc_6ee7e0ce-6e6a-4883-8edb-ae075dd61bfe">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMTAtMS0xLTYwMDA3_8067fa11-e7a6-4299-b29e-e0bbb2c3da81">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMTYtMS0xLTYwMDA3_23615bbe-58cb-4e46-a235-593b918cfe9d">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjAtMTAtMS0xLTYwMDA3_f491a711-91f8-44ef-b2c6-a6550e0b5059">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjAtMTYtMS0xLTYwMDA3_94758a9b-3f81-45a3-90c1-8957bfa7da76">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMi0xLTEtNjAwMDc_be952a09-9a56-4ef7-9d4c-425dd94674a1">58,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtNC0xLTEtNjAwMDc_d964e8e4-e0f8-4c05-ba7e-a58d2734c4e1">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35e8617f6b8b4839961ae2d42367307e_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtNi0xLTEtNjAwMDc_a1d26d0c-4b2b-4d65-a611-a4d173fe62c1">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e8617f6b8b4839961ae2d42367307e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtOC0xLTEtNjAwMDc_dddff24e-4324-4626-9cd9-df1356736387">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006e36115c06446280acc29186452555_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTAtMS0xLTYwMDA3_3d346d9d-0a63-4dd2-b04e-9cbe55bcf585">546,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if21be33b2a2f4c259a0dc8988e8c8bbb_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTItMS0xLTYwMDA3_d8bf8487-0279-4c9a-9b0a-43f905105675">425,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTQtMS0xLTYwMDA3_806611d9-01ea-4fa7-8357-70b727cf3320">22,744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407de99cf96a455d8396a71ae495f64b_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTYtMS0xLTYwMDA3_12d3b78d-fd5e-491b-ab81-6ffaa68d11a8">98,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 8 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNC0yLTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293">110,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNC00LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f">55,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNi0yLTEtMS01ODQzMA_e98b5d6f-fb8f-40a9-ad9b-05aaaa6dbc9f">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNi00LTEtMS01ODQzMA_e683d50a-9b46-4611-adbb-3050492f0fa8">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNy0yLTEtMS01ODQzMA_522245e0-ecca-4696-bef0-e414b9182554">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNy00LTEtMS01ODQzMA_0a680d76-6bce-4789-9ad2-8dc98ba8023f">937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in deferred taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOC0yLTEtMS01ODQzMA_ae8a7edb-b20d-4280-9b8b-a8d2371e90f6">25,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOC00LTEtMS01ODQzMA_cd5b57d0-c121-4467-828e-38b99411a90c">11,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOS0yLTEtMS01ODQzMA_7f01498f-6a15-4221-a9d5-8a8359aa7cce">5,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOS00LTEtMS01ODQzMA_7dae11db-a4ea-497c-a66f-f5a2a25873cd">6,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTAtMi0xLTEtNTg0MzA_ea75529c-7d84-4e16-9642-f343f1f05ed2">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTAtNC0xLTEtNTg0MzA_35df11ff-9045-4a56-b554-b28eee7c4114">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTEtMi0xLTEtNTg0MzA_0cb69e76-5be0-4340-85a5-42919202db72">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTEtNC0xLTEtNTg0MzA_3b242792-01c4-4601-87f0-10633252ca97">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net changes in assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTUtMi0xLTEtNTg0MzA_19c4fac0-87c7-4956-9ece-e5731bc2d735">27,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTUtNC0xLTEtNTg0MzA_d984b427-13e6-4d97-b012-43bbc5a27eee">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTYtMi0xLTEtNTg0MzA_a2b2c5a6-c2a3-476e-8171-2f02170516b3">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTYtNC0xLTEtNTg0MzA_9f58230a-116e-4471-b4ed-0efdad1075ab">3,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable &amp; other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTctMi0xLTEtNTg0MzA_19410b53-9332-4fa2-9985-8397b72ce0b0">11,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTctNC0xLTEtNTg0MzA_34b1c1d4-a576-42a8-8a73-0da78e8b1963">201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTgtMi0xLTEtNTg0MzA_28f35528-e4ec-474c-97e0-359aa5837c42">4,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTgtNC0xLTEtNTg0MzA_2af457a4-8ef2-44c9-890b-ead237720d8e">2,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTktMi0xLTEtNTg0MzA_550f410f-947c-4e70-aef0-97aacf1ba770">3,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTktNC0xLTEtNTg0MzA_82780ef0-423b-4cb2-bf3a-875e08532fd9">2,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjAtMi0xLTEtNTg0MzA_8a46fa6b-d2f4-48ef-94bd-944e62310cdf">54,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjAtNC0xLTEtNTg0MzA_19e691d7-280e-468b-b4fd-58e7690fbb64">54,804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjMtMi0xLTEtNTg0MzA_0dd1a518-39b4-4a50-a15d-cfbcbd50631a">716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjMtNC0xLTEtNTg0MzA_ad6d7785-e52b-435b-930f-8518d0af7545">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the disposition of the hospital products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjQtMi0xLTEtNTg0MzA_802167f0-b82f-423b-852a-1d306b520112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjQtNC0xLTEtNTg0MzA_a3929248-ad8f-4c03-8875-7475fbd48c82">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjUtMi0xLTEtNTg0MzA_477bcd30-7a4a-42a4-9bec-1e995a70146d">59,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjUtNC0xLTEtNTg0MzA_6c44c2b3-eada-4924-a0e6-d25c5c2b0bd7">83,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjYtMi0xLTEtNTg0MzA_31fb9460-cfed-4b51-91aa-bec796efd593">2,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjYtNC0xLTEtNTg0MzA_caddb341-58c6-4b8e-865b-c9bf3c5bd886">58,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjctMi0xLTEtNTg0MzA_8e8e4a30-4c1b-4066-9bb0-9c3080be3a35">56,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjctNC0xLTEtNTg0MzA_4b5c651c-bb69-4bd7-8052-eb44f7db470e">41,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzAtMi0xLTEtNTg0MzA_abd131a7-0ffd-42f9-98a2-9c501519c3ad">4,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzAtNC0xLTEtNTg0MzA_32561011-9568-44f4-a850-faa78e6078e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of shares off the at-the-market offering program </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItMi0xLTEtNjE3MTA_d8ca61b5-6f0b-4fd7-a2b7-3ef39fd98ed1">10,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItNC0xLTEtNjI0NTE_4700b936-8d62-4225-b54b-e87c81881aad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from stock option exercises and employee share purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzEtMi0xLTEtNTg0MzA_ea8ae94c-29b5-40c3-8a4d-c0a06710aa42">2,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzEtNC0xLTEtNTg0MzA_94b6118e-32f3-4bb6-a229-2ae2871010fe">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItMi0xLTEtNTg0MzA_0e84e78e-6b51-48eb-9141-a77d6eb5c5e1">7,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItNC0xLTEtNTg0MzA_89812c38-5c24-46c4-be4e-ba298dd5b563">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzQtMi0xLTEtNTg0MzA_06692972-cd04-466d-b65d-f61a63050387">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzQtNC0xLTEtNTg0MzA_3723982e-5bed-4174-b6a1-8597f0d701f5">621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzYtMi0xLTEtNTg0MzA_82ce2b92-360e-4689-943f-44c0061fdda2">10,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzYtNC0xLTEtNTg0MzA_11187b13-3a28-4d7b-9474-9e3cc705f85b">13,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzctMi0xLTEtNTg0MzA_8d58280c-863b-4ba7-a63c-6d7a4947e720">50,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c35d690609413bbeb5dca96b91b6b7_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzctNC0xLTEtNTg0MzA_3c5fc37c-80fa-464a-8118-7d45da6fe2be">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzgtMi0xLTEtNTg0MzA_9bdfae84-c5d9-4be4-a59e-37d4be64cc12">60,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407de99cf96a455d8396a71ae495f64b_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzgtNC0xLTEtNTg0MzA_4a357850-86d0-4468-b525-367404643035">58,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDEtMi0xLTEtNTg0MzA_e93be031-589a-4a7f-9b72-142a6a0dd601">9,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDEtNC0xLTEtNTg0MzA_e4886344-4350-452b-97f3-df9b2ceee03b">6,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes (refund) paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDItMi0xLTEtNTg0MzA_b0d8343b-f7a3-4ec0-a948-68c54d0b6b19">32,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDItNC0xLTEtNTg0MzA_a13e5378-e6dd-4d0d-b88d-901cad5b1528">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 9 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)&#160;</span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_37"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM3OQ_db529e78-04c5-4a76-aa01-56a0188b8a58" continuedAt="i6ad8946eb55e40238cbd6eb12f7f8013" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6ad8946eb55e40238cbd6eb12f7f8013" continuedAt="ic16cc4c8cb474844b0fc33344e2302f5"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="avdl:NatureOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM4NQ_5c185e66-9d4c-44e0-be5b-906a5c766090" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On July 18, 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) granted tentative approval to LUMRYZ for this indication. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. The Company is primarily focused on obtaining final FDA approval of LUMRYZ. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;), which is listed in the FDA&#8217;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book or a court earlier determines that patent is not infringed, invalid or otherwise unenforceable. The FDA&#8217;s tentative approval can be subject to change based on new information that may come to the FDA&#8217;s attention between such time as the tentative approval and potential final approval. The Company cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any commercialized products in its portfolio.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="avdl:LiquidityAndGoingConcernPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzgxNQ_0382b492-b86f-4bfb-b152-16dc282a7baa" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY3MQ_7a9ca94f-76cf-4d45-aebb-37ab8a208178">60,715</ix:nonFraction> of cash and cash equivalents and $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY2Mg_9d528860-536a-467d-9ef8-de265b1ee6b8">45,760</ix:nonFraction> of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#8217;s ability to generate revenue is expected to start following the launch of LUMRYZ, which is dependent, in part, on final approval of LUMRYZ by the FDA. As of September 30, 2022, the Company has $<ix:nonFraction unitRef="usd" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY4MA_f2e536ba-7e6b-4881-9960-c996c77db66f">26,375</ix:nonFraction> aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY4OQ_b2271afc-4d19-4949-ae4f-ffa3d4541698">4.50</ix:nonFraction>% exchangeable senior notes due February 2023 (the &#8220;February 2023 Notes&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY5Ng_5cd36913-c384-48fc-b6e0-ff5db2cad224">117,375</ix:nonFraction>&#160;aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcwNg_72bcc6d2-c028-4869-ade1-5a27357397bb">4.50</ix:nonFraction>% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;) (together, the &#8220;2023 Notes&#8221;). The Company does not currently have sufficient available liquidity to repay the outstanding balance of the October 2023 Notes. These conditions and events raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In response to these conditions and events, the Company is evaluating various financing strategies to obtain sufficient additional liquidity to meet its operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. The potential sources of financing that the Company is evaluating include one or any combination of royalty financing, secured or unsecured debt, convertible debt and equity. In addition, the Company&#8217;s financing strategy could also include refinancing or negotiating new terms for the 2023 Notes. The Company also currently has authorized and available the use of its at-the-market offering program (&#8220;ATM Program&#8221;), described in more detail below, which could provide the Company up to approximately $<ix:nonFraction unitRef="usd" contextRef="ic846f79390da411baf672e11138d8640_I20220930" decimals="-3" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcxMw_94b70368-5295-4e26-9b39-ebaa7050d170">135,000</ix:nonFraction> (as of September 30, 2022), net of commissions, if fully utilized. While the Company has the ability to utilize the ATM Program, it intends to pursue the other financing strategies described above. Based on the Company&#8217;s ability to raise funds through the ATM Program, the Company has determined that it is probable that such proceeds would provide sufficient additional capital to meet the Company&#8217;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. As a result, the Company has concluded that management&#8217;s plans are probable of being achieved to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The sources of financing described above that could be available to the Company and the timing and probability of obtaining sufficient capital depends, in part, on obtaining final FDA approval of LUMRYZ, resolving any legal and regulatory matters that could preclude the Company from launching LUMRYZ and future capital market conditions. If the Company&#8217;s current assumptions regarding timing of potential final approval, the timing of the launch of LUMRYZ or if there are any other changes or differences in our current assumptions that negatively impact our financing strategy, the Company may have to further </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 10 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic16cc4c8cb474844b0fc33344e2302f5" continuedAt="iaf306cf3a3584530b949a66583fe5ac2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reduce expenditures or significantly delay, scale back or discontinue the development or commercialization of LUMRYZ in order to extend its cash resources. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Offering Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 5, 2020, the Company entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an ATM Program under which the Company may offer and sell its American Depositary Shares (&#8220;ADSs&#8221;, and such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to <ix:nonFraction unitRef="number" contextRef="idf727c0cbc0d4d77aecbe73f9e0c4cbb_I20200205" decimals="3" name="avdl:SaleOfStockCommissionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcyMw_b7153947-5e83-48cb-8c41-ddeecc24ed29">3.0</ix:nonFraction>% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $<ix:nonFraction unitRef="usd" contextRef="iaa1afa74539c4902922f142c1210083f_I20200214" decimals="-3" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcyOQ_db3b7f1c-ace8-4cc7-93b1-6f928fee48f1">50,000</ix:nonFraction> of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#8217;s Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Prospectus&#8221;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#8217;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Prospectus&#8221;), in order to allocate up to $<ix:nonFraction unitRef="usd" contextRef="if65bfb99cbf2433ab28b9b155376252c_I20220831" decimals="-3" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzczOA_71b12196-b610-4e16-9192-58bfdc423b45">100,000</ix:nonFraction> in additional ADSs to the ATM Program. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had issued and sold <ix:nonFraction unitRef="shares" contextRef="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930" decimals="-3" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc2OQ_fbfc6a88-8021-4584-abea-d577c8c721f0">1,768</ix:nonFraction> ADSs, resulting in net proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc3Ng_16a10e95-790b-4e2a-951d-e2b5344f7b74">10,532</ix:nonFraction>, pursuant to the 2020 Prospectus. The Company may offer and sell up to an additional $<ix:nonFraction unitRef="usd" contextRef="icf4ca9e79bab4ceda5ce5f8750665f49_I20220930" decimals="-3" name="avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc4NQ_11a0f526-7674-422d-897f-81791202bed8">39,142</ix:nonFraction> of ADSs under the ATM Program that remain available for sale pursuant to the 2020 Prospectus and also up to $<ix:nonFraction unitRef="usd" contextRef="i2b516ef9e5224745a478640fa35c9afe_I20220930" decimals="-3" name="avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc5NA_b6a3cfd7-1ac2-4d16-becf-2513e429aeb7">100,000</ix:nonFraction> of ADSs available for sale under the ATM Program pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM4OA_b8220f98-87db-4e08-b819-7f8b8f2f0601" continuedAt="i7dd8bb1c367242cb812cbbc7d0a91824" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of September&#160;30, 2022, which is derived from the prior year 2021 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on March 16, 2022.</span></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf306cf3a3584530b949a66583fe5ac2"><ix:continuation id="i7dd8bb1c367242cb812cbbc7d0a91824">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzc0OA_323dabbf-2652-4557-be23-87abd59f8d6c" continuedAt="i19c820210c714f7abe1bc7fd3440f39a" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i19c820210c714f7abe1bc7fd3440f39a" continuedAt="i43324ddbac7e460f8be1728f0789d24a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 11 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i43324ddbac7e460f8be1728f0789d24a"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzc1NA_1ad5366e-73ea-431c-a3b1-1283dae6b9ed" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9034e3eea5954251b56209f67d99c46b_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0yLTEtMS01ODQzMA_e48644fa-f1dc-4c0b-bd50-55f3768fa1e3">31,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d21dc155e64f37a446b0e84d4976b3_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC00LTEtMS01ODQzMA_dd99bda9-ca30-4508-8caf-e50d70e006ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9be88a5186547af9bac2db96c0d314c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC02LTEtMS01ODQzMA_9bb7d8a3-299d-4177-9e8d-a9d3a620d4f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5b4e9bf4294ad3855eba74063db7bf_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC04LTEtMS01ODQzMA_278aa762-2a35-4999-b99f-135d005842c9">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1fbf65244d44e5b30d39291b2fee91_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0xMC0xLTEtNTg0MzA_9f202913-bdeb-4bea-8764-e94aa0890359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7732fc52cd52433585e6e3881ca0de58_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0xMi0xLTEtNTg0MzA_d7ae94e9-e929-4c09-a2b6-e723b12ce825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3773002d244c34aea4fe21b68c31f8_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0yLTEtMS01ODQzMA_35c1ec9a-0fec-45ff-9773-9ab683c40fc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a16e746e11428a8a70889cb36973ac_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS00LTEtMS01ODQzMA_5eb0fd40-4fb7-47cb-90fd-573f6598f29c">9,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4659da3e5e6e4b81ac8a8c5d5408d5ed_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS02LTEtMS01ODQzMA_733b48b7-24fa-45e1-b144-1e4e649bff65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3636fc86bf4e418c691cc2e41b6d3e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS04LTEtMS01ODQzMA_0c7aec3d-3318-488e-9e02-5892a5625889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47dcccfa7c50438eb45d7d48956a6b42_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0xMC0xLTEtNTg0MzA_9d236f06-fe53-44ee-ab1c-174e92c068ae">16,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie39a1b6970aa4db987b72e4f7b8b1e55_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0xMi0xLTEtNTg0MzA_9b82ad07-d36f-458d-8271-7ffd758e2de7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3a19c47255496184d2a49062a6a184_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0yLTEtMS01ODQzMA_75788527-bcad-4fe5-bed4-02a28d335f60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if37b82ee9ff1453bb386fd75f1d28653_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi00LTEtMS01ODQzMA_4eb49393-be1a-4ee0-9405-2934ddcf9809">3,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f623a32e9c42a78b39d8b1336e8ed0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi02LTEtMS01ODQzMA_7d65675a-89ff-4711-8e55-b437c2a04051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eadf013ec464baa8c05eace10107933_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi04LTEtMS01ODQzMA_3934feb6-b599-421e-af42-3992936711d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a672b4236141ea87f8252cc44a0803_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0xMC0xLTEtNTg0MzA_6044d4a6-f7dc-462d-b194-89124f990c69">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83b8410c35f458bb9cc1c09bfed7f76_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0xMi0xLTEtNTg0MzA_968c0310-206d-4185-b75a-5d01fc9f2522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead5d1bc954d49df81b5bdb5758886e6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0yLTEtMS01ODQzMA_bf419443-222e-448a-a127-2bfd9ba0370d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabde77903698481883f2e97de186f6c5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy00LTEtMS01ODQzMA_4af04b7a-aa75-4dee-95d3-1ee63c6c4aa5">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1fb3c05c2d4391aac196e02ae0db2d_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy02LTEtMS01ODQzMA_20f67808-9012-485f-9b13-975922511de0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie64cc03ea55a4af785d07e9c36ed47f3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy04LTEtMS01ODQzMA_95973544-3d6a-4fb1-93c0-543396369fd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ba686307084b878761e39792b65749_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0xMC0xLTEtNTg0MzA_5c934bdf-a631-4378-ae8c-c656d7591d10">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c8ac8d5610497498f8d8ff97b74668_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0xMi0xLTEtNTg0MzA_4687cbda-a732-4005-83f7-b33ceb0a4ce0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43f7d3853b624df8b8d498a70765a7d3_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0yLTEtMS01ODQzMA_4aee4237-2f42-4024-a3c8-719bbb12dc56">31,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29b635783cf44814ab114c3ec2777bbc_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC00LTEtMS01ODQzMA_c346d251-f1a0-430f-9972-b8c272f8cce2">14,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33c84835d749403fad63d02da1c19f19_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC02LTEtMS01ODQzMA_52789878-768e-4331-9cb3-321f50b7933c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008389be6902419a89fb4467f69d8cf5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC04LTEtMS01ODQzMA_3777b7b8-b801-48d4-a798-bb059770937e">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc7fd82afc824c2d809f04c9d1209c92_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0xMC0xLTEtNTg0MzA_177a1933-60ef-478c-a195-6ea19e16b022">28,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie24d32544eb3492583f742640967b39f_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0xMi0xLTEtNTg0MzA_1d33094e-9c0d-4ef3-a805-41faeaa84312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended September&#160;30, 2022 and December&#160;31, 2021, respectively, there were no transfers in and out of&#160;Level 3. During the three and nine months ended September&#160;30, 2022 and 2021, respectively, the Company did not recognize any allowances for credit losses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its $<ix:nonFraction unitRef="usd" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzA4NQ_c7b6e8b2-7adc-4540-92da-319612bec1d1">26,375</ix:nonFraction> aggregate principal amount of its February 2023 Notes and its $<ix:nonFraction unitRef="usd" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzIwNQ_b8717319-70a0-4461-ac99-8c76205d83ad">117,375</ix:nonFraction>&#160;aggregate principal amount of its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair values of the February 2023 Notes and the October 2023 Notes at September&#160;30, 2022 are $<ix:nonFraction unitRef="usd" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzYzOA_f592ac45-364d-4ae1-bb4d-146ec1cc53fa">25,584</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzY0NQ_e2063ec6-0e5c-449f-9bc8-5510d49640e8">101,970</ix:nonFraction>, respectively. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the Company&#8217;s debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyMQ_86061546-2a6f-48d7-8c1d-4e32c091980c" continuedAt="iabde9481c5574d22ba188f817edd9c8a" escape="true">Marketable Securities&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iabde9481c5574d22ba188f817edd9c8a" continuedAt="ifa9fdd4cd6674eca9354048c43a3cd50">The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; (deficit) equity, net of income tax effects. As of September&#160;30, 2022, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  </ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 12 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifa9fdd4cd6674eca9354048c43a3cd50" continuedAt="i858c9b9366974c48898c747bf2ec49fe"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNw_e4762f22-85ba-4b62-a7d0-e2b7c0fb244b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;September&#160;30, 2022 and December&#160;31, 2021, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy0yLTEtMS01ODQzMA_5dcbd74b-8179-4aa9-b702-d76f9619d124">32,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy00LTEtMS01ODQzMA_6e37d21c-5ebf-42d2-835b-766bf46a530e">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy02LTEtMS01ODQzMA_d4f33cdf-32b2-423d-ad71-885975fe2393">1,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy04LTEtMS01ODQzMA_09414653-4f48-431e-a831-ad7ed734b9cb">31,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC0yLTEtMS01ODQzMA_a5249c1e-bda6-4b2f-a028-e53d7c6686c9">9,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC00LTEtMS01ODQzMA_0b8adcfb-1787-4772-b817-25ba4af0dc72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC02LTEtMS01ODQzMA_0a8b64ca-27b1-4be1-ad26-f8fb9f1bf1bc">707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC04LTEtMS01ODQzMA_a41ea72d-3b26-4052-a7da-1a95feebae16">9,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS0yLTEtMS01ODQzMA_e5917d5d-7cee-4f01-9268-e0c19e43cfb8">3,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS00LTEtMS01ODQzMA_ba473c94-d458-47c7-96da-604f42fba973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS02LTEtMS01ODQzMA_b78c451b-fa02-46ef-9b7f-4acfda79d29f">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS04LTEtMS01ODQzMA_4c2b4c09-259a-4287-aea4-91b17d973981">3,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi0yLTEtMS01ODQzMA_8c5a22f9-d9e7-4f4c-a590-8dbec01992ce">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi00LTEtMS01ODQzMA_0ffa03dd-61d2-4075-9c8d-04ead0196136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi02LTEtMS01ODQzMA_f557ad00-dbb0-49c3-8189-6f578f0bcbe4">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi04LTEtMS01ODQzMA_8d8d3860-26e5-4860-ba4c-30d57e812bf0">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy0yLTEtMS01ODQzMA_b78135a7-bf9c-4f39-b43b-91a99e1ee2d8">48,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy00LTEtMS01ODQzMA_16a3b001-fd5c-4689-a54c-2534b059ba0d">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy02LTEtMS01ODQzMA_024438dd-38be-4b46-8dd2-5895615f258b">2,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy04LTEtMS01ODQzMA_9f17740c-be75-464e-838f-e072e99e654e">45,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy0yLTEtMS01ODQzMA_407eb824-a75d-46d0-99da-157eefbdcf79">78,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy00LTEtMS01ODQzMA_5dc314c5-d9d6-4f57-80c1-332fa072f239">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy02LTEtMS01ODQzMA_c7c14e1b-6dfb-4cbf-94f2-0cf18e52e192">1,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy04LTEtMS01ODQzMA_38e821a6-1770-40a6-ad58-ec0b7effdc06">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC0yLTEtMS01ODQzMA_fd082326-e471-4511-9403-aa900baa1e8b">16,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC00LTEtMS01ODQzMA_e8c3c791-5dc2-49f3-a7a3-22ea5d68628e">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC02LTEtMS01ODQzMA_7d59fcca-046a-4b61-9fb4-0f0dcf4074c7">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC04LTEtMS01ODQzMA_3ea54996-62d6-4914-b8e5-9c68386a9dad">16,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f88e70592e4720b210f17465179f02_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS0yLTEtMS01ODQzMA_2a9a5cde-be20-4049-88ff-f708f325e311">9,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f88e70592e4720b210f17465179f02_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS00LTEtMS01ODQzMA_624d0180-2f09-4a55-a264-21b594ae2c8e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9f88e70592e4720b210f17465179f02_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS02LTEtMS01ODQzMA_8c57f6a4-7b3f-470e-88c2-1e068ebff926">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f88e70592e4720b210f17465179f02_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS04LTEtMS01ODQzMA_6a02cfe4-df02-4c6c-ae6c-01297255bbbc">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8be616cca445759476d602725c21af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi0yLTEtMS01ODQzMA_017a3f96-0b86-4b11-a79a-d41046af104c">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8be616cca445759476d602725c21af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi00LTEtMS01ODQzMA_67d69f31-5651-41ac-a3da-7f920a161413">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8be616cca445759476d602725c21af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi02LTEtMS01ODQzMA_d639c20e-f703-4ba3-9050-87c4ad15c686">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8be616cca445759476d602725c21af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi04LTEtMS01ODQzMA_67825146-3355-461d-a6c1-f4458b219fb0">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy0yLTEtMS01ODQzMA_b72ba1a3-f866-4249-a970-86c75fd0a653">106,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy00LTEtMS01ODQzMA_e5281349-099d-444a-a55a-5989fb9c95c3">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy02LTEtMS01ODQzMA_64c81456-36a1-4391-8f3e-96a8fc68403b">1,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy04LTEtMS01ODQzMA_c98fe333-d4c6-4d27-b85e-48cc826a75f6">106,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income, net in the accompanying unaudited condensed consolidated statements of loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTA1MA_c6d66a7f-fd62-4df4-be82-6c2fed081414">64</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTA1Nw_18b1f306-05cf-45a1-8714-6968099d3142">22</ix:nonFraction> for the three months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTE2OA_b911a47b-c83f-4f6b-b44e-0b09365024b7">61</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTE3NQ_6bfd57a3-d4ea-4fbc-9e42-d725db5e175c">66</ix:nonFraction> for the three months ended September&#160;30, 2022 and 2021, respectively. We recognized gross realized gains of $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTI2OA_9b79447f-08e3-48f3-90ad-ecc37158bff3">372</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTI3NQ_a67421f8-0819-4529-874f-29cd246f28e6">74</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTM4Mg_c48a859a-c950-4008-b922-fd2bf1bdd9a7">1,092</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTM4OQ_4ed69d6d-5808-4fff-942b-87b50323db78">173</ix:nonFraction> for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNA_114e88e6-c5cc-4fbd-a73b-d13a568ad2a7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy0yLTEtMS01ODQzMA_15032774-41c8-4f40-b458-190246baddf5">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy00LTEtMS01ODQzMA_37cb7797-2345-46c6-af62-faa5dd2e2257">7,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy02LTEtMS01ODQzMA_39629695-5789-4b15-a4c6-af66bd19a505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy04LTEtMS01ODQzMA_5fbded90-2764-4662-8129-0dceb35f06fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy0xMC0xLTEtNTg0MzA_a41ea72d-3b26-4052-a7da-1a95feebae16">9,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC0yLTEtMS01ODQzMA_e7c445df-bfd3-42c0-8934-3775645a9e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC00LTEtMS01ODQzMA_6576d64a-fdf3-4269-8e3f-9cdd07bfdeb4">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC02LTEtMS01ODQzMA_52ee7af0-ca73-4a16-aa21-6945de567087">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC04LTEtMS01ODQzMA_d3a0536c-253f-4503-8f17-2d059ee1c18f">866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC0xMC0xLTEtNTg0MzA_4c2b4c09-259a-4287-aea4-91b17d973981">3,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi0yLTEtMS01ODQzMA_046d39b9-b197-451d-9c82-710aa4ca5412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi00LTEtMS01ODQzMA_dbcc2cef-2525-47b7-a01e-dcc7321a6f2b">1,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi02LTEtMS01ODQzMA_e3eea333-1847-4ebc-9d3c-758c39a52927">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi04LTEtMS01ODQzMA_51f109a6-8741-4735-b7a7-c69e7f7f4f1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi0xMC0xLTEtNTg0MzA_8d8d3860-26e5-4860-ba4c-30d57e812bf0">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a02dd313384743b867f33cd4c52454_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy0yLTEtMS01ODQzMA_0fa25841-088c-4bb7-a108-5a2e674dcae7">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a02dd313384743b867f33cd4c52454_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy00LTEtMS01ODQzMA_86b08b6c-72ed-4c43-878b-73bb090985a1">11,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a02dd313384743b867f33cd4c52454_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy02LTEtMS01ODQzMA_2d80a4eb-90a4-4430-8d83-cdffaf0ae4a9">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a02dd313384743b867f33cd4c52454_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy04LTEtMS01ODQzMA_45f16ed8-d52c-45a9-9584-e9a7bc6f84f1">866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a02dd313384743b867f33cd4c52454_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy0xMC0xLTEtNTg0MzA_d7a54ae6-b84a-4706-a86a-412a8df9274c">14,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable debt securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNQ_603a3198-6ca0-41dd-97a9-b2d47bb58f31" continuedAt="i065f852e25fd421986f6d187279dc809" escape="true">The following table shows the gross unrealized losses and fair value of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2022. The unrealized losses in the table below are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 13 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i858c9b9366974c48898c747bf2ec49fe"><ix:continuation id="i065f852e25fd421986f6d187279dc809"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0yLTEtMS01ODQzMA_dac16de3-2b69-4597-b453-b847592f234a">6,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi00LTEtMS01ODQzMA_08afb0d5-cad7-47bb-8fa7-bb35df246460">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi02LTEtMS01ODQzMA_a857f2bd-1af9-4115-b03d-8871c7478855">2,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi04LTEtMS01ODQzMA_dab9d372-45f3-49b3-a96e-99eccb055cec">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0xMC0xLTEtNTg0MzA_93186a9c-1d4c-47de-b836-c53b18481210">9,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0xMi0xLTEtNTg0MzA_8b8073da-ab32-40c7-a907-8bfa77d2479a">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0yLTEtMS01ODQzMA_dbf9192a-0045-48e8-98e6-c10c3f69924c">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy00LTEtMS01ODQzMA_096bb593-b4c9-4b60-b02d-81743158ea85">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy02LTEtMS01ODQzMA_f77d227e-fe60-467f-b5ef-9ef34d3a95ba">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy04LTEtMS01ODQzMA_7f952f4d-337d-4340-992e-dd88abc8c02a">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0xMC0xLTEtNTg0MzA_321a453e-f5b9-4cb3-9904-e49f3ee1ae7b">3,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0xMi0xLTEtNTg0MzA_7255f266-f0f7-49bf-aaf4-43feb00a6463">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0yLTEtMS01ODQzMA_3c9b2103-46f1-4a45-8f32-c5cfb5d9c396">1,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC00LTEtMS01ODQzMA_e1d2be1b-b171-4c7d-b410-8571c453d851">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC02LTEtMS01ODQzMA_44252b98-0857-43d9-bdb3-b3efc994d446">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC04LTEtMS01ODQzMA_d299dbec-3ec4-4c32-a8d1-570de6078f23">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0xMC0xLTEtNTg0MzA_6be43190-9b96-45fc-82e5-64ca5964d4fa">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0xMi0xLTEtNTg0MzA_1f949a16-be8b-4ae0-875e-80be76261cd3">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0yLTEtMS01ODQzMA_f3bbe709-9589-43ff-b786-18cb54674210">8,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS00LTEtMS01ODQzMA_b1813eb0-f1c9-41a7-bd4e-0aefd4e1c389">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS02LTEtMS01ODQzMA_5d730193-47a2-431b-896f-17a511150255">5,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS04LTEtMS01ODQzMA_5f86da40-47fa-442c-9e34-069e38fddf5e">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0xMC0xLTEtNTg0MzA_4ac11457-215c-4258-a0b1-ab7963119138">14,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0xMi0xLTEtNTg0MzA_01c3b2ae-107c-4ff6-b5ce-a95d2ca44bbb">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzI5ODUzNDg5NTE3Nw_cc54e30c-6aeb-41c4-9b7c-261e86e21749" continuedAt="i83b455ba54dd48a2916bcbc83314e6ae" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i83b455ba54dd48a2916bcbc83314e6ae" continuedAt="ia0a3f61bcef3422d8a4395b1018e9fdd"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTE3NTc_7fa33dab-7972-48ed-9dc2-4b692bd1299a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjYyYmFlZjkyNGU5NzRiOTc4YTVhYTQ2ZWJkYjJiY2VmXzI0_2ac83b69-dff6-4138-bd11-792211db5099"><ix:nonFraction unitRef="number" contextRef="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjYyYmFlZjkyNGU5NzRiOTc4YTVhYTQ2ZWJkYjJiY2VmXzI0_721eb78f-6b08-4a8f-b93b-553289c8aadf">4.50</ix:nonFraction></ix:nonFraction>% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0yLTEtMS01ODQzMA_c7b6e8b2-7adc-4540-92da-319612bec1d1">26,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS00LTEtMS01ODQzMA_645a23a2-755d-4f67-a9f4-8315573db4c6">143,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjUxMjNhZmFkYjJkMDRlOTdhNGM2YjE4OTQzYWJhYTVjXzI0_cd424f4a-e059-4bca-8159-ccfeda0c164e">4.50</ix:nonFraction>% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi0yLTEtMS01ODQzMA_b8717319-70a0-4461-ac99-8c76205d83ad">117,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7728b1ad8844b9c8acb4b0a1e2a5eee_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi00LTEtMS01ODQzMA_fa8210c4-d3a8-4dd9-9ba5-ad40458840c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMy0yLTEtMS01ODQzMA_277c228b-1953-47bc-b2fe-2c4fc286ed02">7,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b46577c09a4108b4d6e3e1474da619_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMy00LTEtMS01ODQzMA_4bd012b5-7c46-4545-bb12-bdbd97958f45">1,353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNC0yLTEtMS01ODQzMA_24cb5f98-4caa-4794-81a5-a39948842c61">136,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b46577c09a4108b4d6e3e1474da619_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNC00LTEtMS01ODQzMA_a69a8314-c8f8-428f-b153-7e6c5c41135a">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjM5ODRjODdiYjc4MzQ4YjE4YzZiMjhiNGQxNjYxNmI2XzM3_de69a0dc-3eea-4ad6-8b2d-03ab4883765a">76</ix:nonFraction> unamortized debt discount and issuance costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy0yLTEtMS01ODQzMA_72712c95-e81a-492d-aac5-a83458c36799">26,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy00LTEtMS01ODQzMA_2c593174-1968-4ec0-b1e7-aaad83929b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfOC0yLTEtMS01ODQzMA_c91c3f9d-f3ab-4a6f-8965-87a248cf0978">109,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfOC00LTEtMS01ODQzMA_57b79fc4-697f-4241-b393-7bea3c3158a8">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMxNw_75f48946-6750-4bef-ae68-61c99797fcab">3,564</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMyNA_22d9482f-92a9-491e-bb1a-fdc9d5397503">1,929</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMzMA_9db84af5-6160-46b9-81ff-49ba4ebf0408">1,646</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMzNQ_cb8bd59c-7164-4aed-b4c8-6301842c3015">1,617</ix:nonFraction> for each period, respectively, and the amortization of debt issuance costs and debt discount, totaling $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM0MA_6a652e19-df69-467a-8478-a88f0f8fbcb0">1,918</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM0NA_80c8d79f-2f47-4073-bc69-993ef4e61f01">312</ix:nonFraction> for each period, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and 2021, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2MA_7b033d9a-e69f-4dea-b0eb-2a77acdf0ebd">9,087</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2NA_1a0e7e3c-1af4-4b0e-b2db-129b6200d714">5,788</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2OA_0e03287d-0e94-4da2-8e83-079440e7a637">4,852</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM3OQ_c053e954-3fdd-499c-97e6-59851eabaced">4,851</ix:nonFraction> for each period, respectively, and the amortization of debt issuance costs and debt discount of $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM4Mw_b25213d3-f2de-4934-9de5-26c30000cec5">4,147</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM4Nw_31f601b0-0e8f-4061-8b3f-c67a52365026">937</ix:nonFraction> for each period, respectively. Current period interest expense also includes $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="avdl:AdditionalInterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM5MQ_857918f7-6d43-42c1-8498-8676c82f9af7">88</ix:nonFraction> of additional interest expense owed to be in compliance with certain terms of the February 2023 Notes indenture and is not applicable to future periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), issued $<ix:nonFraction unitRef="usd" contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTk1_cc9782b5-2809-48a8-9997-3570fbe2e722">125,000</ix:nonFraction> aggregate principal amount of its February 2023 Notes in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a <ix:nonNumeric contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216" name="avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTE3NTY_f1399dac-cdff-4352-b987-b93b75f37a3c">30-day</ix:nonNumeric> option to purchase up to an additional $<ix:nonFraction unitRef="usd" contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216" decimals="-3" name="avdl:DebtInstrumentOptiontoIncreaseFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTMyNA_761eee2d-090f-456f-9290-84ca233fe976">18,750</ix:nonFraction> aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $<ix:nonFraction unitRef="usd" contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTUyMw_d89b9194-d66f-4486-b5b9-c833e6226246">137,560</ix:nonFraction>. The February 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2022, the Issuer completed the exchange of $<ix:nonFraction unitRef="usd" contextRef="i3ad36b5fcb3045a68356e8cc78da6a85_I20220405" decimals="-3" name="avdl:DebtInstrumentExchangeAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTkyNQ_70ab392e-302e-4037-b440-cfc2416644e3">117,375</ix:nonFraction> of its February 2023 Notes for a new series of its October 2023 Notes (the &#8220;Exchange Transaction&#8221;). The remaining $<ix:nonFraction unitRef="usd" contextRef="i6c50635ba7df4b1f8f3cea8c28c4bd5b_I20220405" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE1Mw_2510b2fa-4836-4b1b-87ca-de947afc4a5d">26,375</ix:nonFraction> aggregate principal amount of the February 2023 Notes were not exchanged and maintain a maturity date of February 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $<ix:nonFraction unitRef="usd" contextRef="i700854cc6b274bb6aa14c33e39284fc2_D20220405-20220405" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjM5Mg_cf214829-bfb3-4d7f-ab5e-2f7356b18030">4,804</ix:nonFraction> in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="i8f34651b6e804b898cbacfb584c9a8e9_D20220405-20220405" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjU1MA_9ddba2c5-41cd-48e3-9fd2-60b1884678a2">5,450</ix:nonFraction> in fees to third parties that were expensed as part of the completed Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $<ix:nonFraction unitRef="usd" contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405" decimals="-3" name="avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjczNA_362e546c-0e7b-4526-a5c1-b5149617aa8f"><ix:nonFraction unitRef="usd" contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405" decimals="-3" name="avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjczNA_7a6c379e-4e0f-4746-a003-9cabca02f3bb">5,508</ix:nonFraction></ix:nonFraction>, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $<ix:nonFraction unitRef="usd" contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405" decimals="-3" name="avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjkwNQ_4f0d7ff9-b7ce-45ec-b7cb-9be73aac8550">5,508</ix:nonFraction> are amortized over the remaining term of the October 2023 Notes as a component of interest expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of <ix:nonFraction unitRef="rate" contextRef="ibb4289596c9445e5b6b589951af85b2f_D20180216-20180216" decimals="INF" name="avdl:AmericanDepositorySharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzExMA_b05dade5-1c75-4a07-a584-13c26b2c6ac3">92.6956</ix:nonFraction> ADSs per $1 principal amount of 2023 Notes (so long as the principal amount of such holder&#8217;s 2023 Notes not exchanged is at least $<ix:nonFraction unitRef="usd" contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216" decimals="0" name="avdl:AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzI0Mw_81256930-468a-476a-bbad-e22fa7a3e397">200</ix:nonFraction>), which is equivalent to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216" decimals="2" name="avdl:AmericanDepositarySharesOptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzMxNA_90b1840b-9db7-465d-b06e-934a58360ffb">10.79</ix:nonFraction> per ADS. Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">February 2023 Notes</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 14 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia0a3f61bcef3422d8a4395b1018e9fdd" continuedAt="ie517e47cd6e04ef38e7b489f27fa0144"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the February 2023 Notes may convert their February 2023 Notes, at their option, prior to the close of business on the business day immediately preceding the maturity date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">October 2023 Notes</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the October 2023 Notes may convert their October 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding May 1, 2023, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after May 1, 2023 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzc2Mg_386183ed-95c1-436b-a9e7-e1c14e3bde78">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzgwNw_508bcbe0-6ff0-45f0-850b-ee02e8547ae7">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of October 2023 Notes, as determined following a request by a holder of the October 2023 Notes, for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405" decimals="2" name="avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfODA3Ng_34cad267-f692-4402-be1b-a76cd7d8ef3f">98</ix:nonFraction>% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding May 1, 2023, regardless of whether a holder of the October 2023 Notes has the right to require the Company to repurchase the October 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding May 1, 2023, all or any portion of a holder&#8217;s October 2023 Notes may be surrendered for exchange at any time from or after the date that is <ix:nonFraction unitRef="day" contextRef="i544add4877ba4985a689c57ae1698e30_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfODc3OA_6ebd89a1-e725-4353-a6e1-8e5fba1ae628">95</ix:nonFraction> scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until <ix:nonNumeric contextRef="i544add4877ba4985a689c57ae1698e30_D20220405-20220405" name="avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTAyNg_63cc3ca7-a1c7-4c05-a654-d7742601e1f8">35</ix:nonNumeric> trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least <ix:nonFraction unitRef="day" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTYwNw_34ccec0b-d1d8-4da4-aaba-2fbd396f87a9">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="day" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTY3Mw_556a047c-8aff-4753-a82f-d2bac2205054">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTgyMg_cc773291-7323-4a85-8e99-7baa8f3f154a">130</ix:nonFraction>% of the exchange price on each applicable trading day. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the October 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding May 1, 2023, then a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the October 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the October 2023 Notes may exchange its October 2023 Notes until the redemption price has been paid or duly provided for.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least <ix:nonFraction unitRef="number" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA3OTQ_9f2077b0-a52d-4447-80e2-a1153261b275">130</ix:nonFraction>% of the Exchange Price then in effect for at least <ix:nonFraction unitRef="day" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA4NDc_34ccec0b-d1d8-4da4-aaba-2fbd396f87a9">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA5MDM_556a047c-8aff-4753-a82f-d2bac2205054">30</ix:nonFraction> consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ie517e47cd6e04ef38e7b489f27fa0144" continuedAt="if86ec9b41e8c4df79f309aec8f94d87c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#8217;s ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company has therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if86ec9b41e8c4df79f309aec8f94d87c">, as amended by ASU 2020-06.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 15 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTk1MA_259d5db4-9a0d-4ad9-a876-70ee97268717" continuedAt="ief69cd787f4e457bbc795bd6c45da23c" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ief69cd787f4e457bbc795bd6c45da23c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The income tax provision was $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNTg_dba8bea4-e4a1-4309-a49b-6cdb9c71e061">70</ix:nonFraction> for the three months ended September&#160;30, 2022 resulting in an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTQw_8e90f840-91a5-4ead-aac9-27d58b64b764">0.3</ix:nonFraction>)%. The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTcx_905af191-07a2-4de6-9ee1-ce63a7463c80">5,101</ix:nonFraction> for the three months ended September 30, 2021 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMjUz_da1d2124-392f-409a-bfe2-01032e768710">18.8</ix:nonFraction>%. The change in the effective income tax rate for the three months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the net operating losses during the current period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The income tax provision was $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNTI5_93750112-5f66-4538-b3b9-4c50a03dfee4">25,940</ix:nonFraction> for the nine months ended September&#160;30, 2022 resulting in an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNjA5_5732e4fa-436b-431f-bcf6-9ed5a6bb61de">30.9</ix:nonFraction>)%. The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNjQw_1855921f-1b4c-4c65-94ed-30912df71709">11,473</ix:nonFraction> for the nine months ended September 30, 2021 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNzIw_c17b7b24-4413-4b1a-96e8-cc648b19f481">17.3</ix:nonFraction>%. The change in the effective income tax rate for the nine months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the deferred tax assets during the current period.       </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September&#160;30, 2022, the Company collected all of the outstanding receivables due to the Company related to net operating loss carrybacks under the Coronavirus Aid, Relief, and Economic Security Act for losses incurred during 2019, which were carried back to 2015.</span></div></ix:continuation><div><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTI4_c1aef7a9-20c2-478a-a418-5f6758bfd1f8" continuedAt="i2f2df27d6c2c40528a5e80f407aa8ba8" escape="true">Other Assets and Liabilities&#160;</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2f2df27d6c2c40528a5e80f407aa8ba8" continuedAt="i3153b97358e84e3b841b8945ff5268d2"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTQ4_8321f539-fbb2-42d7-a3e7-93ad9b1217de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMi0yLTEtMS01ODQzMA_cdefd497-627c-4d04-9fdd-6c4b521a6da0">3,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMi00LTEtMS01ODQzMA_3abe7a6a-5ccb-403b-8693-587ce60ed654">3,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMy0yLTEtMS01ODQzMA_bb911296-d581-435b-9d6a-797ee0931e1f">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMy00LTEtMS01ODQzMA_b5dcc6d6-673a-4e1a-842b-3a3b198cb520">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNC0yLTEtMS01ODQzMA_a9cb63bb-66f5-4625-b6dd-a293076096de">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNC00LTEtMS01ODQzMA_cfa8e126-d2b4-4ed5-9b60-ce51106c38ed">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNS0yLTEtMS01ODQzMA_783220f9-bf03-4fe4-a3d2-065c9627ebec">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNS00LTEtMS01ODQzMA_b13d7c2b-d9c8-4451-99e9-147132b1fe6b">29,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNi0yLTEtMS01ODQzMA_494d5626-ce6c-446a-ab08-03245d1ff5de">4,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNi00LTEtMS01ODQzMA_220c0467-f193-420e-81f0-9fbd9cfe1292">32,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTM2_d945acb0-1177-47d4-b3e1-5b6737cb4dd3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMi0yLTEtMS01ODQzMA_f3defa47-6263-4ccd-bfd1-d1a652cd4eaa">10,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMi00LTEtMS01ODQzMA_d35f9973-28d7-4f0e-b5b0-6031ad37008a">8,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMy0yLTEtMS01ODQzMA_4031b9b8-1ec5-4850-aa4b-85b7dbc3b492">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMy00LTEtMS01ODQzMA_31549103-4f0d-4576-a4ba-757b69fe3076">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNC0yLTEtMS01ODQzMA_184af210-dfc9-4a6e-a3d0-841a31833d1b">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNC00LTEtMS01ODQzMA_1438249d-a9af-4121-b524-5a9ee56a49c4">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNS0yLTEtMS01ODQzMA_d7b6b62d-c1d6-45db-bd06-884e762c78b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNS00LTEtMS01ODQzMA_6e627fd6-0aa1-429d-970e-9666868bef90">24,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNi0yLTEtMS01ODQzMA_37a8dc34-8a31-4ea9-a36f-a8fa72682ae8">11,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNi00LTEtMS01ODQzMA_7670056d-989f-4e1f-bfff-24f299440176">33,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTMw_f813fdb8-6ae7-43bb-9e04-98d9d35c80b0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMi0yLTEtMS01ODQzMA_f9a9271c-45b2-4335-8c1e-55ec2526963b">4,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMi00LTEtMS01ODQzMA_10ba45d2-b66a-4461-a6dc-906713aaf208">2,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMy0yLTEtMS01ODQzMA_c397dad1-fe93-4870-8513-a4268f0a49c9">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMy00LTEtMS01ODQzMA_f45c0c19-a0c0-48a7-b5dd-fde04e4c9902">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNC0yLTEtMS01ODQzMA_50780068-28a4-478d-8033-1d1b8ecf1fe0">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNC00LTEtMS01ODQzMA_9c2e92b1-7b18-41b7-b137-4086c055d643">3,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:AccruedOutsourceContractCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNS0yLTEtMS01ODQzMA_5c8ae02a-5826-4092-9ab5-77dd2d70fb3b">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:AccruedOutsourceContractCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNS00LTEtMS01ODQzMA_830558a9-c403-485b-9a72-b2e95735e37f">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:AccruedTradeDiscountsAndRebates" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNi0yLTEtMS01ODQzMA_ccb871b6-c272-4ee2-8168-6871a87d1449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:AccruedTradeDiscountsAndRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNi00LTEtMS01ODQzMA_5b6decb3-b47b-439b-9155-354fa944a440">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNy0yLTEtMS01ODQzMA_8134d770-0dfb-4ce3-9e7f-6bea5690deae">7,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNy00LTEtMS01ODQzMA_4a17971f-3b9a-44a7-9658-ad2e1e137d7f">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 16 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3153b97358e84e3b841b8945ff5268d2"><div style="margin-bottom:1pt"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTM4_afe4734b-0b6a-497a-a35e-a19c2fd8358e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi0yLTEtMS02MTgxNg_8d932ef2-ae27-4841-8adc-ad20c2b5e707">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi00LTEtMS02MTgyNA_6b3f8445-24a0-41ae-ae10-eec548740f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi0yLTEtMS01ODQzMA_2b2d7014-c6b5-4393-9741-aafd09ac32c9">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi00LTEtMS01ODQzMA_cf7acc71-db7c-4f49-9971-5e002824f231">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:AccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMy0yLTEtMS01ODQzMA_2ce198d4-0a1a-42d5-b015-fe2d9cebe9c4">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:AccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMy00LTEtMS01ODQzMA_11c467e0-0bc3-48b8-8e10-54a74551704f">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNC0yLTEtMS01ODQzMA_ec9e6e79-8c48-4aa6-ac61-7e8246cdc41c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNC00LTEtMS01ODQzMA_92ed30ff-f80b-43e4-82e8-2ff0e758f24c">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNS0yLTEtMS01ODQzMA_ade9c414-1092-436b-baf3-da33ec140e01">3,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNS00LTEtMS01ODQzMA_0f7461f0-2964-4eac-bb2b-9e1682720bf7">5,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt"><span><br/></span></div><div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTMy_ae6562a0-10b2-45fb-84aa-1c8581e12b86" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMi0yLTEtMS01ODQzMA_517a08ea-725d-4f06-8768-47133ceb1a54">5,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMi00LTEtMS01ODQzMA_3476dadc-d86d-4c1d-a2c9-026deb9a62b5">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMy0yLTEtMS01ODQzMA_ff2444e0-8727-4717-8cb5-f756e187ad09">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMy00LTEtMS01ODQzMA_527a91e3-17c8-4447-99ff-14bdf16ab24f">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfNC0yLTEtMS01ODQzMA_f5779c93-f6e8-4809-b069-0ff09aac6a46">5,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfNC00LTEtMS01ODQzMA_23f22a0a-c7e2-4936-988b-21cd072676c7">3,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_1093"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njc0_34ceb8a7-34cd-4c45-9a83-76180df058dc" continuedAt="i7a2d1deec4de46a6908bcf7c5e335e22" escape="true">Share Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7a2d1deec4de46a6908bcf7c5e335e22"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Performance-Based Stock Options</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Board of Directors approved the grant of performance-based stock options to certain executive officers and employees. These performance-based stock options vest upon both the achievement of certain commercial milestones and specific service conditions. As of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i95fb7b72db174d1c930b80d69d55059e_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njc2_4431af2d-d03f-4a74-8c16-caa0408f11db">2,165</ix:nonFraction> performance-based stock options were outstanding, none of which had vested. The weighted-average grant date fair value of the performance-based stock options was $<ix:nonFraction unitRef="usdPerShare" contextRef="i95fb7b72db174d1c930b80d69d55059e_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njgz_982d8f7a-e5c9-4e6d-9588-68a5ae8afdf1">3.71</ix:nonFraction>. The Company has not yet recognized any related share-based compensation expense as the commercial milestones have not been met; however, in the event that the performance conditions are met, $<ix:nonFraction unitRef="usd" contextRef="i4bb2365318f346929309ffb2b2636041_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njkw_4e70d7eb-27b8-4dc1-8dc9-c02961f2e7b2">8,032</ix:nonFraction> will be recognized by the Company for the performance-based stock options outstanding as of September&#160;30, 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMjI5OA_592988dd-387a-4a9c-bd39-6b94169279ea" continuedAt="i15896234d56c4a64a177c27444a4178e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i15896234d56c4a64a177c27444a4178e" continuedAt="icb24ae64a5bb41e2ba7e43d87d66a9ea"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s Employee Share Purchase Plan (&#8220;ESPP&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligations under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. The dilutive effect of the performance share unit awards (&#8220;PSUs&#8221;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 17 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icb24ae64a5bb41e2ba7e43d87d66a9ea" continuedAt="ic36f692bfde5447f8b19b38438114afd"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMjMwNQ_94da0300-0ffc-4094-8ad1-ff413d8afb70" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding, in thousands, is as follows:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy0yLTEtMS01ODQzMA_903d5fb5-9beb-4051-b36a-90f776890e42">20,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy00LTEtMS01ODQzMA_19d713e7-4fa4-455d-8759-4d5ff9639e9d">22,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy02LTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293">110,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy04LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f">55,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC0yLTEtMS01ODQzMA_9969ad27-65f0-4216-8687-00dad41775a7">60,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC00LTEtMS01ODQzMA_868aca26-ac2c-4100-9723-4daa35a5bb05">58,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC02LTEtMS01ODQzMA_2ddcffea-e3e7-4dbd-8162-5695c996a7d8">59,359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC04LTEtMS01ODQzMA_35a79509-4891-4fbb-9089-94de062fa2f7">58,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS0yLTEtMS01ODQzMA_51d42b8c-848a-4ef4-a0d0-bf2c3ab0bd2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS00LTEtMS01ODQzMA_84e2859e-5a62-4dcc-9993-5fb3156a96bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS02LTEtMS01ODQzMA_24584410-f7bb-4f73-8adc-ab8630fd2d68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS04LTEtMS01ODQzMA_b9e8c0e0-925e-4d0b-a086-3e2f5d5046d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtMi0xLTEtNTg0MzA_8181d0bf-3708-4af2-a56a-ba79195041b1">60,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtNC0xLTEtNTg0MzA_b140e392-f162-4032-a86f-de62f331eea9">58,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtNi0xLTEtNTg0MzA_0df80f58-b73e-4504-bd30-956093e6d12c">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtOC0xLTEtNTg0MzA_cacfc616-0c21-4ba5-b9de-1332613b09bd">58,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtMi0xLTEtNTg0MzA_8f509a30-11eb-4aca-b5bf-f7308b9ffb2f">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtNC0xLTEtNTg0MzA_ff8bb5b9-1473-4164-b5ef-54c7fb17a758">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtNi0xLTEtNTg0MzA_1af93a8b-5631-467d-b2b3-917f2b375b53">1.85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtOC0xLTEtNTg0MzA_489a082f-b3f2-4956-bd78-29f8ea934ebb">0.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtMi0xLTEtNTg0MzA_3a101310-fe44-4855-9a5e-03b20d6bc3bd">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtNC0xLTEtNTg0MzA_6729ca7e-3683-48b0-8b23-466bd1480934">0.38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtNi0xLTEtNTg0MzA_3a4738f5-732e-4bdc-949d-accfa4be8daa">1.85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtOC0xLTEtNTg0MzA_e69c0b4d-6858-42bd-bc73-db105d8368c8">0.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic36f692bfde5447f8b19b38438114afd">Potential ordinary shares of&#160;<ix:nonFraction unitRef="shares" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTY3Mg_5055dc51-cb83-41b8-ae33-195c084ffa42">18,722</ix:nonFraction>&#160;and&#160;<ix:nonFraction unitRef="shares" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTY3OQ_11558229-625b-44ae-8e54-f2866b90a7e4">15,684</ix:nonFraction>&#160;were excluded from the calculation of weighted average shares for the three months ended September&#160;30, 2022 and 2021, respectively, and potential ordinary shares of <ix:nonFraction unitRef="shares" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTgyOQ_d49b34fb-9cd3-4906-a1de-66d94073fde8">18,925</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTgzNg_79342c7f-30b4-41f2-87cc-778d3ab8493e">15,497</ix:nonFraction> were excluded from the calculation of weighted average shares for the nine months ended September&#160;30, 2022 and 2021 because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and nine months ended September&#160;30, 2022 and 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</ix:continuation>&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RleHRyZWdpb246ZWRmN2FjMDc4ZjA0NDVhZWIwYmNhZTQ0MWM4ZjIxODVfMzkz_2755eb99-266f-4956-b29a-6f2eebd85623" continuedAt="i8c923d2f55b8485ba6aebb357a56fcee" escape="true">Comprehensive Loss&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i8c923d2f55b8485ba6aebb357a56fcee"><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RleHRyZWdpb246ZWRmN2FjMDc4ZjA0NDVhZWIwYmNhZTQ0MWM4ZjIxODVfMzky_1c17a86a-e2c6-4d36-ad8e-4118f8b889cb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and nine months ended September&#160;30, 2022 and 2021, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b395e51b07443339e8545ddcb926fec_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC0yLTEtMS01ODQzMA_f93d18e5-932e-4c7e-9f05-f830265db8a7">24,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6552bf81cec348cba10fdb3ad7a1af92_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC00LTEtMS01ODQzMA_59951ad1-bbac-48e4-b6ad-e79529d7a1eb">23,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68fd68b84e214afeb6ac688372c7b9b2_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC02LTEtMS01ODQzMA_108f45ec-cfee-41f3-bcb7-103af50443fe">23,855</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifef4b6bda88f459a829bd244521b420f_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC04LTEtMS01ODQzMA_362c2f60-d69f-46d6-8e7b-418edbb388a9">22,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfec458cab2647ec9baffeb95d1d2718_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS0yLTEtMS01ODQzMA_1aa8e094-79e2-45cd-8c8b-6ccc67641262">647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa65319a9bbf4a30919b395ad1dce174_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS00LTEtMS01ODQzMA_6780d415-1c73-4a7f-9f7f-e349bedf18b7">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1c144896d5e4e3a83ac70f08d710d09_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS02LTEtMS01ODQzMA_b14ab056-c12f-4654-af08-53944523b901">1,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ffebca8fd84c3e8cfc2a78874bfac7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS04LTEtMS01ODQzMA_dda0a731-1639-4ab1-a9fa-9039a2b55c1e">839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91c2787e79e44ae873764654f563d0c_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi0yLTEtMS01ODQzMA_1621cb09-44b4-48e5-89e5-ad2861775d07">25,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124b04c0e92f4d0fb431541e53c91932_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi00LTEtMS01ODQzMA_71475570-ed55-4ecb-906c-cca22df55ac1">23,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91c2787e79e44ae873764654f563d0c_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi02LTEtMS01ODQzMA_83b15bb8-6500-4144-8e65-2d225be02d55">25,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124b04c0e92f4d0fb431541e53c91932_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi04LTEtMS01ODQzMA_323c7797-ae6e-4ab2-8cc4-dae1ce43e06e">23,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd2203e3e99413c90a5be54a528a206_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS0yLTEtMS01ODQzMA_cfe2fa38-a5d6-4881-bf4d-f69a99d9d77d">1,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d9478444524a59af93cc2f7ef2a1e8_I20210630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS00LTEtMS01ODQzMA_b5f62b40-694d-4d9e-a4d9-c8fe5578e4d1">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida0df7aa69fe43dbb346fad573194ef4_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS02LTEtMS01ODQzMA_3302523a-608f-439a-a072-601bbf97584a">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b75dc6dfac4a31922574bf257cd0d3_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS04LTEtMS01ODQzMA_d284d026-72ca-4b3c-a64a-037eb8121977">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N182Mw_b201427a-793e-4a64-9171-366534267c91">&#8212;</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N182Nw_e39ccbc7-3d58-4131-8d8d-52d768c9f358">59</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N183MQ_1512047c-dacb-4f0b-9a6f-25657ff86c65">&#8212;</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N183OA_c3456c5f-7771-4f1b-ab34-5a7389dfa6c8">220</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd7da939b0f43d5bf4ee7d265fa9078_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMi0xLTEtNTg0MzA_2d90fd4d-5836-435c-bf11-6ff7ebfe6f2c">934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dd2ac44366649d6822cdcb681c75934_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtNC0xLTEtNTg0MzA_e2290844-178c-4913-8ba6-b0c640ea57e1">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i531c84d42a854c188abebdccb7a5cbb9_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtNi0xLTEtNTg0MzA_d64df8bf-89c6-4c2f-905d-b24f99fe9e35">2,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b6e419f0e784181bbd1f69a1ef3e998_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtOC0xLTEtNTg0MzA_c4dbc12b-ad53-48bc-8bdc-1ce51e279254">854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89275b0e02ad490a9cea278805a53efe_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtMi0xLTEtNTg0MzA_0d1b6dac-cda4-41b9-a7b2-24ac15d18ef4">2,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a81c1516d914bc5afcc186a3bb51380_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtNC0xLTEtNTg0MzA_4c7d2803-73cc-45a8-863c-2fb9baa2ab5d">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89275b0e02ad490a9cea278805a53efe_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtNi0xLTEtNTg0MzA_04604483-4f16-438d-b179-ba202fb44237">2,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a81c1516d914bc5afcc186a3bb51380_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtOC0xLTEtNTg0MzA_0e342bc7-a4d9-42c0-8d37-d123258c47a4">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83a69202d1114ffc970a48ee40981389_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItMi0xLTEtNTg0MzA_ec40537c-6833-44c0-a7ca-2e56adc8558d">27,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItNC0xLTEtNTg0MzA_08141a9b-3dff-4a51-83dd-9b78da409bff">22,744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83a69202d1114ffc970a48ee40981389_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItNi0xLTEtNTg0MzA_0850fa76-0f9a-4ef1-83df-20ad7658b17d">27,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItOC0xLTEtNTg0MzA_145fa84c-0cf3-498a-9084-e16383fe99df">22,744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfMTA1Nzc_b9d69d83-e390-41e5-bb4a-9d7882625d6b" continuedAt="if953a593616d4b6eb050945c7c0f5804" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="if953a593616d4b6eb050945c7c0f5804" continuedAt="ia312a648cf8a456c8c14d69988184e2a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to the Company&#8217;s business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At September 30, 2022 and December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 18 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia312a648cf8a456c8c14d69988184e2a" continuedAt="ieb9576c6ec5d4afca2cfd10cf98d37c7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Jazz Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#8220;Avadel CNS&#8221;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel CNS&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#8217; Counterclaims (&#8220;the Jazz First Amended Answer&#8221;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;) de-listed from the Orange Book and seeking to have the motion resolved concurrent with the parties&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#8217; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#8217;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#8217; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was held on October 25, 2022. At the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#8217; request and scheduled the hearing for November 15, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 19 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieb9576c6ec5d4afca2cfd10cf98d37c7" continuedAt="i02cd6fe88b8c40a99707deda4b10e746"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second Jazz Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fourth Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 15, 2022, Jazz filed another formal complaint (the &#8220;Fourth Complaint&#8221;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent from the Orange Book, which is pending in response to the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 21, 2022, Jazz served the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Fourth Avadel Answer&#8221;) with the Court in response to the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) de-listing of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#8220;Sherman Act&#8221;); and v) attempted monopolization under the Sherman Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avadel Complaint</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 20 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i02cd6fe88b8c40a99707deda4b10e746" continuedAt="i5e88941901a04610a2ed34dfbeede278"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#8220;Avadel Plaintiffs&#8221;) filed a formal complaint (the &#8220;Avadel Complaint&#8221;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#8220;Jazz Parties&#8221;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#8217; trade secrets. The Avadel Complaint further includes typical relief requests such as injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#8217; scientists.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#8217; response to that Motion was filed with the Court on July 29, 2022. Jazz&#8217;s reply was filed with the Court on August 5, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administrative Procedure Act</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#8220;Federal Defendants&#8221;) in the United States District Court for the District of Columbia (the &#8220;DC Court&#8221;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#8217;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#8217;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#8217;s unopposed motion to intervene in the case to defend the FDA&#8217;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#8217;s and Jazz&#8217;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#8217;s motion and the Federal Defendants and Jazz&#8217;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent de-listed from the FDA&#8217;s Orange Book described above in the section regarding the First Jazz Complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2021 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield Capital L.P. (&#8220;Deerfield&#8221;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the Company&#8217;s pediatric assets, the Company guaranteed to Deerfield the quarterly royalty payment of&#160;<ix:nonFraction unitRef="number" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="INF" name="avdl:PercentageOfRoyaltyPayableOnNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTQ3Nw_abfdafc8-1daf-4879-94db-a30ae9d98579">15</ix:nonFraction>%&#160;on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i0bb2f5402fe644e0bce0169c6c82e87e_I20220930" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTYxMQ_14d7827a-3737-4d3b-b5e6-bd1a25ad6d5a">10,300</ix:nonFraction>. Given the Company&#8217;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTc3NQ_0a2f26b9-f6e4-4db4-b0cd-1c7a1641cb78">844</ix:nonFraction> at September&#160;30, 2022. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 21 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i5e88941901a04610a2ed34dfbeede278"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, Inc., guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="avdl:GuaranteeAssetCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfMTAyNjc_e5cb90c6-89e7-4c67-b29a-13b2b5caa667">841</ix:nonFraction> at September&#160;30, 2022. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_64"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfODE3_5d82e005-1f3a-4c09-b256-ea96ac345da7" continuedAt="iad26bd722834419488df9469fd8501de" escape="true">Restructuring Costs</ix:nonNumeric></span></div><ix:continuation id="iad26bd722834419488df9469fd8501de"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Corporate Restructuring Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost structure optimization efforts included a nearly <ix:nonFraction unitRef="number" contextRef="i143ad04a470f4af39f1d8a4f532972a0_D20220601-20220831" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfMjk4_59c7c870-1d01-4693-a8f2-488fae3e75c7">50</ix:nonFraction>% reduction in its workforce that was completed at the end of August 2022 (the &#8220;2022 Corporate Restructuring Plan&#8221;). Restructuring income of $<ix:nonFraction unitRef="usd" contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNDIy_351c564b-e649-4795-aef2-38a6439924ff">69</ix:nonFraction> associated with this plan, comprised primarily of adjustments to the estimate of severance related costs, were recorded in the three months ended September&#160;30, 2022. Restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNTQ5NzU1ODE0ODg3_86cc86d2-286c-440a-869e-ec949cac63fe">3,523</ix:nonFraction> associated with this plan, comprised primarily of severance related costs, were recorded in the nine months ended September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfODE5_b32dd8fc-ebff-41cf-98dc-fa993f963da8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.913%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfMi0yLTEtMS01ODQzMA_f3c74531-edaf-4104-bb63-e56eab6f9b7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="avdl:RestructuringChargesExcludingOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfMy0yLTEtMS01ODQzMA_e266a32a-74f1-464d-8cc0-4144719c4d4f">3,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNC0yLTEtMS02MTExNQ_4c2d5db9-6a29-44f5-9141-8d431ec7ad66">2,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" decimals="-3" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNS0yLTEtMS02MTEzMA_2fe1b104-4454-490a-97fe-cb7da7f9f881">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at September 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNC0yLTEtMS01ODQzMA_5cf3361c-6d35-47ee-af86-1db7a5010106">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 Corporate Restructuring Plan liabilities of $<ix:nonFraction unitRef="usd" contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNzE5_5cf3361c-6d35-47ee-af86-1db7a5010106">1,480</ix:nonFraction> are included in the unaudited condensed consolidated balance sheet in accrued expenses at September&#160;30, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12: <ix:nonNumeric contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfMjE1Nw_8599cdcd-084a-4efa-8d6a-f38432ab89be" continuedAt="i2abf34d9f1874ac4ba6f9e7ee2010e94" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2abf34d9f1874ac4ba6f9e7ee2010e94">On November 4, 2022, the Company repurchased $<ix:nonFraction unitRef="usd" contextRef="i92ccb82c6cb44edb9963e6452b789279_I20221104" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfOTM0NTg0ODg0MjUzNg_804be9ff-f45c-400b-82c0-a5b46e3d2cbd">8,875</ix:nonFraction> of its February 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i5643a43d090c46a387889dbf7fcfb224_D20221104-20221104" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfOTM0NTg0ODg0MjU0NA_31034b83-de25-445b-8b2e-9f6ccbaef2a9">8,653</ix:nonFraction> of cash consideration through an open market purchase.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 22 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND&#160;RESULTS OF OPERATIONS&#160;</span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_85"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You should read the discussion and analysis of our financial condition and results of operations set forth in this Item 2 together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties, and reference is made to the &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; set forth immediately following the Table of Contents of this Quarterly Report on Form 10-Q for further information on the forward looking statements herein. In addition, you should read the &#8220;Risk Factors&#8221; section in Part I, Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 16, 2022 and Part II, Item 1A in this Quarterly Report on Form 10-Q for a discussion of additional important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. We are primarily focused on obtaining final United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of LUMRYZ. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of the date of this Quarterly Report, we do not have any commercialized products in our portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LUMRYZ</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LUMRYZ is an investigational once-at-bedtime formulation of sodium oxybate that uses our proprietary drug-delivery technology for the treatment of cataplexy or EDS in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Immediate release sodium oxybate is approved in the U.S. for the treatment of cataplexy or EDS in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as an immediate-release formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 18, 2022, the FDA granted tentative approval to LUMRYZ for the treatment of cataplexy or EDS in adults suffering from narcolepsy. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;), which is listed in the FDA&#8217;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book, a court earlier determines that the REMS Patent is not infringed, invalid or otherwise unenforceable, or a court determines that the FDA erred in requiring certification. The FDA&#8217;s tentative approval can be subject to change based on new information that may come to the FDA&#8217;s attention between such time as the tentative approval and potential final approval. We cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA. In an effort to expedite the time between a potential final approval of LUMYRZ and product availability, we are advancing our preparations for the commercial launch of LUMRYZ, which, assuming final FDA approval in June 2023, is anticipated to occur in the third quarter of 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 23 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to clinical data generated for LUMRYZ, we conducted a Phase 3 clinical trial of LUMRYZ, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients who received at least one dose of LUMRYZ or placebo, and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient and last visit was completed at the end of the first quarter of 2020, and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-at-bedtime LUMRYZ, the highest dose administered in the trial, demonstrated statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test (&#8220;MWT&#8221;), clinical global impression-improvement (&#8220;CGI-I&#8221;), and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-at-bedtime LUMRYZ to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of LUMRYZ discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted LUMRYZ orphan drug designation for the treatment of narcolepsy, which makes LUMRYZ potentially eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several LUMRYZ-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed in our open-label extension (&#8220;OLE&#8221;)/switch study of LUMRYZ as a potential treatment for cataplexy or EDS in patients with narcolepsy (the &#8220;RESTORE study&#8221;). The RESTORE study is examining the long-term safety and maintenance of efficacy of LUMRYZ in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-at-bedtime LUMRYZ, regardless of whether they participated in REST-ON. In May 2021, inclusion criteria were expanded to allow for oxybate na&#239;ve patients to enter the study.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described LUMRYZ improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM sleep to stage N1. LUMRYZ also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1. A second poster described the statistically significant improvements in the Epworth Sleepiness Scale (&#8220;ESS&#8221;), both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at week 3, for the lowest 6 g dose, compared to placebo. LUMRYZ did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the 35th Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 (&#8220;NT1&#8221;) or Type 2 (&#8220;NT2&#8221;). Additionally, a post-hoc analysis showed that LUMRYZ was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. In August 2021, the primary results from the REST-ON trial were published by Kushida et al. in the journal SLEEP. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New data was presented at the American College of Chest Physicians annual meeting (&#8220;CHEST&#8221;), beginning October 17, 2021, including additional post-hoc analyses from the REST-ON trial, demonstrating a greater proportion of patients receiving LUMRYZ experienced reductions in weekly cataplexy attacks and improvement in mean sleep latency compared to placebo, as well as the results of a discrete choice experiment, indicating that the overall driver of patient preference between sodium oxybate treatments is a once-at-bedtime, versus twice-nightly, formulation.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New data was presented at World Sleep 2022 congress, which was held March 11 through 16, 2022 in Rome, Italy. A total of eight posters were presented, including five new post-hoc analyses from the REST-ON trial. Most notably, the post-hoc analyses showed that LUMRYZ demonstrated improvement in subjective measures of daytime sleepiness, sleep quality and refreshing nature of sleep as early as week 1 with the 4.5 g starting dose, with even greater improvement at week 2 soon after starting the 6 g dose compared to placebo. Additional post-hoc analyses, stratified by narcolepsy type, as well as concomitant stimulant use, or without stimulants, demonstrated positive results that are generally consistent with previously reported positive endpoints from REST-ON and add to the existing body of evidence for LUMRYZ.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 24 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the results of a discrete choice experiment (&#8220;DCE&#8221;) were presented, which confirmed that once-at-bedtime dosing, when compared to twice-nightly dosing, was the most important attribute driving both patient and clinician preference for overall oxybate product choice, as well as patient quality of life and reduction of patient anxiety/stress; dosing frequency (twice-nightly versus once-at-bedtime) was also viewed as a more important attribute as compared to other attributes assessed, including sodium content. Accompanying the DCE was a background survey for both patients and clinicians, which showed that dosing frequency was noted as a significant stressor by both patients and clinicians. The World Sleep 2022 presentations also included the first presentation of an interim safety analysis from the ongoing RESTORE study, which showed that LUMRYZ has generally been well-tolerated, with some patients receiving therapy for more than 18 months. No new safety signals have been observed as of October 21, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional peer-reviewed publications have included the improvement on DNS, the first DCE and a Plain Language Summary reviewing sodium oxybate and cardiovascular health, which did not identify a signal of cardiovascular disease in the twenty years that sodium oxybate has been available. At the annual SLEEP Congress in June 2022, nine posters were presented, including five post-hoc analyses from REST-ON of the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analysis showing a low number-needed-to-treat to achieve effectiveness across all three evaluated doses, as well as effect sizes, showing a moderate-to-high effect for improving MWT, ESS, and number of cataplexy attacks; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation via various statistical methods to handle missing data that LUMRYZ improved EDS and cataplexy symptoms versus placebo; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation of benefit for NT1 and NT2 for DNS and ESS; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation of benefit for subgroups taking stimulants and those without stimulants for DNS and ESS; and </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Early efficacy (Week 1 and Week 2) for ESS, refreshing nature of sleep and quality of sleep. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, interim data from RESTORE were presented demonstrating that a high proportion of patients switching from twice-nightly sodium oxybate formulations had difficulty in taking the second dose, with a high proportion (92.5%) stating a preference for the once-at-bedtime dosing regimen and that most participants (62%) switching from twice-nightly sodium oxybate formulations had a stable dose equal to their starting dose; participants not currently taking sodium oxybate formulations or oxybate naive reached a stable dose with 2&#8211;4 dose titrations within 4 weeks. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe LUMRYZ has the potential to demonstrate improved dosing compliance, safety and patient satisfaction over the current standards of care for cataplexy or EDS in patients with narcolepsy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MICROPUMP Drug-Delivery Technology</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MICROPUMP drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which has the potential to improve dosing compliance, reduce toxicity and improve patient compliance. We believe there could be product development opportunities for our MICROPUMP drug-delivery technology, representing either life cycle opportunities, whereby additional intellectual property can be added to a pharmaceutical product to extend the commercial viability of a currently marketed product, or innovative formulation opportunities for new chemical entities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Business Trends and Highlights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In operating our business and monitoring our performance, we consider a number of performance measures, as well as trends affecting our industry as a whole, which include the following:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Healthcare and Regulatory Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Various health care reform laws in the U.S. may impact our ability to successfully commercialize our products and technologies. The success of our commercialization efforts may depend on the extent to which the government health administration authorities, the health insurance funds in the E.U. Member States, private health insurers and other third-party payers in the U.S. will reimburse consumers for the cost of healthcare products and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 25 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competition and Technological Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry continues to be intense and is expected to increase. We compete with other pharmaceutical and biotechnology companies. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our products, product candidates, or drug delivery platforms obsolete or noncompetitive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Pricing Environment for Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The pricing environment continues to be in the political spotlight in the U.S. As a result, the need to obtain and maintain appropriate pricing for pharmaceutical products may become more challenging due to, among other things, the attention being paid to healthcare cost containment and other austerity measures in the U.S. and worldwide.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.53pt">Generics Playing a Larger Role in Healthcare:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Generic pharmaceutical products will continue to play a large role in the U.S. healthcare system. As such, we expect to see generic competition for our products in the future. If LUMRYZ receives final FDA approval, we anticipate LUMRYZ may face competition from manufacturers of generic twice-nightly sodium oxybate formulations, who have reached settlement agreements with the current marketer, which allows for entry of an authorized generic in 2023, or earlier under certain circumstances. For example, Hikma Pharmaceuticals plc is expected to launch an authorized generic version of sodium oxybate in 2023 or earlier, depending on certain circumstances. Beyond the potential of an authorized generic from Hikma Pharmaceuticals plc, there are other potential future competitive products and additional generic twice-nightly sodium oxybate formulations that could impact the marketplace. </span></div><div style="padding-left:33.75pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Access to and Cost of Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have a recent history of generating losses from operations and expect to continue generating losses until we are able to launch LUMRYZ, if final FDA approval is obtained, and generate revenues sufficient to generate positive cash flow from operations. Similar to other businesses in our industry and at our stage of development, we will continue to rely on external sources of capital to fund our business. The process of raising capital and associated cost of such capital for a company of our financial profile can be difficult and potentially expensive. If the need were to arise to raise additional capital, access to that capital may be difficult, expensive and/or dilutive and, as a result, could create liquidity challenges for us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Net Loss from Operations in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We do not have any commercialized products in our portfolio. We will incur substantial expenses to further the clinical development of and continue our preparations for the commercial launch of LUMRYZ, which, assuming final FDA approval in June 2023, is anticipated to occur in the third quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, we have seen the profound impact that the coronavirus (&#8220;COVID-19&#8221;) pandemic is having on human health, the global economy and society at large. We have continued to actively monitor the COVID-19 pandemic, as well as new variants of the virus and recent increases in case numbers, and have taken measures to mitigate the potential impacts to our employees and business, such as continuing to offer a work from home policy. We believe the ongoing impact of COVID-19 and measures to prevent its spread could impact our business in a number of ways, including: i) possibly delaying our ongoing RESTORE study; ii) disruptions to our supply chain and third parties; iii) allowing our employees to work from home for an extended period of time; and iv) hindering sales efforts for LUMRYZ, if final FDA approval is obtained. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition. Despite vaccination efforts, future developments and impact on our operations remain uncertain and cannot be predicted with confidence, including the duration of the COVID-19 pandemic, new variants of the virus, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or we, may direct, which may result in extending continued business disruptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Corporate Restructuring Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we announced a plan to optimize our cost structure to reduce total quarterly cash operating expenses to between $12,000 and $14,000, excluding inventory purchases. The targeted reduction in cash operating expenses, together with cash, cash equivalents and marketable securities currently on hand, is expected to extend our cash runway to the middle of 2023 and the FDA&#8217;s decision regarding final approval of LUMRYZ, which could occur in June 2023 or possibly sooner. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost structure optimization efforts included a nearly 50% reduction in our workforce (the &#8220;2022 Corporate Restructuring Plan&#8221;). See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11: Restructuring Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 26 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering Program</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 5, 2020, we entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program (&#8220;ATM Program&#8221;) under which we may offer and sell our American Depositary Shares (&#8220;ADSs&#8221;, and such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as our sales agent. We agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with our Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Prospectus&#8221;). In August 2022, we filed an additional prospectus, dated September 12, 2022, included with our new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Prospectus&#8221;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, we had issued and sold 1,768 ADSs, resulting in net proceeds to us of approximately $10,532, pursuant to the 2020 Prospectus. We may offer and sell up to an additional $39,142 of ADSs under the ATM Program that remain available for sale pursuant to the 2020 Prospectus and also up to $100,000 of ADSs available for sale under the ATM Program pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Highlights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlights of our consolidated results for the three and nine months ended September&#160;30, 2022 are as follows:&#160;</span></div><div><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Operating loss was $16,960 and $75,523 for the three and nine months ended September&#160;30, 2022, respectively, compared to operating loss of $25,663 and $62,410 for the three and nine months ended September&#160;30, 2021, respectively. Selling, general and administrative expenses increased during the nine months ended September 30, 2022 by $10,066, driven by the increased legal and compensation spend of approximately $7,400 and $2,800, respectively, as well as approximately $5,450 of debt issuance costs as part of the exchange of $117,375 of our 4.50% exchangeable senior notes due February 2023 (the &#8220;February 2023 Notes&#8221;) for a new series of 4.50% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;, together with the February 2023 Notes, the &#8220;2023 Notes&#8221;) (the &#8220;Exchange Transaction&#8221;), offset by lower commercial spend. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss was $20,146 and $110,014 for the three and nine months ended September&#160;30, 2022, respectively, compared to net loss of $22,002 and $55,028 in the same periods last year, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted net loss per share was $0.33 and $1.85 for the three and nine months ended September&#160;30, 2022, respectively, compared to diluted net loss per share of $0.38 and $0.94 in the same period last year, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash and marketable securities decreased $50,746 to $106,475 at September&#160;30, 2022, from $157,221 at December&#160;31, 2021. The decrease in cash during the nine months ended September 30, 2022 was driven primarily by net cash used in operating activities of $54,938, which included $9,660 of interest payments, approximately $5,450 of fees paid to third parties that were expensed as part of the completed Exchange Transaction and approximately $4,800 of insurance premiums. The decrease in cash was also due to the payment of approximately $4,800 in fees to note holders of the October 2023 Notes that are amortized as interest expense over the remaining term of the October 2023 Notes. The uses of cash described above were offset by the receipt of approximately $32,323 of tax refund claims associated with the carry-back of 2019 losses and net proceeds of $10,532 from the sale and issuance of ADSs under the ATM Program.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. To prepare these financial statements, management makes estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosures of contingent assets and liabilities. Actual results could be significantly different from these estimates.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note 1 of the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021 Form 10-K&#8221;). The SEC suggests companies provide additional disclosure on those accounting policies considered most critical. The SEC considers an accounting policy to be critical if it is important to our financial condition and results of operations and requires significant judgments and estimates on the part of management in its application. Our estimates are often based on complex judgments, probabilities and assumptions that management believes to be reasonable, but that are inherently uncertain and unpredictable. It is also possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 27 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of alternative estimated amounts. For a complete discussion of our critical accounting policies, see the &#8220;Critical Accounting Policies&#8221; section of the Management&#8217;s Discussion &amp; Analysis in our 2021 Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts) for the&#160;three&#160;months ended&#160;September&#160;30, 2022&#160;and&#160;2021, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,960)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,076)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,146)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,002)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts) for the&#160;nine&#160;months ended&#160;September&#160;30, 2022&#160;and&#160;2021, respectively:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(529)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring expense (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,747.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,523)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,410)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,113)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,087)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,299)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,074)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,501)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (benefit) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,014)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,028)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,986)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.91)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 28 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased&#160;$1,447&#160;or&#160;33.0%&#160;during the&#160;three&#160;months ended&#160;September&#160;30, 2022&#160;as compared to the same period in the prior year. This decrease was driven by lower research and development production costs during the current period of approximately $1,100 and lower compensation related costs of approximately $400 due to decreased headcount as a result of employees affected by the 2022 Corporate Restructuring Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased&#160;$529&#160;or&#160;3.5%&#160;during the&#160;nine&#160;months ended&#160;September&#160;30, 2022&#160;as compared to the same period in the prior year. This decrease was driven by lower research and development production costs during the current period of approximately $1,300 and share-based compensation costs of approximately $400, partially offset by higher API purchases of $1,200, the majority of which were purchased in the three months ended March 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses decreased&#160;$7,187&#160;or&#160;33.8%&#160;during the&#160;three&#160;months ended&#160;September&#160;30, 2022&#160;as compared to the same period in the prior year, driven by lower marketing and market access activities of approximately $5,400, lower compensation costs of approximately $1,400, lower medical affairs activities of approximately $1,000, and lower consulting fees of $600. These costs were partially offset by higher legal costs of approximately $1,200.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased&#160;$10,066&#160;or&#160;21.2%&#160;during the&#160;nine&#160;months ended&#160;September&#160;30, 2022&#160;as compared to the same period in the prior year, driven by higher legal costs of approximately $7,400, debt issuance costs of approximately $5,450 related to the Exchange Transaction, higher compensation costs of $2,800, and higher public relationship activities of $1,100. The increase in selling, general and administrative expense was offset by lower marketing and market access activities of approximately $3,500, lower medical affairs activities of $1,700, and lower other consulting fees of $1,600. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restructuring Expense (Income)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring expense (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,747.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring expense (income) increased $3,576 or 6,747.2% during the&#160;nine&#160;months ended&#160;September&#160;30, 2022&#160;as compared to the same period in the prior year, driven by the 2022 Corporate Restructuring Plan, which was announced in June 2022. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11: Restructuring Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investment and Other Income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 29 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income, net decreased $1,028 or 67.1% during the nine months ended September&#160;30, 2022 as compared to the same period in the prior year. This decrease was driven by higher net realized losses on our marketable securities of approximately $400 and less interest received on our marketable securities of approximately $800 in comparison to the prior period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $1,635 or 84.8% during the three months ended September&#160;30, 2022 as compared to the same period in the prior year. Interest expense increased by approximately $900 due to non-cash amortization of the $5,500 of debt discount related to the change in the fair value of the conversion feature of the October 2023 Notes. In addition, interest expense increased by $700 due to non-cash amortization of the $4,800 of debt issuance fees paid to note holders that participated in the Exchange Transaction in April 2022. These fees are amortized over the life of the October 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $3,299 or 57.0% during the nine months ended September&#160;30, 2022 as compared to the same period in the prior year. Interest expense increased by approximately $1,800 due to non-cash amortization of the $5,500 of debt discount related to the change in the fair value of the conversion feature of the October 2023 Notes. In addition, interest expense increased by $1,400 due to amortization of the $4,800 of debt issuance fees paid to note holders that participated in the Exchange Transaction in April 2022. These fees are amortized over the life of the October 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Tax Provision (Benefit):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision was $70 for the three months ended September&#160;30, 2022 resulting in an effective tax rate of (0.3)%. The income tax benefit was $5,101 for the three months ended September&#160;30, 2021 resulting in an effective tax rate of 18.8%. The change in the effective tax rate for the three months ended September&#160;30, 2022 is primarily due to the valuation allowances that were recorded against the net operating losses generated during the period.     </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Tax Provision (Benefit):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision was $25,940 for the nine months ended September&#160;30, 2022 resulting in an effective tax rate of (30.9)%. The income tax benefit was $11,473 for the nine months ended September&#160;30, 2021 resulting in an effective tax rate of 17.3%. The change in the effective tax rate for the nine months ended September&#160;30, 2022 is primarily driven by the valuation allowances recorded against our deferred tax assets during the period.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 30 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from operating, investing and financing activities, as reflected in the unaudited condensed consolidated statements of cash flows, are summarized in the following table:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,911.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $54,938 and $54,804 for the nine months ended September&#160;30, 2022 and 2021, respectively. Net cash used in operating activities for the nine months ended September&#160;30, 2022 was driven by net loss of $110,014, partially offset by favorable non-cash adjustments of $37,562 and favorable changes in working capital of $17,514. For the nine months ended September&#160;30, 2021, net cash used in operating activities was driven by net loss of $55,028, unfavorable change in non-cash adjustments of $2,793, and favorable changes in working capital of $3,017. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The September&#160;30, 2022 net favorable change in working capital was driven by the receipt of $32,323 of refund claims associated with the carryback of 2019 losses during the nine months ended September 30, 2022, of which $3,265 is an overpayment that will be repaid to the Internal Revenue Service. This was offset by the timing of payments made related to our accounts payable and accrual balances. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $56,823 and $41,609 for the nine months ended September&#160;30, 2022 and 2021, respectively. Net cash provided by investing activities for the nine months ended September&#160;30, 2022 was due to net proceeds received from the excess of sales over purchases of marketable securities of $57,539. Net cash provided by investing activities for the nine months ended September&#160;30, 2021 was driven by proceeds from the disposition of the hospital products of $16,500, as well as net proceeds received from the excess of sales over purchases of marketable securities of $25,135.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the nine months ended September&#160;30, 2022 was $7,921, driven by the sale of ADSs through the ATM Program, resulting in net proceeds to us of approximately $10,532, and by $2,192 of proceeds from stock option exercises and employee share purchase plan (&#8220;ESPP&#8221;) issuances, offset by the payment of $4,803 of debt issuance fees associated with the Exchange Transaction. Net cash provided by financing activities for the nine months ended September&#160;30, 2021 of $263 related to proceeds from stock option exercises and ESPP issuances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adequacy of our cash resources depends on the outcome of certain business conditions including the cost of our LUMRYZ clinical development, commercial launch plans and the FDA&#8217;s decision regarding final approval of LUMRYZ, our cost structure, and other factors set forth in &#8220;Risk Factors&#8221; within Part I, Item 1A of our Annual Report on Form 10-K filed with the SEC on March 16, 2022. To complete the LUMRYZ clinical development and commercial launch plans we will need to commit substantial resources, which could result in future losses or otherwise limit our opportunities or affect our ability to operate our business. Our assumptions concerning the outcome of certain business conditions may prove to be wrong or other factors may adversely affect our business, and as a result we could exhaust or significantly decrease our available cash and marketable securities balances which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business. Additionally, we are unable to estimate the near- or long-term impacts of COVID-19 and inflation, which may have a material adverse impact on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we announced a plan to optimize our cost structure to reduce total quarterly cash operating expenses to between $12,000 and $14,000, excluding inventory purchases. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 31 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q and approximately $60,715 of cash and cash equivalents and $45,760 of marketable securities available for use to fund our operations, debt service and capital requirements. Our ability to generate revenue is expected to start following the launch of LUMRYZ, which is dependent, in part, on final approval of LUMRYZ by the FDA. As of September 30, 2022, we have $26,375 aggregate principal amount of the February 2023 Notes and $117,375&#160;aggregate principal amount of the October 2023 Notes. We do not currently have sufficient available liquidity to repay the outstanding balance of the October 2023 Notes. These conditions and events raise substantial doubt about our ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In response to these conditions and events, we are evaluating various financing strategies to obtain sufficient additional liquidity to meet its operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. The potential sources of financing that we are evaluating include one or any combination of royalty financing, secured or unsecured debt, convertible debt and equity. In addition, our financing strategy could also include refinancing or negotiating new terms for the 2023 Notes. We also currently have authorized and available the use of our ATM Program, described in more detail below, which could provide us up to approximately $135,000 (as of September 30, 2022), net of commissions, if fully utilized. While we have the ability to utilize the ATM Program, we intend to pursue the other financing strategies described above. Based on our ability to raise funds through the ATM Program, we have determined that it is probable that such proceeds would provide sufficient additional capital to meet our operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. As a result, we have concluded that that management&#8217;s plans are probable of being achieved to alleviate the substantial doubt about our ability to continue as a going concern.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The sources of financing described above that could be available to us and the timing and probability of obtaining sufficient capital depends, in part, on obtaining final FDA approval of LUMRYZ, resolving any legal and regulatory matters that could preclude us from launching LUMRYZ and future capital market conditions. If our current assumptions regarding timing of potential final approval, the timing of the launch of LUMRYZ or if there are any other changes or differences in our current assumptions that negatively impact our financing strategy, we may have to further reduce expenditures or significantly delay, scale back or discontinue the development or commercialization of LUMRYZ in order to extend our cash resources. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Offering Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September 30, 2022, we had issued and sold 1,768 ADSs, resulting in net proceeds to us of approximately $10,532, pursuant to the 2020 Prospectus. We may offer and sell up to an additional $39,142 of ADSs under the ATM Program that remain available for sale pursuant to the 2020 Prospectus and also up to $100,000 of ADSs available for sale under the ATM Program pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. We accrue for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At September&#160;30, 2022 and December&#160;31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on our consolidated financial position, results of operations, cash flows or liquidity. For information regarding legal proceedings we are involved in, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10: Commitments and Contingencies - Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_103"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to interest rate risk as a result of our portfolio of marketable securities. The primary objectives of our investment policy are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and competitive yield. Although our investments are subject to market risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or certain types of investment. Our investment policy allows us to maintain a portfolio of cash equivalents and marketable </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 32 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities in a variety of instruments, including U.S. federal government and federal agency securities, European Government bonds, corporate bonds or commercial paper issued by U.S. or European corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, tax-exempt obligations of states, agencies, and municipalities in the U.S and Europe, and equities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 50 basis point change in interest rates would not result in a material decrease or increase in the fair value of our securities due to the general short-term nature of our investment portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Foreign Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange risk as the functional currency financial statements of a non-U.S. subsidiary is translated to U.S. dollars. The assets and liabilities of this non-U.S. subsidiary having a functional currency other than the U.S. dollar is translated into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average exchange rate for the reporting period for revenue and expense accounts. The cumulative foreign currency translation adjustment is recorded as a component of accumulated other comprehensive loss in shareholders&#8217; (deficit) equity. The reported results of this non-U.S. subsidiary will be influenced by their translation into U.S. dollars by currency movements against the U.S. dollar. Our primary currency translation exposure is related to one subsidiary that has functional currencies denominated in euro. A 10% strengthening/weakening in the rates used to translate the results of our non-U.S. subsidiaries that have functional currencies denominated in euro as of September&#160;30, 2022 would have had an immaterial impact on net loss for the three and nine months ended September&#160;30, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactional exposure arises where transactions occur in currencies other than the functional currency. Transactions in foreign currencies are recorded at the exchange rate prevailing at the date of the transaction. The resulting monetary assets and liabilities are translated into the appropriate functional currency at exchange rates prevailing at the balance sheet date and the resulting gains and losses are reported in investment and other income, net in the condensed consolidated statements of loss. As of September&#160;30, 2022, our primary exposure is to transaction risk related to euro net monetary assets and liabilities held by subsidiaries with a U.S. dollar functional currency. Realized and unrealized foreign exchange gains and losses resulting from transactional exposure were immaterial for the three and nine months ended September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Inflation Risk</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inflation generally affects us by increasing our costs of labor and supplies and the costs of our third parties we rely on for the development, manufacture and supply of our product candidates. We do not believe that inflation had a material effect on our business, financial condition or results of operations during the three and nine months ended September&#160;30, 2022. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, we may experience some effect in the near future (especially if inflation rates continue to rise) due to an impact on the costs to conduct clinical trials, the costs to prepare for the potential commercialization of LUMRYZ, labor costs we incur to attract and retain qualified personnel, and other operational costs. Inflationary costs could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_106"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of September&#160;30, 2022, the end of the period covered by this Quarterly Report on Form 10-Q.&#160;The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.&#160;Based on their evaluation, as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were effective as of September&#160;30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weakness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Remediation of Previously Reported Material Weakness</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 33 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously described in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, management had identified a material weakness in the Company&#8217;s internal controls over financial reporting specifically related to its February 2023 Notes indenture. The Company is committed to maintaining a strong internal control environment and implemented measures in the first quarter of 2022 to remediate the control deficiency contributing to the material weakness. Specifically, management implemented a remediation plan that included:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adoption of additional control procedures surrounding timely and periodic evaluation of all terms of the Company&#8217;s debt agreements and the associated calculation of interest expense in accordance with the terms of any such debt agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A review of all Company contractual and debt agreements for potential terms or tentative conditions that could impact the calculation of interest expense similar to those terms underlying the control deficiency alongside the Exchange Transaction on April 5, 2022, noting none.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes these additional internal controls and procedures will ensure the completeness and accuracy of the calculation and timely payment of interest expense, classification of debt and compliance with terms of the Company&#8217;s debt agreements.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management evaluated the design and operational effectiveness of the remediation activities and concluded that there is sufficient evidence that the previously reported material weakness pertaining to the February 2023 Notes indenture had been remediated as of June 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Changes in Internal Controls</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rule 13a-15 or 15d-15 that occurred during the three months ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_109"></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_112"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10: Commitments and Contingencies - Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Company&#8217;s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth below, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 16, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Lead Product Candidate, Future Product Candidates Clinical Development and Commercialization</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We cannot be certain that our lead product candidate or future product candidates will receive marketing approval. Without marketing approval, we will not be able to commercialize our lead product candidate or future product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have devoted significant financial resources and business efforts to the development of our lead product candidate. We cannot be certain that our lead product candidate or future product candidates will receive marketing approval.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The development of a product candidate and issues relating to its approval and marketing are subject to extensive regulation by the FDA in the U.S. and by comparable regulatory authorities in other countries. We are not permitted to market our lead product candidate or future product candidates in the U.S. until we receive approval of an NDA by the FDA. The time required to obtain approval by the FDA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 34 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An NDA must include extensive preclinical and clinical data and supporting information to establish the product candidate&#8217;s safety and effectiveness for each desired indication. An NDA must also include significant information regarding the chemistry, manufacturing and controls for the product. Obtaining approval of an NDA is a lengthy, expensive and uncertain process, and we may not be successful in obtaining approval. For example, we submitted an NDA to the FDA for LUMRYZ, also known as FT218, for the treatment of cataplexy or EDS in adults with narcolepsy to the FDA in December 2020 through the Section 505(b)(2) regulatory pathway. In February 2021, the FDA assigned LUMRYZ a PDUFA target action date of October 15, 2021. In October 2021, the FDA notified us that its review was still ongoing and action would not be taken by the PDUFA date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 24, 2022, we were notified by the FDA that the LUMRYZ NDA patent statement pertaining to the REMS Patent was deemed inappropriate. As such, the FDA requested the Company add a certification to the REMS Patent to its NDA. On June 29, 2022, we announced that we had submitted a Paragraph IV patent certification pertaining to the REMS Patent to LUMRYZ&#8217;s NDA. On July 15, 2022, Jazz filed a patent infringement suit in the U.S. District of Delaware asserting that LUMRYZ will infringe at least one claim of that patent. The filing of that lawsuit triggers a regulatory stay on FDA approval of LUMRYZ. On July 18, 2022, we received tentative approval from the FDA for LUMRYZ for the treatment of cataplexy or EDS in adults suffering from narcolepsy. As such, we anticipate a decision regarding the final approval of LUMRYZ from the FDA on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book or a court earlier determines the patent is not infringed, invalid or otherwise unenforceable. Our receipt of tentative approval does not mean we will receive final FDA approval for the LUMRYZ NDA in a timely manner or at all. In addition, a drug product that is granted tentative approval, like LUMRYZ, may be subject to additional review before final approval. The FDA&#8217;s tentative approval of LUMRYZ was based on information available to the FDA at the time of the tentative approval letter (i.e., information in the application and the status of current good manufacturing practices of the facilities used in the manufacturing and testing of the drug product) and is therefore subject to change on the basis of new information that may come to the FDA&#8217;s attention. We cannot legally market LUMRYZ in the U.S. until we obtain final approval from the FDA. Any delay or setback in obtaining final approval or the commercialization of our lead product candidate will adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The FDA has substantial discretion in the drug approval process, including the ability to delay, limit or deny approval of a product candidate for many reasons. For example, the FDA:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;could determine that we cannot rely on the Section 505(b)(2) regulatory pathway or other pathways we have selected, as applicable, for our product candidate;</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;could determine that the information provided by us was inadequate, contained clinical deficiencies or otherwise failed to demonstrate the safety and effectiveness of our product candidate for any indication;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may not find the data from bioequivalence studies and/or clinical trials sufficient to support the submission of an NDA or to obtain marketing approval in the U.S., including any findings that the clinical and other benefits of our product candidate outweigh their safety risks;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may disagree with our trial design or our interpretation of data from preclinical studies, bioequivalence studies and/or clinical trials, or may change the requirements for approval even after it has reviewed and commented on the design for our trials;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may determine that we have identified the wrong listed drug or drugs or that approval of our Section 505(b)(2) application for our product candidate is blocked by patent or non-patent exclusivity of the listed drug or drugs or of other previously approved drugs with the same conditions of approval as our product candidate, as applicable;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may identify deficiencies in the manufacturing processes or facilities of third-party manufacturers with which we enter into agreements for the manufacturing of our product candidate;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may audit some or all of our clinical research study sites to determine the integrity of our data and may reject any or all of such data;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may approve our lead product candidate for fewer or more limited indications than we request, or may grant approval contingent on the performance of costly post-approval clinical trials;</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may change its approval policies or adopt new regulations; or</span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;may not approve the labeling claims that we believe are necessary or desirable for the successful commercialization of our lead product candidate. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 35 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if a product is approved, the FDA may limit the indications for which the product may be marketed, require extensive warnings on the product labeling and/or require expensive and time-consuming clinical trials and/or reporting as conditions of approval. Regulators of other countries and jurisdictions have their own procedures for the approval of product candidates with which we must comply prior to marketing in those countries or jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have submitted an NDA for LUMRYZ in the U.S. and will evaluate filing potentially elsewhere. We have determined, following FDA consultation, that the 505(b)(2) approval pathway, which permits an NDA applicant to rely on the FDA&#8217;s previous findings of safety or effectiveness and data from studies that were not conducted by or for the applicant and for which the applicant has not obtained a right of reference, is the appropriate pathway for a LUMRYZ NDA. There can be no assurances, however, that the 505(b)(2) approval pathway in the U.S., or similar approval pathways outside of the U.S., will be available for our product candidate or that the FDA or other regulatory authorities will approve our product candidate through an application based on such pathways.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Obtaining regulatory approval for marketing of a product candidate in one country does not ensure that we will be able to obtain regulatory approval in any other country. In addition, delays in approvals or rejections of marketing applications in the U.S. or other countries may be based upon many factors, including regulatory requests for additional analyses, reports, data, preclinical studies and clinical trials, regulatory questions regarding different interpretations of data and results, changes in regulatory policy during the period of product development and the emergence of new information regarding our product candidate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Financial Position and Capital Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Uncertainties relating to our ability to procure additional debt, equity or other financing prior to the maturity of our outstanding exchangeable senior notes raises substantial doubt about our ability to continue as a going concern. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September 30, 2022, we had an accumulated shareholders&#8217; deficit of approximately $12.4 million and approximately $60.7 million of cash and cash equivalents and $45.8 million of marketable securities available for use to fund our operations and capital requirements. Within twelve months of the date of this Quarterly Report, our interest and principal payments of $143.8 million aggregate principal amount of our outstanding exchangeable senior notes will fall due. Consequently, absent further actions by the Company, these matters raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements in this Quarterly Report on Form 10-Q are issued.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have a recent history of generating losses and negative cash flows from operations. Our ability to generate revenue is expected to start following the launch of LUMRYZ, which is dependent, in part, on final approval of LUMRYZ by the FDA. Our unaudited financial statements have been prepared under the assumption that we will continue as a going concern for the next twelve months. Our ability to continue as a going concern is dependent upon our ability to obtain additional debt, equity or other financing or otherwise address the upcoming maturities of our outstanding exchangeable senior notes. If we are not able to resolve the going concern prior to the issuance of our financial statements for the fiscal year ending December 31, 2022, the reaction of investors to the inclusion of a going concern statement by our auditors, and our potential inability to continue as a going concern in future years could materially adversely affect our share price and our ability to raise new capital or enter into strategic alliances. Furthermore, we also could be required to seek funds through arrangements with collaborative partners or otherwise that may require us to relinquish rights to some of our intellectual property or product candidates or otherwise agree to terms unfavorable to us.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Regulation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We will need to obtain regulatory approval of any proposed product names for our product candidates, and any failure or delay associated with such approval may adversely impact our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any name we intend to use for our product candidates will require approval from the FDA or other regulatory authorities in jurisdictions where we may seek approval regardless of whether we have secured a trademark registration from the USPTO or similar protection in other jurisdictions. The FDA and other regulatory authorities each typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. The FDA or other regulatory authorities in jurisdictions where we may seek approval may object to any product name we submit if it believes the name inappropriately implies medical claims. If the FDA or other regulatory authorities in jurisdictions where we may seek approval objects to any of our proposed product names, we may be required to adopt an alternative name for our product candidates. There is no guarantee that we will be able to use the same proprietary name for our product candidates in each jurisdiction where we market our products, if approved. If we adopt an alternative name, we would lose the benefit of any existing trademark applications for such product candidate and may be required to expend significant additional resources in an effort to identify a suitable product name that would qualify under applicable trademark laws, not infringe the existing rights of third </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 36 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">parties and be acceptable to the FDA or other regulatory authorities. The FDA has tentatively accepted our proprietary name for our lead product candidate, LUMRYZ. Final acceptance of a proposed proprietary name occurs as part of the final approval of the drug product. We may be unable to build a successful brand identity for a new proprietary name or trademark in a timely manner or at all, which would limit our ability to commercialize our product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Reliance on Third Parties</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commercialization of LUMRYZ, if granted final approval by the FDA, will require us to expand our organization and we may experience difficulties in managing this growth, which could disrupt our operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of our reduction in workforce, which was announced in June 2022, we expect to employ approximately 35 full-time employees. If LUMRYZ is finally approved by the FDA, we expect to expand our full-time employee base to advance the commercialization of LUMRYZ. Our management may need to divert a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product candidates. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to recognize and/or grow revenues could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize LUMRYZ, if finally approved, and compete effectively will depend, in part, on our ability to effectively manage any future growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our competitors develop and market technologies or products that are safer, more effective or less costly than ours, or obtain regulatory approval and market such products before we do, our commercial opportunity may be diminished or eliminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry is intense and is expected to increase. We compete with other pharmaceutical and biotechnology companies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The introduction of new products in the U.S. market that compete with, or otherwise disrupt the market for, LUMRYZ, if finally approved, would adversely affect sales of our product candidate. For example, in the future, we expect LUMRYZ to face competition from manufacturers of generic twice-nightly sodium oxybate formulations who have reached settlement agreements with the current brand product marketer. Hikma Pharmaceuticals is expected to launch an authorized generic version of twice-nightly sodium oxybate in 2023 or earlier, depending on certain circumstances. There are other potential future competitive products that could impact the marketplace who have reached settlement agreements with the current brand product marketer, which allows for entry of other authorized generics in 2023 and other generic products in 2026, or earlier for both under certain circumstances. Beyond generics, there are other potential future competitive products that could impact the narcolepsy treatment marketplace.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA approves a competitor&#8217;s application for a product candidate before our application for a similar product candidate, and grants such competitor a period of exclusivity, the FDA may take the position that it cannot approve our 505(b)(2) application for a similar product candidate until the exclusivity period expires. Additionally, even if our 505(b)(2) application for a product candidate is approved first, and we receive a period of statutory marketing exclusivity, we may still be subject to competition from other companies with approved products or approved 505(b)(2) NDAs for different conditions of use that would not be restricted by a grant of exclusivity to us.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors have substantially greater financial, technological, manufacturing, marketing, managerial and research and development resources and experience than we do. Furthermore, acquisitions of competing companies by large pharmaceutical companies could enhance our competitors&#8217; resources. Accordingly, our competitors may be able to develop, obtain regulatory approval and gain market share for their products more rapidly than us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our cost structure optimization efforts, including a reduction in workforce, announced in June 2022, may not result in anticipated savings, could result in total costs and expenses that are greater than expected and could disrupt our business.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 37 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we announced a reduction in workforce of nearly 50 percent in connection with cost structure optimization efforts. We may not realize, in full or in part, the anticipated benefits and cost savings from our cost structure optimization efforts due to unforeseen difficulties, delays or unexpected costs. If we are unable to realize the expected operational efficiencies and cost savings from the restructuring, our operating results and financial condition would be adversely affected. We also cannot guarantee that we will not have to undertake additional workforce reductions or restructuring activities in the future. Furthermore, our cost structure optimization efforts may be disruptive to our operations. For example, our workforce reductions could yield unanticipated consequences, such as attrition beyond planned staff reductions, increased difficulties in our day-to-day operations and reduced employee morale. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we need to take further restructuring actions, necessary third-party consents may not be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we announced our cost structure optimization efforts to reduce our quarterly cash operating expenses through a reduction in workforce of nearly 50 percent. We had previously carried out a workforce reduction in February 2019. Our management may determine we need to take further restructuring actions to achieve additional cost savings, to generate additional capital needed for our business strategy, or for other purposes. Certain restructuring scenarios that management consider could require obtaining the consent of third parties, such as holders of our Exchangeable Senior Notes due February 2023 (the &#8220;February 2023 Notes&#8221;). For example, the voluntary bankruptcy filing by Avadel Specialty Pharmaceuticals LLC (&#8220;Specialty Pharma&#8221;) in February 2019 required the consent of holders of a majority in principal amount of our February 2023 Notes in order to avoid a default under the Indenture governing such February 2023 Notes. While we were successful in obtaining that consent, there can be no assurance we will be successful in obtaining additional consents in the future from such holders or from other third parties whose consents may be required. Failure to obtain these third-party consents would prevent us from taking additional restructuring actions, which could have a material adverse effect on our cash flow, financial resources and ability to successfully pursue our business strategy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Intellectual Property</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">An NDA submitted under Section 505(b)(2) subjects us to the risk that we may be subject to a patent infringement lawsuit that would delay or prevent the review or approval of our product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The LUMRYZ NDA was submitted under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;). Section 505(b)(2) permits the submission of an NDA where at least some of the information required for approval comes from preclinical studies or clinical trials that were not conducted by, or for, the applicant and for which the applicant has not obtained a right of reference. A 505(b)(2) NDA enables the applicant to reference published literature for which the applicant does not have a right of reference and the FDA&#8217;s previous findings of safety and effectiveness for a previously approved drug.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For 505(b)(2) NDAs, the patent certification and related provisions of the Hatch-Waxman Amendments apply. Accordingly, if the applicant relies for approval on the safety or effectiveness information for a previously approved drug, referred to as a listed drug, the applicant is required to include patent certifications in its 505(b)(2) NDA regarding any applicable patents covering the listed drug. If there are applicable patents listed in the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, for the listed drug, and the applicant seeks to obtain approval prior to the expiration of one or more of those patents, the applicant is required to submit a Paragraph IV certification indicating their belief that the relevant patents are invalid or unenforceable or will not be infringed by the manufacture, use or sale of the product that is the subject of the 505(b)(2) application. Otherwise, the 505(b)(2) NDA cannot be approved by the FDA until the expiration of any patents listed in the Orange Book for the listed drug. On May 24, 2022, we were notified by the FDA that the LUMRYZ NDA patent statement pertaining to the REMS Patent was deemed inappropriate. On June 29, 2022, we announced that we had submitted a Paragraph IV certification pertaining to the REMS Patent to LUMRYZ&#8217;s NDA. On July 15, 2022, Jazz filed a patent infringement suit in the U.S. District of Delaware asserting that LUMRYZ will infringe at least one claim of that patent. The filing of that lawsuit triggers a regulatory stay on final FDA approval of LUMRYZ. As such, we anticipate the FDA&#8217;s decision regarding final approval on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book or a court earlier determines the patent is not infringed, invalid or otherwise unenforceable. There can be no assurance that we will not be required to submit a Paragraph IV certification in respect of any future product candidates for which we seek approval under Section 505(b)(2).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following any Paragraph IV certification that may be required, an applicant will be required to provide notice of that certification to the NDA holder and patent owner. Under the Hatch-Waxman Amendments, the patent owner may file a patent infringement lawsuit after receiving such notice. If a patent infringement lawsuit is filed within 45 days of the patent owner&#8217;s or NDA holder&#8217;s receipt of notice (whichever is later), a one-time, automatic stay of the FDA&#8217;s ability to approve the 505(b)(2) NDA is triggered, which typically extends for 30 months unless patent litigation is resolved in favor of the Paragraph IV filer or the patent expires before that time. Accordingly, we may invest a significant amount of time and expense in the development of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 38 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">one or more product candidates only to be subject to significant delay and patent litigation before such product candidates may be commercialized, if at all.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, a 505(b)(2) NDA will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the listed drug, or for any other drug with the same protected conditions of approval as our product, has expired. The FDA also may require us to perform one or more additional clinical trials or measurements to support the change from the listed drug, which could be time consuming and could substantially delay our achievement of regulatory approval. The FDA also may reject any future 505(b)(2) NDAs and require us to submit traditional NDAs under Section 505(b)(1), which would require extensive data to establish safety and effectiveness of the product for the proposed use and could cause delay and additional costs. In addition, the FDA could reject any future 505(b)(2) application and require us to submit a Section 505(b)(1) NDA or a Section 505(j) ANDA if, before the submission of our 505(b)(2) application, the FDA approves an application for a product that is pharmaceutically equivalent to ours and determines that our product is inappropriate for review through the 505(b)(2) pathway. These factors, among others, may limit our ability to commercialize our product candidates successfully. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">General Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Our business is affected by macroeconomic conditions, including rising inflation, interest rates and supply chain constraints.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:107%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Various macroeconomic factors could adversely affect our business and the results of our operations and financial condition, including changes in inflation, interest rates and overall economic conditions and uncertainties such as those resulting from the current and future conditions in the global financial markets. Recent supply chain constraints have led to higher inflation, which if sustained could have a negative impact on the Company's product candidate development, commercialization preparations for LUMYRZ (if approved) and operations. If inflation or other factors were to significantly increase our business costs, our ability to develop our current pipeline and new therapeutic products may be negatively affected. Interest rates, the liquidity of the credit markets and the volatility of the capital markets could also affect the operation of our business and our ability to raise capital on favorable terms, or at all, in order to fund our operations. Similarly, these macroeconomic factors could affect the ability of our third-party suppliers and manufacturers to manufacture clinical trial materials for our product candidates and the potential commercial launch of LUMRYZ.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 39 -</span></div></div></div><div id="ib6974235a8bb456c8a9779e6f98b5b6d_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#8225;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-divisemployment.htm">First Amendment to Employment Agreement, dated as of September 28, 2022, between Avadel Management Corporation and Gregory J. Divis</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#8225;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-mchughemploymen.htm">First Amendment to Employment Agreement, dated as of September 28, 2022, between Avadel Management Corporation and Thomas S. McHugh</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#8225;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-kimemploymentag.htm">First Amendment to Employment Agreement, dated as of September 28, 2022, between Avadel Management Corporation and Richard Kim</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q32022.htm">Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q32022.htm">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q32022.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q32022.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) </span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Furnished herewith.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8225;&#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVADEL PHARMACEUTICALS PLC</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 40 -</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-divisemployment.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idafb91e3dd614e11afb7a99deef43e58_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FIRST AMENDMENT TO EMPLOYMENT AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This First Amendment to Employment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made effective as of September 28, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between Avadel Management Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Gregory J. Divis (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WITNESSETH</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive are parties to an Amended Employment Agreement dated as of June 3, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive wish to amend certain provisions of the Employment Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Executive is entering into this Amendment for good and valuable consideration set forth herein as well as in consideration and as a condition of his continued employment with the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Employment Agreement.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual agreements and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 3.2(i) of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) severance pay in an amount equal to 1.5 times the Executive&#8217;s then-current annual base salary, which shall be paid in substantially equal installments in accordance with the Company&#8217;s normal payroll practices&#59; provided that, solely to the extent such severance pay is exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and does not constitute &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, the Company may, in its sole discretion, elect to pay such amount in a lump sum within 60 days following the date of termination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The last sentence of Section 3.2 of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Severance Indemnity (to the extent payable in installments) shall be paid in substantially equal installments in accordance with the Company&#8217;s payroll practice over 18 months commencing within 60 days after the date of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the 60-day period begins in one calendar year and ends in a second calendar year, the Severance Amount, to the extent it qualifies as &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the date of termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 4 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.RESTRICTIVE COVENANTS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.044%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:15.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the fullest extent permitted under applicable law, at all times during the Executive&#8217;s employment by the Company and for a period of five (5) years after termination of the Executive&#8217;s employment with the Company, the Executive (i) shall hold in strictest confidence all Restricted Information (as hereinafter defined), (ii) shall not directly or indirectly use, copy, disclose or otherwise distribute any Restricted Information, except for the benefit of a member of the Avadel Group of Companies to the extent necessary to perform his obligations to Avadel plc and the Company under this Agreement, and (iii) shall not disclose any Restricted Information to any person, firm, corporation or other entity without written authorization of the Chief Executive Officer or Board of Directors of Avadel plc.  Any breach of any provision of this Section 4.1(a) shall be considered a material breach of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:12.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As used in this Section 4, the following terms shall have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information (as hereinafter defined) and any Trade Secrets (as hereinafter defined).</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any information of or about any member of the Avadel Group of Companies, and any of the employees, customers and&#47;or suppliers of any member of the Avadel Group of Companies, which is not generally known outside of the Avadel Group of Companies, which the Executive obtains (whether before, on or after the date of this Agreement) in connection with the Executive&#8217;s employment with the Company, and which may be useful to any competitor of the Avadel Group of Companies or the disclosure of which would be damaging to any member of the Avadel Group of Companies.  Confidential Information includes, but is not limited to, any and all of the following information about any member of the Avadel Group of Companies&#58; (A) information about products, product candidates, and research and development plans, activities and results (including information about planned and in-process clinical trials)&#59; (B) information about business and employment policies, marketing methods and the targets of those methods, finances, business plans, promotional materials and price lists&#59; (C) the manner or terms upon which products or services are obtained from suppliers or on which products or services are provided to customers&#59; (D) without duplication of item (A) above, the nature, origin, composition, performance and development of any products or services&#59; (E) information about finances, financial condition, results of operations and prospects&#59; and (F) information about employees, consultants or customers or suppliers.  For the avoidance of doubt, Confidential Information shall not include information that (1) is or has been made generally available to the public through the disclosure thereof in a manner that was authorized by the Company and did not violate any common law or contractual right of the applicable party&#59; (2) is or becomes generally available to the public other than as a result of a disclosure by the Executive in violation of the provisions hereof&#59; or (3) was already in the possession of the Executive without an obligation of confidentiality prior to the date his employment with the Company began.</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trade Secret</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information to the extent such information constitutes a trade secret under applicable law.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Certain Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the foregoing, the Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a Trade Secret that (i) is made (A) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney, and (B) solely for purposes of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding filed in a lawsuit or other proceeding, if such filing is made under seal.  If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the Trade Secret to the Executive&#8217;s attorney and use the Trade Secret in the court proceeding, if the Executive (i) files any document containing the Trade Secret under seal and (ii) does not disclose the Trade Secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Invention Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Executive will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by the Executive (alone or jointly with others) or under the Executive&#8217;s direction during the period of the Executive&#8217;s employment.  The Executive acknowledges that all work performed by him is on a &#8220;work for hire&#8221; basis, and the Executive hereby does assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all his right, title and interest in all Developments that (a) relate to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed, manufactured or sold by the Avadel Group of Companies or which may be used with such products or services&#59; or (b) result from tasks assigned to him by the Avadel Group of Companies&#59; or (c) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Avadel Group of Companies (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company-Related Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  For the avoidance of doubt, this Section 4.2 applies to the Executive&#8217;s entire service relationship with the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:13.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">To preclude any possible uncertainty, the Executive has set forth on Exhibit A attached hereto a complete list of Developments that the Executive has, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of his employment with the Company that he considers to be his property or the property of third parties and that he wishes to have excluded from the scope of this Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If disclosure of any such Prior Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that he is not to list such Prior Inventions in Exhibit A but is only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason.  The Executive has also listed on Exhibit A all patents and patent applications in which he is named as an inventor, other than those which have been assigned to the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Patent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If no such disclosure is attached, the Executive represents that there are no Prior Inventions or Other Patent Rights.  If, in the course of the Executive&#8217;s employment with the Company, he incorporates a Prior Invention into a Company product, process or machine or other work done for the Avadel Group of Companies, the Executive hereby grants to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.  Notwithstanding the foregoing, the Executive will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company&#8217;s prior written consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">This Agreement does not obligate the Executive to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on the Executive&#8217;s own time and does not relate to the business efforts or research and development efforts in which, during the period of his employment, the Avadel Group of Companies actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the Avadel Group of Companies.  However, the Executive will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion.  The Executive understands that to the extent this Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 4.2 will be interpreted not to apply to any invention that a court rules and&#47;or the Company agrees falls within such classes.  The Executive also hereby waives all claims to any moral rights or other special rights which the Executive may have or accrue in any Company-Related Developments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to protect Confidential Information and goodwill, during the Executive&#8217;s employment with the Company and for a period of one (1) year after the termination of the Executive&#8217;s employment with the Company for any reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, anywhere in the United States or in any other country in which the Avadel Group of Companies does business, engage or otherwise participate in any business that develops, manufactures or markets any products, or performs any services, that are competitive with the products or services of the Avadel Group of Companies, or products or services that the Avadel Group of Companies or its affiliates, has under development or that are the subject of active planning at any time during the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Non-Solicitation of Employees and Contractors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit or attempt to solicit any employee, consultant or other contractor of or service provider to any member of the Avadel Group of Companies with whom the Executive had Material Contact to perform services for the Executive or for any other business or entity, whether as an executive, consultant, partner or participant in any such business or entity, or to terminate or lessen any such employee&#8217;s, consultant&#8217;s or other contractor&#8217;s service with any member of the Avadel Group of Companies.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means contact in person, by telephone, or by paper or electronic correspondence in furtherance of the business of any member of the Avadel Group of Companies.  This Section 4.4 shall cease to be applicable to any activity of the Executive from and after such time as all members of the Avadel </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Solicitation of Customers and Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit any actual or prospective customers or suppliers of any member of the Avadel Group of Companies with whom the Executive had Material Contact, for the purpose of selling any products or services which compete with the business of any member of the Avadel Group of Companies. This Section 4.5 shall cease to be applicable to any activity of the Executive from and after such time as all members of the Avadel Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive agrees that it would be difficult to measure any damages caused to the Company that might result from any breach by the Executive of any portion of Sections 4.1 through 4.5, and that in any event money damages would be an inadequate remedy for any such breach.  Accordingly, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of Section 4.1 through 4.5, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach without showing or proving any actual damage to the Company and without the posting of a bond.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Agreement, the Company and the Executive hereby acknowledge and agree that&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  Nothing in this Agreement shall prohibit the Executive from reporting possible violations of Federal, State or other law or regulations to, or filing a charge or other complaint with, any governmental agency or entity, including but not limited to the Department of Justice, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, Congress, and any Inspector General, or making any other disclosures that are protected under any whistleblower provisions of Federal, State or other law or regulation or assisting in any such investigation or proceeding.</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  Nothing herein limits the Executive&#8217;s ability to communicate with any such governmental agency or entity or otherwise participate in any such investigation or proceeding that may be conducted by any such governmental agency or entity, including providing documents or other information, without notice to the Company. </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)  The Executive does not need the prior authorization of the Company to make any such reports or disclosures, and the Executive is not required to notify the Company that the Executive made any such reports or disclosures or is assisting in any such investigation.  </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)  The Executive (A) does not waive any rights to any individual monetary recovery or other awards in connection with reporting any such information to any such governmental agency or entity, (B) does not breach any confidentiality or other provision hereunder in connection with any such reporting or disclosures, and (C) will not be prohibited from receiving any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">amounts hereunder as the result of making any such reports or disclosures or assisting with any such investigation or proceeding.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">All other provisions of the Employment Agreement shall remain in full force and effect according to their respective terms, and nothing contained herein shall be deemed a waiver of any right or abrogation of any obligation otherwise existing under the Employment Agreement except to the extent specifically provided for herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding the place where this Amendment may be executed by any of the parties hereto, the parties expressly agree that all of the terms and provisions hereof shall be construed in accordance with and governed by the laws of the State of Missouri, without giving effect to the principles of choice or conflicts of laws thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures on this Amendment may be conveyed by facsimile or other electronic transmission and shall be binding upon the parties so transmitting their signatures. Counterparts with original signatures shall be provided to the other parties following the applicable facsimile or other electronic transmission&#59; provided, that failure to provide the original counterpart shall have no effect on the validity or the binding nature of this Amendment.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><div id="idafb91e3dd614e11afb7a99deef43e58_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the Amendment Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">THE COMPANY</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AVADEL MANAGEMENT CORPORATION</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Angela Woods &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  Angela Woods</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;   Vice President</font></div><div style="padding-left:175.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;    THE EXECUTIVE</font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Gregory J. Divis                              &#160;&#160;&#160;&#160;    </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     Gregory J. Divis</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Avadel Management Corporation</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From&#58;&#160;&#160;&#160;&#160;EMPLOYEE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  _____________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SUBJECT&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior Inventions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No inventions or improvements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional sheets attached</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a list of all patents and patent applications in which I have been named as an inventor&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;None</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-mchughemploymen.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4fe0eeb4eaff433b98f26f29665233a7_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FIRST AMENDMENT TO EMPLOYMENT AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This First Amendment to Employment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made effective as of September 28, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between Avadel Management Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Thomas S. McHugh (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WITNESSETH</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive are parties to an Employment Agreement dated as of May 15, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive wish to amend certain provisions of the Employment Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Executive is entering into this Amendment for good and valuable consideration set forth herein as well as in consideration and as a condition of his continued employment with the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Employment Agreement.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual agreements and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 2.2 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:45pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive shall be eligible for a potential annual bonus with a target payout of no less than forty five percent (45%) of the Executive&#8217;s base salary based upon the Executive&#8217;s achievement of certain business and individual performance objectives as well as the performance of Avadel plc against its objectives as determined by the Company.  The Company may review the Executive&#8217;s bonus target from time to time, and, in the Company&#8217;s sole discretion, make any increases that the Company deems warranted.  Subject to the requirement that the Executive shall be employed by a member of the Avadel Group of Companies on the date that the bonus is deemed earned by the Compensation Committee of the Company&#8217;s Board of Directors, any bonus payments due hereunder shall be paid to the Executive no later than March 15 of the calendar year following the applicable year to which the annual bonus relates, subject to ordinary and lawful deductions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 3.2(i) of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) severance pay in an amount equal to 1.0 times the Executive&#8217;s then-current annual base salary, which shall be paid in substantially equal installments in accordance with the Company&#8217;s normal payroll practices&#59; provided that, solely to the extent such severance pay is exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and does not constitute &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, the Company may, in its sole discretion, elect to pay such amount in a lump sum within 60 days following the date of termination&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.044%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The last sentence of Section 3.2 of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The amounts payable under this Section 3.2 (to the extent payable in installments) shall be paid in substantially equal installments in accordance with the Company&#8217;s payroll practice over 12 months commencing within 60 days after the date of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the 60-day period begins in one calendar year and ends in a second calendar year, the Severance Amount, to the extent it qualifies as &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the date of termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 3.3 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) If the Executive terminates this Agreement and his employment with the Company for Good Reason or if the Executive&#8217;s employment with the Company is terminated by the Company without Cause or by non-renewal of this Agreement by the Company, and such termination occurs during a Change of Control Period (as hereinafter defined), then, in addition to the Executive being eligible for the Severance Pay and Benefits, subject to the terms of Section 3.2 above, and notwithstanding any other provision in any applicable equity compensation plan and&#47;or individual stock option plan or agreement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) all of Executive&#8217;s stock options and other stock-based awards (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the date of termination or (ii) the effective date of the Separation and Release Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accelerated Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that any termination or forfeiture of the unvested portion of such Equity Awards that would otherwise occur on the date of termination in the absence of this Agreement will be delayed until the effective date of the Separation and Release Agreement and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation and Release Agreement becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Equity Awards shall occur during the period between the date of termination and the Accelerated Vesting Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the Executive&#8217;s outstanding and vested stock options as of the Executive&#8217;s termination of employment date will remain exercisable until the eighteen (18) month anniversary of the termination of employment date&#59; provided, however, that the post-termination exercise period for any individual stock option right will not extend beyond its original maximum term as of the original date of the grant (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) The Executive&#8217;s receipt of the foregoing (i) and (ii) is conditioned upon his execution and delivery to the Company of the Separation and Release Agreement within the time period set forth in the Separation and Release Agreement and in no event more than sixty (60) days following the date of termination of the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 4 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.RESTRICTIVE COVENANTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:15.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the fullest extent permitted under applicable law, at all times during the Executive&#8217;s employment by the Company and for a period of five (5) years after termination of the Executive&#8217;s employment with the Company, the Executive (i) shall hold in strictest confidence all Restricted Information (as hereinafter defined), (ii) shall not directly or indirectly use, copy, disclose or otherwise distribute any Restricted Information, except for the benefit of a member of the Avadel Group of Companies to the extent necessary to perform his obligations to Avadel plc and the Company under this Agreement, and (iii) shall not disclose any Restricted Information to any person, firm, corporation or other entity without written authorization of the Chief Executive Officer or Board of Directors of Avadel plc.  Any breach of any provision of this Section 4.1(a) shall be considered a material breach of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:12.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As used in this Section 4, the following terms shall have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information (as hereinafter defined) and any Trade Secrets (as hereinafter defined).</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any information of or about any member of the Avadel Group of Companies, and any of the employees, customers and&#47;or suppliers of any member of the Avadel Group of Companies, which is not generally known outside of the Avadel Group of Companies, which the Executive obtains (whether before, on or after the date of this Agreement) in connection with the Executive&#8217;s employment with the Company, and which may be useful to any competitor of the Avadel Group of Companies or the disclosure of which would be damaging to any member of the Avadel Group of Companies.  Confidential Information includes, but is not limited to, any and all of the following information about any member of the Avadel Group of Companies&#58; (A) information about products, product candidates, and research and development plans, activities and results (including information about planned and in-process clinical trials)&#59; (B) information about business and employment policies, marketing methods and the targets of those methods, finances, business plans, promotional materials and price lists&#59; (C) the manner or terms upon which products or services are obtained from suppliers or on which products or services are provided to customers&#59; (D) without duplication of item (A) above, the nature, origin, composition, performance and development of any products or services&#59; (E) information about finances, financial condition, results of operations and prospects&#59; and (F) information about employees, consultants or customers or suppliers.  For the avoidance of doubt, Confidential Information shall not include information that (1) is or has been made generally available to the public through the disclosure thereof in a manner that was authorized by the Company and did not violate any common law or contractual right of the applicable party&#59; (2) is or becomes generally available to the public other than as a result of a disclosure by the Executive in violation of the provisions hereof&#59; or (3) was already in the possession of the Executive without an obligation of confidentiality prior to the date his employment with the Company began.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trade Secret</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information to the extent such information constitutes a trade secret under applicable law.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Certain Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the foregoing, the Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a Trade Secret that (i) is made (A) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney, and (B) solely for purposes of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding filed in a lawsuit or other proceeding, if such filing is made under seal.  If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the Trade Secret to the Executive&#8217;s attorney and use the Trade Secret in the court proceeding, if the Executive (i) files any document containing the Trade Secret under seal and (ii) does not disclose the Trade Secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Invention Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Executive will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by the Executive (alone or jointly with others) or under the Executive&#8217;s direction during the period of the Executive&#8217;s employment.  The Executive acknowledges that all work performed by him is on a &#8220;work for hire&#8221; basis, and the Executive hereby does assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all his right, title and interest in all Developments that (a) relate to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed, manufactured or sold by the Avadel Group of Companies or which may be used with such products or services&#59; or (b) result from tasks assigned to him by the Avadel Group of Companies&#59; or (c) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Avadel Group of Companies (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company-Related Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  For the avoidance of doubt, this Section 4.2 applies to the Executive&#8217;s entire service relationship with the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:13.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">To preclude any possible uncertainty, the Executive has set forth on Exhibit A attached hereto a complete list of Developments that the Executive has, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of his employment with the Company that he considers to be his property or the property of third parties and that he wishes to have excluded from the scope of this Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If disclosure of any such Prior Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that he is not to list such Prior Inventions in Exhibit A but is only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">inventions has not been made for that reason.  The Executive has also listed on Exhibit A all patents and patent applications in which he is named as an inventor, other than those which have been assigned to the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Patent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If no such disclosure is attached, the Executive represents that there are no Prior Inventions or Other Patent Rights.  If, in the course of the Executive&#8217;s employment with the Company, he incorporates a Prior Invention into a Company product, process or machine or other work done for the Avadel Group of Companies, the Executive hereby grants to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.  Notwithstanding the foregoing, the Executive will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company&#8217;s prior written consent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">This Agreement does not obligate the Executive to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on the Executive&#8217;s own time and does not relate to the business efforts or research and development efforts in which, during the period of his employment, the Avadel Group of Companies actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the Avadel Group of Companies.  However, the Executive will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion.  The Executive understands that to the extent this Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 4.2 will be interpreted not to apply to any invention that a court rules and&#47;or the Company agrees falls within such classes.  The Executive also hereby waives all claims to any moral rights or other special rights which the Executive may have or accrue in any Company-Related Developments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to protect Confidential Information and goodwill, during the Executive&#8217;s employment with the Company and for a period of one (1) year after the termination of the Executive&#8217;s employment with the Company for any reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, anywhere in the United States or in any other country in which the Avadel Group of Companies does business, engage or otherwise participate in any business that develops, manufactures or markets any products, or performs any services, that are competitive with the products or services of the Avadel Group of Companies, or products or services that the Avadel Group of Companies or its affiliates, has under development or that are the subject of active planning at any time during the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Non-Solicitation of Employees and Contractors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit or attempt to solicit any employee, consultant or other contractor of or service provider to any member of the Avadel Group of Companies with whom the Executive had Material Contact to perform services for the Executive or for any other business or entity, whether as an executive, consultant, partner or participant in any such business or entity, or to terminate or lessen any such employee&#8217;s, consultant&#8217;s or other contractor&#8217;s service with any member of the Avadel Group of Companies.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means contact in person, by telephone, or by paper or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">electronic correspondence in furtherance of the business of any member of the Avadel Group of Companies.  This Section 4.4 shall cease to be applicable to any activity of the Executive from and after such time as all members of the Avadel Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Solicitation of Customers and Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit any actual or prospective customers or suppliers of any member of the Avadel Group of Companies with whom the Executive had Material Contact, for the purpose of selling any products or services which compete with the business of any member of the Avadel Group of Companies. This Section 4.5 shall cease to be applicable to any activity of the Executive from and after such time as all members of the Avadel Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive agrees that it would be difficult to measure any damages caused to the Company that might result from any breach by the Executive of any portion of Sections 4.1 through 4.5, and that in any event money damages would be an inadequate remedy for any such breach.  Accordingly, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of Section 4.1 through 4.5, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach without showing or proving any actual damage to the Company and without the posting of a bond.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Agreement, the Company and the Executive hereby acknowledge and agree that&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  Nothing in this Agreement shall prohibit the Executive from reporting possible violations of Federal, State or other law or regulations to, or filing a charge or other complaint with, any governmental agency or entity, including but not limited to the Department of Justice, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, Congress, and any Inspector General, or making any other disclosures that are protected under any whistleblower provisions of Federal, State or other law or regulation or assisting in any such investigation or proceeding.</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  Nothing herein limits the Executive&#8217;s ability to communicate with any such governmental agency or entity or otherwise participate in any such investigation or proceeding that may be conducted by any such governmental agency or entity, including providing documents or other information, without notice to the Company. </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)  The Executive does not need the prior authorization of the Company to make any such reports or disclosures, and the Executive is not required to notify the Company that the Executive made any such reports or disclosures or is assisting in any such investigation.  </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)  The Executive (A) does not waive any rights to any individual monetary recovery or other awards in connection with reporting any such information to any such governmental agency or entity, (B) does not breach </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any confidentiality or other provision hereunder in connection with any such reporting or disclosures, and (C) will not be prohibited from receiving any amounts hereunder as the result of making any such reports or disclosures or assisting with any such investigation or proceeding.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">All other provisions of the Employment Agreement shall remain in full force and effect according to their respective terms, and nothing contained herein shall be deemed a waiver of any right or abrogation of any obligation otherwise existing under the Employment Agreement except to the extent specifically provided for herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding the place where this Amendment may be executed by any of the parties hereto, the parties expressly agree that all of the terms and provisions hereof shall be construed in accordance with and governed by the laws of the State of Missouri, without giving effect to the principles of choice or conflicts of laws thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures on this Amendment may be conveyed by facsimile or other electronic transmission and shall be binding upon the parties so transmitting their signatures. Counterparts with original signatures shall be provided to the other parties following the applicable facsimile or other electronic transmission&#59; provided, that failure to provide the original counterpart shall have no effect on the validity or the binding nature of this Amendment.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="i4fe0eeb4eaff433b98f26f29665233a7_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the Amendment Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">THE COMPANY</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AVADEL MANAGEMENT CORPORATION</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Angela Woods&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  Angela Woods</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;   Vice President</font></div><div style="padding-left:175.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;    THE EXECUTIVE</font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Thomas S. McHugh&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     Thomas S. McHugh</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="i4fe0eeb4eaff433b98f26f29665233a7_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Avadel Management Corporation</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From&#58;&#160;&#160;&#160;&#160;EMPLOYEE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  _____________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SUBJECT&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior Inventions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No inventions or improvements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional sheets attached</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a list of all patents and patent applications in which I have been named as an inventor&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;None</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>exhibit103-kimemploymentag.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i28afe288d0fd48fbbd290eeedd189444_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FIRST AMENDMENT TO EMPLOYMENT AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This First Amendment to Employment Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made effective as of September 28, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between Avadel Management Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Richard Kim (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WITNESSETH</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive are parties to an Employment Agreement dated as of March 18, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive wish to amend certain provisions of the Employment Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Executive is entering into this Amendment for good and valuable consideration set forth herein as well as in consideration and as a condition of his continued employment with the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Employment Agreement.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual agreements and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 3.2(i) of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) severance pay in an amount equal to 1.0 times the Executive&#8217;s then-current annual base salary (the &#8220;Severance Amount&#8221;), which shall be paid in substantially equal installments in accordance with the Company&#8217;s normal payroll practices&#59; provided that, solely to the extent such severance pay is exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and does not constitute &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, the Company may, in its sole discretion, elect to pay such amount in a lump sum within 60 days following the date of termination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The last sentence of Section 3.2 of the Employment Agreement is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The amounts payable under this Section 3.2 (to the extent payable in installments) shall be paid in substantially equal installments in accordance with the Company&#8217;s payroll practice over 12 months commencing within 60 days after the date of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the 60-day period begins in one calendar year and ends in a second calendar year, the Severance Amount, to the extent it qualifies as &#8220;non-qualified deferred compensation&#8221; within the meaning of Section 409A of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the date of termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 3.3 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.044%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) If the Executive terminates this Agreement and his employment with the Company for Good Reason or if the Executive&#8217;s employment with the Company is terminated by the Company without Cause or by non-renewal of this Agreement by the Company, and such termination occurs during a Change of Control Period (as hereinafter defined), then, in addition to the Executive being eligible for the Severance Pay and Benefits, subject to the terms of Section 3.2 above, and notwithstanding any other provision in any applicable equity compensation plan and&#47;or individual stock option plan or agreement&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) all of Executive&#8217;s stock options and other stock-based awards (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the date of termination or (ii) the effective date of the Separation and Release Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accelerated Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that any termination or forfeiture of the unvested portion of such Equity Awards that would otherwise occur on the date of termination in the absence of this Agreement will be delayed until the effective date of the Separation and Release Agreement and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation and Release Agreement becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Equity Awards shall occur during the period between the date of termination and the Accelerated Vesting Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the Executive&#8217;s outstanding and vested stock options as of the Executive&#8217;s termination of employment date will remain exercisable until the eighteen (18) month anniversary of the termination of employment date&#59; provided, however, that the post-termination exercise period for any individual stock option right will not extend beyond its original maximum term as of the original date of the grant (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) The Executive&#8217;s receipt of the foregoing (i) and (ii) is conditioned upon his execution and delivery to the Company of the Separation and Release Agreement within the time period set forth in the Separation and Release Agreement and in no event more than sixty (60) days following the date of termination of the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Section 4 of the Employment Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.RESTRICTIVE COVENANTS</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:15.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Restriction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the fullest extent permitted under applicable law, at all times during the Executive&#8217;s employment by the Company and for a period of five (5) years after termination of the Executive&#8217;s employment with the Company, the Executive (i) shall hold in strictest confidence all Restricted Information (as hereinafter defined), (ii) shall not directly or indirectly use, copy, disclose or otherwise distribute any Restricted Information, except for the benefit of a member of the Avadel Group of Companies to the extent necessary to perform his obligations to Avadel plc and the Company under this Agreement, and (iii) shall not disclose any Restricted Information to any person, firm, corporation or other entity without written authorization of the Chief Executive Officer or Board of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Directors of Avadel plc.  Any breach of any provision of this Section 4.1(a) shall be considered a material breach of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:12.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As used in this Section 4, the following terms shall have the meanings set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information (as hereinafter defined) and any Trade Secrets (as hereinafter defined).</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any information of or about any member of the Avadel Group of Companies, and any of the employees, customers and&#47;or suppliers of any member of the Avadel Group of Companies, which is not generally known outside of the Avadel Group of Companies, which the Executive obtains (whether before, on or after the date of this Agreement) in connection with the Executive&#8217;s employment with the Company, and which may be useful to any competitor of the Avadel Group of Companies or the disclosure of which would be damaging to any member of the Avadel Group of Companies.  Confidential Information includes, but is not limited to, any and all of the following information about any member of the Avadel Group of Companies&#58; (A) information about products, product candidates, and research and development plans, activities and results (including information about planned and in-process clinical trials)&#59; (B) information about business and employment policies, marketing methods and the targets of those methods, finances, business plans, promotional materials and price lists&#59; (C) the manner or terms upon which products or services are obtained from suppliers or on which products or services are provided to customers&#59; (D) without duplication of item (A) above, the nature, origin, composition, performance and development of any products or services&#59; (E) information about finances, financial condition, results of operations and prospects&#59; and (F) information about employees, consultants or customers or suppliers.  For the avoidance of doubt, Confidential Information shall not include information that (1) is or has been made generally available to the public through the disclosure thereof in a manner that was authorized by the Company and did not violate any common law or contractual right of the applicable party&#59; (2) is or becomes generally available to the public other than as a result of a disclosure by the Executive in violation of the provisions hereof&#59; or (3) was already in the possession of the Executive without an obligation of confidentiality prior to the date his employment with the Company began.</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Trade Secret</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Confidential Information to the extent such information constitutes a trade secret under applicable law.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.03pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Certain Permitted Disclosures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding the foregoing, the Executive will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a Trade Secret that (i) is made (A) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney, and (B) solely for purposes of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding filed in a lawsuit or other proceeding, if such filing is made under seal.  If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the Trade Secret to the Executive&#8217;s attorney and use the Trade Secret in the court proceeding, if the Executive (i) files any document </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">containing the Trade Secret under seal and (ii) does not disclose the Trade Secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Invention Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">The Executive will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by the Executive (alone or jointly with others) or under the Executive&#8217;s direction during the period of the Executive&#8217;s employment.  The Executive acknowledges that all work performed by him is on a &#8220;work for hire&#8221; basis, and the Executive hereby does assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all his right, title and interest in all Developments that (a) relate to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed, manufactured or sold by the Avadel Group of Companies or which may be used with such products or services&#59; or (b) result from tasks assigned to him by the Avadel Group of Companies&#59; or (c) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Avadel Group of Companies (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company-Related Developments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  For the avoidance of doubt, this Section 4.2 applies to the Executive&#8217;s entire service relationship with the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:13.02pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">To preclude any possible uncertainty, the Executive has set forth on Exhibit A attached hereto a complete list of Developments that the Executive has, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of his employment with the Company that he considers to be his property or the property of third parties and that he wishes to have excluded from the scope of this Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If disclosure of any such Prior Invention would cause the Executive to violate any prior confidentiality agreement, the Executive understands that he is not to list such Prior Inventions in Exhibit A but is only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason.  The Executive has also listed on Exhibit A all patents and patent applications in which he is named as an inventor, other than those which have been assigned to the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Patent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If no such disclosure is attached, the Executive represents that there are no Prior Inventions or Other Patent Rights.  If, in the course of the Executive&#8217;s employment with the Company, he incorporates a Prior Invention into a Company product, process or machine or other work done for the Avadel Group of Companies, the Executive hereby grants to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.  Notwithstanding the foregoing, the Executive will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company&#8217;s prior written consent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:9.69pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">This Agreement does not obligate the Executive to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on the Executive&#8217;s own time and does not relate to the business efforts or research and development efforts in which, during the period of his employment, the Avadel Group of Companies actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the Avadel Group of Companies.  However, the Executive will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion.  The Executive understands that to the extent this Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 4.2 will be interpreted not to apply to any invention that a court rules and&#47;or the Company agrees falls within such classes.  The Executive also hereby waives all claims to any moral rights or other special rights which the Executive may have or accrue in any Company-Related Developments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to protect Confidential Information and goodwill, during the Executive&#8217;s employment with the Company and for a period of one (1) year after the termination of the Executive&#8217;s employment with the Company for any reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, anywhere in the United States or in any other country in which the Avadel Group of Companies does business, engage or otherwise participate in any business that develops, manufactures or markets any products, or performs any services, that are competitive with the products or services of the Avadel Group of Companies, or products or services that the Avadel Group of Companies or its affiliates, has under development or that are the subject of active planning at any time during the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Non-Solicitation of Employees and Contractors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit or attempt to solicit any employee, consultant or other contractor of or service provider to any member of the Avadel Group of Companies with whom the Executive had Material Contact to perform services for the Executive or for any other business or entity, whether as an executive, consultant, partner or participant in any such business or entity, or to terminate or lessen any such employee&#8217;s, consultant&#8217;s or other contractor&#8217;s service with any member of the Avadel Group of Companies.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means contact in person, by telephone, or by paper or electronic correspondence in furtherance of the business of any member of the Avadel Group of Companies.  This Section 4.4 shall cease to be applicable to any activity of the Executive from and after such time as all members of the Avadel Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Non-Solicitation of Customers and Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Restricted Period, the Executive shall not, directly or indirectly, solicit any actual or prospective customers or suppliers of any member of the Avadel Group of Companies with whom the Executive had Material Contact, for the purpose of selling any products or services which compete with the business of any member of the Avadel Group of Companies. This Section 4.5 shall cease to be applicable to any activity of the Executive from and after such time as all members of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Avadel Group of Companies have ceased all business activities or have made a decision to cease all business activities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30pt;text-decoration:underline">Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive agrees that it would be difficult to measure any damages caused to the Company that might result from any breach by the Executive of any portion of Sections 4.1 through 4.5, and that in any event money damages would be an inadequate remedy for any such breach.  Accordingly, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of Section 4.1 through 4.5, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach without showing or proving any actual damage to the Company and without the posting of a bond.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.68pt;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Agreement, the Company and the Executive hereby acknowledge and agree that&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)  Nothing in this Agreement shall prohibit the Executive from reporting possible violations of Federal, State or other law or regulations to, or filing a charge or other complaint with, any governmental agency or entity, including but not limited to the Department of Justice, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, Congress, and any Inspector General, or making any other disclosures that are protected under any whistleblower provisions of Federal, State or other law or regulation or assisting in any such investigation or proceeding.</font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)  Nothing herein limits the Executive&#8217;s ability to communicate with any such governmental agency or entity or otherwise participate in any such investigation or proceeding that may be conducted by any such governmental agency or entity, including providing documents or other information, without notice to the Company. </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)  The Executive does not need the prior authorization of the Company to make any such reports or disclosures, and the Executive is not required to notify the Company that the Executive made any such reports or disclosures or is assisting in any such investigation.  </font></div><div style="margin-bottom:12pt;padding-left:54pt;padding-right:36pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)  The Executive (A) does not waive any rights to any individual monetary recovery or other awards in connection with reporting any such information to any such governmental agency or entity, (B) does not breach any confidentiality or other provision hereunder in connection with any such reporting or disclosures, and (C) will not be prohibited from receiving any amounts hereunder as the result of making any such reports or disclosures or assisting with any such investigation or proceeding.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">All other provisions of the Employment Agreement shall remain in full force and effect according to their respective terms, and nothing contained herein shall be deemed a waiver of any right or abrogation of any obligation otherwise existing under the Employment Agreement except to the extent specifically provided for herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding the place where this Amendment may be executed by any of the parties hereto, the parties expressly agree that all of the terms and provisions hereof shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">construed in accordance with and governed by the laws of the State of Missouri, without giving effect to the principles of choice or conflicts of laws thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Signatures on this Amendment may be conveyed by facsimile or other electronic transmission and shall be binding upon the parties so transmitting their signatures. Counterparts with original signatures shall be provided to the other parties following the applicable facsimile or other electronic transmission&#59; provided, that failure to provide the original counterpart shall have no effect on the validity or the binding nature of this Amendment.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="i28afe288d0fd48fbbd290eeedd189444_41"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the Amendment Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">THE COMPANY</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AVADEL MANAGEMENT CORPORATION</font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:175.7pt;text-indent:49.7pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Angela Woods&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;  Angela Woods</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58;  Vice President </font></div><div style="padding-left:175.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;    THE EXECUTIVE</font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:175.5pt"><font><br></font></div><div style="padding-left:216pt;text-indent:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Richard Kim&#160;&#160;&#160;&#160;                         &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     Richard Kim</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div><div id="i28afe288d0fd48fbbd290eeedd189444_44"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Avadel Management Corporation</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">From&#58;&#160;&#160;&#160;&#160;EMPLOYEE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  _____________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SUBJECT&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior Inventions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No inventions or improvements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional sheets attached</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The following is a list of all patents and patent applications in which I have been named as an inventor&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;None</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See below&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________________________________________</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311q32022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibfc371a738c8401a91b7e5310ad7d5ed_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory J. Divis, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312q32022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9c0203481285426580bfc841840af171_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas S. McHugh, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;9, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321q32022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3820f5a844cf4753a60e8548e16073c1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended September&#160;30, 2022 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Executive Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;9, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322q32022.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i0c570d7ca6384ac097a4506724db5c2e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended September&#160;30, 2022 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Financial Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>avdl-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avdl="http://www.avadel.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avadel.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.avadel.com/role/Coverpage">
        <link:definition>0000001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical">
        <link:definition>0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.avadel.com/role/FairValueMeasurement">
        <link:definition>0000011 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.avadel.com/role/MarketableSecurities">
        <link:definition>0000012 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.avadel.com/role/LongTermDebt">
        <link:definition>0000013 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.avadel.com/role/IncomeTaxes">
        <link:definition>0000014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilities" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities">
        <link:definition>0000015 - Disclosure - Other Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.avadel.com/role/ShareBasedCompensation">
        <link:definition>0000016 - Disclosure - Share Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.avadel.com/role/NetLossPerShare">
        <link:definition>0000017 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLoss" roleURI="http://www.avadel.com/role/ComprehensiveLoss">
        <link:definition>0000018 - Disclosure - Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.avadel.com/role/CommitmentsandContingencies">
        <link:definition>0000019 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCosts" roleURI="http://www.avadel.com/role/RestructuringCosts">
        <link:definition>0000020 - Disclosure - Restructuring Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.avadel.com/role/SubsequentEvents">
        <link:definition>0000021 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000022 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.avadel.com/role/FairValueMeasurementTables">
        <link:definition>0000023 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.avadel.com/role/MarketableSecuritiesTables">
        <link:definition>0000024 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.avadel.com/role/LongTermDebtTables">
        <link:definition>0000025 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesTables" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables">
        <link:definition>0000026 - Disclosure - Other Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.avadel.com/role/NetLossPerShareTables">
        <link:definition>0000027 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossTables" roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossTables">
        <link:definition>0000028 - Disclosure - Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsTables" roleURI="http://www.avadel.com/role/RestructuringCostsTables">
        <link:definition>0000029 - Disclosure - Restructuring Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000030 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementMeasuredonRecurringBasisDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails">
        <link:definition>0000031 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNarrativeDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails">
        <link:definition>0000032 - Disclosure - Fair Value Measurement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesSummaryofMarketableSecuritiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
        <link:definition>0000033 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>0000034 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofMaturitiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails">
        <link:definition>0000035 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails">
        <link:definition>0000036 - Disclosure - Marketable Securities - Schedule of Unrealized Loss on Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtDetails" roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails">
        <link:definition>0000037 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000038 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000039 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>0000040 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails">
        <link:definition>0000041 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesAccruedExpensesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails">
        <link:definition>0000042 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails">
        <link:definition>0000043 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails">
        <link:definition>0000044 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationDetails">
        <link:definition>0000045 - Disclosure - Share Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareReconciliationofBasicandDilutedCalculationDetails" roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails">
        <link:definition>0000046 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareNarrativeDetails" roleURI="http://www.avadel.com/role/NetLossPerShareNarrativeDetails">
        <link:definition>0000047 - Disclosure - Net Loss Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossComponentsDetails" roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails">
        <link:definition>0000048 - Disclosure - Comprehensive Income (Loss) - Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000049 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsNarrativeDetails" roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails">
        <link:definition>0000050 - Disclosure - Restructuring Costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsSeveranceObligationDetails" roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails">
        <link:definition>0000051 - Disclosure - Restructuring Costs - Severance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.avadel.com/role/SubsequentEventsDetails">
        <link:definition>0000052 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="avdl_AtTheMarketOfferingProgramMember" abstract="true" name="AtTheMarketOfferingProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" abstract="false" name="DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_AccruedTradeDiscountsAndRebates" abstract="false" name="AccruedTradeDiscountsAndRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherNoncurrentReceivables" abstract="false" name="OtherNoncurrentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherLiabilitiesMiscellaneousCurrent" abstract="false" name="OtherLiabilitiesMiscellaneousCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" abstract="false" name="OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeAssetCurrentCarryingValue" abstract="false" name="GuaranteeAssetCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" abstract="true" name="DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_NatureOfBusinessPolicyPolicyTextBlock" abstract="false" name="NatureOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" abstract="false" name="DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" abstract="true" name="FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_SaleOfStockCommissionPercentage" abstract="false" name="SaleOfStockCommissionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_CouponInterestExpense" abstract="false" name="CouponInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDue2023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OtherGuarantorObligationsCurrentCarryingValue" abstract="false" name="OtherGuarantorObligationsCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" abstract="false" name="DebtInstrumentConvertibleScheduledThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_A2022CorporateRestructuringPlanMember" abstract="true" name="A2022CorporateRestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentExchangeAmount" abstract="false" name="DebtInstrumentExchangeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_PercentageOfRoyaltyPayableOnNetSales" abstract="false" name="PercentageOfRoyaltyPayableOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_OpenMarketSalesAgreement2020ProspectusMember" abstract="true" name="OpenMarketSalesAgreement2020ProspectusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentOptiontoIncreaseFaceAmount" abstract="false" name="DebtInstrumentOptiontoIncreaseFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_LiquidityAndGoingConcernPolicyTextBlock" abstract="false" name="LiquidityAndGoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" abstract="false" name="RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" abstract="false" name="IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositorySharesConversionRatio" abstract="false" name="AmericanDepositorySharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="avdl_AdditionalInterestExpenseDebt" abstract="false" name="AdditionalInterestExpenseDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" abstract="false" name="DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeCurrent" abstract="false" name="GuaranteeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeNoncurrent" abstract="false" name="GuaranteeNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MutualAndMoneyMarketFundsMember" abstract="true" name="MutualAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" abstract="false" name="DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesOptionPricePerShare" abstract="false" name="AmericanDepositarySharesOptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDueOctober2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" abstract="false" name="TaxLiabilitiesAndOtherNoncurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDueOctober22023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" abstract="false" name="DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_RestructuringChargesExcludingOtherAdjustments" abstract="false" name="RestructuringChargesExcludingOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AccruedInterestCurrent" abstract="false" name="AccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" abstract="false" name="MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OpenMarketSalesAgreement2022ProspectusMember" abstract="true" name="OpenMarketSalesAgreement2022ProspectusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" abstract="false" name="AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AccruedOutsourceContractCosts" abstract="false" name="AccruedOutsourceContractCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>avdl-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9f9bde9-e6e7-4ee4-9e4c-29ff5d303612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a349910-29ab-4a5b-a26b-8cbf3445ba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b9f9bde9-e6e7-4ee4-9e4c-29ff5d303612" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a349910-29ab-4a5b-a26b-8cbf3445ba7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ec320163-2e12-4fdd-8a86-d472913b22b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b9f9bde9-e6e7-4ee4-9e4c-29ff5d303612" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ec320163-2e12-4fdd-8a86-d472913b22b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca9990d-8ac2-4cd1-8c21-477161f0218d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_72516b25-b538-49f1-a88b-48152f88c2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca9990d-8ac2-4cd1-8c21-477161f0218d" xlink:to="loc_us-gaap_OperatingIncomeLoss_72516b25-b538-49f1-a88b-48152f88c2f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4c8cb55b-8a4e-426b-911a-2daa7dd7eb80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca9990d-8ac2-4cd1-8c21-477161f0218d" xlink:to="loc_us-gaap_InterestExpenseDebt_4c8cb55b-8a4e-426b-911a-2daa7dd7eb80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_c3ff066f-692a-490e-9b26-0da92d801d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca9990d-8ac2-4cd1-8c21-477161f0218d" xlink:to="loc_us-gaap_InvestmentIncomeNet_c3ff066f-692a-490e-9b26-0da92d801d2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_11fef7c1-faa7-41d0-b2af-80b7a48df004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca9990d-8ac2-4cd1-8c21-477161f0218d" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_11fef7c1-faa7-41d0-b2af-80b7a48df004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_63b2beba-4845-454c-bc94-99080b848f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cabe5a78-c8c7-4286-8096-bf42557e1ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_63b2beba-4845-454c-bc94-99080b848f44" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cabe5a78-c8c7-4286-8096-bf42557e1ba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_22c3cc5a-430c-4775-87e2-6b0e8e972d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_63b2beba-4845-454c-bc94-99080b848f44" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_22c3cc5a-430c-4775-87e2-6b0e8e972d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c5d57286-ead3-4496-8a64-8d379b11776b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_63b2beba-4845-454c-bc94-99080b848f44" xlink:to="loc_us-gaap_RestructuringCharges_c5d57286-ead3-4496-8a64-8d379b11776b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63b906e1-126b-4114-8a43-92c8b0b8ede4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_cb66e1c1-83ea-4512-b87f-fa6d9840d63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_63b906e1-126b-4114-8a43-92c8b0b8ede4" xlink:to="loc_us-gaap_CostsAndExpenses_cb66e1c1-83ea-4512-b87f-fa6d9840d63c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d904bfad-ada3-4e1c-abed-12c47c092251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_856afbee-0ac1-4ae1-a222-abfe4674a8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d904bfad-ada3-4e1c-abed-12c47c092251" xlink:to="loc_us-gaap_NetIncomeLoss_856afbee-0ac1-4ae1-a222-abfe4674a8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6d9e6727-f3ec-422c-9d7d-a70e9a54080d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d904bfad-ada3-4e1c-abed-12c47c092251" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6d9e6727-f3ec-422c-9d7d-a70e9a54080d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_93b9ce73-19d2-4778-a525-a74718370c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a07380f7-b01a-401c-b47a-6e9d4dbf853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_93b9ce73-19d2-4778-a525-a74718370c60" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a07380f7-b01a-401c-b47a-6e9d4dbf853d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3fc13b11-7d1e-4aac-8951-ad75ee489781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_93b9ce73-19d2-4778-a525-a74718370c60" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3fc13b11-7d1e-4aac-8951-ad75ee489781" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5097133c-4ff8-49d1-a52c-437dc00f1905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f893ba2f-31bc-4b00-8e2b-ac9f2b3197ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5097133c-4ff8-49d1-a52c-437dc00f1905" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f893ba2f-31bc-4b00-8e2b-ac9f2b3197ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7a382713-bab3-4925-b3a5-32b78c6f293d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5097133c-4ff8-49d1-a52c-437dc00f1905" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7a382713-bab3-4925-b3a5-32b78c6f293d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_88936eb1-ea6a-4e46-a0b9-d708764a043c" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5097133c-4ff8-49d1-a52c-437dc00f1905" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_88936eb1-ea6a-4e46-a0b9-d708764a043c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f44e33a9-4bac-4170-a1c4-f5bd74f50ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5097133c-4ff8-49d1-a52c-437dc00f1905" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f44e33a9-4bac-4170-a1c4-f5bd74f50ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2ee92f1e-3256-491e-8ca0-1f8be964698a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c9bab52e-2e04-4309-96d5-53ef1c93ea48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2ee92f1e-3256-491e-8ca0-1f8be964698a" xlink:to="loc_us-gaap_Liabilities_c9bab52e-2e04-4309-96d5-53ef1c93ea48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b83ed542-10b5-4cc4-8520-747da275fb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2ee92f1e-3256-491e-8ca0-1f8be964698a" xlink:to="loc_us-gaap_StockholdersEquity_b83ed542-10b5-4cc4-8520-747da275fb54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_10b89764-85df-4a46-95f1-0f32b3dc6769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_30eeda89-2f74-4c7e-a591-2996c5d6bdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10b89764-85df-4a46-95f1-0f32b3dc6769" xlink:to="loc_us-gaap_LiabilitiesCurrent_30eeda89-2f74-4c7e-a591-2996c5d6bdf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_393a9584-d3b6-4ae7-8a47-e3cfa8c96710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10b89764-85df-4a46-95f1-0f32b3dc6769" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_393a9584-d3b6-4ae7-8a47-e3cfa8c96710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8aa64caa-2b59-4c22-ba0a-d4649cc9b0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10b89764-85df-4a46-95f1-0f32b3dc6769" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8aa64caa-2b59-4c22-ba0a-d4649cc9b0b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_64f069b8-a7e8-4659-adba-aa4db3e0b401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10b89764-85df-4a46-95f1-0f32b3dc6769" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_64f069b8-a7e8-4659-adba-aa4db3e0b401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8b62616a-f108-48b7-9c7a-5aff074278ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8b62616a-f108-48b7-9c7a-5aff074278ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_af8a8ad6-9307-41af-907c-1d0b08950322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_af8a8ad6-9307-41af-907c-1d0b08950322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_51ebe8c6-efa1-4acb-9ae7-743057d5b8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:to="loc_us-gaap_CommonStockValue_51ebe8c6-efa1-4acb-9ae7-743057d5b8ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_998107e2-5132-4a15-af85-3a967092af8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_998107e2-5132-4a15-af85-3a967092af8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_74f78d8f-0f60-479e-8853-ee7adc737285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0e44b59c-04b9-4b39-8a8b-0ca99866eaca" xlink:to="loc_us-gaap_PreferredStockValue_74f78d8f-0f60-479e-8853-ee7adc737285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3182b6ac-8350-4017-8982-69d348eb6001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_us-gaap_AssetsCurrent_3182b6ac-8350-4017-8982-69d348eb6001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f507b82-e9ce-47d9-9279-7a5c0da602f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f507b82-e9ce-47d9-9279-7a5c0da602f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_72595549-0c52-492c-b3b2-f0f08d737243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_72595549-0c52-492c-b3b2-f0f08d737243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f7f9abd0-c1fd-4236-96c5-4dded80b7b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_us-gaap_Goodwill_f7f9abd0-c1fd-4236-96c5-4dded80b7b83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_c8cec299-7e16-4aea-a2fd-2c7bee1b9670" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_c8cec299-7e16-4aea-a2fd-2c7bee1b9670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c8d920e5-eab0-4987-a614-0d86c47faa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c2c51c48-97f4-4869-a0eb-895e909de201" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c8d920e5-eab0-4987-a614-0d86c47faa3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_259a79bf-d91e-4c41-a811-310aed38fa41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:to="loc_us-gaap_LongTermDebtCurrent_259a79bf-d91e-4c41-a811-310aed38fa41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6ab20c2b-6b16-408c-aa5f-d4b0cdde3482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6ab20c2b-6b16-408c-aa5f-d4b0cdde3482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e3b17c7c-522b-4a9a-a089-1ea3c452f8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:to="loc_us-gaap_AccountsPayableCurrent_e3b17c7c-522b-4a9a-a089-1ea3c452f8cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_01a86767-ea4c-4852-9fda-f306efeaebdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_01a86767-ea4c-4852-9fda-f306efeaebdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ec75e6bc-1ce7-42eb-ae87-623b15eeadcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc6e1cef-34c8-4476-8055-15c9bd022c8a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ec75e6bc-1ce7-42eb-ae87-623b15eeadcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c9057e7-fb67-4152-b59e-4c2623508f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddf428b7-3434-44a2-98b3-3267bafe487e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c9057e7-fb67-4152-b59e-4c2623508f27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddf428b7-3434-44a2-98b3-3267bafe487e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0cd4023-4873-4473-b8ee-0d6ca190acb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c9057e7-fb67-4152-b59e-4c2623508f27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0cd4023-4873-4473-b8ee-0d6ca190acb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_caf1cd58-d125-4e4f-8067-b99e5101442c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c9057e7-fb67-4152-b59e-4c2623508f27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_caf1cd58-d125-4e4f-8067-b99e5101442c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_403fedc4-7300-4de9-8483-bafe78109a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c9057e7-fb67-4152-b59e-4c2623508f27" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_403fedc4-7300-4de9-8483-bafe78109a94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83d25a27-bc45-42f4-8e9b-21b01c72e113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ea3b3f05-82a9-49f5-8fd3-817263b66d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83d25a27-bc45-42f4-8e9b-21b01c72e113" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ea3b3f05-82a9-49f5-8fd3-817263b66d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0e3e3722-f389-4618-8459-a4cba19b6fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83d25a27-bc45-42f4-8e9b-21b01c72e113" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0e3e3722-f389-4618-8459-a4cba19b6fec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_47cf52e2-04b4-4708-8286-f4d042d2dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83d25a27-bc45-42f4-8e9b-21b01c72e113" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_47cf52e2-04b4-4708-8286-f4d042d2dc3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_989168b4-104e-4986-ba3c-f5fbcc45fd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83d25a27-bc45-42f4-8e9b-21b01c72e113" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_989168b4-104e-4986-ba3c-f5fbcc45fd2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71233402-59aa-4e2c-9d89-26d2cee2509f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_NetIncomeLoss_71233402-59aa-4e2c-9d89-26d2cee2509f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_5fdda83f-bb1c-4685-b2e0-33bdb5fb85fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_DepreciationAndAmortization_5fdda83f-bb1c-4685-b2e0-33bdb5fb85fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_18a47b28-b469-44f7-a3df-eac7fbd51bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_18a47b28-b469-44f7-a3df-eac7fbd51bbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c984498e-6301-4df2-8acf-2f73864942b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c984498e-6301-4df2-8acf-2f73864942b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b9acddcf-270a-4002-a31d-d65600ac1612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_ShareBasedCompensation_b9acddcf-270a-4002-a31d-d65600ac1612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3465372c-bec8-4c9a-a431-47bb1d0d7bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_3465372c-bec8-4c9a-a431-47bb1d0d7bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5d4912db-ddf6-43bf-87dd-8cda30ba815e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5d4912db-ddf6-43bf-87dd-8cda30ba815e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_caacb721-7b7f-4e56-8cfa-ce32ea19fb00" xlink:href="avdl-20220930.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_caacb721-7b7f-4e56-8cfa-ce32ea19fb00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5110be0e-6a72-4677-8a11-058d45b0cd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5110be0e-6a72-4677-8a11-058d45b0cd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7e54065e-8ac0-45c7-9a2f-4a481f426b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7e54065e-8ac0-45c7-9a2f-4a481f426b35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_ef7ffffd-9fd7-46ed-8440-040ffad8a58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_ef7ffffd-9fd7-46ed-8440-040ffad8a58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_39a43b44-a43c-4bd0-bdd0-67831073bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_65fb3d05-0f99-4d50-82f4-a0b3711cc3e5" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_39a43b44-a43c-4bd0-bdd0-67831073bad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2416855-9ec7-479c-95ab-d9ac70825aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_72e4b641-a8be-45f6-80cd-a0df279db58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2416855-9ec7-479c-95ab-d9ac70825aa1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_72e4b641-a8be-45f6-80cd-a0df279db58d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_530d888b-09ab-4f39-8ac2-6da65fb7f196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2416855-9ec7-479c-95ab-d9ac70825aa1" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_530d888b-09ab-4f39-8ac2-6da65fb7f196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8b1ce85e-eabe-4698-a506-aa9bc787fe46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2416855-9ec7-479c-95ab-d9ac70825aa1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8b1ce85e-eabe-4698-a506-aa9bc787fe46" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ebf3d48b-a0d2-4fac-bf3a-7aa175627590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dd7ce6a6-8178-451d-9388-113f7abe94a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ebf3d48b-a0d2-4fac-bf3a-7aa175627590" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dd7ce6a6-8178-451d-9388-113f7abe94a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_39f9e1c8-182c-469c-a1d8-26bc2f18f4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_98fb2607-8a89-4de5-b8c3-6cd2f8c706bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_39f9e1c8-182c-469c-a1d8-26bc2f18f4e7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_98fb2607-8a89-4de5-b8c3-6cd2f8c706bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_91bd33ad-2873-4e53-9d37-e64f717cce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_39f9e1c8-182c-469c-a1d8-26bc2f18f4e7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_91bd33ad-2873-4e53-9d37-e64f717cce1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6270610c-562c-42f5-bc09-cf444989a834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_39f9e1c8-182c-469c-a1d8-26bc2f18f4e7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6270610c-562c-42f5-bc09-cf444989a834" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c3fcdfb-b8b3-424b-9580-44f6ead1dc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_209bd45d-9e82-47c1-a54b-5e5187f8901a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c3fcdfb-b8b3-424b-9580-44f6ead1dc3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_209bd45d-9e82-47c1-a54b-5e5187f8901a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_3777ef15-8919-4035-8345-de57ee230f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c3fcdfb-b8b3-424b-9580-44f6ead1dc3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_3777ef15-8919-4035-8345-de57ee230f54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_26b10ec6-64fc-45e3-a597-6be090597891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c3fcdfb-b8b3-424b-9580-44f6ead1dc3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_26b10ec6-64fc-45e3-a597-6be090597891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7d584af3-aff9-4f17-a5b3-02f13edab914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c3fcdfb-b8b3-424b-9580-44f6ead1dc3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7d584af3-aff9-4f17-a5b3-02f13edab914" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ac60278e-73b0-4da8-9d16-550cef5b1dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_467677ca-078b-47ca-b7f2-aa69e2c0e4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ac60278e-73b0-4da8-9d16-550cef5b1dea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_467677ca-078b-47ca-b7f2-aa69e2c0e4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3662788a-a394-42c6-af50-2cbc2dbe14d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ac60278e-73b0-4da8-9d16-550cef5b1dea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3662788a-a394-42c6-af50-2cbc2dbe14d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_364d90d6-feb2-4f13-9d05-71415b8651ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_6cea9db1-976c-4fa9-b0ac-9a4245041543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_364d90d6-feb2-4f13-9d05-71415b8651ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_6cea9db1-976c-4fa9-b0ac-9a4245041543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_613c31ca-714d-470c-b46f-185b15656c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_364d90d6-feb2-4f13-9d05-71415b8651ec" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_613c31ca-714d-470c-b46f-185b15656c08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8d74ca52-8b21-4510-b936-d7b41567a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0458c7fe-b79b-4b9c-9611-61a374b68906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8d74ca52-8b21-4510-b936-d7b41567a09e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0458c7fe-b79b-4b9c-9611-61a374b68906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b3e20eb9-3a32-41ea-b967-411fd1fa1647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8d74ca52-8b21-4510-b936-d7b41567a09e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b3e20eb9-3a32-41ea-b967-411fd1fa1647" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f0d178b-5394-4964-b5c5-254f4e88e46d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b4f4b1e2-86ca-475a-9d7c-c6d9cd09cc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f0d178b-5394-4964-b5c5-254f4e88e46d" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b4f4b1e2-86ca-475a-9d7c-c6d9cd09cc77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_34b18a86-b119-4ec3-84bb-c72d968b9734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f0d178b-5394-4964-b5c5-254f4e88e46d" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_34b18a86-b119-4ec3-84bb-c72d968b9734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_e024123b-8656-4d52-ae7c-cd82fe4677a1" xlink:href="avdl-20220930.xsd#avdl_GuaranteeCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f0d178b-5394-4964-b5c5-254f4e88e46d" xlink:to="loc_avdl_GuaranteeCurrent_e024123b-8656-4d52-ae7c-cd82fe4677a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_38505910-a2f9-4dec-96d0-1b9fb5ed4068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f0d178b-5394-4964-b5c5-254f4e88e46d" xlink:to="loc_us-gaap_OtherAssetsCurrent_38505910-a2f9-4dec-96d0-1b9fb5ed4068" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2e56f88e-0a52-4a8e-bfaa-ebc67c0055d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6144e58d-d672-447f-b36e-10359371e638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2e56f88e-0a52-4a8e-bfaa-ebc67c0055d1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_6144e58d-d672-447f-b36e-10359371e638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_2547f2f1-f25b-465a-b733-740f760311c6" xlink:href="avdl-20220930.xsd#avdl_GuaranteeNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2e56f88e-0a52-4a8e-bfaa-ebc67c0055d1" xlink:to="loc_avdl_GuaranteeNoncurrent_2547f2f1-f25b-465a-b733-740f760311c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_ada18524-0ced-4542-ba2a-d4f6997b6976" xlink:href="avdl-20220930.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2e56f88e-0a52-4a8e-bfaa-ebc67c0055d1" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_ada18524-0ced-4542-ba2a-d4f6997b6976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_4d3d13dd-8a8b-4f05-b4a8-ab012ad525d3" xlink:href="avdl-20220930.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2e56f88e-0a52-4a8e-bfaa-ebc67c0055d1" xlink:to="loc_avdl_OtherNoncurrentReceivables_4d3d13dd-8a8b-4f05-b4a8-ab012ad525d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_8ab1e46a-dabb-4452-ac54-4b34c865bb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:to="loc_us-gaap_AccruedSalariesCurrent_8ab1e46a-dabb-4452-ac54-4b34c865bb2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_0943cae1-0cc7-4c56-94a5-ee4cb67b84ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:to="loc_us-gaap_RestructuringReserveCurrent_0943cae1-0cc7-4c56-94a5-ee4cb67b84ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_646ccac9-abd8-4f4f-8717-ee11080bf6a9" xlink:href="avdl-20220930.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_646ccac9-abd8-4f4f-8717-ee11080bf6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_be19c77f-2c17-472c-bf67-affafd0faf98" xlink:href="avdl-20220930.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:to="loc_avdl_AccruedOutsourceContractCosts_be19c77f-2c17-472c-bf67-affafd0faf98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5e286f03-8efc-499e-9346-e2cef4c8f2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_31df5cbe-ac8c-4e62-933b-88cb95b98c9e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5e286f03-8efc-499e-9346-e2cef4c8f2e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4d73332a-9feb-41ab-8e45-79977a132bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f589140e-a0c0-4f54-b32b-a7a0606bafb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4d73332a-9feb-41ab-8e45-79977a132bc0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f589140e-a0c0-4f54-b32b-a7a0606bafb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_9ce0f014-38a7-4a96-bad2-b6a262774769" xlink:href="avdl-20220930.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4d73332a-9feb-41ab-8e45-79977a132bc0" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_9ce0f014-38a7-4a96-bad2-b6a262774769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_1fa90132-01d4-41b8-90e5-96694f2085e7" xlink:href="avdl-20220930.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4d73332a-9feb-41ab-8e45-79977a132bc0" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_1fa90132-01d4-41b8-90e5-96694f2085e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_8bad5edc-04fb-4144-a4df-3e51b268aa63" xlink:href="avdl-20220930.xsd#avdl_AccruedInterestCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4d73332a-9feb-41ab-8e45-79977a132bc0" xlink:to="loc_avdl_AccruedInterestCurrent_8bad5edc-04fb-4144-a4df-3e51b268aa63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9fa6c0-568a-4e61-9054-2f3f64cd8926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_2f2ad0dc-e55b-4133-b789-a6364bfe79d5" xlink:href="avdl-20220930.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9fa6c0-568a-4e61-9054-2f3f64cd8926" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_2f2ad0dc-e55b-4133-b789-a6364bfe79d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_cb5d200b-a3df-4d6f-81a7-e89886bc3efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_ef9fa6c0-568a-4e61-9054-2f3f64cd8926" xlink:to="loc_us-gaap_GuarantyLiabilities_cb5d200b-a3df-4d6f-81a7-e89886bc3efe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_201677ed-fb63-4bc4-bcce-cbb834b8fa8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_72b736b7-ce85-4c93-8968-a9eb9641379f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_201677ed-fb63-4bc4-bcce-cbb834b8fa8e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_72b736b7-ce85-4c93-8968-a9eb9641379f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8315ef0d-6683-427b-97fd-88e11e84975f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_201677ed-fb63-4bc4-bcce-cbb834b8fa8e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8315ef0d-6683-427b-97fd-88e11e84975f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>avdl-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20220930.xsd#Coverpage"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended" id="i51732d1c2279481d9ef8ad47ac29b45e_Coverpage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ba04c8a1-d866-4e60-ab27-bb01917b52ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentType_ba04c8a1-d866-4e60-ab27-bb01917b52ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9b58614f-3fc0-43a2-9632-277fdcfb4692" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentQuarterlyReport_9b58614f-3fc0-43a2-9632-277fdcfb4692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_36b7001d-e5ed-46e2-859d-38dbbfc0515e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentPeriodEndDate_36b7001d-e5ed-46e2-859d-38dbbfc0515e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9e4c3107-54af-4bf6-8484-5053c6f0e19e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentTransitionReport_9e4c3107-54af-4bf6-8484-5053c6f0e19e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5d812c16-f5a2-4a74-bd9a-8851ae64b9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityFileNumber_5d812c16-f5a2-4a74-bd9a-8851ae64b9d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_77b6cb73-a4e6-4ed9-9a34-61b1dcda608e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityRegistrantName_77b6cb73-a4e6-4ed9-9a34-61b1dcda608e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e7fff235-0018-4336-aa3f-db44b1dbc270" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e7fff235-0018-4336-aa3f-db44b1dbc270" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_84d082ff-6200-4fed-8a4c-c6118efa1271" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityTaxIdentificationNumber_84d082ff-6200-4fed-8a4c-c6118efa1271" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b0e2fd55-16f4-4da6-b397-c3ff0a4bdc6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressAddressLine1_b0e2fd55-16f4-4da6-b397-c3ff0a4bdc6b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_543793ba-8761-401e-b5c1-d6a81e77c793" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressCityOrTown_543793ba-8761-401e-b5c1-d6a81e77c793" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_27dad97c-316d-4304-81cc-c4af32b8e345" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressPostalZipCode_27dad97c-316d-4304-81cc-c4af32b8e345" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a85414ad-b52e-4a9c-8870-298f98b2b268" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressCountry_a85414ad-b52e-4a9c-8870-298f98b2b268" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_d7220045-8f4b-4763-8a4f-cc624d345f10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CountryRegion_d7220045-8f4b-4763-8a4f-cc624d345f10" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_843c5f2b-a61b-4414-b4f9-594a555d10d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CityAreaCode_843c5f2b-a61b-4414-b4f9-594a555d10d3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3e90aa74-836d-4f5a-9b28-87761402cf78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_LocalPhoneNumber_3e90aa74-836d-4f5a-9b28-87761402cf78" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_87ee2418-d6d7-4c28-8c8a-e3abc234895b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_Security12bTitle_87ee2418-d6d7-4c28-8c8a-e3abc234895b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_75123091-f2ac-4a8a-b0a6-1f7d3b8e8c1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_TradingSymbol_75123091-f2ac-4a8a-b0a6-1f7d3b8e8c1b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_73df189d-3410-4158-a917-098fd20a6c9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_SecurityExchangeName_73df189d-3410-4158-a917-098fd20a6c9a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_105b086d-cdac-4e63-a944-c92c33ff1097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCurrentReportingStatus_105b086d-cdac-4e63-a944-c92c33ff1097" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_36030d2c-02d4-417e-8b6e-dd947af9f75c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityInteractiveDataCurrent_36030d2c-02d4-417e-8b6e-dd947af9f75c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_322f7e31-cf06-425d-87e1-85998cf71244" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityFilerCategory_322f7e31-cf06-425d-87e1-85998cf71244" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6509785a-8205-492c-a95c-14d9b0456287" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntitySmallBusiness_6509785a-8205-492c-a95c-14d9b0456287" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4407d8fe-031c-407b-a18b-98163b92fda4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityEmergingGrowthCompany_4407d8fe-031c-407b-a18b-98163b92fda4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b2dce575-e2dc-44a0-a0e8-be6dfc90f2a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityShellCompany_b2dce575-e2dc-44a0-a0e8-be6dfc90f2a1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9f5cfdfa-e3c5-45ef-96f6-886529dfc58d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9f5cfdfa-e3c5-45ef-96f6-886529dfc58d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_55af3cd7-c55f-4b1c-96d7-43a4f92400d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCentralIndexKey_55af3cd7-c55f-4b1c-96d7-43a4f92400d1" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f3d6f798-3496-45a4-a3f0-e1f1a984256d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CurrentFiscalYearEndDate_f3d6f798-3496-45a4-a3f0-e1f1a984256d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_998931db-37f6-424a-a3b9-50c0a43aac49" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentFiscalYearFocus_998931db-37f6-424a-a3b9-50c0a43aac49" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4cbb351e-9b1e-402a-8003-e102440b2756" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4cbb351e-9b1e-402a-8003-e102440b2756" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5018ac72-04d9-4603-b158-544c198e5cc3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_AmendmentFlag_5018ac72-04d9-4603-b158-544c198e5cc3" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_d9186cd9-9ab1-4221-9752-1570b8a26af0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_NoTradingSymbolFlag_d9186cd9-9ab1-4221-9752-1570b8a26af0" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:to="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_5f4632bc-e427-4413-bf25-c614b166b5c0_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:to="loc_dei_ExchangeDomain_5f4632bc-e427-4413-bf25-c614b166b5c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:to="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_4b7cdec5-eb34-4034-b174-70e5f480d78d" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:to="loc_exch_XNMS_4b7cdec5-eb34-4034-b174-70e5f480d78d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="extended" id="if2a31c380c4d4b9fb0088668da301b2a_CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_a51cb9d6-3c3c-4cce-a862-fe51704edbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_SharesOutstanding_a51cb9d6-3c3c-4cce-a862-fe51704edbc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68ae3d12-f1ab-4251-8641-9f8cb4f3ea85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockholdersEquity_68ae3d12-f1ab-4251-8641-9f8cb4f3ea85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f503adf-f50f-481e-81f3-e8eb1fb9dba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_NetIncomeLoss_4f503adf-f50f-481e-81f3-e8eb1fb9dba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21d34f08-e19d-47d0-8154-2384179bba45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21d34f08-e19d-47d0-8154-2384179bba45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_88486477-f5da-4271-8e13-bb119234bb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_88486477-f5da-4271-8e13-bb119234bb2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49c6a041-3045-4bc4-97fc-087e2b7b6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49c6a041-3045-4bc4-97fc-087e2b7b6caa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_40e0f41b-5e7d-4602-8f6d-84610b139ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_40e0f41b-5e7d-4602-8f6d-84610b139ec0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_822fe9ca-8ba3-4d67-89ec-48410ca41b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_822fe9ca-8ba3-4d67-89ec-48410ca41b18" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63678997-ede9-4c59-bd59-1b40f4558ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63678997-ede9-4c59-bd59-1b40f4558ce1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_211fb2a9-d629-4942-a3e8-f27417a833d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_211fb2a9-d629-4942-a3e8-f27417a833d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6dee38ce-cced-4d11-97a8-ddeab24d786c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6dee38ce-cced-4d11-97a8-ddeab24d786c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9f93313c-e338-4089-8a3e-0f10da5b8b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9f93313c-e338-4089-8a3e-0f10da5b8b88" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_32cf968e-2217-4b5b-a923-5b82f16dcc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_32cf968e-2217-4b5b-a923-5b82f16dcc21" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_7bef793d-7423-4436-9c7c-149488d9d32e" xlink:href="avdl-20220930.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_7bef793d-7423-4436-9c7c-149488d9d32e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e188a8d1-6f0c-4f6d-87f4-be38e34ea156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e188a8d1-6f0c-4f6d-87f4-be38e34ea156" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4f35b6a1-39d8-4ff0-82bb-3b5afa667ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_85c8fcb4-0c54-4d23-b30a-9de200626df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:to="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1096010c-346c-420b-80e0-9eaf8d7a7f98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:to="loc_us-gaap_EquityComponentDomain_1096010c-346c-420b-80e0-9eaf8d7a7f98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:to="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_924dbc14-bffd-483c-825f-1e7b39fcc957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_CommonStockMember_924dbc14-bffd-483c-825f-1e7b39fcc957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_26ec1eeb-5f88-4221-a2d1-b6ea34e146b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_PreferredStockMember_26ec1eeb-5f88-4221-a2d1-b6ea34e146b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2e13462d-0917-4bc3-8ba9-ffe1e756e4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2e13462d-0917-4bc3-8ba9-ffe1e756e4c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_db983e60-627f-4342-8173-201ccc43d743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_RetainedEarningsMember_db983e60-627f-4342-8173-201ccc43d743" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b19783e6-e4b7-40ff-9ef8-5ac09d76b38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b19783e6-e4b7-40ff-9ef8-5ac09d76b38d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1cb5a826-e9cd-479f-90af-fc2de356e963_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1cb5a826-e9cd-479f-90af-fc2de356e963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e5dfda51-a339-4374-9d7f-69f3dd57f9ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e5dfda51-a339-4374-9d7f-69f3dd57f9ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i65446e85ac974b43811c89f6a978f562_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52ea9861-35f2-46ad-b3af-058c8c4f5088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52ea9861-35f2-46ad-b3af-058c8c4f5088" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1ab889f9-f1ad-4c9f-9693-07e603974642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1ab889f9-f1ad-4c9f-9693-07e603974642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3122c461-0377-485c-8123-fbe66c16aee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3122c461-0377-485c-8123-fbe66c16aee3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4aeac431-64b1-4c70-9258-9c0bbf4ba6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4aeac431-64b1-4c70-9258-9c0bbf4ba6f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_d5999ddf-e42b-4eda-bc90-ff50d9321c9a" xlink:href="avdl-20220930.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_d5999ddf-e42b-4eda-bc90-ff50d9321c9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockCommissionPercentage_07d7ff3e-653f-4b23-bab6-7ac0b10a85a5" xlink:href="avdl-20220930.xsd#avdl_SaleOfStockCommissionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_SaleOfStockCommissionPercentage_07d7ff3e-653f-4b23-bab6-7ac0b10a85a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6644a720-0d1b-409c-adb1-9132de2abad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6644a720-0d1b-409c-adb1-9132de2abad9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6013d7fc-16ae-495a-85e7-48e9e2f05bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6013d7fc-16ae-495a-85e7-48e9e2f05bc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_8c770f6d-d7eb-49f6-8382-8774c0f636e7" xlink:href="avdl-20220930.xsd#avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_8c770f6d-d7eb-49f6-8382-8774c0f636e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:href="avdl-20220930.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:to="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember_3220dfa1-3e4f-41c5-8330-1e9179ca40dd" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2020ProspectusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:to="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember_3220dfa1-3e4f-41c5-8330-1e9179ca40dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember_3a54d235-dc1d-44ad-adba-b263309ebc0d" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2022ProspectusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:to="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember_3a54d235-dc1d-44ad-adba-b263309ebc0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_10a8b619-9fdd-47fb-850c-0166179339be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:to="loc_us-gaap_EquityComponentDomain_10a8b619-9fdd-47fb-850c-0166179339be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:to="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f1e63c3b-4d3f-4b58-b47d-8cbec9a8c6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:to="loc_us-gaap_CommonStockMember_f1e63c3b-4d3f-4b58-b47d-8cbec9a8c6dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94a2510b-14b7-4680-be3d-267714da95d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94a2510b-14b7-4680-be3d-267714da95d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_234d1973-0dd7-41eb-886e-6d32f1e46985" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_234d1973-0dd7-41eb-886e-6d32f1e46985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_9a87ece1-2a3d-405c-9016-e140d0099c1d" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_9a87ece1-2a3d-405c-9016-e140d0099c1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b84860b2-34f4-4bc8-9e8d-c3cd967640bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b84860b2-34f4-4bc8-9e8d-c3cd967640bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7aa76790-b6bf-4d7c-919e-cb60d6e64f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:to="loc_us-gaap_SeniorNotesMember_7aa76790-b6bf-4d7c-919e-cb60d6e64f66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended" id="i877222bcc21442f2a854a59b452d02b9_FairValueMeasurementMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_18d9bfa5-c819-4d65-835e-223b54151376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_18d9bfa5-c819-4d65-835e-223b54151376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4d117301-f81c-4fae-bc4c-b812c6e497a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4d117301-f81c-4fae-bc4c-b812c6e497a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2adc0bc-332a-4cc0-acb9-be1250c14ef6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a2adc0bc-332a-4cc0-acb9-be1250c14ef6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5ac4ac32-a7b0-48a1-aad9-f9245cf5e704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5ac4ac32-a7b0-48a1-aad9-f9245cf5e704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07978cb9-cd9b-49bd-8611-5d081fc7d7dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_07978cb9-cd9b-49bd-8611-5d081fc7d7dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_82e74685-1ef9-43d1-b6f4-7455d2bd4598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_82e74685-1ef9-43d1-b6f4-7455d2bd4598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0de9d36e-de4c-442f-bb01-fc1dfe4aec9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0de9d36e-de4c-442f-bb01-fc1dfe4aec9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a6b801d3-8602-47b1-9002-4be7db1baff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a6b801d3-8602-47b1-9002-4be7db1baff1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_788f4862-3c3c-46e5-ac9b-6964605609b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_788f4862-3c3c-46e5-ac9b-6964605609b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_150cdd43-eb21-4467-86bf-0587d1e9c27d" xlink:href="avdl-20220930.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_150cdd43-eb21-4467-86bf-0587d1e9c27d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a5842903-9cc0-4f6b-9bbf-ecdd95a65a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a5842903-9cc0-4f6b-9bbf-ecdd95a65a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4144f72-4166-47b7-b78e-56c51a13cc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4144f72-4166-47b7-b78e-56c51a13cc5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_a8264c73-4076-4f0a-9bfb-e4528d079ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_a8264c73-4076-4f0a-9bfb-e4528d079ee0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" id="ia65e59eef7aa4805aef769714babe16f_FairValueMeasurementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_af5c14e2-eca3-450f-b532-3da4a010a47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_af5c14e2-eca3-450f-b532-3da4a010a47b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7189ae58-8a53-48f7-a1d4-882e4e8abecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7189ae58-8a53-48f7-a1d4-882e4e8abecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8d9bcd2c-80ee-4450-91fe-b38f62f97dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_LongTermDebtFairValue_8d9bcd2c-80ee-4450-91fe-b38f62f97dce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fbd5981c-6488-4b1b-b5a0-5b4bb307954f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fbd5981c-6488-4b1b-b5a0-5b4bb307954f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1607651c-49a1-4e21-9175-4f8172f2a581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:to="loc_us-gaap_SeniorNotesMember_1607651c-49a1-4e21-9175-4f8172f2a581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:to="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cda425c1-8993-45f8-8f3b-d002142df194_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cda425c1-8993-45f8-8f3b-d002142df194_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_312a8e9e-8e61-40b9-966a-6d7a506c2df9" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_312a8e9e-8e61-40b9-966a-6d7a506c2df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_29c57fa9-173c-4a95-9cec-3f21f7a5b3ca" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_29c57fa9-173c-4a95-9cec-3f21f7a5b3ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended" id="i154f717fb1da4c3c958f4f9440ab5783_MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb7ada96-75e3-4dd5-863d-bc54560517ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb7ada96-75e3-4dd5-863d-bc54560517ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2abe391-c34c-4100-8743-d8a88a2dbe98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2abe391-c34c-4100-8743-d8a88a2dbe98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a0d1e1ef-d6ad-4351-8e09-cc3130108e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a0d1e1ef-d6ad-4351-8e09-cc3130108e3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_77e8768f-bbb9-41e0-a81e-876edaf79bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_77e8768f-bbb9-41e0-a81e-876edaf79bff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3785682-e09c-4809-8b04-1c926ade734a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f3785682-e09c-4809-8b04-1c926ade734a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d586773d-ab6a-469c-bcba-3a2d0cd044d7" xlink:href="avdl-20220930.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d586773d-ab6a-469c-bcba-3a2d0cd044d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_54711331-786c-43a1-aa9e-1619c49d2c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_54711331-786c-43a1-aa9e-1619c49d2c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_af53b0ad-297c-488a-b4bc-3e72191c44d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_af53b0ad-297c-488a-b4bc-3e72191c44d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_4fff4685-0ae3-4ebb-940c-90b2647257ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_4fff4685-0ae3-4ebb-940c-90b2647257ee" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended" id="ia5f349c7323c447b98025c596896639f_MarketableSecuritiesScheduleofMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ac763741-280a-4afb-b05d-3fc6ce67e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ac763741-280a-4afb-b05d-3fc6ce67e9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c56a56de-2cc2-4e1f-bed0-7836f720b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c56a56de-2cc2-4e1f-bed0-7836f720b14f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_908b692f-8360-4e26-a2dc-3ac2f8f433c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_908b692f-8360-4e26-a2dc-3ac2f8f433c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d97f339f-c033-4350-8a84-58aca0703bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d97f339f-c033-4350-8a84-58aca0703bca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf7a12c6-74a3-4e83-ba44-e5f44ee34181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf7a12c6-74a3-4e83-ba44-e5f44ee34181" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1bdf92a-54a0-43de-be3b-214a0f493aac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1bdf92a-54a0-43de-be3b-214a0f493aac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_09e3b606-40c3-4fab-bb41-29b1706d6c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_09e3b606-40c3-4fab-bb41-29b1706d6c43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0903313b-4fd0-467f-b313-2134a08b615f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0903313b-4fd0-467f-b313-2134a08b615f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_44612bad-4565-44e1-91cf-b95122672299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_44612bad-4565-44e1-91cf-b95122672299" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_7efd66c1-4ade-4ce0-9a0d-a5c33b6eff91" xlink:href="avdl-20220930.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_7efd66c1-4ade-4ce0-9a0d-a5c33b6eff91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended" id="i90e0392a59b84123b1b1e3e2b8a05c2e_MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ae6a463c-d914-409b-828a-5dfdb8b84912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ae6a463c-d914-409b-828a-5dfdb8b84912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_34f74e5b-4cf8-42e9-a6f1-cd1d45a799bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_34f74e5b-4cf8-42e9-a6f1-cd1d45a799bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_bd57e81a-f6f5-44db-b541-4a0fcb323f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_bd57e81a-f6f5-44db-b541-4a0fcb323f8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6b7bf22c-7244-49c0-af91-2f5b673fedb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6b7bf22c-7244-49c0-af91-2f5b673fedb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a1b4dd96-8486-4244-8582-644859922b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a1b4dd96-8486-4244-8582-644859922b3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_daaca863-d619-41de-9088-1736ad7c8fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_daaca863-d619-41de-9088-1736ad7c8fb2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:to="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_477056e2-037a-4944-8a81-4c662702327c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_477056e2-037a-4944-8a81-4c662702327c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_826df01e-43ad-4139-a0b4-06a97a0d86b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_826df01e-43ad-4139-a0b4-06a97a0d86b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1a4a2d31-06a5-4685-b8c4-3e57a9fd108c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1a4a2d31-06a5-4685-b8c4-3e57a9fd108c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_1053e8c9-5d19-4ac5-881a-b7afb79a4cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_1053e8c9-5d19-4ac5-881a-b7afb79a4cce" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended" id="i22fafc7c0810406c89c027fe733b4132_LongTermDebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1f5316a-ea3a-4d9c-8996-a8019b3c9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1f5316a-ea3a-4d9c-8996-a8019b3c9344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_38fa67cc-5209-4789-a3f7-3adb59596c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_38fa67cc-5209-4789-a3f7-3adb59596c9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_959be169-a2e6-4a1e-822a-0cff468f98cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebt_959be169-a2e6-4a1e-822a-0cff468f98cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f7886060-bb3c-4660-bb5b-644d2c1ad873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebtCurrent_f7886060-bb3c-4660-bb5b-644d2c1ad873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3facc8bb-1980-4b24-b4a1-ccb33849d337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3facc8bb-1980-4b24-b4a1-ccb33849d337" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d29676b4-4db7-447d-bb88-a6e896d2aa3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d29676b4-4db7-447d-bb88-a6e896d2aa3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_70e95eb0-eb38-49e8-b777-6e44dc3b735a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:to="loc_us-gaap_SeniorNotesMember_70e95eb0-eb38-49e8-b777-6e44dc3b735a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:to="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_76cd3f76-3664-42a1-9383-6d89dec92f6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_76cd3f76-3664-42a1-9383-6d89dec92f6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_abf328f9-a53e-4b41-bc38-cd84c3593da6" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_abf328f9-a53e-4b41-bc38-cd84c3593da6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_780984a2-3512-4808-a099-dcd5ceefb581" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_780984a2-3512-4808-a099-dcd5ceefb581" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i9a919e74420349e8b4fb3a12b2cd809c_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d613e9ad-26fc-498e-842d-2f45dd4200a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_InterestExpenseDebt_d613e9ad-26fc-498e-842d-2f45dd4200a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_a1716537-6a6e-442e-8588-30328ac5c8e0" xlink:href="avdl-20220930.xsd#avdl_CouponInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_CouponInterestExpense_a1716537-6a6e-442e-8588-30328ac5c8e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_4c09b83b-5ced-474f-8a20-fc762e453755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_4c09b83b-5ced-474f-8a20-fc762e453755" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_0d8c7dcf-c81f-4412-9caf-9123e94fa6c4" xlink:href="avdl-20220930.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_0d8c7dcf-c81f-4412-9caf-9123e94fa6c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6877ae2b-5a1b-4679-a9f7-2c6e323aa8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6877ae2b-5a1b-4679-a9f7-2c6e323aa8c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_6c1488e0-73fb-48ea-997b-b812bde50397" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_6c1488e0-73fb-48ea-997b-b812bde50397" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_72480a21-8b07-433f-8f3a-23cf158a95b2" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_72480a21-8b07-433f-8f3a-23cf158a95b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d74f7ddd-c3ae-4175-b651-8b8ad6e8005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d74f7ddd-c3ae-4175-b651-8b8ad6e8005b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount_2c41354e-f618-4702-bc34-9d5873c1ed2c" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentExchangeAmount_2c41354e-f618-4702-bc34-9d5873c1ed2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4b2ef403-7b77-4712-a038-b05a72051452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4b2ef403-7b77-4712-a038-b05a72051452" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_1f75bfca-9385-4f1e-a4a4-132b4685923c" xlink:href="avdl-20220930.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_1f75bfca-9385-4f1e-a4a4-132b4685923c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_7294fe63-879b-430f-a91b-5108a99dba2d" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_7294fe63-879b-430f-a91b-5108a99dba2d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_076247c7-1767-4808-85c0-d9f31229cf21" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_076247c7-1767-4808-85c0-d9f31229cf21" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_3cadd44e-573e-489f-bae6-d98ec6183c18" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_3cadd44e-573e-489f-bae6-d98ec6183c18" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_46750853-963f-4698-b860-a2de7250e098" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_46750853-963f-4698-b860-a2de7250e098" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_0433a088-bd39-4afd-bd54-989edb642339" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_0433a088-bd39-4afd-bd54-989edb642339" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_2c461f57-3f62-4581-8a60-3daa8a7b10fc" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_2c461f57-3f62-4581-8a60-3daa8a7b10fc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_974e4999-406c-4df5-b8fb-dcd17ad1d2eb" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_974e4999-406c-4df5-b8fb-dcd17ad1d2eb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_634f47ae-7d21-4269-b238-160a16a65cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_634f47ae-7d21-4269-b238-160a16a65cf4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_9255a8b8-76b2-40fb-9a5b-e8905346ef00" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_9255a8b8-76b2-40fb-9a5b-e8905346ef00" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ea605cd3-d5e4-41ba-949c-18f60f391b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ea605cd3-d5e4-41ba-949c-18f60f391b22" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b3cad3de-5a0e-4cd7-817d-f42e9d672b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b3cad3de-5a0e-4cd7-817d-f42e9d672b03" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_5067a246-a0f9-4623-be21-b274c45a1593" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_5067a246-a0f9-4623-be21-b274c45a1593" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_03048c85-3808-4618-b44d-2e7e12a6c5b1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_03048c85-3808-4618-b44d-2e7e12a6c5b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_47f7dbb8-3e0b-4799-8b80-ad12eafc8621" xlink:href="avdl-20220930.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_47f7dbb8-3e0b-4799-8b80-ad12eafc8621" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_4b931062-7ea5-4638-841d-a19b9f25dae1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_4b931062-7ea5-4638-841d-a19b9f25dae1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0e84603f-fb42-49bc-bb5f-1bda12e6e6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:to="loc_us-gaap_ConvertibleDebtMember_0e84603f-fb42-49bc-bb5f-1bda12e6e6e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_32a56f68-9d54-4138-ac12-e1c5c01aab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:to="loc_us-gaap_SeniorNotesMember_32a56f68-9d54-4138-ac12-e1c5c01aab70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember_644a1c68-0294-479c-814e-45d8be584592" xlink:href="avdl-20220930.xsd#avdl_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:to="loc_avdl_ThirdPartyMember_644a1c68-0294-479c-814e-45d8be584592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4ef95668-4281-40d5-b104-2706174d3883_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4ef95668-4281-40d5-b104-2706174d3883_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_97c9ac89-a311-4acb-b4dd-9a929b428603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_97c9ac89-a311-4acb-b4dd-9a929b428603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ae4ca6b5-9f67-48bd-9d20-4426be58b440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ae4ca6b5-9f67-48bd-9d20-4426be58b440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_dc5d3462-3b10-43c4-9681-c2b329a9946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_dc5d3462-3b10-43c4-9681-c2b329a9946b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#ShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationDetails" xlink:type="extended" id="i52e9be9f5ba14c8996ec9257046440f7_ShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4d6d91d-f6e5-485d-ba23-5816a5523e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4d6d91d-f6e5-485d-ba23-5816a5523e5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e59de3f-c6d3-4b4a-b60e-19753eed196d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e59de3f-c6d3-4b4a-b60e-19753eed196d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4d1fe65d-0e9f-4f80-8d1a-787e9728c9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4d1fe65d-0e9f-4f80-8d1a-787e9728c9ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:to="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81382c67-ee60-4b09-a10d-a458691f1e2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81382c67-ee60-4b09-a10d-a458691f1e2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_74a23e74-63d5-4afd-98dd-6b89fd450ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:to="loc_us-gaap_PerformanceSharesMember_74a23e74-63d5-4afd-98dd-6b89fd450ba1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#ComprehensiveIncomeLossComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="extended" id="i1c5ed2f6f4c44446a76919d20fe2b32c_ComprehensiveIncomeLossComponentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_356d3538-ac0e-4c5b-8b8a-68d60edbf5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_356d3538-ac0e-4c5b-8b8a-68d60edbf5fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1c9032a-c8c5-4923-93cb-e60d0438204b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1c9032a-c8c5-4923-93cb-e60d0438204b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e9d6db7-52b9-4891-9857-1151923de3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_928bf496-5f64-4bae-a421-8bf141a6f372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_928bf496-5f64-4bae-a421-8bf141a6f372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:to="loc_us-gaap_EquityComponentDomain_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:to="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_98f88ad0-b4bd-4b27-9210-c8384db43334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_98f88ad0-b4bd-4b27-9210-c8384db43334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_8d0cd367-25da-48e2-ab54-57d8a4c18949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_8d0cd367-25da-48e2-ab54-57d8a4c18949" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i7a900567dcbe43bd9968d85bee2ad4f9_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_3177ffe1-b46d-4ea3-857c-046af93892c2" xlink:href="avdl-20220930.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_3177ffe1-b46d-4ea3-857c-046af93892c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_8c1c92eb-066d-4d9f-aca9-73fc62f2840e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_8c1c92eb-066d-4d9f-aca9-73fc62f2840e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue_2d1dd490-44d4-407b-8e9f-66a06f2ae121" xlink:href="avdl-20220930.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_avdl_GuaranteeAssetCurrentCarryingValue_2d1dd490-44d4-407b-8e9f-66a06f2ae121" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:to="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0794dd1d-a8f7-40b8-a522-541d25d01986_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:to="loc_srt_RangeMember_0794dd1d-a8f7-40b8-a522-541d25d01986_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:to="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b6f88552-47ab-45e9-b203-26685ed42ffa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:to="loc_srt_MaximumMember_b6f88552-47ab-45e9-b203-26685ed42ffa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#RestructuringCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended" id="i4690fcd3d08044939d2d198b52afa29e_RestructuringCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4d5c9197-bdf7-4e6d-a822-f8ca8f5f593e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4d5c9197-bdf7-4e6d-a822-f8ca8f5f593e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b569e167-f219-4d30-8aee-969c9e75ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringCharges_b569e167-f219-4d30-8aee-969c9e75ab10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_58a7db44-2176-4402-a524-38c8a604bc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringReserve_58a7db44-2176-4402-a524-38c8a604bc81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:to="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_953d1ed6-1f1f-488a-95b1-e52256b5e746_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:to="loc_us-gaap_RestructuringPlanDomain_953d1ed6-1f1f-488a-95b1-e52256b5e746_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:to="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_4b176aab-29f2-4dd4-807d-08a852ca91ba" xlink:href="avdl-20220930.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_4b176aab-29f2-4dd4-807d-08a852ca91ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended" id="i8c51a434cbe74af2b024fa9fd0d79785_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f6b150c5-20bc-495e-88b2-725cb2e50061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f6b150c5-20bc-495e-88b2-725cb2e50061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b63c1777-e2b8-4fd8-98ff-81263d27d738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b63c1777-e2b8-4fd8-98ff-81263d27d738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:to="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef83fc53-a29f-4d6c-8511-b30c6f006ccd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef83fc53-a29f-4d6c-8511-b30c6f006ccd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_88186b99-680e-43c8-851b-0b595ff6bbe1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_88186b99-680e-43c8-851b-0b595ff6bbe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6a727cca-6a03-4859-8333-d052feca18e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6a727cca-6a03-4859-8333-d052feca18e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_103e9dc5-848f-434d-afdb-c1f8da37d317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:to="loc_us-gaap_SeniorNotesMember_103e9dc5-848f-434d-afdb-c1f8da37d317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d8ef5730-4c60-41b6-83e9-5402257f6f71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d8ef5730-4c60-41b6-83e9-5402257f6f71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_89017ea8-305e-4002-bf03-a9e390630572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:to="loc_us-gaap_SubsequentEventMember_89017ea8-305e-4002-bf03-a9e390630572" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>avdl-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a0dde626-4fa6-44a3-b630-6c85333ce304_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 Year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_13c76b76-2471-4c01-bb9f-f7ef0fc9753a_terseLabel_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer allowances</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_label_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued trade discounts and rebates</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_documentation_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:href="avdl-20220930.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:to="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_63c3c0d3-081e-4425-b6f2-8e71ab4092c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5fa687e9-1e2a-4b63-938d-e7f0de016038_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_490fa46a-1bf0-48ab-86b6-1bcadbf93126_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due October 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a2b9ae02-93bf-4f94-a70d-448fa4bfca5c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_4fd3bf49-90a0-4eeb-91c6-adf2fc30d531_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_9d003be3-5776-417b-adaf-ff837658cae3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_da9e3287-639e-455b-804d-95f5866822c3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principle amount of exchangeable senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_a7a2391b-ec78-4c13-9a6a-ba5818d482b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_78552609-a8ba-4620-8e60-6839f4f2e1e5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4aab427b-fcc2-4683-9d23-47a887d343e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5a58e715-77b2-4c58-8634-9b88bf874f76_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e24dbb90-c887-4c25-a219-5b2d039e40d0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_188f3145-399a-4c52-824b-0d13b1a00ce9_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADSs, conversion ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_label_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_documentation_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:to="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_5060a538-1c5e-4919-81c4-f5570ba5bf8e_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase aggregate principal amount, term (in days)</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:to="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_877005e5-b442-4cb3-b3fd-fe1cd4274308_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_6215536c-6a2a-4825-9acf-f12f9f484af1_verboseLabel_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax liabilities</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_documentation_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:href="avdl-20220930.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:to="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_cfecb2de-26ee-4d35-aeb0-d9cba7baceba_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d824f6a-2418-44f6-9c2a-37f3208cf096_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe2c4aef-9901-45af-bc8e-ac5d35e87ac6_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_de98e97a-a71a-401f-9494-34839f5e7d1b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days (in days)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4ad22d6f-ff01-4b1a-ad39-86a1fec82d8e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2c54b5a7-2363-4dd5-9651-f8d1b708151c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_ba42bcf2-35fa-450d-8368-004b7295b5b3_verboseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credit Receivable Non Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The non current portion of tax credit receivable on research and development as on the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_66e19346-22a9-406c-9eb5-4394ae44e3fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c6cfe9a7-0b1d-4cba-879e-2b3f102ff6db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_33dadf54-48ad-4df7-8770-b24e8c1e115b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_2c4405d9-0bc9-4eda-a414-f849a228f94e_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_24db1f82-f016-4d10-a61f-025a11f290b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_31e8478a-f6ef-4645-a961-81bee222521f_terseLabel_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_label_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_documentation_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:href="avdl-20220930.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:to="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_60d911f9-ecca-4a54-b95a-aa7173cb0da4_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets:</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_5d6dc195-3fad-4047-acc9-073ec5464f9b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cd7756c8-4e85-4236-b726-59ef279afe77_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 60,885 issued and outstanding at September&#160;30, 2022 and 58,620 issued and outstanding at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_c94711e2-00c7-4198-a063-786778b77339_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_3b39cb19-6804-47e5-b604-9692b73569eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SaleOfStockCommissionPercentage_a49ccfcf-eee5-4467-81a4-67f39f1d8537_terseLabel_en-US" xlink:label="lab_avdl_SaleOfStockCommissionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission percentage</link:label>
    <link:label id="lab_avdl_SaleOfStockCommissionPercentage_label_en-US" xlink:label="lab_avdl_SaleOfStockCommissionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Commission Percentage</link:label>
    <link:label id="lab_avdl_SaleOfStockCommissionPercentage_documentation_en-US" xlink:label="lab_avdl_SaleOfStockCommissionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Commission Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockCommissionPercentage" xlink:href="avdl-20220930.xsd#avdl_SaleOfStockCommissionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SaleOfStockCommissionPercentage" xlink:to="lab_avdl_SaleOfStockCommissionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_2d526e2e-5955-4bbf-8e3e-b46e28b66dcb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_68b5386f-4040-4523-8e0d-b9b271d4d78a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_85cfdc4a-2dfb-4841-a745-0b4b20c1d2e4_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1db8aa12-46cf-42e6-b59f-39ed6452b49f_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_711489c3-c3e9-4b7c-ad86-a20a288ce3e9_terseLabel_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan</link:label>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_label_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan [Member]</link:label>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_documentation_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember" xlink:href="avdl-20220930.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2022CorporateRestructuringPlanMember" xlink:to="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fc98264f-8a73-4a21-8aef-88524c3ed187_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_38085f9c-55ee-4835-b9f0-f483b3a696a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_88acb460-9db3-4be6-90e3-ee3a548ef437_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_da82611d-10cf-4af7-aef2-de3c8678609d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_844c0dbd-a74b-4da0-8d09-4e1f95e4fd2f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_64196141-0981-4e3c-9a11-4652841f8a85_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dd0534e1-bf7f-4599-846f-55f3dd783c0d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at January 1,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_84bd1d90-c7b7-46a4-a81a-aaa2c9c1d1e7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at September 30,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_5a0a9b06-44b4-4a38-a805-73beb8809c85_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_00ad3bc1-9ac4-437e-a870-d1d009b36acf_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2a4eff1a-f6a3-4a79-905b-c12119aa27d5_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_23171690-19bf-4905-ac02-c62f8587767a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans or conditional grants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a24d0f6c-2df9-4661-9a93-6a8882d6f992_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_92cdebb5-8a85-4ba4-acd1-217f0f451620_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_08b7e085-2787-466f-9760-335b789c5a5f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_08335b58-2597-4677-afc0-adf618ea5f2d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_085b616c-609a-493c-8eea-7c1554d2aff2_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_d944b2f0-af7f-4b51-b6ff-aa4950442000_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_630e8856-3705-4313-9d48-164b52735bcf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-5 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_4ba6273d-b7e6-48e4-9cf9-7a757e1e790f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CouponInterestExpense_a5fb0dea-6ca7-4fff-b976-7bd10cbf38ae_terseLabel_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_label_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_documentation_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense" xlink:href="avdl-20220930.xsd#avdl_CouponInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CouponInterestExpense" xlink:to="lab_avdl_CouponInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_3e5c300a-a55a-4f0f-a241-51cbf0a1a812_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_6be1a88b-328a-4c0c-b524-510b1e1a481e_verboseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale and Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_40e04d3d-788c-4933-a5b4-bf6728319aa0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringChargesExcludingOtherAdjustments_a6290501-6883-457a-9ee5-d5206eef75f7_verboseLabel_en-US" xlink:label="lab_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges for employee severance, benefits and other costs</link:label>
    <link:label id="lab_avdl_RestructuringChargesExcludingOtherAdjustments_label_en-US" xlink:label="lab_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Excluding Other Adjustments</link:label>
    <link:label id="lab_avdl_RestructuringChargesExcludingOtherAdjustments_documentation_en-US" xlink:label="lab_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Excluding Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:href="avdl-20220930.xsd#avdl_RestructuringChargesExcludingOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:to="lab_avdl_RestructuringChargesExcludingOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2211e7f7-f8b3-4ed9-b56c-2d8e3a6dd8da_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1258376a-f2f3-4c77-a90f-329bd4f1fc9a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4840483c-3f3b-4316-8198-d98764b390e7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_146395ec-6e19-4ffe-95fd-1516acab9ec3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_f4d0f2e0-5b3e-4297-a3a8-01a55bc04ca6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1768fb9e-4de9-4a31-8308-d96e4f9c7b5b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_edcddfbd-b00a-41d9-bbd6-0e11e73d989c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_205856dc-fdb0-4df6-bdc9-64129b3a87f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_420cc511-5641-4462-b03a-2fd60c84e888_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_753b3034-84bf-4085-a03c-d5ae5608c933_terseLabel_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_label_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Excluding Money Market Funds, Available For Sale [Member]</link:label>
    <link:label id="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_documentation_en-US" xlink:label="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Excluding Money Market Funds, Available For Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:href="avdl-20220930.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:to="lab_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_90abec56-6b8a-4c43-9896-2fcc27621991_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_bba98c18-9281-45d7-82b9-87bc141b8c82_terseLabel_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of October 2023 Notes conversion feature</link:label>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_label_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</link:label>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_documentation_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:href="avdl-20220930.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:to="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_29ec172a-c832-42ad-89d1-89037c3e5e12_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_7df0e0b4-4042-43d0-9855-f3d14c6c4762_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_524506d0-5bd9-44ec-9af1-40fd77e150ea_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, liability</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2ed1a9c1-cf57-4b10-8fb8-4a9eb0efedb2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock option exercises and employee share purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_3822b3d7-76a1-465b-87a1-f1e780d22467_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b67f9f18-3313-435b-9e82-0f4a59b21e27_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d77d4bd5-c1b2-47c4-83ba-c3195dd487ee_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_80a0c0eb-22d3-4405-a452-5316c0d024cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_15261f70-ffaa-4754-8f3a-947e489fb842_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_48b4c79d-d239-4485-b919-ab9de8262add_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_082b6dfe-7513-4fa7-b1fe-ab5cdb3a57ff_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4fc8f211-d32f-4ffa-a20b-0b4e8fbb90df_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_17d9fbb8-47c8-450a-944f-d452ea339f7b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_531ab83f-9f6c-4283-993c-7e104d0b71f2_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember_7b0f096d-1319-4fcc-9260-c8ec6e7a9c57_terseLabel_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2022 Prospectus</link:label>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember_label_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2022 Prospectus [Member]</link:label>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember_documentation_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2022 Prospectus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2022ProspectusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:to="lab_avdl_OpenMarketSalesAgreement2022ProspectusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_85ddf366-7160-42a0-81b2-32d6b44efef2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_48a0c164-ee84-4052-904f-dedc990cf8ce_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_8f21953e-45b2-453b-bbba-7f82b3f78eca_terseLabel_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of royalty payable on net sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_label_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Royalty Payable On Net Sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_documentation_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of royalty that has to be paid by the company as per the royalty agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:href="avdl-20220930.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:to="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_72c0272c-fdeb-4984-a20f-261abe710172_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_62db273d-76d1-46e7-bc37-8645cea7bb33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_d318a465-e99d-4e14-9af2-72b5879239c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_1ad959bc-aa78-4b4d-a223-242f7108695a_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_67f05489-8307-4e24-8bf5-0bfb88f1618c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_77edacaf-99bd-4bfa-9de2-dc22f1be44f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt discount and issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_afcf420d-8ac4-4893-8ebf-681151942ccf_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS, option price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_c98b9abe-aff0-4445-8607-2629f0ae48ec_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business days (in days)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:to="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_d2fa4bd5-6f5d-4e5a-ae8c-40eb4139fef1_terseLabel_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program</link:label>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_label_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program [Member]</link:label>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_documentation_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember" xlink:href="avdl-20220930.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember" xlink:to="lab_avdl_AtTheMarketOfferingProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_bf04b567-398d-4084-83ed-260207fdf638_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_41d6ab0c-3287-4335-b995-56f8f7faa688_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f75126af-d00f-47fe-8fdb-1f752c75e51b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5263d59a-7d08-4cae-83eb-3a5a224d8e16_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a6cc1dd7-a218-4ce5-b768-db87355a0953_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b2ba6bc-1c61-415b-bf07-04791c3066c0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5c000b49-9a6e-47ec-8103-9fe2eadcb9d9_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_34d9ab6f-268f-4892-8079-a7e54cadd2f8_terseLabel_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds [Member]</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:href="avdl-20220930.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:to="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_5abc897c-0f63-4b45-8d50-2a41da39d851_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_34217a8f-279d-4439-8316-c829ea0a27a9_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration for repurchase of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_d48169f8-f91d-474d-912b-f2c7ad4060b1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the disposition of the hospital products</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_13929011-f471-4899-9ee1-7eab0ee17c0a_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember_c14b3290-85d0-4388-aaed-f1190a6319a7_terseLabel_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2020 Prospectus</link:label>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember_label_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2020 Prospectus [Member]</link:label>
    <link:label id="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember_documentation_en-US" xlink:label="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Sales Agreement, 2020 Prospectus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2020ProspectusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:to="lab_avdl_OpenMarketSalesAgreement2020ProspectusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_860ba17f-a864-4d73-8cb8-cb101936f013_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3e3f76b8-45bb-4baf-945c-6656053fea38_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7017a1cc-cf96-4ac6-a6e7-cee17a0b821c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_babea34e-b0dc-4839-a9dc-aa659b51ada0_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_17d1e61f-3a80-44a5-befe-e9bb20edf3ee_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_327f9499-0c83-48fd-9fc9-6eddc79e04e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2d899a74-fce6-4910-ae96-bffff9077d36_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f3990256-ac51-478b-89e3-2aa8f2b93e79_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_c02169bb-1b10-4b27-8a07-d9c5edf18fe5_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:href="avdl-20220930.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_99b0f014-9cbd-4d39-b44d-9b14c26c95fd_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_769b21de-8150-4c51-92e7-bd0e816e9bcd_terseLabel_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued outsource contract costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_label_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_documentation_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts" xlink:href="avdl-20220930.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedOutsourceContractCosts" xlink:to="lab_avdl_AccruedOutsourceContractCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_5958ab3c-9e33-4493-a518-cf907325896b_terseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_19fa72c4-39c1-4858-afbf-4a71006f6bdb_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7128dead-244b-4fce-8653-42d5427967ee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5dcc5127-d5a5-43b7-bc2c-9f817e8b9ee3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d1ed5174-dcc5-4c64-a64d-4fa94e47774f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_89554121-e18d-4825-8c09-7e592d53f804_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_579a3de1-131b-4612-b788-b3c5bf854a09_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8cc8d17e-67e2-4446-aa57-d7362ed25845_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2f1fe588-a106-4321-9e3c-4c8f1cfb458c_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_d35e8b91-6201-4a87-8ebc-c5d76b1e242d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under at-the-market offering program, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_690dabce-c669-4455-9531-7ed238490975_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9f0ed5d-6487-407b-a03f-20f429c69b9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f32eb6e5-a6af-4b2c-bed8-b62694259875_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f3b5438a-c473-425d-9b35-bc65269027f9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_6e996151-60ba-47f1-be46-f99eb8b07c0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss) gain on marketable debt securities, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ba1aeaaf-ec9a-444e-8cbb-907992378e4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes (refund) paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6a3e0c34-6c60-42ee-b8bc-0eee31398422_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_98571408-c409-4420-b8e9-f7aa0534903d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5115349b-aa1f-40cd-b5cd-1781fb40b9fc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_951175f5-7d1a-422f-9fc3-0ba341b02eea_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_1c9302aa-0b74-4f16-8de1-34d77d2ce80d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_5dfc5aa1-c72b-4b2f-8ca7-5604266a9366_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_fdc84818-9206-45d9-9d17-7d3d04e8f523_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e3e587dc-355c-498b-86b5-12648ca8a0e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fc2ce51e-c40e-4df5-9db5-9d4f59c39c69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of shares outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_65aa84f2-fb31-405f-8aa3-8bfd221da068_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_2bcfc936-2ec5-4157-8811-2f9384c8e7dc_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_794238da-8cd0-46dc-96be-ee185b9becea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days (in days)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_50cb96d3-15af-4b7a-9723-a557e44d3a43_terseLabel_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due 2023</link:label>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_label_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:href="avdl-20220930.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:to="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e298920c-0eed-4487-823a-1fd05f680e67_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_63b5b27e-d212-4662-a722-0560f3756369_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_c2e2c111-f0f2-4206-a53f-64c441f7b81b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_01289a1d-a2c4-49b1-af95-176b90d3ac00_terseLabel_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:href="avdl-20220930.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:to="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_a4d77fe1-acce-45ba-8498-901ded6e3a06_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_c259f9ba-362c-4a36-883c-240919dd1f74_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ab4a59ef-501a-4a6f-b64b-1418ff0ab985_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2d0429fc-0826-4cc5-8358-cff5e9e9c63b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_53ff274d-579d-4498-9154-821f0f791067_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other fixed-income securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5f618249-1254-44c8-a0c7-4aa60e7b7c39_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8a4b2e64-0b5b-4f77-95b9-b39f458a12c9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_061052b9-ba74-4051-9dac-b94c0944f614_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_0f2724cc-cce3-4567-a9aa-cc595cdb2e19_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expense</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_bb37f1c3-55ab-4fa2-b9e9-9a083eac7b87_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_050f438c-5539-4eec-beb5-7a3dab28c959_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_118af784-c38b-45d6-ad95-b8c7a89c048f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_cb2549fc-affd-41b4-b0ab-c5bc13495684_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_9e875be4-50b2-4d54-8827-666e8ea34605_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_c408caff-7f44-4547-baef-47089d50c172_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_50654f1e-f285-44a9-bc12-d6d8efaf7205_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_234df8e0-e3eb-4b9a-a213-f5f10894a10e_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities - U.S.</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_71d61c72-33e1-4859-b2d0-94858ab867ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_380d0006-b425-4c95-9d6d-a5e259f25cac_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_eabc4f88-372a-4ca3-a801-c9e870427325_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_ab444982-0d3a-4add-9f49-c0385edaa4ef_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_aa70155c-ddb2-4ffa-ae03-049d0142eeb7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_db2d2c16-218d-482c-9320-31eabe38714f_negatedTerseLabel_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_label_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Research and Development Tax Credit Receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_documentation_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in research and development tax credit receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:href="avdl-20220930.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:to="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_85ea11f6-ea4e-4515-859c-7b22163b316a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_f107e6a1-afe5-4d3a-9f44-eddd8e67d602_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_35b5255e-4e6b-4950-898c-b259815c674c_terseLabel_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_label_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Receivables</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_documentation_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount of other noncurrent receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables" xlink:href="avdl-20220930.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherNoncurrentReceivables" xlink:to="lab_avdl_OtherNoncurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ThirdPartyMember_4ee615ab-4a84-4bfd-bdc4-566715fa823f_terseLabel_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_avdl_ThirdPartyMember_label_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_avdl_ThirdPartyMember_documentation_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember" xlink:href="avdl-20220930.xsd#avdl_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ThirdPartyMember" xlink:to="lab_avdl_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c04d807a-dba9-4a11-932a-1e73635eda30_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses, greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_046b32ec-094f-4592-a381-981615a4e217_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units (PSUs)</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_136c4d41-cd15-4846-b4d1-01e17584dcbe_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_dd4fcff3-3ed5-48fd-9c2b-82034e188f58_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_6ba149a2-65ff-41e6-b72b-819f6795c403_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_92ca5888-b764-4e4e-8c5f-69d867df7648_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f0448ba3-9a1e-47e5-a4fd-8babead0d7f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_66e0c814-45e9-48af-bb55-3077a9d221f1_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d8be0aec-6921-4ef6-b08c-fd602aa8025e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_073e5c69-1794-450f-afcc-de1eeb86372d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_1ed804a1-ca32-4df2-a14a-7836cd91f723_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_e9b909a3-91fb-4ce0-bd8f-b5471cd348f5_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6ccd6575-91e4-40ea-8d5c-22e679be6022_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b5ca8eec-4850-48be-804c-e03577908403_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_94a51036-1997-4bef-8dd9-88777863dbc3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b33cd669-f250-42f7-912b-02a1ae8d9553_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_e25d9242-1047-4314-bc31-537f9d6de171_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_2ee56df6-c601-414a-b83d-b59ef29822f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_f385e357-8d52-4ed6-b029-89027451dc07_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_3569eb9c-c20f-47f1-b05e-2894fcef873d_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4d04f771-b639-488f-8b46-6b5646212649_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_61e5ccc2-d832-4f3e-bbe4-a14183aace86_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (income) expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ad33fc95-6d2b-4b60-b8bd-d317a4d93d32_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; (deficit) equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_530c0afc-12e1-48c4-ab71-48fc249570fe_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_02d0905c-9ebf-479f-953f-38b520b32bb1_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf179664-ea13-4152-a922-114f255cd2ec_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_cdd752a5-3f71-4e34-87f2-d0e8f90c5a21_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_0318b810-8acf-4aa2-81bf-573866eb443a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_369ed740-d56d-4168-8282-5adc2082ff46_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_e4a29ceb-2830-4136-8f7e-84c1073cb60b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_cebc7f79-378d-43e6-bf0f-9e4318772a31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_ea0283bb-7e8a-4082-8a8f-980d828d182e_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d08d6e04-6ceb-4ee7-868e-1fe7ff88d7e8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturity Dates</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_9002281b-8192-478a-8307-b10a76a7952a_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day(as a percent)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:to="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_c07322c8-8d53-4abe-bb38-6baf7d1b2a5f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, tax expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_57e36a81-212a-4900-95fd-c00a8dccadd1_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_653f6cbf-763f-4d81-9f78-9f8365013030_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of shares off the at-the-market offering program</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_3f767248-7d99-4fef-a6be-1dde133047a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_893c3bcd-6cd8-4c9e-a3c7-af510d67fbd8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_086fa9c1-44f7-4675-80b0-0cd2d391e944_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb4e389e-367b-4621-a128-be24ebd29998_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0af03f0a-2132-4b09-a44c-6b36bcfd1e14_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrealized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_73f5f68f-734f-40ca-ad9f-35da95f39af9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_5be62192-de87-4ac4-a684-36fe79ef86d0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_2526e639-b9fc-4d48-b857-5cdc4f0dce19_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_1e2f5d18-1369-4a6b-be2d-08b62f24f71d_terseLabel_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional interest expense</link:label>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_label_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Interest Expense, Debt</link:label>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_documentation_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt" xlink:href="avdl-20220930.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AdditionalInterestExpenseDebt" xlink:to="lab_avdl_AdditionalInterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a68140aa-54d8-4525-8703-3a23da6807ba_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_c4e2221f-62a5-4e4e-a69b-2836cc355fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4d045544-1ddf-4e92-bb9d-a7da76025bf3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1e372aba-b429-49ee-a03d-7aa8da1d22e6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3accb0c3-9ab4-40ab-9088-3b04463eecb7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_81ece6cc-c453-4c0b-a77b-3e52cafd3e9d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_04c8be46-bb77-444f-893d-2cb5aa88e15e_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase aggregate principal amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:to="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_87ee3516-93aa-4fb1-a82f-c5d1f6c6730f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_6aba6b31-b47b-494c-aa14-2265da57fb15_terseLabel_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets at contract manufacturing organizations</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_label_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_documentation_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:href="avdl-20220930.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:to="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_061f30cb-af58-451d-9c7e-1dc7d25f2771_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_887dda83-5cc4-4cc6-b73b-1994d14c2b0c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at September&#160;30, 2022 and 488 issued and outstanding at December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_d7b9daaa-f8e1-4143-9c89-6653d5c5833d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_5354ff51-b2aa-44ca-b414-8682f5c3ad1d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_911a29f1-3fdc-4854-b9fc-1685003b4e5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_623f7ad0-4b99-471a-b040-a810a1b24893_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value of unseparated embedded conversion feature</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:to="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_12f3323a-97be-4511-9beb-3f01f985b4e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b1903551-edaa-409a-8996-5836cd662343_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a242e204-e1d5-44db-ade5-0b35f3418aea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_7f8a74df-ac57-4ae9-99d0-3616d538c0b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_e9763455-a62f-4596-9c60-ae9c42924cd1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_93518529-c7b2-46fa-a0f3-38082b75f798_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_640bcdb9-6fe8-4d86-babe-dc178b9a0259_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_296290ad-63fa-42c5-8a67-f462cfd246fa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fce5dfdd-7234-4b68-8aa3-e140030ab4d2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_52ef7eec-4e6c-4381-bce1-f661589d230c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_1f2b57d9-e1d2-4ac5-bf19-44d7612b3c41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_675a88ab-b296-4c5a-86ec-7f259a71429d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d68836c1-afce-4f5a-a665-26b531272442_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fb9d7120-8362-4260-af24-e9d213554718_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9bcacb27-8a8b-45cb-948e-4964ecac1618_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a7f2bd5a-a400-4f21-9b29-650c1bcf74e5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_5d19c71e-84e6-4206-b636-6d0bab3a4811_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_eb6832be-692f-4b50-b0bd-d956bdd2ca85_terseLabel_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate offering price of ADS under shelf registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_label_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_documentation_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:href="avdl-20220930.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:to="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_49dd7bd6-050f-491a-8c5a-58fcd76d1899_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from release of certain liabilities</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_3e6510a8-d204-4609-bf9c-2e16f2f70598_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from release of certain liabilities</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cd45e423-4151-435d-ab58-35dc9d768f3a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_58cbcb53-70e3-4980-8d29-be1313565459_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c99b6021-c27d-40d3-adca-edccc2eb75b7_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss:</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f47bd856-d454-4edd-8fb1-33127ad38ed5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6a06f890-bc83-409e-806d-e8e8879c8412_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_b70e0fa7-d4bf-4951-92d0-f09161d543e2_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5eb578a7-4b7e-449d-9013-dc8e3457c189_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4c363e46-4c14-4dc6-8728-49784e0afbc3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_421f4d2b-0d3c-4234-ba9f-57e8bb0b8ec7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized gain</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_1dd6e10f-cab4-481b-93d8-f48da18753df_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_27af5357-7cd5-4e61-b19a-0cef6e64a556_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share &#8211; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_990f9691-422c-42cc-919e-de54fa4815fa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_5da7f680-ec12-4a22-af51-ac830eadf726_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_a2fa1b83-64b1-4fee-ad6d-6bbbf1c51318_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_037f0e93-a843-4f6e-8985-ba19fae46f5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &amp; other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ec757286-93c3-4119-b7d6-0f9fb4de1749_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_b23db9b0-1b79-4ccc-8547-71a4dc72e476_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNMS_2f65a383-cfd9-47d5-8ef3-3440a1dc29b7_terseLabel_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET)</link:label>
    <link:label id="lab_exch_XNMS_label_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNMS" xlink:to="lab_exch_XNMS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_de6ce3ee-ccd2-45eb-a44c-db7921864897_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_92badc95-892a-4a53-9ca3-d6586279646b_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_4fc9898c-96eb-45c3-be3f-15f2e535327a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_e4054664-1721-495c-b332-18e0c488c290_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7358575d-c52f-418b-bf16-d5562051dd0e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_62d6d926-555c-4614-9edb-f7322b87678b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1ff54523-9a70-4646-917b-8eb024bfa960_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_73dd1ded-bc92-4b60-ab95-c0870b9d527c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_4a789239-9fc1-4bda-8f06-26d6084318d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_07a0ffc0-5182-40ab-a109-16de106e3adf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_fb150afa-a508-4600-aed1-aa77e03443bd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_425a10e6-3323-4e02-9393-f2b91d981de1_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share &#8211; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e4b8666b-50e6-48b4-b998-bc02ca626b09_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_e6d95df8-aa51-4549-9997-30e0cc081414_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_c65a9ad8-748c-4525-8755-eb020c8a336f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_eb25511a-509e-4f09-abef-1ead6d7fbcc0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3f2c22aa-8ed1-4499-8e60-2f46b112230f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedInterestCurrent_c76be7f9-ce4e-4842-9da0-35478d5ac85d_terseLabel_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_label_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_documentation_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent" xlink:href="avdl-20220930.xsd#avdl_AccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedInterestCurrent" xlink:to="lab_avdl_AccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_2dfeb63b-c6a0-4b80-896e-177f684c11c3_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_dd2560d5-aee7-40b0-868f-05618cc3c338_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_9d9f1909-129f-4787-a8f3-eb6047397296_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6a0d2221-4911-4599-8199-97edaa59a7d0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_98195365-2d84-416d-a3e4-ee4dd7e70ee2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_b04e6f42-d603-4db6-914a-a70eb4757695_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0eee93d4-1159-460e-9ffc-bc9b7e9236bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_69d227cd-241c-4771-bdaa-6b15f9b2f4d9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a47db8d0-91d0-47f8-8cf5-c1b3092b5c9c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a9d10889-770b-45ca-a7eb-e148617babfa_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_46d54fb5-b7b7-4964-a8fd-0793d7a9de60_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d19185f6-cbc8-426f-9cf8-f5c61e873e2b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive loss, net of income tax benefit of $&#8212;, $59, $&#8212; and $220, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_03c436f2-7000-4249-a2b3-31534bbbf35a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1c8fe24a-7ade-4e6a-bdde-c65d42bf7a8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b46c0d67-7103-4c33-acba-73cd4cb0d3b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_63e30340-9386-4403-bfc8-7e186c8f1f3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ba6a4b60-ace0-4ff1-b9a8-54074b3d42a1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_c6ebce34-e821-490a-80f2-5ad6e4c0a37b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d3320cd7-1ccc-40e8-abe5-ae7819ad2ce3_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive business days (in days)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:to="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a034e2e4-6635-4c37-9571-f81e70b27d9e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d1ae1670-31c1-4794-8716-4a7a107ca1b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_a1bf99f1-f5ca-4841-ba3b-1422a7c74396_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e961a751-e012-4a4c-b9fa-6c585ee2bcbc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_e1b5b197-2b89-420d-bf27-dc99f673a10d_verboseLabel_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Business Policy [Policy Text Block]</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for nature of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:href="avdl-20220930.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:to="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ce591a92-6709-4edb-8bca-72e029e44571_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeCurrent_66725d0b-9b63-4618-b4c6-d638023c2b3a_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_label_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent" xlink:href="avdl-20220930.xsd#avdl_GuaranteeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeCurrent" xlink:to="lab_avdl_GuaranteeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_44c375e1-7db9-4254-ad8d-4b5445988cb9_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b4fcef1c-3747-44ab-9fa3-7b927784f7cd_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_80901fd4-7694-4e66-9bb8-2bd73a8fa8b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_270ed946-96cd-4211-8b6d-1ff41c655318_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeNoncurrent_e1f1090f-2a5b-42ef-82aa-13a282cd4c4b_verboseLabel_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_label_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent" xlink:href="avdl-20220930.xsd#avdl_GuaranteeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeNoncurrent" xlink:to="lab_avdl_GuaranteeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3c77ed66-e090-45e7-a73d-412d57acb421_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_397b6b87-2067-4010-916c-cf1d94c42da6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_58d2ac3f-1806-47bf-a296-41943ab90f2a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_cf64c751-db72-4f87-ab62-c975b57cbc9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_494a8d91-3888-4104-b607-fe59d489997c_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_d8ad1773-1da8-42d3-9401-10fd19e67782_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS, minimum amount of principal amount for exchange</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Minimum Amount Of Principal Amount For Exchange</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Minimum Amount Of Principal Amount For Exchange</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:to="lab_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_e8cd8d53-3877-4e19-9357-9b3a1fa97ef7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_34f7b75c-ac51-4548-b99b-403898b4426a_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, exchange amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchange Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchange Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentExchangeAmount" xlink:to="lab_avdl_DebtInstrumentExchangeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_640dd036-a59a-43f6-b258-17c950d51105_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_135c124e-6de5-47e9-b016-1f2a75991000_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8d7ad15c-7fd5-4d23-82b9-aef78db12e43_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_e6863c70-dbdc-47ab-b4a9-d3e6ac8b721e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_29995955-8aae-4257-9df1-900740d00366_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff6ed7f3-e2d9-41dc-9013-07736563835d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_bbfbedde-8909-44a7-9752-4175f4d0c4e3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7240c79a-4e61-4da0-9857-bcde0b817a3a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61a859b2-ab11-43bb-b466-be226d25e442_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9d33768b-62cf-4ea9-929d-cf6a3c0884eb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_1490ac9f-f0d6-4dd2-be3b-32a171368750_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c2a20b59-70ab-4938-90b0-eedcfc3bbf8a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a86343fb-c754-46d7-8123-a2eedb7001c9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_bdc59ecf-bc60-4cae-b113-194668799c13_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_441d4ac4-78c9-46e5-863a-daf73d589f19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_21c1af1a-0b2a-4f72-84b1-9dcf97f48564_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6d1c97d2-c204-4499-8927-e51630ab6df1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_776b32b4-49b2-497c-a06b-503b2c573aa0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f264a81c-fe97-44b0-ad0b-001c16d30543_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_4c349fd2-a954-4b73-ba86-df4d47cd41ef_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled threshold trading days (in days)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:to="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_0e946f3f-7c33-4dd2-bebc-3476ef5c4ad9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_a5cc02b0-4459-41e4-aa7a-54dfe30553ff_terseLabel_en-US" xlink:label="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining value of ADSs available for sale</link:label>
    <link:label id="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_label_en-US" xlink:label="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining American Depositary Shares Available For Sale Under Shelf Registration, Amount</link:label>
    <link:label id="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_documentation_en-US" xlink:label="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining American Depositary Shares Available For Sale Under Shelf Registration, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:href="avdl-20220930.xsd#avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:to="lab_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_ba661250-2999-4e7a-bb8b-af8c56b977a8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_e196d954-c882-4a0f-a265-26603c1dd117_terseLabel_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern</link:label>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_label_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern [Policy Text Block]</link:label>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:href="avdl-20220930.xsd#avdl_LiquidityAndGoingConcernPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:to="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_738ef967-70fd-4ec1-9460-251af04c3b37_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8b4134c0-306d-4d2b-83c6-68380be77e56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_daa6d0a0-b61c-472d-bd94-9a1517b5d463_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3e64ddcf-b770-45ed-bf07-52a714819d8d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_31ba5efd-80f9-4249-9769-1fd3695be551_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a8869b27-810d-4e03-bf13-4c869dfe32af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_16d8c33a-3a80-4244-b343-93667fc6775b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_089f02b6-bf93-465f-963b-7bd0f28220e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7002b8f5-c724-4df9-83b0-d1915f39df90_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bd2905a5-b0b6-48f7-85e3-62086821a1fa_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_dd65563e-ba0e-4de9-bc8f-d604350fd879_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ed5da45-abdf-44c3-8425-8e71c250c41c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0b83a5b7-5a1d-4999-90a7-5518e5314f41_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_4f9b0d27-46e1-40a1-8d65-42d3f6204842_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a0f61030-53ba-45b8-aced-03224609e608_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_0620dc07-6797-4e80-9b16-b2939f4433b6_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Asset, Current Carrying Value</link:label>
    <link:label id="lab_avdl_GuaranteeAssetCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Asset, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue" xlink:href="avdl-20220930.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeAssetCurrentCarryingValue" xlink:to="lab_avdl_GuaranteeAssetCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_5ecdc4a8-44ef-411f-bde6-99d4b817dec3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e4509f13-422b-48cb-9007-1ea93148cefd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_30f45e65-feb5-486a-a10a-36de3be8c87a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_31843eea-2de0-405b-8d3a-6b4046c82b11_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected number of positions eliminated (as a percent)</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3952f525-f3c6-43a1-a036-e8052680ea4d_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_d6f5f1fe-c433-4531-9bd4-9284fc36b084_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>avdl-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:766d7f96-7359-45e8-b779-0ed5044638bd,g:d605e0fb-e7f5-4b7f-9c43-f1afdd964245-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20220930.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cba601ae-e8af-4a9c-b108-94561e14681f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cba601ae-e8af-4a9c-b108-94561e14681f" xlink:to="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:to="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_5f4632bc-e427-4413-bf25-c614b166b5c0" xlink:to="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_4b7cdec5-eb34-4034-b174-70e5f480d78d" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_a14f623b-b28f-4fa4-a0d6-59f20270de81" xlink:to="loc_exch_XNMS_4b7cdec5-eb34-4034-b174-70e5f480d78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_95f9a794-fefc-4ea6-95ff-5900a111462d" xlink:to="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ba04c8a1-d866-4e60-ab27-bb01917b52ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentType_ba04c8a1-d866-4e60-ab27-bb01917b52ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9b58614f-3fc0-43a2-9632-277fdcfb4692" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentQuarterlyReport_9b58614f-3fc0-43a2-9632-277fdcfb4692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_36b7001d-e5ed-46e2-859d-38dbbfc0515e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentPeriodEndDate_36b7001d-e5ed-46e2-859d-38dbbfc0515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9e4c3107-54af-4bf6-8484-5053c6f0e19e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentTransitionReport_9e4c3107-54af-4bf6-8484-5053c6f0e19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5d812c16-f5a2-4a74-bd9a-8851ae64b9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityFileNumber_5d812c16-f5a2-4a74-bd9a-8851ae64b9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_77b6cb73-a4e6-4ed9-9a34-61b1dcda608e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityRegistrantName_77b6cb73-a4e6-4ed9-9a34-61b1dcda608e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e7fff235-0018-4336-aa3f-db44b1dbc270" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e7fff235-0018-4336-aa3f-db44b1dbc270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_84d082ff-6200-4fed-8a4c-c6118efa1271" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityTaxIdentificationNumber_84d082ff-6200-4fed-8a4c-c6118efa1271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b0e2fd55-16f4-4da6-b397-c3ff0a4bdc6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressAddressLine1_b0e2fd55-16f4-4da6-b397-c3ff0a4bdc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_543793ba-8761-401e-b5c1-d6a81e77c793" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressCityOrTown_543793ba-8761-401e-b5c1-d6a81e77c793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_27dad97c-316d-4304-81cc-c4af32b8e345" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressPostalZipCode_27dad97c-316d-4304-81cc-c4af32b8e345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_a85414ad-b52e-4a9c-8870-298f98b2b268" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityAddressCountry_a85414ad-b52e-4a9c-8870-298f98b2b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_d7220045-8f4b-4763-8a4f-cc624d345f10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CountryRegion_d7220045-8f4b-4763-8a4f-cc624d345f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_843c5f2b-a61b-4414-b4f9-594a555d10d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CityAreaCode_843c5f2b-a61b-4414-b4f9-594a555d10d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3e90aa74-836d-4f5a-9b28-87761402cf78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_LocalPhoneNumber_3e90aa74-836d-4f5a-9b28-87761402cf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_87ee2418-d6d7-4c28-8c8a-e3abc234895b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_Security12bTitle_87ee2418-d6d7-4c28-8c8a-e3abc234895b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_75123091-f2ac-4a8a-b0a6-1f7d3b8e8c1b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_TradingSymbol_75123091-f2ac-4a8a-b0a6-1f7d3b8e8c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_73df189d-3410-4158-a917-098fd20a6c9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_SecurityExchangeName_73df189d-3410-4158-a917-098fd20a6c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_105b086d-cdac-4e63-a944-c92c33ff1097" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCurrentReportingStatus_105b086d-cdac-4e63-a944-c92c33ff1097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_36030d2c-02d4-417e-8b6e-dd947af9f75c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityInteractiveDataCurrent_36030d2c-02d4-417e-8b6e-dd947af9f75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_322f7e31-cf06-425d-87e1-85998cf71244" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityFilerCategory_322f7e31-cf06-425d-87e1-85998cf71244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6509785a-8205-492c-a95c-14d9b0456287" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntitySmallBusiness_6509785a-8205-492c-a95c-14d9b0456287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4407d8fe-031c-407b-a18b-98163b92fda4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityEmergingGrowthCompany_4407d8fe-031c-407b-a18b-98163b92fda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b2dce575-e2dc-44a0-a0e8-be6dfc90f2a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityShellCompany_b2dce575-e2dc-44a0-a0e8-be6dfc90f2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9f5cfdfa-e3c5-45ef-96f6-886529dfc58d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9f5cfdfa-e3c5-45ef-96f6-886529dfc58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_55af3cd7-c55f-4b1c-96d7-43a4f92400d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_EntityCentralIndexKey_55af3cd7-c55f-4b1c-96d7-43a4f92400d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f3d6f798-3496-45a4-a3f0-e1f1a984256d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_CurrentFiscalYearEndDate_f3d6f798-3496-45a4-a3f0-e1f1a984256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_998931db-37f6-424a-a3b9-50c0a43aac49" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentFiscalYearFocus_998931db-37f6-424a-a3b9-50c0a43aac49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4cbb351e-9b1e-402a-8003-e102440b2756" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4cbb351e-9b1e-402a-8003-e102440b2756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5018ac72-04d9-4603-b158-544c198e5cc3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_AmendmentFlag_5018ac72-04d9-4603-b158-544c198e5cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_d9186cd9-9ab1-4221-9752-1570b8a26af0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_8b16dfd5-c81f-452a-879d-b2adfcb35271" xlink:to="loc_dei_NoTradingSymbolFlag_d9186cd9-9ab1-4221-9752-1570b8a26af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_40b77ce1-8f75-4a61-a58b-739b6fb4a320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_40b77ce1-8f75-4a61-a58b-739b6fb4a320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0fd7a42a-ad50-4590-b999-630f8d492e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0fd7a42a-ad50-4590-b999-630f8d492e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1db0d1da-3f6f-415c-b49e-35e800f808a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:to="loc_us-gaap_RestructuringCharges_1db0d1da-3f6f-415c-b49e-35e800f808a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8f6a6e52-2ee9-423e-8124-8e9d8daef719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8ca7c41d-58c8-4c53-bba4-ca6c0d48eed6" xlink:to="loc_us-gaap_CostsAndExpenses_8f6a6e52-2ee9-423e-8124-8e9d8daef719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9e7cfac2-0bbf-45c9-a098-150bf8775d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_OperatingIncomeLoss_9e7cfac2-0bbf-45c9-a098-150bf8775d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_5592d2da-27fa-4b7e-9d2c-7950ef4e746d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_InvestmentIncomeNet_5592d2da-27fa-4b7e-9d2c-7950ef4e746d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_c6300900-31ee-4a5b-91f9-d5b7a531cb40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_InterestExpenseDebt_c6300900-31ee-4a5b-91f9-d5b7a531cb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_e902b750-8963-4cd6-a08e-1f278b3abaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_e902b750-8963-4cd6-a08e-1f278b3abaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3382bcb3-e99e-42d9-beb2-364da4e8ba58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3382bcb3-e99e-42d9-beb2-364da4e8ba58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_403dae3b-4163-4d80-b628-5dd95cc62f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_403dae3b-4163-4d80-b628-5dd95cc62f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_24f1712b-c956-420c-a8bf-c46bfe494175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_NetIncomeLoss_24f1712b-c956-420c-a8bf-c46bfe494175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_533e3534-d89f-449b-8ec3-a66a954009db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_EarningsPerShareBasic_533e3534-d89f-449b-8ec3-a66a954009db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8764e5f-cc34-4244-bfd8-8e8d168b638f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8764e5f-cc34-4244-bfd8-8e8d168b638f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e8aadf9-ae85-4879-8d1a-b3b426110930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e8aadf9-ae85-4879-8d1a-b3b426110930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_02258b66-b9c5-4cfe-a516-40740751abf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_afa364be-b24d-4830-9011-e740979701dc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_02258b66-b9c5-4cfe-a516-40740751abf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e03c6c2-e462-4e5c-8892-8b5770839ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_860a7832-7e36-46bd-86e3-d528bae7107a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e03c6c2-e462-4e5c-8892-8b5770839ac2" xlink:to="loc_us-gaap_NetIncomeLoss_860a7832-7e36-46bd-86e3-d528bae7107a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_574aed22-74ea-4983-a414-eda42af054a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e03c6c2-e462-4e5c-8892-8b5770839ac2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_574aed22-74ea-4983-a414-eda42af054a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f8bede94-0b37-4f0e-8584-ff2888e671f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_574aed22-74ea-4983-a414-eda42af054a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f8bede94-0b37-4f0e-8584-ff2888e671f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_119eb3cb-cb40-42d9-9b3c-69042ccd7801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_574aed22-74ea-4983-a414-eda42af054a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_119eb3cb-cb40-42d9-9b3c-69042ccd7801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae7aa91c-fb7e-4ed8-89ce-1af04fff1907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_574aed22-74ea-4983-a414-eda42af054a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae7aa91c-fb7e-4ed8-89ce-1af04fff1907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ed03397-beb3-4074-9918-fb4b2097ac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5e03c6c2-e462-4e5c-8892-8b5770839ac2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4ed03397-beb3-4074-9918-fb4b2097ac9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ffd34afa-231a-4d9f-9755-5a047926ea91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7180f701-f6f7-49fe-8f05-e3bb9b5274a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ffd34afa-231a-4d9f-9755-5a047926ea91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7180f701-f6f7-49fe-8f05-e3bb9b5274a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_56203413-106d-4785-b75e-ed340ba413b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56203413-106d-4785-b75e-ed340ba413b0" xlink:to="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42cff598-986b-49da-a450-0d39760e184b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_42cff598-986b-49da-a450-0d39760e184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4e7866a4-fc19-46a7-aa39-db7976ff8c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4e7866a4-fc19-46a7-aa39-db7976ff8c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_978700dd-627a-4e19-bfc5-29d1e86eec86" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_978700dd-627a-4e19-bfc5-29d1e86eec86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_71174c1b-05d5-4279-9231-eb9155230351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_71174c1b-05d5-4279-9231-eb9155230351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_da213ab8-ab36-479b-a8f7-6529a77078b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_15fc23ab-34b2-471e-bf6a-72d4c5c6345e" xlink:to="loc_us-gaap_AssetsCurrent_da213ab8-ab36-479b-a8f7-6529a77078b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_744fb2b9-098d-4609-beca-4541f2c72c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_744fb2b9-098d-4609-beca-4541f2c72c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f87d715c-a198-45c6-9535-b7d23dd2eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f87d715c-a198-45c6-9535-b7d23dd2eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cbb4ff73-57f9-4e21-8ccb-c3a25882c0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_Goodwill_cbb4ff73-57f9-4e21-8ccb-c3a25882c0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_cd2292d5-deef-40bf-8c88-6f89c3a64568" xlink:href="avdl-20220930.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_cd2292d5-deef-40bf-8c88-6f89c3a64568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_395a2179-92b7-47af-a1d6-3fa7bca23e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_395a2179-92b7-47af-a1d6-3fa7bca23e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b0aa8974-2fbb-4be0-9682-869e41b2c948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5bf310db-d4a3-4f6c-8f74-d79ac931724b" xlink:to="loc_us-gaap_Assets_b0aa8974-2fbb-4be0-9682-869e41b2c948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56203413-106d-4785-b75e-ed340ba413b0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8d63fbb9-51fc-4cea-98d9-157081c24248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_LongTermDebtCurrent_8d63fbb9-51fc-4cea-98d9-157081c24248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_76bad688-09e7-4152-86f9-2d9ea5ae0119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_76bad688-09e7-4152-86f9-2d9ea5ae0119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1fa01b6b-d675-4606-9d8a-eadccf752945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_AccountsPayableCurrent_1fa01b6b-d675-4606-9d8a-eadccf752945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_025224fd-8396-4292-b18e-7cf608f6fc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_025224fd-8396-4292-b18e-7cf608f6fc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b208ad73-e039-4fe9-bd7b-8301482c34d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b208ad73-e039-4fe9-bd7b-8301482c34d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a2b5447d-51ad-4268-ac2f-fa4017632e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_36da4195-0966-490e-9af1-06a5a09274f3" xlink:to="loc_us-gaap_LiabilitiesCurrent_a2b5447d-51ad-4268-ac2f-fa4017632e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_37ad110e-f988-4c50-9d63-bb20b5d1cf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_37ad110e-f988-4c50-9d63-bb20b5d1cf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2064158f-c56a-44da-82ee-8b459e66c9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2064158f-c56a-44da-82ee-8b459e66c9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f20b0ca6-9165-4a65-8e03-318c6b2ab703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f20b0ca6-9165-4a65-8e03-318c6b2ab703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9acdd4e9-34ce-450a-8640-469c4806b3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_Liabilities_9acdd4e9-34ce-450a-8640-469c4806b3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_968026df-7454-46e2-bdc1-94a082632885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_PreferredStockValue_968026df-7454-46e2-bdc1-94a082632885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4e0b12a0-b5f9-49fe-ac5e-a6a733ee936b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_CommonStockValue_4e0b12a0-b5f9-49fe-ac5e-a6a733ee936b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ba941aff-a66b-441e-aaa0-56848334b98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ba941aff-a66b-441e-aaa0-56848334b98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9da6e272-3a62-4134-85e3-cb6226ce7eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9da6e272-3a62-4134-85e3-cb6226ce7eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_286724a5-4e95-4d58-8359-f57cb498f3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_286724a5-4e95-4d58-8359-f57cb498f3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b873f31-ff39-4894-96ff-66470b96b7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a3e00720-a3f7-4253-b38e-0df324f9bd79" xlink:to="loc_us-gaap_StockholdersEquity_3b873f31-ff39-4894-96ff-66470b96b7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0bd44cf-e746-40af-9cca-d8ed8003040b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bf37ea7c-e13e-452b-9f43-c5fd3ca97c6b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c0bd44cf-e746-40af-9cca-d8ed8003040b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ed348085-88d2-4942-9a99-9a72be9b874e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ed348085-88d2-4942-9a99-9a72be9b874e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_06b627d8-ce07-46c7-8770-da381fe79773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_06b627d8-ce07-46c7-8770-da381fe79773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b6f56f52-4986-4ab1-a00a-0ac9f087a11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b6f56f52-4986-4ab1-a00a-0ac9f087a11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9c030f21-7724-45f1-b8c2-7008b29abb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9c030f21-7724-45f1-b8c2-7008b29abb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_86c21f7e-3dab-46a3-8363-c4d2d63fc0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_86c21f7e-3dab-46a3-8363-c4d2d63fc0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bdd22312-13eb-496b-a323-3cc0576a67d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bdd22312-13eb-496b-a323-3cc0576a67d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f1f15a5c-bb3b-4320-8cd7-b7df42520e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_CommonStockSharesIssued_f1f15a5c-bb3b-4320-8cd7-b7df42520e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d6f895c0-6661-4135-819e-419ee8678abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1d92491f-8b6d-4955-801f-b00b83450c73" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d6f895c0-6661-4135-819e-419ee8678abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fc00d640-7224-465d-a514-dc3b501e3836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fc00d640-7224-465d-a514-dc3b501e3836" xlink:to="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1096010c-346c-420b-80e0-9eaf8d7a7f98" xlink:to="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_924dbc14-bffd-483c-825f-1e7b39fcc957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_CommonStockMember_924dbc14-bffd-483c-825f-1e7b39fcc957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_26ec1eeb-5f88-4221-a2d1-b6ea34e146b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_PreferredStockMember_26ec1eeb-5f88-4221-a2d1-b6ea34e146b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2e13462d-0917-4bc3-8ba9-ffe1e756e4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2e13462d-0917-4bc3-8ba9-ffe1e756e4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_db983e60-627f-4342-8173-201ccc43d743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_RetainedEarningsMember_db983e60-627f-4342-8173-201ccc43d743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b19783e6-e4b7-40ff-9ef8-5ac09d76b38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1ea073de-f10c-44db-8e6a-35939341037a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b19783e6-e4b7-40ff-9ef8-5ac09d76b38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1cb5a826-e9cd-479f-90af-fc2de356e963" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e5dfda51-a339-4374-9d7f-69f3dd57f9ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_296a94a4-950d-40b8-a559-be91e57aa97a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e5dfda51-a339-4374-9d7f-69f3dd57f9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e7650e54-e87b-4e3a-9b1b-d94c214695c4" xlink:to="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0e6ba357-2bb9-41de-8170-b3c26d7dd76c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_a51cb9d6-3c3c-4cce-a862-fe51704edbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_SharesOutstanding_a51cb9d6-3c3c-4cce-a862-fe51704edbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68ae3d12-f1ab-4251-8641-9f8cb4f3ea85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockholdersEquity_68ae3d12-f1ab-4251-8641-9f8cb4f3ea85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f503adf-f50f-481e-81f3-e8eb1fb9dba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_NetIncomeLoss_4f503adf-f50f-481e-81f3-e8eb1fb9dba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21d34f08-e19d-47d0-8154-2384179bba45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21d34f08-e19d-47d0-8154-2384179bba45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_88486477-f5da-4271-8e13-bb119234bb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_88486477-f5da-4271-8e13-bb119234bb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49c6a041-3045-4bc4-97fc-087e2b7b6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_49c6a041-3045-4bc4-97fc-087e2b7b6caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_40e0f41b-5e7d-4602-8f6d-84610b139ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_40e0f41b-5e7d-4602-8f6d-84610b139ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_822fe9ca-8ba3-4d67-89ec-48410ca41b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_822fe9ca-8ba3-4d67-89ec-48410ca41b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63678997-ede9-4c59-bd59-1b40f4558ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_63678997-ede9-4c59-bd59-1b40f4558ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_211fb2a9-d629-4942-a3e8-f27417a833d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_211fb2a9-d629-4942-a3e8-f27417a833d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6dee38ce-cced-4d11-97a8-ddeab24d786c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6dee38ce-cced-4d11-97a8-ddeab24d786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9f93313c-e338-4089-8a3e-0f10da5b8b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9f93313c-e338-4089-8a3e-0f10da5b8b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_32cf968e-2217-4b5b-a923-5b82f16dcc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_32cf968e-2217-4b5b-a923-5b82f16dcc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_7bef793d-7423-4436-9c7c-149488d9d32e" xlink:href="avdl-20220930.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_7bef793d-7423-4436-9c7c-149488d9d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e188a8d1-6f0c-4f6d-87f4-be38e34ea156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e188a8d1-6f0c-4f6d-87f4-be38e34ea156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4f35b6a1-39d8-4ff0-82bb-3b5afa667ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_SharesOutstanding_4f35b6a1-39d8-4ff0-82bb-3b5afa667ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_85c8fcb4-0c54-4d23-b30a-9de200626df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e1cb7c-0676-4502-83db-a16498da304a" xlink:to="loc_us-gaap_StockholdersEquity_85c8fcb4-0c54-4d23-b30a-9de200626df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_709819d8-5879-475e-96c3-3b7e709dd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_709819d8-5879-475e-96c3-3b7e709dd2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_05dde85c-4cbb-4697-abe5-8d41ef1709d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_709819d8-5879-475e-96c3-3b7e709dd2be" xlink:to="loc_us-gaap_NetIncomeLoss_05dde85c-4cbb-4697-abe5-8d41ef1709d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_709819d8-5879-475e-96c3-3b7e709dd2be" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3424f476-b782-473a-b3ef-a98f5eae5814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_DepreciationAndAmortization_3424f476-b782-473a-b3ef-a98f5eae5814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_94e1b52c-e5f3-49f4-99c4-84d80365c033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_94e1b52c-e5f3-49f4-99c4-84d80365c033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d4fb92e0-f294-424b-9852-85e7acc58bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d4fb92e0-f294-424b-9852-85e7acc58bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f6aeba14-5b84-44b2-b866-b13a7bf26b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_ShareBasedCompensation_f6aeba14-5b84-44b2-b866-b13a7bf26b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_b47260c7-69e6-447b-b9a0-63c7487d96f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_b47260c7-69e6-447b-b9a0-63c7487d96f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_de0c6cfc-0efd-4172-b026-f62145916259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_de0c6cfc-0efd-4172-b026-f62145916259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2317ddee-0b73-4601-94bd-9f98f79b8cb6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7ec27964-344b-472d-a84d-d79bcdb63381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7ec27964-344b-472d-a84d-d79bcdb63381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_80131e45-2176-486c-8efc-100b7fecf5a5" xlink:href="avdl-20220930.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_80131e45-2176-486c-8efc-100b7fecf5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f5e10802-9c30-4284-88bb-71f4eee91983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f5e10802-9c30-4284-88bb-71f4eee91983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_150168f0-84aa-4795-93f6-c9d275d21da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_150168f0-84aa-4795-93f6-c9d275d21da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_6b6431f3-fd15-4718-88d1-abd229334143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d452ea7f-78d1-48c2-bb79-dae20df9cd44" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_6b6431f3-fd15-4718-88d1-abd229334143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12ae737d-b8b1-485c-b53a-bc24cc401c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_709819d8-5879-475e-96c3-3b7e709dd2be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12ae737d-b8b1-485c-b53a-bc24cc401c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0d8e183-0d8d-4800-a9fd-515483542933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0d8e183-0d8d-4800-a9fd-515483542933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_21c19f68-4760-4146-abd4-05f630b0167e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_21c19f68-4760-4146-abd4-05f630b0167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5e76b88e-256b-4c34-8a7d-631cab241e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5e76b88e-256b-4c34-8a7d-631cab241e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e418bda0-30f2-423c-b6a8-ea251dadb574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e418bda0-30f2-423c-b6a8-ea251dadb574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b7bcde1c-c0ee-484f-9580-268863309691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac6f7da9-ab8a-46b2-bb25-318f8990ed5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b7bcde1c-c0ee-484f-9580-268863309691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_efb17f8d-fddb-49c1-b987-b99a589ecc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_efb17f8d-fddb-49c1-b987-b99a589ecc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa6d3129-86a3-40c6-af4f-efcd635f526d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa6d3129-86a3-40c6-af4f-efcd635f526d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9ced2bfe-a3c1-4698-ae28-76f0f91b2ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9ced2bfe-a3c1-4698-ae28-76f0f91b2ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e41105d-c5fe-4973-8a80-0e378ed00f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bbf24c06-dcd5-4985-a26a-8a6015984660" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1e41105d-c5fe-4973-8a80-0e378ed00f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c958f23-2656-4f28-a3ea-03348bf30f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c958f23-2656-4f28-a3ea-03348bf30f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_76bbcfbe-144d-4a58-a10a-cc932c805eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_76bbcfbe-144d-4a58-a10a-cc932c805eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_062fac9b-7bea-4393-8e65-b5a9d101098c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_062fac9b-7bea-4393-8e65-b5a9d101098c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a1769799-34e3-4b54-a711-6d5c6fabab34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a1769799-34e3-4b54-a711-6d5c6fabab34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d9b34850-36fb-4654-9703-ec4a25d86b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5c25770-fa7e-45be-9232-c4a9db11b942" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d9b34850-36fb-4654-9703-ec4a25d86b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_a67134ac-6853-411a-b4ab-1a81b87e3a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d9b34850-36fb-4654-9703-ec4a25d86b64" xlink:to="loc_us-gaap_InterestPaidNet_a67134ac-6853-411a-b4ab-1a81b87e3a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a1fd0296-a048-42f9-85ce-51711bd3534c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d9b34850-36fb-4654-9703-ec4a25d86b64" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a1fd0296-a048-42f9-85ce-51711bd3534c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical" xlink:type="simple" xlink:href="avdl-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ad21fae-1384-4b7d-8f84-7e34f4fb2908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ab6efe9e-45ce-4399-867b-009024f16074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ad21fae-1384-4b7d-8f84-7e34f4fb2908" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ab6efe9e-45ce-4399-867b-009024f16074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="avdl-20220930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_661a48d2-24b3-4855-b474-15f07928fa10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_aff172a0-2714-4f8f-bc2d-2b5c7af966c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_661a48d2-24b3-4855-b474-15f07928fa10" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_aff172a0-2714-4f8f-bc2d-2b5c7af966c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8fc7cf15-6010-439f-b0bf-a501af0276dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_eb2ae968-167f-41cd-887f-9ffa4773c2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8fc7cf15-6010-439f-b0bf-a501af0276dd" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_eb2ae968-167f-41cd-887f-9ffa4773c2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecurities" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_adad4e90-2f22-46d9-b211-9959bc0827e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_6641d6d0-805a-4852-af8b-a0fc369d3642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_adad4e90-2f22-46d9-b211-9959bc0827e4" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_6641d6d0-805a-4852-af8b-a0fc369d3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebt" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed112e15-e6bc-4ce2-a250-e672c8b701a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c5e97cad-cd88-4aa9-b3c4-99362b206125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed112e15-e6bc-4ce2-a250-e672c8b701a2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c5e97cad-cd88-4aa9-b3c4-99362b206125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxes" xlink:type="simple" xlink:href="avdl-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e0b8cd46-5818-411a-bdf3-2bbca72fae9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a147ddf9-fe9c-4947-a006-cf6a36731fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e0b8cd46-5818-411a-bdf3-2bbca72fae9e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a147ddf9-fe9c-4947-a006-cf6a36731fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_70d92aee-3733-4928-bfe5-f01d11e627ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_5a92ea09-2056-4238-9f8e-14b49dc37fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_70d92aee-3733-4928-bfe5-f01d11e627ee" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_5a92ea09-2056-4238-9f8e-14b49dc37fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="avdl-20220930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c226317-e04b-4df8-8ae9-9422e96309ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ced56503-a4ab-4fb7-b8cc-92ba2d9816fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4c226317-e04b-4df8-8ae9-9422e96309ee" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ced56503-a4ab-4fb7-b8cc-92ba2d9816fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShare" xlink:type="simple" xlink:href="avdl-20220930.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_83cbe409-23a4-4045-bd8f-23f5ba6770ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_873c3ece-ebdd-4f87-9f84-5448320d1f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_83cbe409-23a4-4045-bd8f-23f5ba6770ee" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_873c3ece-ebdd-4f87-9f84-5448320d1f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="simple" xlink:href="avdl-20220930.xsd#ComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4e1ae095-7608-45af-a91d-098c045465c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_28e2029d-b58a-4bdd-88b3-d32261ae80a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4e1ae095-7608-45af-a91d-098c045465c4" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_28e2029d-b58a-4bdd-88b3-d32261ae80a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="avdl-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5c2a7ff8-d948-4429-b321-3df3ca390405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ad401bd-8cb7-4e1b-829c-cdb00da3399f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5c2a7ff8-d948-4429-b321-3df3ca390405" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ad401bd-8cb7-4e1b-829c-cdb00da3399f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCosts" xlink:type="simple" xlink:href="avdl-20220930.xsd#RestructuringCosts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_65caf6b2-bcb9-4d74-8b50-4bd86e2d44a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0ff9d14b-265b-4fcd-a4fe-2a77a395cae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_65caf6b2-bcb9-4d74-8b50-4bd86e2d44a7" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0ff9d14b-265b-4fcd-a4fe-2a77a395cae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEvents" xlink:type="simple" xlink:href="avdl-20220930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_73f2c600-2314-4c9d-8fff-ac4331e5d516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3350a350-ae8e-4622-baff-3e5cd6d64fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_73f2c600-2314-4c9d-8fff-ac4331e5d516" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3350a350-ae8e-4622-baff-3e5cd6d64fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="avdl-20220930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d59c2b7e-957a-4515-a7dc-9d542471a45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_723c26f2-cbfc-4bc6-8477-7f9ad22d2879" xlink:href="avdl-20220930.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d59c2b7e-957a-4515-a7dc-9d542471a45a" xlink:to="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_723c26f2-cbfc-4bc6-8477-7f9ad22d2879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock_0366879f-bb6e-4cc6-8860-e562c068fbff" xlink:href="avdl-20220930.xsd#avdl_LiquidityAndGoingConcernPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d59c2b7e-957a-4515-a7dc-9d542471a45a" xlink:to="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock_0366879f-bb6e-4cc6-8860-e562c068fbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c6ebb51a-1bae-4ffc-8584-b1f2e7e81bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d59c2b7e-957a-4515-a7dc-9d542471a45a" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c6ebb51a-1bae-4ffc-8584-b1f2e7e81bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_95ae8d53-5629-4b26-b7e7-297c71c1e65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d82be6a-7a6e-4ccd-a348-301fca813478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95ae8d53-5629-4b26-b7e7-297c71c1e65a" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d82be6a-7a6e-4ccd-a348-301fca813478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_46e52ade-2d8f-4205-8734-2a545b3841bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_8beb0d86-069a-49a7-8a7e-1514cb494264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_46e52ade-2d8f-4205-8734-2a545b3841bf" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_8beb0d86-069a-49a7-8a7e-1514cb494264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0cc254d4-240d-4f87-bbf0-2ea513d8101b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_46e52ade-2d8f-4205-8734-2a545b3841bf" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0cc254d4-240d-4f87-bbf0-2ea513d8101b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_d92aead7-1cf4-48f4-be3d-ffe22c9becd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_46e52ade-2d8f-4205-8734-2a545b3841bf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_d92aead7-1cf4-48f4-be3d-ffe22c9becd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_17d533d9-ea67-4d45-b133-3ea055509fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ef4d03f4-db19-45a4-8391-966f18d4b7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17d533d9-ea67-4d45-b133-3ea055509fb9" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ef4d03f4-db19-45a4-8391-966f18d4b7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_5a43f1f2-0eb0-48f4-aac3-17e4249023b1" xlink:href="avdl-20220930.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:to="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_5a43f1f2-0eb0-48f4-aac3-17e4249023b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_9276d799-583e-418c-9ec5-8dda768b201a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_9276d799-583e-418c-9ec5-8dda768b201a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_4bd77d8e-79d0-4c91-b03b-b14a807471df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_4bd77d8e-79d0-4c91-b03b-b14a807471df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7aba8531-edaa-4e0a-bd90-c9920d1bcb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7aba8531-edaa-4e0a-bd90-c9920d1bcb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_5ed0666d-bc69-4ac8-864b-9a45a0faa7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_0e4e6365-61be-440f-b622-f8142307f37b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_5ed0666d-bc69-4ac8-864b-9a45a0faa7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_44774168-2361-4987-a294-33d3f7510e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4b6d1b27-82f6-4e85-8f4c-0a1d0544a50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_44774168-2361-4987-a294-33d3f7510e6a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4b6d1b27-82f6-4e85-8f4c-0a1d0544a50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#ComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_866147b6-47bc-44c3-9913-7370117a79d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd1e7ddb-ec52-46d3-82c3-cef816c62843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_866147b6-47bc-44c3-9913-7370117a79d6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_dd1e7ddb-ec52-46d3-82c3-cef816c62843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="simple" xlink:href="avdl-20220930.xsd#RestructuringCostsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_235133e2-c06c-4d1a-9401-81676e2897d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_94692871-14a0-4912-8642-2cf3b2a798ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_235133e2-c06c-4d1a-9401-81676e2897d1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_94692871-14a0-4912-8642-2cf3b2a798ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fc9db692-630e-43d2-a46e-4185c7136cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc9db692-630e-43d2-a46e-4185c7136cd5" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5be0cad3-3f67-40e2-9e4d-aad97c7e23e3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:href="avdl-20220930.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_41b5c8aa-c75b-4d54-a5be-4be90911454e" xlink:to="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember_3220dfa1-3e4f-41c5-8330-1e9179ca40dd" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2020ProspectusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:to="loc_avdl_OpenMarketSalesAgreement2020ProspectusMember_3220dfa1-3e4f-41c5-8330-1e9179ca40dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember_3a54d235-dc1d-44ad-adba-b263309ebc0d" xlink:href="avdl-20220930.xsd#avdl_OpenMarketSalesAgreement2022ProspectusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember_b5752e4d-241c-42a1-955a-97ad66d579e7" xlink:to="loc_avdl_OpenMarketSalesAgreement2022ProspectusMember_3a54d235-dc1d-44ad-adba-b263309ebc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_10a8b619-9fdd-47fb-850c-0166179339be" xlink:to="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f1e63c3b-4d3f-4b58-b47d-8cbec9a8c6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_42d0e584-9406-4b65-8acd-6da59d848750" xlink:to="loc_us-gaap_CommonStockMember_f1e63c3b-4d3f-4b58-b47d-8cbec9a8c6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_94a2510b-14b7-4680-be3d-267714da95d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_234d1973-0dd7-41eb-886e-6d32f1e46985" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_234d1973-0dd7-41eb-886e-6d32f1e46985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_9a87ece1-2a3d-405c-9016-e140d0099c1d" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_594f8b84-e995-4afc-8d50-ba426b243fea" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_9a87ece1-2a3d-405c-9016-e140d0099c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b84860b2-34f4-4bc8-9e8d-c3cd967640bc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7aa76790-b6bf-4d7c-919e-cb60d6e64f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57d97086-e300-41a9-ba22-78668f1350f3" xlink:to="loc_us-gaap_SeniorNotesMember_7aa76790-b6bf-4d7c-919e-cb60d6e64f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_ae7c4e2b-0cf8-4e4d-90ce-1a271d34e4ed" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52ea9861-35f2-46ad-b3af-058c8c4f5088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_52ea9861-35f2-46ad-b3af-058c8c4f5088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1ab889f9-f1ad-4c9f-9693-07e603974642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1ab889f9-f1ad-4c9f-9693-07e603974642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3122c461-0377-485c-8123-fbe66c16aee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3122c461-0377-485c-8123-fbe66c16aee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4aeac431-64b1-4c70-9258-9c0bbf4ba6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4aeac431-64b1-4c70-9258-9c0bbf4ba6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_d5999ddf-e42b-4eda-bc90-ff50d9321c9a" xlink:href="avdl-20220930.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_d5999ddf-e42b-4eda-bc90-ff50d9321c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockCommissionPercentage_07d7ff3e-653f-4b23-bab6-7ac0b10a85a5" xlink:href="avdl-20220930.xsd#avdl_SaleOfStockCommissionPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_SaleOfStockCommissionPercentage_07d7ff3e-653f-4b23-bab6-7ac0b10a85a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6644a720-0d1b-409c-adb1-9132de2abad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6644a720-0d1b-409c-adb1-9132de2abad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6013d7fc-16ae-495a-85e7-48e9e2f05bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6013d7fc-16ae-495a-85e7-48e9e2f05bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_8c770f6d-d7eb-49f6-8382-8774c0f636e7" xlink:href="avdl-20220930.xsd#avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ae488adc-1f73-4db8-8ef2-654d433c156f" xlink:to="loc_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount_8c770f6d-d7eb-49f6-8382-8774c0f636e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_70d6b4d1-bf1f-45f4-9a52-03661d4158f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_70d6b4d1-bf1f-45f4-9a52-03661d4158f7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a2adc0bc-332a-4cc0-acb9-be1250c14ef6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5ac4ac32-a7b0-48a1-aad9-f9245cf5e704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_71eaff77-c6a0-45e7-a152-523a364d9d53" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5ac4ac32-a7b0-48a1-aad9-f9245cf5e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07978cb9-cd9b-49bd-8611-5d081fc7d7dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_82e74685-1ef9-43d1-b6f4-7455d2bd4598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_82e74685-1ef9-43d1-b6f4-7455d2bd4598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0de9d36e-de4c-442f-bb01-fc1dfe4aec9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0de9d36e-de4c-442f-bb01-fc1dfe4aec9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a6b801d3-8602-47b1-9002-4be7db1baff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0ca56877-9ae6-4105-9556-b75063abace7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a6b801d3-8602-47b1-9002-4be7db1baff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_788f4862-3c3c-46e5-ac9b-6964605609b3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_150cdd43-eb21-4467-86bf-0587d1e9c27d" xlink:href="avdl-20220930.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_150cdd43-eb21-4467-86bf-0587d1e9c27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a5842903-9cc0-4f6b-9bbf-ecdd95a65a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a5842903-9cc0-4f6b-9bbf-ecdd95a65a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4144f72-4166-47b7-b78e-56c51a13cc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e4144f72-4166-47b7-b78e-56c51a13cc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_a8264c73-4076-4f0a-9bfb-e4528d079ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b202a7d-befd-42f3-b2e8-72c22d75dba6" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_a8264c73-4076-4f0a-9bfb-e4528d079ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3f9eace8-8c8c-497e-9eea-8ca8f0ef78cc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_18d9bfa5-c819-4d65-835e-223b54151376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_18d9bfa5-c819-4d65-835e-223b54151376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4d117301-f81c-4fae-bc4c-b812c6e497a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a54b748-ca65-4695-a064-ae6dcb266012" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4d117301-f81c-4fae-bc4c-b812c6e497a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_08697aa5-9693-4288-9b76-2dbeb44462f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08697aa5-9693-4288-9b76-2dbeb44462f2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fbd5981c-6488-4b1b-b5a0-5b4bb307954f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1607651c-49a1-4e21-9175-4f8172f2a581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b81fece3-5e60-454f-8ce2-cac63298065d" xlink:to="loc_us-gaap_SeniorNotesMember_1607651c-49a1-4e21-9175-4f8172f2a581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:to="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cda425c1-8993-45f8-8f3b-d002142df194" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_312a8e9e-8e61-40b9-966a-6d7a506c2df9" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_312a8e9e-8e61-40b9-966a-6d7a506c2df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_29c57fa9-173c-4a95-9cec-3f21f7a5b3ca" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816256bb-ee1e-4668-964f-6fed9bcddc60" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_29c57fa9-173c-4a95-9cec-3f21f7a5b3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d0e98e36-da6e-479f-8d2a-8a63e0ff76b9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_af5c14e2-eca3-450f-b532-3da4a010a47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_af5c14e2-eca3-450f-b532-3da4a010a47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7189ae58-8a53-48f7-a1d4-882e4e8abecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7189ae58-8a53-48f7-a1d4-882e4e8abecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8d9bcd2c-80ee-4450-91fe-b38f62f97dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e08214f7-ed64-43e6-935e-603fd5db6ccd" xlink:to="loc_us-gaap_LongTermDebtFairValue_8d9bcd2c-80ee-4450-91fe-b38f62f97dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_95a3f79a-1ff2-4b6b-a702-a88372918265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_95a3f79a-1ff2-4b6b-a702-a88372918265" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f3785682-e09c-4809-8b04-1c926ade734a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d586773d-ab6a-469c-bcba-3a2d0cd044d7" xlink:href="avdl-20220930.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d586773d-ab6a-469c-bcba-3a2d0cd044d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_54711331-786c-43a1-aa9e-1619c49d2c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_54711331-786c-43a1-aa9e-1619c49d2c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_af53b0ad-297c-488a-b4bc-3e72191c44d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_af53b0ad-297c-488a-b4bc-3e72191c44d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_4fff4685-0ae3-4ebb-940c-90b2647257ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f85c8de0-438a-4702-ad91-02314388b9a0" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_4fff4685-0ae3-4ebb-940c-90b2647257ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9d6ba7af-f3a9-4b64-953b-e95f729ce750" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1fb5f11f-e9ac-4bad-be93-46b7168a635a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb7ada96-75e3-4dd5-863d-bc54560517ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eb7ada96-75e3-4dd5-863d-bc54560517ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2abe391-c34c-4100-8743-d8a88a2dbe98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2abe391-c34c-4100-8743-d8a88a2dbe98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a0d1e1ef-d6ad-4351-8e09-cc3130108e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a0d1e1ef-d6ad-4351-8e09-cc3130108e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_77e8768f-bbb9-41e0-a81e-876edaf79bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_a2489329-448a-4617-beca-440cb4492779" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_77e8768f-bbb9-41e0-a81e-876edaf79bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f2b1e36d-620d-4680-87fa-8032c34e0299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_29069b5d-cb37-4f61-a3c6-764de5967a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f2b1e36d-620d-4680-87fa-8032c34e0299" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_29069b5d-cb37-4f61-a3c6-764de5967a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_c35486d8-a8da-4740-81ed-c7f23b884174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f2b1e36d-620d-4680-87fa-8032c34e0299" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_c35486d8-a8da-4740-81ed-c7f23b884174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2de983c8-7f14-4cd8-ba3a-6e859559b435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2de983c8-7f14-4cd8-ba3a-6e859559b435" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1bdf92a-54a0-43de-be3b-214a0f493aac" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_09e3b606-40c3-4fab-bb41-29b1706d6c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_09e3b606-40c3-4fab-bb41-29b1706d6c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0903313b-4fd0-467f-b313-2134a08b615f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0903313b-4fd0-467f-b313-2134a08b615f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_44612bad-4565-44e1-91cf-b95122672299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_44612bad-4565-44e1-91cf-b95122672299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_7efd66c1-4ade-4ce0-9a0d-a5c33b6eff91" xlink:href="avdl-20220930.xsd#avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c45be6c4-288e-4e40-9129-14a38068b417" xlink:to="loc_avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember_7efd66c1-4ade-4ce0-9a0d-a5c33b6eff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_16af2bdb-274e-4d46-823c-e72533c7e5de" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ac763741-280a-4afb-b05d-3fc6ce67e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ac763741-280a-4afb-b05d-3fc6ce67e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c56a56de-2cc2-4e1f-bed0-7836f720b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c56a56de-2cc2-4e1f-bed0-7836f720b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_908b692f-8360-4e26-a2dc-3ac2f8f433c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_908b692f-8360-4e26-a2dc-3ac2f8f433c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d97f339f-c033-4350-8a84-58aca0703bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d97f339f-c033-4350-8a84-58aca0703bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf7a12c6-74a3-4e83-ba44-e5f44ee34181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_32442b8c-0962-41b8-9289-914f43124646" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cf7a12c6-74a3-4e83-ba44-e5f44ee34181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_56859388-5354-4796-8fac-4f2bd8f4bb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_56859388-5354-4796-8fac-4f2bd8f4bb76" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:to="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_477056e2-037a-4944-8a81-4c662702327c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_826df01e-43ad-4139-a0b4-06a97a0d86b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_826df01e-43ad-4139-a0b4-06a97a0d86b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1a4a2d31-06a5-4685-b8c4-3e57a9fd108c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1a4a2d31-06a5-4685-b8c4-3e57a9fd108c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_1053e8c9-5d19-4ac5-881a-b7afb79a4cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_47fc5b98-9ea9-4ae1-9e38-2d81023391dc" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_1053e8c9-5d19-4ac5-881a-b7afb79a4cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_ea7e2fdb-12df-4d36-a2e8-28dcdc4e7a46" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ae6a463c-d914-409b-828a-5dfdb8b84912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ae6a463c-d914-409b-828a-5dfdb8b84912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_34f74e5b-4cf8-42e9-a6f1-cd1d45a799bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_34f74e5b-4cf8-42e9-a6f1-cd1d45a799bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_bd57e81a-f6f5-44db-b541-4a0fcb323f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_bd57e81a-f6f5-44db-b541-4a0fcb323f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6b7bf22c-7244-49c0-af91-2f5b673fedb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6b7bf22c-7244-49c0-af91-2f5b673fedb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a1b4dd96-8486-4244-8582-644859922b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a1b4dd96-8486-4244-8582-644859922b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_daaca863-d619-41de-9088-1736ad7c8fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9baf14c6-a65e-40e1-b36e-cd1533998a42" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_daaca863-d619-41de-9088-1736ad7c8fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bd51874e-4ee5-4be2-bfd4-b789673a4c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd51874e-4ee5-4be2-bfd4-b789673a4c61" xlink:to="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29676b4-4db7-447d-bb88-a6e896d2aa3e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_70e95eb0-eb38-49e8-b777-6e44dc3b735a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1cd1f840-11a9-4727-83d9-948a8ea8d531" xlink:to="loc_us-gaap_SeniorNotesMember_70e95eb0-eb38-49e8-b777-6e44dc3b735a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:to="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_76cd3f76-3664-42a1-9383-6d89dec92f6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_abf328f9-a53e-4b41-bc38-cd84c3593da6" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_abf328f9-a53e-4b41-bc38-cd84c3593da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_780984a2-3512-4808-a099-dcd5ceefb581" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_462c4b86-0896-413d-9fe8-8d5c6f80a1c1" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_780984a2-3512-4808-a099-dcd5ceefb581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cbf1fbb-33a1-4e5d-9d2f-02906cff4975" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1f5316a-ea3a-4d9c-8996-a8019b3c9344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a715ee84-a60f-4b96-9af3-cdf0f01059c3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1f5316a-ea3a-4d9c-8996-a8019b3c9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_38fa67cc-5209-4789-a3f7-3adb59596c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_38fa67cc-5209-4789-a3f7-3adb59596c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_959be169-a2e6-4a1e-822a-0cff468f98cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebt_959be169-a2e6-4a1e-822a-0cff468f98cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f7886060-bb3c-4660-bb5b-644d2c1ad873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebtCurrent_f7886060-bb3c-4660-bb5b-644d2c1ad873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3facc8bb-1980-4b24-b4a1-ccb33849d337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9400dfa2-09b7-4c40-90ba-49db3e52f1bd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3facc8bb-1980-4b24-b4a1-ccb33849d337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8247c679-2d0a-460a-b583-a0b4c1fc7cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8247c679-2d0a-460a-b583-a0b4c1fc7cf0" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c81ade65-aaac-407b-a4d9-e7eee2e8dc6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_5067a246-a0f9-4623-be21-b274c45a1593" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_5067a246-a0f9-4623-be21-b274c45a1593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_03048c85-3808-4618-b44d-2e7e12a6c5b1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_03048c85-3808-4618-b44d-2e7e12a6c5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_47f7dbb8-3e0b-4799-8b80-ad12eafc8621" xlink:href="avdl-20220930.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_47f7dbb8-3e0b-4799-8b80-ad12eafc8621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_4b931062-7ea5-4638-841d-a19b9f25dae1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9777a89-75ce-40a0-8c60-a9665184e075" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member_4b931062-7ea5-4638-841d-a19b9f25dae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9e7d2a81-921f-4a0f-b0c4-b0d9cfcc9435" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0e84603f-fb42-49bc-bb5f-1bda12e6e6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:to="loc_us-gaap_ConvertibleDebtMember_0e84603f-fb42-49bc-bb5f-1bda12e6e6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_32a56f68-9d54-4138-ac12-e1c5c01aab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3042aa66-0d9c-4ec6-9acf-6fa979dbef91" xlink:to="loc_us-gaap_SeniorNotesMember_32a56f68-9d54-4138-ac12-e1c5c01aab70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_47569ac7-1d2d-4db8-a7f0-04b2f3d68e1f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember_644a1c68-0294-479c-814e-45d8be584592" xlink:href="avdl-20220930.xsd#avdl_ThirdPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62f08592-371b-4189-9d50-773046a15ce3" xlink:to="loc_avdl_ThirdPartyMember_644a1c68-0294-479c-814e-45d8be584592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_4ef95668-4281-40d5-b104-2706174d3883" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_97c9ac89-a311-4acb-b4dd-9a929b428603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_97c9ac89-a311-4acb-b4dd-9a929b428603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ae4ca6b5-9f67-48bd-9d20-4426be58b440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ae4ca6b5-9f67-48bd-9d20-4426be58b440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_dc5d3462-3b10-43c4-9681-c2b329a9946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72d42b24-2e48-4fae-8d7e-2bcd389226c1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_dc5d3462-3b10-43c4-9681-c2b329a9946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_e07fb334-0344-4478-b730-4bb99249c4a8" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d613e9ad-26fc-498e-842d-2f45dd4200a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_InterestExpenseDebt_d613e9ad-26fc-498e-842d-2f45dd4200a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_a1716537-6a6e-442e-8588-30328ac5c8e0" xlink:href="avdl-20220930.xsd#avdl_CouponInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_CouponInterestExpense_a1716537-6a6e-442e-8588-30328ac5c8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_4c09b83b-5ced-474f-8a20-fc762e453755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_4c09b83b-5ced-474f-8a20-fc762e453755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_0d8c7dcf-c81f-4412-9caf-9123e94fa6c4" xlink:href="avdl-20220930.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_0d8c7dcf-c81f-4412-9caf-9123e94fa6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6877ae2b-5a1b-4679-a9f7-2c6e323aa8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6877ae2b-5a1b-4679-a9f7-2c6e323aa8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_6c1488e0-73fb-48ea-997b-b812bde50397" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_6c1488e0-73fb-48ea-997b-b812bde50397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_72480a21-8b07-433f-8f3a-23cf158a95b2" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_72480a21-8b07-433f-8f3a-23cf158a95b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d74f7ddd-c3ae-4175-b651-8b8ad6e8005b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d74f7ddd-c3ae-4175-b651-8b8ad6e8005b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount_2c41354e-f618-4702-bc34-9d5873c1ed2c" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentExchangeAmount_2c41354e-f618-4702-bc34-9d5873c1ed2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4b2ef403-7b77-4712-a038-b05a72051452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4b2ef403-7b77-4712-a038-b05a72051452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_1f75bfca-9385-4f1e-a4a4-132b4685923c" xlink:href="avdl-20220930.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_1f75bfca-9385-4f1e-a4a4-132b4685923c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_7294fe63-879b-430f-a91b-5108a99dba2d" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_7294fe63-879b-430f-a91b-5108a99dba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_076247c7-1767-4808-85c0-d9f31229cf21" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_076247c7-1767-4808-85c0-d9f31229cf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_3cadd44e-573e-489f-bae6-d98ec6183c18" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange_3cadd44e-573e-489f-bae6-d98ec6183c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_46750853-963f-4698-b860-a2de7250e098" xlink:href="avdl-20220930.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_46750853-963f-4698-b860-a2de7250e098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_0433a088-bd39-4afd-bd54-989edb642339" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_0433a088-bd39-4afd-bd54-989edb642339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_2c461f57-3f62-4581-8a60-3daa8a7b10fc" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_2c461f57-3f62-4581-8a60-3daa8a7b10fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_974e4999-406c-4df5-b8fb-dcd17ad1d2eb" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_974e4999-406c-4df5-b8fb-dcd17ad1d2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_634f47ae-7d21-4269-b238-160a16a65cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_634f47ae-7d21-4269-b238-160a16a65cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_9255a8b8-76b2-40fb-9a5b-e8905346ef00" xlink:href="avdl-20220930.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_9255a8b8-76b2-40fb-9a5b-e8905346ef00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ea605cd3-d5e4-41ba-949c-18f60f391b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_ea605cd3-d5e4-41ba-949c-18f60f391b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b3cad3de-5a0e-4cd7-817d-f42e9d672b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_99b36b65-2d95-40c9-8054-c41f8662b99c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b3cad3de-5a0e-4cd7-817d-f42e9d672b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b223fe70-cdbc-4c56-baca-d9aed9b04fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41878f2c-3f84-4f8a-98d0-d0e7b2adf689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b223fe70-cdbc-4c56-baca-d9aed9b04fce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41878f2c-3f84-4f8a-98d0-d0e7b2adf689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cb56717d-3272-40e2-b10f-5665072b70f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b223fe70-cdbc-4c56-baca-d9aed9b04fce" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cb56717d-3272-40e2-b10f-5665072b70f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5c77fa32-64f5-436b-b9ce-6355c234b753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5c77fa32-64f5-436b-b9ce-6355c234b753" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_8a92458a-ee2b-4c04-8805-e28d0a994d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_8a92458a-ee2b-4c04-8805-e28d0a994d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5edf864f-b115-40d6-bc56-65ee36ca1d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:to="loc_us-gaap_OtherAssetsCurrent_5edf864f-b115-40d6-bc56-65ee36ca1d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_0f260b6e-2613-4e74-81cf-476a52b72886" xlink:href="avdl-20220930.xsd#avdl_GuaranteeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:to="loc_avdl_GuaranteeCurrent_0f260b6e-2613-4e74-81cf-476a52b72886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b7ffc267-64ae-47e0-938f-3874c5e7a1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b7ffc267-64ae-47e0-938f-3874c5e7a1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e0fa32be-c640-4bee-9c7a-def76e9673bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_f8ba85cf-48b9-43b0-b379-3e53c8889a67" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e0fa32be-c640-4bee-9c7a-def76e9673bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9655908b-a87a-4b6c-a2f7-da62f9eb9a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9655908b-a87a-4b6c-a2f7-da62f9eb9a13" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_77a43a5e-2d1e-452f-9826-73250ab18e3a" xlink:href="avdl-20220930.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_77a43a5e-2d1e-452f-9826-73250ab18e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_6972e7a3-f192-4ad0-9286-db1fe198d08f" xlink:href="avdl-20220930.xsd#avdl_GuaranteeNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:to="loc_avdl_GuaranteeNoncurrent_6972e7a3-f192-4ad0-9286-db1fe198d08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_27b2faf9-798f-465d-ba79-478af42b15cd" xlink:href="avdl-20220930.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:to="loc_avdl_OtherNoncurrentReceivables_27b2faf9-798f-465d-ba79-478af42b15cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0ddc88ce-eee9-41df-8907-671fdb41f9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_0ddc88ce-eee9-41df-8907-671fdb41f9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_08681573-ecca-4f6b-a4eb-50d6798e734f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_b2169fc2-fdd8-4b6e-ada5-96a18c7b332a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_08681573-ecca-4f6b-a4eb-50d6798e734f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_502de101-55d5-4c02-85f4-3764b3c109cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_502de101-55d5-4c02-85f4-3764b3c109cc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bedd3f85-a12d-4233-8218-878f8850c787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bedd3f85-a12d-4233-8218-878f8850c787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_755712d8-7e4c-4610-a172-0b6ddf7fc802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_us-gaap_RestructuringReserveCurrent_755712d8-7e4c-4610-a172-0b6ddf7fc802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_03dcc778-f275-49c3-a944-b9a83f71a053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_us-gaap_AccruedSalariesCurrent_03dcc778-f275-49c3-a944-b9a83f71a053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_68f2709f-25d8-4a42-9ecf-def71fab2f25" xlink:href="avdl-20220930.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_avdl_AccruedOutsourceContractCosts_68f2709f-25d8-4a42-9ecf-def71fab2f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_f6639ed7-dc3f-4dab-88b9-0617ca4e85f0" xlink:href="avdl-20220930.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_f6639ed7-dc3f-4dab-88b9-0617ca4e85f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4767225b-d44b-48bb-870b-6695aa958ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_cb55591d-4a77-4050-81d6-2b83bf16a5a7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4767225b-d44b-48bb-870b-6695aa958ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_1d6f6cc9-048e-49c8-835e-4d0833c3e995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_1d6f6cc9-048e-49c8-835e-4d0833c3e995" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_304996f1-7d6c-41a6-b88e-bea145143337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_304996f1-7d6c-41a6-b88e-bea145143337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_13c3d19e-912d-4d00-a7bd-2aed92c0bfc3" xlink:href="avdl-20220930.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_13c3d19e-912d-4d00-a7bd-2aed92c0bfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_e6a473ab-ffbe-4272-b39f-ea6c07462db1" xlink:href="avdl-20220930.xsd#avdl_AccruedInterestCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:to="loc_avdl_AccruedInterestCurrent_e6a473ab-ffbe-4272-b39f-ea6c07462db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_b5052a95-88ea-4f22-a8dc-1d8b743fdfda" xlink:href="avdl-20220930.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_b5052a95-88ea-4f22-a8dc-1d8b743fdfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_37d1712b-0b06-48e3-bea8-b6392dd19a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_eca418dc-9a84-477c-b87b-34ad7b5b0710" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_37d1712b-0b06-48e3-bea8-b6392dd19a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_b262b72e-4557-4883-ad48-efdca7adb037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_43eabcfe-c960-431d-86ba-39dc8ac16b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_b262b72e-4557-4883-ad48-efdca7adb037" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_43eabcfe-c960-431d-86ba-39dc8ac16b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_bf646f6b-c4e5-42c5-b40f-ef74b16f9207" xlink:href="avdl-20220930.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_43eabcfe-c960-431d-86ba-39dc8ac16b84" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_bf646f6b-c4e5-42c5-b40f-ef74b16f9207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_2fa44c02-1d40-40b8-b448-186b728b996a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_43eabcfe-c960-431d-86ba-39dc8ac16b84" xlink:to="loc_us-gaap_GuarantyLiabilities_2fa44c02-1d40-40b8-b448-186b728b996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_724ba784-45e8-4fed-a423-1726f196f837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_43eabcfe-c960-431d-86ba-39dc8ac16b84" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_724ba784-45e8-4fed-a423-1726f196f837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#ShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67216a27-11cd-4ab8-80e9-caa1f39f548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67216a27-11cd-4ab8-80e9-caa1f39f548d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:to="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_81382c67-ee60-4b09-a10d-a458691f1e2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_74a23e74-63d5-4afd-98dd-6b89fd450ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73171942-351a-4818-b438-1e6f86e4078f" xlink:to="loc_us-gaap_PerformanceSharesMember_74a23e74-63d5-4afd-98dd-6b89fd450ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_699995c9-3c95-483c-98be-06faaee7e801" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4d6d91d-f6e5-485d-ba23-5816a5523e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4d6d91d-f6e5-485d-ba23-5816a5523e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e59de3f-c6d3-4b4a-b60e-19753eed196d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e59de3f-c6d3-4b4a-b60e-19753eed196d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4d1fe65d-0e9f-4f80-8d1a-787e9728c9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f42742af-2fff-4c22-8158-72f6822a3a0a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4d1fe65d-0e9f-4f80-8d1a-787e9728c9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_08cfb0d5-50bf-40be-ae19-981fca77bf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_499c1bf1-59fb-4e1e-ba15-5a3740ddc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08cfb0d5-50bf-40be-ae19-981fca77bf4d" xlink:to="loc_us-gaap_NetIncomeLoss_499c1bf1-59fb-4e1e-ba15-5a3740ddc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fc6f553-51d8-4055-b679-603fe84e27ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08cfb0d5-50bf-40be-ae19-981fca77bf4d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fc6f553-51d8-4055-b679-603fe84e27ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bf2b6e6c-f3b2-41f0-ae49-e0e67f8f2d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fc6f553-51d8-4055-b679-603fe84e27ee" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bf2b6e6c-f3b2-41f0-ae49-e0e67f8f2d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d60c8996-84e5-4932-bdd1-f7e792af2774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fc6f553-51d8-4055-b679-603fe84e27ee" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d60c8996-84e5-4932-bdd1-f7e792af2774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1158320b-613e-42f5-9fee-5884552e80d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9fc6f553-51d8-4055-b679-603fe84e27ee" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1158320b-613e-42f5-9fee-5884552e80d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1c8bdf6b-b052-45af-a0c8-f0bbf45d9e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08cfb0d5-50bf-40be-ae19-981fca77bf4d" xlink:to="loc_us-gaap_EarningsPerShareBasic_1c8bdf6b-b052-45af-a0c8-f0bbf45d9e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_12760379-5e22-4330-ba1b-ead3e0b3b853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08cfb0d5-50bf-40be-ae19-981fca77bf4d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_12760379-5e22-4330-ba1b-ead3e0b3b853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#NetLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_699d4360-e719-408d-a757-498707c03af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84a1c596-e24b-4705-85cc-c6cad6967a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_699d4360-e719-408d-a757-498707c03af8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84a1c596-e24b-4705-85cc-c6cad6967a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#ComprehensiveIncomeLossComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_fd95e5f9-d920-4815-bcad-3cd06408e66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_fd95e5f9-d920-4815-bcad-3cd06408e66a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_419521fa-67d3-4b5b-bf4b-952bfaa6dfb5" xlink:to="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e08ad272-5560-4f55-ae1c-f75c60c3b910" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_98f88ad0-b4bd-4b27-9210-c8384db43334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_98f88ad0-b4bd-4b27-9210-c8384db43334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_8d0cd367-25da-48e2-ab54-57d8a4c18949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eeb9033b-907e-41dc-932f-14e93445ab81" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_8d0cd367-25da-48e2-ab54-57d8a4c18949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70d98091-9512-42c0-97af-0a4292d1d257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_356d3538-ac0e-4c5b-8b8a-68d60edbf5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_356d3538-ac0e-4c5b-8b8a-68d60edbf5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1c9032a-c8c5-4923-93cb-e60d0438204b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1c9032a-c8c5-4923-93cb-e60d0438204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e9d6db7-52b9-4891-9857-1151923de3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cf22dcba-4552-4f19-b0f5-d59b632be5e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e9d6db7-52b9-4891-9857-1151923de3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_928bf496-5f64-4bae-a421-8bf141a6f372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6c6baaf1-934b-44b3-94d8-c4b6621d9d41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_928bf496-5f64-4bae-a421-8bf141a6f372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3c223ade-7174-4ff3-a969-74669d729cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3c223ade-7174-4ff3-a969-74669d729cfb" xlink:to="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:to="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0794dd1d-a8f7-40b8-a522-541d25d01986" xlink:to="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b6f88552-47ab-45e9-b203-26685ed42ffa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bfbb0d73-87d1-41c4-a61b-85a79fbb0a36" xlink:to="loc_srt_MaximumMember_b6f88552-47ab-45e9-b203-26685ed42ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_dcc73f1f-ed6e-486c-8c1e-c26a01dc1848" xlink:to="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_3177ffe1-b46d-4ea3-857c-046af93892c2" xlink:href="avdl-20220930.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_3177ffe1-b46d-4ea3-857c-046af93892c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_8c1c92eb-066d-4d9f-aca9-73fc62f2840e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_8c1c92eb-066d-4d9f-aca9-73fc62f2840e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeAssetCurrentCarryingValue_2d1dd490-44d4-407b-8e9f-66a06f2ae121" xlink:href="avdl-20220930.xsd#avdl_GuaranteeAssetCurrentCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_190dd8bc-afc2-4a66-99ff-84bdd69bebf9" xlink:to="loc_avdl_GuaranteeAssetCurrentCarryingValue_2d1dd490-44d4-407b-8e9f-66a06f2ae121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#RestructuringCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8ca34010-ebc2-4682-8d47-4895f71d7d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8ca34010-ebc2-4682-8d47-4895f71d7d5e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:to="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_953d1ed6-1f1f-488a-95b1-e52256b5e746" xlink:to="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_4b176aab-29f2-4dd4-807d-08a852ca91ba" xlink:href="avdl-20220930.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9cae815b-7640-4693-818b-ff49b537b054" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_4b176aab-29f2-4dd4-807d-08a852ca91ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c17aee12-cdd5-4076-90ef-6f6164fae53b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4d5c9197-bdf7-4e6d-a822-f8ca8f5f593e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_4d5c9197-bdf7-4e6d-a822-f8ca8f5f593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b569e167-f219-4d30-8aee-969c9e75ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringCharges_b569e167-f219-4d30-8aee-969c9e75ab10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_58a7db44-2176-4402-a524-38c8a604bc81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_962b13a0-02a3-4dea-a189-e483e74114b6" xlink:to="loc_us-gaap_RestructuringReserve_58a7db44-2176-4402-a524-38c8a604bc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d5f902b3-54ff-46d5-a8d9-2fc8615d7533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d5f902b3-54ff-46d5-a8d9-2fc8615d7533" xlink:to="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_e017f689-b624-4d3f-a0e0-7af36c37ee91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:to="loc_us-gaap_RestructuringReserve_e017f689-b624-4d3f-a0e0-7af36c37ee91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesExcludingOtherAdjustments_0a4719de-848d-4121-9ce9-e5ec7aaa10ee" xlink:href="avdl-20220930.xsd#avdl_RestructuringChargesExcludingOtherAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:to="loc_avdl_RestructuringChargesExcludingOtherAdjustments_0a4719de-848d-4121-9ce9-e5ec7aaa10ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_736e17e6-d2db-4d6b-a2b3-b066589d2599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:to="loc_us-gaap_PaymentsForRestructuring_736e17e6-d2db-4d6b-a2b3-b066589d2599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_aa3461f8-ab86-4d01-83cd-bb699c769145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_aa3461f8-ab86-4d01-83cd-bb699c769145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_78ec8327-f8ae-4a4f-9bd1-d56c4911a440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_db7ccd20-1076-4e30-b2a2-ee0034ccbf4c" xlink:to="loc_us-gaap_RestructuringReserve_78ec8327-f8ae-4a4f-9bd1-d56c4911a440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20220930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_4822ad25-dc9f-458d-9cc6-983f69b47125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_4822ad25-dc9f-458d-9cc6-983f69b47125" xlink:to="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef83fc53-a29f-4d6c-8511-b30c6f006ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_88186b99-680e-43c8-851b-0b595ff6bbe1" xlink:href="avdl-20220930.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7ade957-dc12-4785-a1af-0daf1f39231b" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_88186b99-680e-43c8-851b-0b595ff6bbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a727cca-6a03-4859-8333-d052feca18e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_103e9dc5-848f-434d-afdb-c1f8da37d317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98e5c295-ad16-4fe6-9d21-ad44b184cd2a" xlink:to="loc_us-gaap_SeniorNotesMember_103e9dc5-848f-434d-afdb-c1f8da37d317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d8ef5730-4c60-41b6-83e9-5402257f6f71" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_89017ea8-305e-4002-bf03-a9e390630572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1ebed222-8a73-4b26-8953-2852481da677" xlink:to="loc_us-gaap_SubsequentEventMember_89017ea8-305e-4002-bf03-a9e390630572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1edd8e24-4bd3-4398-9219-2a0acf463e60" xlink:to="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f6b150c5-20bc-495e-88b2-725cb2e50061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f6b150c5-20bc-495e-88b2-725cb2e50061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b63c1777-e2b8-4fd8-98ff-81263d27d738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_26230f17-8636-4044-bfa6-e8680c456a23" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b63c1777-e2b8-4fd8-98ff-81263d27d738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935285136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1341933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 Earlsfort Terrace<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 T380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">901-5201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, nominal value $0.01 per share**<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Smaller Reporting Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,778,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNMS', window );">NASDAQ/NMS (GLOBAL MARKET)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares*<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNMS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNMS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934826928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 4,380<span></span>
</td>
<td class="nump">$ 14,465<span></span>
</td>
<td class="nump">$ 14,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">14,096<span></span>
</td>
<td class="nump">21,283<span></span>
</td>
<td class="nump">57,535<span></span>
</td>
<td class="nump">47,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (income) expense</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,523<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="nump">16,960<span></span>
</td>
<td class="nump">25,663<span></span>
</td>
<td class="nump">75,523<span></span>
</td>
<td class="nump">62,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(16,960)<span></span>
</td>
<td class="num">(25,663)<span></span>
</td>
<td class="num">(75,523)<span></span>
</td>
<td class="num">(62,410)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment and other income, net</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="num">(3,564)<span></span>
</td>
<td class="num">(1,929)<span></span>
</td>
<td class="num">(9,087)<span></span>
</td>
<td class="num">(5,788)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain from release of certain liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(20,076)<span></span>
</td>
<td class="num">(27,103)<span></span>
</td>
<td class="num">(84,074)<span></span>
</td>
<td class="num">(66,501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(5,101)<span></span>
</td>
<td class="nump">25,940<span></span>
</td>
<td class="num">(11,473)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (20,146)<span></span>
</td>
<td class="num">$ (22,002)<span></span>
</td>
<td class="num">$ (110,014)<span></span>
</td>
<td class="num">$ (55,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share &#8211; basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share &#8211; diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">60,201<span></span>
</td>
<td class="nump">58,585<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
<td class="nump">58,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">60,201<span></span>
</td>
<td class="nump">58,585<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
<td class="nump">58,506<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935508304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (20,146)<span></span>
</td>
<td class="num">$ (22,002)<span></span>
</td>
<td class="num">$ (110,014)<span></span>
</td>
<td class="num">$ (55,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation loss</a></td>
<td class="num">(647)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="num">(1,489)<span></span>
</td>
<td class="num">(839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net other comprehensive loss, net of income tax benefit of $&#8212;, $59, $&#8212; and $220, respectively</a></td>
<td class="num">(934)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(854)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss, net of tax</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
<td class="num">(3,969)<span></span>
</td>
<td class="num">(1,693)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (21,727)<span></span>
</td>
<td class="num">$ (22,396)<span></span>
</td>
<td class="num">$ (113,983)<span></span>
</td>
<td class="num">$ (56,721)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936744048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (220)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935858976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 60,715<span></span>
</td>
<td class="nump">$ 50,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">45,760<span></span>
</td>
<td class="nump">106,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">2,077<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,670<span></span>
</td>
<td class="nump">32,826<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">113,222<span></span>
</td>
<td class="nump">192,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,947<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="nump">16,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">11,720<span></span>
</td>
<td class="nump">33,777<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">145,758<span></span>
</td>
<td class="nump">247,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">26,299<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">7,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,965<span></span>
</td>
<td class="nump">7,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,757<span></span>
</td>
<td class="nump">5,270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">41,511<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">109,934<span></span>
</td>
<td class="nump">142,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">5,727<span></span>
</td>
<td class="nump">3,917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">158,198<span></span>
</td>
<td class="nump">169,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; (deficit) equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at September&#160;30, 2022 and 488 issued and outstanding at December&#160;31, 2021</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 60,885 issued and outstanding at September&#160;30, 2022 and 58,620 issued and outstanding at December&#160;31, 2021</a></td>
<td class="nump">608<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">572,626<span></span>
</td>
<td class="nump">549,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(557,770)<span></span>
</td>
<td class="num">(447,756)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(27,909)<span></span>
</td>
<td class="num">(23,940)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="num">(12,440)<span></span>
</td>
<td class="nump">78,244<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; (deficit) equity</a></td>
<td class="nump">$ 145,758<span></span>
</td>
<td class="nump">$ 247,265<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Tax Credit Receivable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non current portion of tax credit receivable on research and development as on the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934842384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, nominal value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued (in shares)</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding (in shares)</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">60,885<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">60,885<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624928691712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preferred shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th">
<div>Additional paid-in capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th">
<div>Accumulated deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive (loss) income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="num">$ (12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 566,916<span></span>
</td>
<td class="num">$ (26,699)<span></span>
</td>
<td class="num">$ (384,187)<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="num">$ (21,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">136,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">542,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,306)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">162,266<span></span>
</td>
<td class="num">$ (12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="num">$ (26,699)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(55,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,616<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">98,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">546,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,744)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">136,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">542,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(19,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,488<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">118,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">544,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(403,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,002)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,002)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,616<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">98,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">546,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,744)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">78,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">549,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(1,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,032<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">55,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">553,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(474,180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,042)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">78,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">549,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(110,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,885<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">(12,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 608<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">572,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557,770)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,909)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,032<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">55,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">553,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(474,180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,042)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(63,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(1,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature', window );">Change in fair value of October 2023 Notes conversion feature</a></td>
<td class="nump">5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,038<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="num">(3,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">560,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(537,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,328)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(20,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs</a></td>
<td class="nump">10,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Amortization of deferred issuance costs</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,885<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">$ (12,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 608<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 572,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (557,770)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (27,909)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934745728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (110,014)<span></span>
</td>
<td class="num">$ (55,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Change in deferred taxes</a></td>
<td class="nump">25,916<span></span>
</td>
<td class="num">(11,322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">5,086<span></span>
</td>
<td class="nump">6,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain from release of certain liabilities</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other adjustments</a></td>
<td class="nump">1,539<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">27,948<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable', window );">Research and development tax credit receivable</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">3,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable &amp; other current liabilities</a></td>
<td class="num">(11,629)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">4,277<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities</a></td>
<td class="num">(3,109)<span></span>
</td>
<td class="num">(2,228)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(54,938)<span></span>
</td>
<td class="num">(54,804)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(716)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the hospital products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">59,873<span></span>
</td>
<td class="nump">83,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(2,334)<span></span>
</td>
<td class="num">(58,591)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">56,823<span></span>
</td>
<td class="nump">41,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments for debt issuance costs</a></td>
<td class="num">(4,803)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="nump">10,532<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock option exercises and employee share purchase plan</a></td>
<td class="nump">2,192<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">7,921<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">201<span></span>
</td>
<td class="num">(621)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">10,007<span></span>
</td>
<td class="num">(13,553)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at January 1,</a></td>
<td class="nump">50,708<span></span>
</td>
<td class="nump">71,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at September 30,</a></td>
<td class="nump">60,715<span></span>
</td>
<td class="nump">58,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">9,660<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes (refund) paid</a></td>
<td class="num">$ (32,323)<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in research and development tax credit receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937150272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935716848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On July 18, 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) granted tentative approval to LUMRYZ for this indication. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. The Company is primarily focused on obtaining final FDA approval of LUMRYZ. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;), which is listed in the FDA&#8217;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book or a court earlier determines that patent is not infringed, invalid or otherwise unenforceable. The FDA&#8217;s tentative approval can be subject to change based on new information that may come to the FDA&#8217;s attention between such time as the tentative approval and potential final approval. The Company cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any commercialized products in its portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $60,715 of cash and cash equivalents and $45,760 of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#8217;s ability to generate revenue is expected to start following the launch of LUMRYZ, which is dependent, in part, on final approval of LUMRYZ by the FDA. As of September 30, 2022, the Company has $26,375 aggregate principal amount of its 4.50% exchangeable senior notes due February 2023 (the &#8220;February 2023 Notes&#8221;) and $117,375&#160;aggregate principal amount of its 4.50% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;) (together, the &#8220;2023 Notes&#8221;). The Company does not currently have sufficient available liquidity to repay the outstanding balance of the October 2023 Notes. These conditions and events raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In response to these conditions and events, the Company is evaluating various financing strategies to obtain sufficient additional liquidity to meet its operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. The potential sources of financing that the Company is evaluating include one or any combination of royalty financing, secured or unsecured debt, convertible debt and equity. In addition, the Company&#8217;s financing strategy could also include refinancing or negotiating new terms for the 2023 Notes. The Company also currently has authorized and available the use of its at-the-market offering program (&#8220;ATM Program&#8221;), described in more detail below, which could provide the Company up to approximately $135,000 (as of September 30, 2022), net of commissions, if fully utilized. While the Company has the ability to utilize the ATM Program, it intends to pursue the other financing strategies described above. Based on the Company&#8217;s ability to raise funds through the ATM Program, the Company has determined that it is probable that such proceeds would provide sufficient additional capital to meet the Company&#8217;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. As a result, the Company has concluded that management&#8217;s plans are probable of being achieved to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The sources of financing described above that could be available to the Company and the timing and probability of obtaining sufficient capital depends, in part, on obtaining final FDA approval of LUMRYZ, resolving any legal and regulatory matters that could preclude the Company from launching LUMRYZ and future capital market conditions. If the Company&#8217;s current assumptions regarding timing of potential final approval, the timing of the launch of LUMRYZ or if there are any other changes or differences in our current assumptions that negatively impact our financing strategy, the Company may have to further </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reduce expenditures or significantly delay, scale back or discontinue the development or commercialization of LUMRYZ in order to extend its cash resources. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Offering Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 5, 2020, the Company entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an ATM Program under which the Company may offer and sell its American Depositary Shares (&#8220;ADSs&#8221;, and such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#8217;s Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Prospectus&#8221;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#8217;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Prospectus&#8221;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company had issued and sold 1,768 ADSs, resulting in net proceeds to the Company of approximately $10,532, pursuant to the 2020 Prospectus. The Company may offer and sell up to an additional $39,142 of ADSs under the ATM Program that remain available for sale pursuant to the 2020 Prospectus and also up to $100,000 of ADSs available for sale under the ATM Program pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of September&#160;30, 2022, which is derived from the prior year 2021 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on March 16, 2022.</span></div>The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934815872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended September&#160;30, 2022 and December&#160;31, 2021, respectively, there were no transfers in and out of&#160;Level 3. During the three and nine months ended September&#160;30, 2022 and 2021, respectively, the Company did not recognize any allowances for credit losses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its $26,375 aggregate principal amount of its February 2023 Notes and its $117,375&#160;aggregate principal amount of its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair values of the February 2023 Notes and the October 2023 Notes at September&#160;30, 2022 are $25,584 and $101,970, respectively. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the Company&#8217;s debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624940379200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities&#160;The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; (deficit) equity, net of income tax effects. As of September&#160;30, 2022, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;September&#160;30, 2022 and December&#160;31, 2021, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,046)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income, net in the accompanying unaudited condensed consolidated statements of loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of $64 and $22 for the three months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $61 and $66 for the three months ended September&#160;30, 2022 and 2021, respectively. We recognized gross realized gains of $372 and $74 for the nine months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $1,092 and $173 for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable debt securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the gross unrealized losses and fair value of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2022. The unrealized losses in the table below are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939078768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,517)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $76 unamortized debt discount and issuance costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,934&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022 and 2021, the total interest expense was $3,564 and $1,929, respectively, with coupon interest expense of $1,646 and $1,617 for each period, respectively, and the amortization of debt issuance costs and debt discount, totaling $1,918 and $312 for each period, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2022 and 2021, the total interest expense was $9,087 and $5,788, respectively, with coupon interest expense of $4,852 and $4,851 for each period, respectively, and the amortization of debt issuance costs and debt discount of $4,147 and $937 for each period, respectively. Current period interest expense also includes $88 of additional interest expense owed to be in compliance with certain terms of the February 2023 Notes indenture and is not applicable to future periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), issued $125,000 aggregate principal amount of its February 2023 Notes in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560. The February 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2022, the Issuer completed the exchange of $117,375 of its February 2023 Notes for a new series of its October 2023 Notes (the &#8220;Exchange Transaction&#8221;). The remaining $26,375 aggregate principal amount of the February 2023 Notes were not exchanged and maintain a maturity date of February 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $4,804 in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $5,450 in fees to third parties that were expensed as part of the completed Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $5,508, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $5,508 are amortized over the remaining term of the October 2023 Notes as a component of interest expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes (so long as the principal amount of such holder&#8217;s 2023 Notes not exchanged is at least $200), which is equivalent to an initial exchange price of approximately $10.79 per ADS. Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">February 2023 Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the February 2023 Notes may convert their February 2023 Notes, at their option, prior to the close of business on the business day immediately preceding the maturity date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">October 2023 Notes</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the October 2023 Notes may convert their October 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding May 1, 2023, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after May 1, 2023 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzc2Mg_386183ed-95c1-436b-a9e7-e1c14e3bde78">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzgwNw_508bcbe0-6ff0-45f0-850b-ee02e8547ae7">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of October 2023 Notes, as determined following a request by a holder of the October 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding May 1, 2023, regardless of whether a holder of the October 2023 Notes has the right to require the Company to repurchase the October 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding May 1, 2023, all or any portion of a holder&#8217;s October 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the October 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding May 1, 2023, then a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the October 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the October 2023 Notes may exchange its October 2023 Notes until the redemption price has been paid or duly provided for.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least 130% of the Exchange Price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#8217;s ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company has therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span>, as amended by ASU 2020-06.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937882048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The income tax provision was $70 for the three months ended September&#160;30, 2022 resulting in an effective tax rate of (0.3)%. The income tax benefit was $5,101 for the three months ended September 30, 2021 resulting in an effective tax rate of 18.8%. The change in the effective income tax rate for the three months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the net operating losses during the current period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The income tax provision was $25,940 for the nine months ended September&#160;30, 2022 resulting in an effective tax rate of (30.9)%. The income tax benefit was $11,473 for the nine months ended September 30, 2021 resulting in an effective tax rate of 17.3%. The change in the effective income tax rate for the nine months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the deferred tax assets during the current period.       </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the nine months ended September&#160;30, 2022, the Company collected all of the outstanding receivables due to the Company related to net operating loss carrybacks under the Coronavirus Aid, Relief, and Economic Security Act for losses incurred during 2019, which were carried back to 2015.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937095488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Assets and Liabilities</a></td>
<td class="text">Other Assets and Liabilities&#160;<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937963760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share Based Compensation</a></td>
<td class="text">Share Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Performance-Based Stock Options</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Board of Directors approved the grant of performance-based stock options to certain executive officers and employees. These performance-based stock options vest upon both the achievement of certain commercial milestones and specific service conditions. As of September&#160;30, 2022, 2,165 performance-based stock options were outstanding, none of which had vested. The weighted-average grant date fair value of the performance-based stock options was $3.71. The Company has not yet recognized any related share-based compensation expense as the commercial milestones have not been met; however, in the event that the performance conditions are met, $8,032 will be recognized by the Company for the performance-based stock options outstanding as of September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937882048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s Employee Share Purchase Plan (&#8220;ESPP&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligations under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. The dilutive effect of the performance share unit awards (&#8220;PSUs&#8221;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding, in thousands, is as follows:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Potential ordinary shares of&#160;18,722&#160;and&#160;15,684&#160;were excluded from the calculation of weighted average shares for the three months ended September&#160;30, 2022 and 2021, respectively, and potential ordinary shares of 18,925 and 15,497 were excluded from the calculation of weighted average shares for the nine months ended September&#160;30, 2022 and 2021 because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and nine months ended September&#160;30, 2022 and 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937882048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and nine months ended September&#160;30, 2022 and 2021, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss, net of income tax benefit of $&#8212;, $59, $&#8212; and $220, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,909)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,909)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937963760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to the Company&#8217;s business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At September 30, 2022 and December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Jazz Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#8220;Avadel CNS&#8221;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel CNS&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#8217; Counterclaims (&#8220;the Jazz First Amended Answer&#8221;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;) de-listed from the Orange Book and seeking to have the motion resolved concurrent with the parties&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#8217; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#8217;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#8217; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was held on October 25, 2022. At the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#8217; request and scheduled the hearing for November 15, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second Jazz Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fourth Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 15, 2022, Jazz filed another formal complaint (the &#8220;Fourth Complaint&#8221;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent from the Orange Book, which is pending in response to the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 21, 2022, Jazz served the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Fourth Avadel Answer&#8221;) with the Court in response to the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) de-listing of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#8220;Sherman Act&#8221;); and v) attempted monopolization under the Sherman Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avadel Complaint</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#8220;Avadel Plaintiffs&#8221;) filed a formal complaint (the &#8220;Avadel Complaint&#8221;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#8220;Jazz Parties&#8221;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#8217; trade secrets. The Avadel Complaint further includes typical relief requests such as injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#8217; scientists.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#8217; response to that Motion was filed with the Court on July 29, 2022. Jazz&#8217;s reply was filed with the Court on August 5, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administrative Procedure Act</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#8220;Federal Defendants&#8221;) in the United States District Court for the District of Columbia (the &#8220;DC Court&#8221;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#8217;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#8217;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#8217;s unopposed motion to intervene in the case to defend the FDA&#8217;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#8217;s and Jazz&#8217;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#8217;s motion and the Federal Defendants and Jazz&#8217;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent de-listed from the FDA&#8217;s Orange Book described above in the section regarding the First Jazz Complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2021 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield Capital L.P. (&#8220;Deerfield&#8221;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the Company&#8217;s pediatric assets, the Company guaranteed to Deerfield the quarterly royalty payment of&#160;15%&#160;on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately&#160;$10,300. Given the Company&#8217;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $844 at September&#160;30, 2022. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, Inc., guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $841 at September&#160;30, 2022. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624937095488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Costs</a></td>
<td class="text">Restructuring Costs<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Corporate Restructuring Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost structure optimization efforts included a nearly 50% reduction in its workforce that was completed at the end of August 2022 (the &#8220;2022 Corporate Restructuring Plan&#8221;). Restructuring income of $69 associated with this plan, comprised primarily of adjustments to the estimate of severance related costs, were recorded in the three months ended September&#160;30, 2022. Restructuring charges of $3,523 associated with this plan, comprised primarily of severance related costs, were recorded in the nine months ended September&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at September 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 Corporate Restructuring Plan liabilities of $1,480 are included in the unaudited condensed consolidated balance sheet in accrued expenses at September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939079056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsOn November 4, 2022, the Company repurchased $8,875 of its February 2023 Notes for $8,653 of cash consideration through an open market purchase.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936642928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_NatureOfBusinessPolicyPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On July 18, 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) granted tentative approval to LUMRYZ for this indication. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. The Company is primarily focused on obtaining final FDA approval of LUMRYZ. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;), which is listed in the FDA&#8217;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#8217;s Orange Book or a court earlier determines that patent is not infringed, invalid or otherwise unenforceable. The FDA&#8217;s tentative approval can be subject to change based on new information that may come to the FDA&#8217;s attention between such time as the tentative approval and potential final approval. The Company cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any commercialized products in its portfolio.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_LiquidityAndGoingConcernPolicyTextBlock', window );">Liquidity and Going Concern</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of September&#160;30, 2022, which is derived from the prior year 2021 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on March 16, 2022.</span>The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_LiquidityAndGoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity and Going Concern</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_LiquidityAndGoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_NatureOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_NatureOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934701152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939073136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Schedule of Available-for-sale and Equity Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;September&#160;30, 2022 and December&#160;31, 2021, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,046)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturity Dates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</a></td>
<td class="text">The following table shows the gross unrealized losses and fair value of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2022. The unrealized losses in the table below are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140625026621584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,517)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $76 unamortized debt discount and issuance costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,934&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935506128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsource contract costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule Of Long Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140625026621584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Reconciliation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding, in thousands, is as follows:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939123936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three and nine months ended September&#160;30, 2022 and 2021, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(839)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,344)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive loss, net of income tax benefit of $&#8212;, $59, $&#8212; and $220, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(934)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at September 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,909)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,909)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939123936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of September&#160;30, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at September 30, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624929070720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Feb. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 60,715<span></span>
</td>
<td class="nump">$ 60,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">45,760<span></span>
</td>
<td class="nump">45,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_SaleOfStockCommissionPercentage', window );">Commission percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,532<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member', window );">4.50 Percent Exchangeable Senior Notes Due October 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember', window );">At-The-Market Offering Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADS under shelf registration</a></td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2020ProspectusMember', window );">Open Market Sales Agreement, 2020 Prospectus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADS under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount', window );">Remaining value of ADSs available for sale</a></td>
<td class="nump">$ 39,142<span></span>
</td>
<td class="nump">39,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2020ProspectusMember', window );">Open Market Sales Agreement, 2020 Prospectus | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares)</a></td>
<td class="nump">1,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of shares</a></td>
<td class="nump">$ 10,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2022ProspectusMember', window );">Open Market Sales Agreement, 2022 Prospectus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADS under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount', window );">Remaining value of ADSs available for sale</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining American Depositary Shares Available For Sale Under Shelf Registration, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_SaleOfStockCommissionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Commission Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_SaleOfStockCommissionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2020ProspectusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2020ProspectusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2022ProspectusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_OpenMarketSalesAgreement2022ProspectusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935453792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 45,760<span></span>
</td>
<td class="nump">$ 106,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">31,481<span></span>
</td>
<td class="nump">78,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">9,178<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">3,458<span></span>
</td>
<td class="nump">9,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">31,481<span></span>
</td>
<td class="nump">78,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">31,481<span></span>
</td>
<td class="nump">78,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">14,279<span></span>
</td>
<td class="nump">28,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">9,178<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">3,458<span></span>
</td>
<td class="nump">9,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936657392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Narrative (Details) - Senior Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 25,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">4.50 Percent Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 101,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936597392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">$ 48,325<span></span>
</td>
<td class="nump">$ 106,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(2,785)<span></span>
</td>
<td class="num">(1,247)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">45,760<span></span>
</td>
<td class="nump">106,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">32,922<span></span>
</td>
<td class="nump">78,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,661)<span></span>
</td>
<td class="num">(1,046)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">31,481<span></span>
</td>
<td class="nump">78,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">9,885<span></span>
</td>
<td class="nump">16,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(707)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,178<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">3,827<span></span>
</td>
<td class="nump">9,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,458<span></span>
</td>
<td class="nump">9,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">1,691<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 1,643<span></span>
</td>
<td class="nump">$ 2,465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624938276240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Marketable securities, realized gain</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 372<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Marketable securities, realized loss</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 1,092<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624928933712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 45,760<span></span>
</td>
<td class="nump">$ 106,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">1,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">7,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">9,178<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">1,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">3,458<span></span>
</td>
<td class="nump">9,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">1,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">$ 2,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">1,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">11,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 14,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934749104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Unrealized Loss on Investments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">$ 8,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized losses, less than 12 months</a></td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, greater than 12 months</a></td>
<td class="nump">5,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized losses, greater than 12 months</a></td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value</a></td>
<td class="nump">14,279<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total unrealized losses</a></td>
<td class="nump">1,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">6,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized losses, less than 12 months</a></td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, greater than 12 months</a></td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized losses, greater than 12 months</a></td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value</a></td>
<td class="nump">9,178<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total unrealized losses</a></td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">1,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized losses, less than 12 months</a></td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, greater than 12 months</a></td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized losses, greater than 12 months</a></td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value</a></td>
<td class="nump">3,458<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total unrealized losses</a></td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">1,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized losses, less than 12 months</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, greater than 12 months</a></td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized losses, greater than 12 months</a></td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value</a></td>
<td class="nump">1,643<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total unrealized losses</a></td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624934718208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">$ (76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities, net</a></td>
<td class="nump">26,299<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">109,934<span></span>
</td>
<td class="nump">142,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">(7,517)<span></span>
</td>
<td class="num">(1,353)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount of debt</a></td>
<td class="nump">136,233<span></span>
</td>
<td class="nump">142,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principle amount of exchangeable senior notes</a></td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50 Percent Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principle amount of exchangeable senior notes</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624929264992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 05, 2022 </div>
<div>USD ($) </div>
<div>day</div>
</th>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>Rate</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,564,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,929,000<span></span>
</td>
<td class="nump">$ 9,087,000<span></span>
</td>
<td class="nump">$ 5,788,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_CouponInterestExpense', window );">Coupon interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,646,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
<td class="nump">4,852,000<span></span>
</td>
<td class="nump">4,851,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,918,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312,000<span></span>
</td>
<td class="nump">4,147,000<span></span>
</td>
<td class="nump">937,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AdditionalInterestExpenseDebt', window );">Additional interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,803,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature', window );">Change in fair value of October 2023 Notes conversion feature</a></td>
<td class="nump">$ 5,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease', window );">Increase in fair value of unseparated embedded conversion feature</a></td>
<td class="nump">5,508,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositorySharesConversionRatio', window );">ADSs, conversion ratio | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9269.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm', window );">Option to purchase aggregate principal amount, term (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount', window );">Option to increase aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from loans or conditional grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange', window );">ADS, minimum amount of principal amount for exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesOptionPricePerShare', window );">ADS, option price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentExchangeAmount', window );">Debt instrument, exchange amount</a></td>
<td class="nump">$ 117,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Convertible Debt | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted', window );">Number of business days (in days)</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays', window );">Consecutive business days (in days)</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay', window );">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day(as a percent)</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Convertible Debt | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days (in days) | day</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays', window );">Scheduled threshold trading days (in days)</a></td>
<td class="text">35 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Convertible Debt | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days (in days) | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days (in days) | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger (as a percent)</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 26,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member', window );">4.50 Percent Exchangeable Senior Notes Due October 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="nump">4,804,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member', window );">4.50 Percent Exchangeable Senior Notes Due October 2023 | Senior Notes | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="nump">$ 5,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdditionalInterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Interest Expense, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdditionalInterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Minimum Amount Of Principal Amount For Exchange</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesOptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Option Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesOptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositorySharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depository Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositorySharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CouponInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Coupon Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CouponInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Scheduled Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Threshold Consecutive Business Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentExchangeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Exchange Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentExchangeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option to Increase Face Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptiontoIncreaseFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=avdl_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=avdl_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624926125360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="num">$ (5,101)<span></span>
</td>
<td class="nump">$ 25,940<span></span>
</td>
<td class="num">$ (11,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">18.80%<span></span>
</td>
<td class="num">(30.90%)<span></span>
</td>
<td class="nump">17.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624928923200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expenses and Other Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">$ 3,745<span></span>
</td>
<td class="nump">$ 3,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_GuaranteeCurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">29,097<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 4,670<span></span>
</td>
<td class="nump">$ 32,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624938242176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Non-Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent', window );">Right of use assets at contract manufacturing organizations</a></td>
<td class="nump">$ 10,979<span></span>
</td>
<td class="nump">$ 8,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_GuaranteeNoncurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherNoncurrentReceivables', window );">Other</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24,128<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 11,720<span></span>
</td>
<td class="nump">$ 33,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of other noncurrent receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936668848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 4,419<span></span>
</td>
<td class="nump">$ 2,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued restructuring</a></td>
<td class="nump">1,515<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">3,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AccruedOutsourceContractCosts', window );">Accrued outsource contract costs</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AccruedTradeDiscountsAndRebates', window );">Customer allowances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 7,965<span></span>
</td>
<td class="nump">$ 7,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedOutsourceContractCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Outsource Contract Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedOutsourceContractCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedTradeDiscountsAndRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedTradeDiscountsAndRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939104768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">$ 3,265<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherGuarantorObligationsCurrentCarryingValue', window );">Guarantee to Deerfield</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AccruedInterestCurrent', window );">Accrued interest</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherLiabilitiesMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 3,757<span></span>
</td>
<td class="nump">$ 5,270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherGuarantorObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Guarantor Obligations, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherGuarantorObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherLiabilitiesMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Miscellaneous, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherLiabilitiesMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936558256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other Non-Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities', window );">Tax liabilities</a></td>
<td class="nump">$ 5,161<span></span>
</td>
<td class="nump">$ 3,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 5,727<span></span>
</td>
<td class="nump">$ 3,917<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Liabilities And Other Noncurrent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935491904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Compensation (Details) - Performance Share Units (PSUs)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares outstanding (in shares) | shares</a></td>
<td class="nump">2,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of shares outstanding (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense | $</a></td>
<td class="nump">$ 8,032<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624929060608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (20,146)<span></span>
</td>
<td class="num">$ (63,444)<span></span>
</td>
<td class="num">$ (26,424)<span></span>
</td>
<td class="num">$ (22,002)<span></span>
</td>
<td class="num">$ (19,581)<span></span>
</td>
<td class="num">$ (13,445)<span></span>
</td>
<td class="num">$ (110,014)<span></span>
</td>
<td class="num">$ (55,028)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted Average Number of Shares Outstanding, Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">60,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
<td class="nump">58,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">60,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
<td class="nump">58,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624939073136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Narrative (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">18,722<span></span>
</td>
<td class="nump">15,684<span></span>
</td>
<td class="nump">18,925<span></span>
</td>
<td class="nump">15,497<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624928944208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Loss) - Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,940)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive loss</a></td>
<td class="num">$ (21,727)<span></span>
</td>
<td class="num">$ (22,396)<span></span>
</td>
<td class="num">(113,983)<span></span>
</td>
<td class="num">$ (56,721)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(27,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(27,909)<span></span>
</td>
<td class="num">(22,744)<span></span>
</td>
<td class="num">(27,909)<span></span>
</td>
<td class="num">(22,744)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(24,697)<span></span>
</td>
<td class="num">(23,229)<span></span>
</td>
<td class="num">(23,855)<span></span>
</td>
<td class="num">(22,627)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive loss</a></td>
<td class="num">(647)<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="num">(1,489)<span></span>
</td>
<td class="num">(839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(25,344)<span></span>
</td>
<td class="num">(23,466)<span></span>
</td>
<td class="num">(25,344)<span></span>
</td>
<td class="num">(23,466)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized (loss) gain on marketable debt securities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(1,631)<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive loss</a></td>
<td class="num">(934)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(854)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (2,565)<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
<td class="num">$ (2,565)<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624938216352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee, liability</a></td>
<td class="nump">$ 844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_GuaranteeAssetCurrentCarryingValue', window );">Guarantee from Armistice</a></td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee, liability</a></td>
<td class="nump">$ 10,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeAssetCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Asset, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeAssetCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_PercentageOfRoyaltyPayableOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty that has to be paid by the company as per the royalty agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_PercentageOfRoyaltyPayableOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936655264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (income) expense</a></td>
<td class="num">$ (69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,523<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember', window );">2022 Corporate Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Expected number of positions eliminated (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624935303776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Severance Obligation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RestructuringChargesExcludingOtherAdjustments', window );">Charges for employee severance, benefits and other costs</a></td>
<td class="nump">3,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(2,043)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other adjustments</a></td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, ending balance</a></td>
<td class="nump">$ 1,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringChargesExcludingOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Excluding Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringChargesExcludingOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140624936695472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - 4.50% Exchangeable Senior Notes Due 2023 - Senior Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Nov. 04, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Cash consideration for repurchase of long-term debt</a></td>
<td class="nump">$ 8,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>avdl-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:avdl="http://www.avadel.com/20220930"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avdl-20220930.xsd" xlink:type="simple"/>
    <context id="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2d88356afacb448386df09e27fc8201c_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i26afda82b1a54595b97eea252e8036f3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i56a91a73aa374140bd351a086c6c55a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f43b68471384987a8e508240d806954_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8cb34e98b804bc2a8b68791f13f017c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b1249cde8f3412792b6a31c6aea2f32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb305ae339da4b9e9da20b480077e5d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc69325a19a142a89fc302cf9e4c995e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f5b47363bca4f2d8091e56f790a6b0a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i226c75787e2147c1b17dd3071938941f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i15e4cd964924474395cd0baba766d16f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i432dbcdc9aae432797d9078759a71608_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i35d6eab9188e4c6ba7d964585d71fe15_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i87ed9d20b39a413c9890b8202a0e2d68_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idf0dcb690e5547d78e784e45c6a81bf8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4406995bd3d645db88eae94e1a61ee22_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i597de771574f44ecbf7bdca7363c74a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i352fb45f049d4e20be6533e5330bed51_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i858c6029c86f470f8ea195b51df7fd90_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0235c181696c43e685632d5e23836a0a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1bf80f97883a4000a3b2582adeac9a34_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2f1c927f07094257b38758d27969490b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i38e1032982cc4ef596e29fa5bd65b3d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i406e727d4c7940eab3bce49cfe84a5b4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7333adc928c34207b1ae3ea0580e1a34_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6fde74b73c43497f867e979065e4f089_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8dcd418f53514c1bbf7914a6f2125336_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i052fb6f4421c4d4f9984b955980c6583_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iea88b7ed2ea84e5ab764b998327d144e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i92a1264cc8b9472daa169711675defb7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5b3f5f57fc524b96b5cfe506a4c5fea0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i83a69202d1114ffc970a48ee40981389_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i34a108c684b944f1949cff98177a2d4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66b3fac2f2f8404794c0c0c3cb9dc2b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id39750e42b8c4306aad61fee7e83a5eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief0230fccabc48f5a6ef37bc48d526f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3c35d690609413bbeb5dca96b91b6b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3bf1ab4f00444c6ab2dda0c89d893b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52a5be02a4754c908aea2eb24daf8a58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2113f33399c94c20b59358750f55db61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2bd8f8d15554ccaa1b7314e61a0bda1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1daef32fcaaf4e3198268352bfe614c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if5d3b32370a14fc9ac68416910db95b4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id1abc68c06e44c02a69a0e3b81539a1b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i213fec939ca94d28a184d48147f2f980_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94d53876fb534cecadcfeab8814f3dc8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i229da85b4f654c07be3b461a8a726d99_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i58d09c1dffe3407b993cb0bf2c8894ab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia1168117551d4a9a8647ed266ee1d21c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i441ab67fef8d46f69ad115a28d4e47b2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4916497bce934c388a6e76aef6e5f8b2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1fb5fe8401174459933a0141de1de360_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1f8355061a09422faca4bfc446a9317f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i78a7bb9eb70c43868a690dbac0c7d90c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id909d7fef83b4684a532a146f36cc21e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9c237b4e52b04e4190505ebcd87c3c0f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67aab025ab13460f81e69e191c346f26_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie15da54ef7274b76b422a70b1c736327_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8f0906d79e940ad870b539d8791c365_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i858bb564a22c494cb368931091b853d9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i35e8617f6b8b4839961ae2d42367307e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i006e36115c06446280acc29186452555_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if21be33b2a2f4c259a0dc8988e8c8bbb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i407de99cf96a455d8396a71ae495f64b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia5fad38fdfbb421d89768bb22556c4b0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic846f79390da411baf672e11138d8640_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idf727c0cbc0d4d77aecbe73f9e0c4cbb_I20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-02-05</instant>
        </period>
    </context>
    <context id="iaa1afa74539c4902922f142c1210083f_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="if65bfb99cbf2433ab28b9b155376252c_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2022ProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icf4ca9e79bab4ceda5ce5f8750665f49_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2020ProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2b516ef9e5224745a478640fa35c9afe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:OpenMarketSalesAgreement2022ProspectusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9034e3eea5954251b56209f67d99c46b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i42d21dc155e64f37a446b0e84d4976b3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia9be88a5186547af9bac2db96c0d314c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6f5b4e9bf4294ad3855eba74063db7bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b1fbf65244d44e5b30d39291b2fee91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7732fc52cd52433585e6e3881ca0de58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a3773002d244c34aea4fe21b68c31f8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i52a16e746e11428a8a70889cb36973ac_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4659da3e5e6e4b81ac8a8c5d5408d5ed_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3d3636fc86bf4e418c691cc2e41b6d3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47dcccfa7c50438eb45d7d48956a6b42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie39a1b6970aa4db987b72e4f7b8b1e55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d3a19c47255496184d2a49062a6a184_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if37b82ee9ff1453bb386fd75f1d28653_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i04f623a32e9c42a78b39d8b1336e8ed0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6eadf013ec464baa8c05eace10107933_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52a672b4236141ea87f8252cc44a0803_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id83b8410c35f458bb9cc1c09bfed7f76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iead5d1bc954d49df81b5bdb5758886e6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iabde77903698481883f2e97de186f6c5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1b1fb3c05c2d4391aac196e02ae0db2d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie64cc03ea55a4af785d07e9c36ed47f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8ba686307084b878761e39792b65749_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42c8ac8d5610497498f8d8ff97b74668_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43f7d3853b624df8b8d498a70765a7d3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i29b635783cf44814ab114c3ec2777bbc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33c84835d749403fad63d02da1c19f19_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i008389be6902419a89fb4467f69d8cf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc7fd82afc824c2d809f04c9d1209c92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie24d32544eb3492583f742640967b39f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5cc5c4400683462b921d63ccb7ac42d0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i824eee128a3c45f7841f91d18b27b288_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9cdc6a0bec0341349445b3e3db552d5c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib25efd41b0a8497088a128e71d6d5557_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25fb303f345248a9a4f13e49293b295b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9f88e70592e4720b210f17465179f02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf8be616cca445759476d602725c21af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92a02dd313384743b867f33cd4c52454_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7728b1ad8844b9c8acb4b0a1e2a5eee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i99b46577c09a4108b4d6e3e1474da619_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-16</instant>
        </period>
    </context>
    <context id="i5585700b61054faf8d529487860514d5_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i3ad36b5fcb3045a68356e8cc78da6a85_I20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="i6c50635ba7df4b1f8f3cea8c28c4bd5b_I20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="i700854cc6b274bb6aa14c33e39284fc2_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="i8f34651b6e804b898cbacfb584c9a8e9_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">avdl:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="ibb4289596c9445e5b6b589951af85b2f_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="i544add4877ba4985a689c57ae1698e30_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="i95fb7b72db174d1c930b80d69d55059e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4bb2365318f346929309ffb2b2636041_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b395e51b07443339e8545ddcb926fec_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6552bf81cec348cba10fdb3ad7a1af92_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i68fd68b84e214afeb6ac688372c7b9b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifef4b6bda88f459a829bd244521b420f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibfec458cab2647ec9baffeb95d1d2718_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifa65319a9bbf4a30919b395ad1dce174_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia1c144896d5e4e3a83ac70f08d710d09_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i76ffebca8fd84c3e8cfc2a78874bfac7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib91c2787e79e44ae873764654f563d0c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i124b04c0e92f4d0fb431541e53c91932_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iddd2203e3e99413c90a5be54a528a206_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i15d9478444524a59af93cc2f7ef2a1e8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ida0df7aa69fe43dbb346fad573194ef4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65b75dc6dfac4a31922574bf257cd0d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cd7da939b0f43d5bf4ee7d265fa9078_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8dd2ac44366649d6822cdcb681c75934_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i531c84d42a854c188abebdccb7a5cbb9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4b6e419f0e784181bbd1f69a1ef3e998_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89275b0e02ad490a9cea278805a53efe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8a81c1516d914bc5afcc186a3bb51380_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0bb2f5402fe644e0bce0169c6c82e87e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i143ad04a470f4af39f1d8a4f532972a0_D20220601-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i92ccb82c6cb44edb9963e6452b789279_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="i5643a43d090c46a387889dbf7fcfb224_D20221104-20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-04</startDate>
            <endDate>2022-11-04</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="day">
        <measure>avdl:day</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N18zLTEtMS0xLTU4NDMw_c1f670aa-20a0-4336-a7c6-a74df1f9465a">0001012477</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N180LTEtMS0xLTU4NDMw_f8273b6c-bd29-48a8-ad21-2566c06c2dd5">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N181LTEtMS0xLTU4NDMw_c2791915-f907-4c0f-acf2-6d29a9e3b00d">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N182LTEtMS0xLTU4NDMw_2616e72e-ea5f-4837-97b4-f884123ed65d">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N183LTEtMS0xLTU4NDMw_5dd5e51e-4bce-4d84-9a5c-762f975958bc">false</dei:AmendmentFlag>
    <dei:NoTradingSymbolFlag
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80L2ZyYWc6OTg5OTk5ODhjMGRiNDkzODhhOGNiNzI3OWUyNGE4MDMvdGFibGU6MmNmZTQwNDUzYTM2NDUwMTg4YjYzMWZkZTY2MDM3NzcvdGFibGVyYW5nZToyY2ZlNDA0NTNhMzY0NTAxODhiNjMxZmRlNjYwMzc3N184LTEtMS0xLTU4NDMw_de899252-ca24-4e29-a48c-90675679d410">true</dei:NoTradingSymbolFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ie3bf1ab4f00444c6ab2dda0c89d893b0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0wLTEtMS01ODQzMA_6946dcf2-15ab-4f20-83ee-a51a11cce42f">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted
      contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzc2Mg_386183ed-95c1-436b-a9e7-e1c14e3bde78">P5D</avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted>
    <avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays
      contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzgwNw_508bcbe0-6ff0-45f0-850b-ee02e8547ae7">P5D</avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays>
    <dei:DocumentType
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY3_e9935b73-4118-42d0-9e29-ed440e0d8968">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY4_0a7b6094-fa7e-4eb0-b208-a6c0f6de239f">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yMzA_5a615a84-17c7-4cfa-983c-0d85ddd99d55">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU3_90eba5c0-87fe-42d2-9f45-a3e168db9b25">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6MzQ2YzcxYTU0NjhiNDQwN2JiM2Y4NjUzZTQ2ZGIxNjEvdGFibGVyYW5nZTozNDZjNzFhNTQ2OGI0NDA3YmIzZjg2NTNlNDZkYjE2MV8wLTAtMS0xLTYzODYwL3RleHRyZWdpb246ZWIwOWEzYmFiNGFlNGE5MzgwOGE3OTJmMzI1NzExM2NfOTM0NTg0ODgzNjE0Mg_44ed0d51-623a-4afa-a0cd-b327472e1218">001-37977</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYx_4cbf1165-8a4e-4e93-b8e2-87005b68eb34">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6Njc0NTI5NzViNDFkNDVhZTk4ZWFmZjZhZDRjNmE2ZjkvdGFibGVyYW5nZTo2NzQ1Mjk3NWI0MWQ0NWFlOThlYWZmNmFkNGM2YTZmOV8wLTAtMS0xLTU4NDMw_35994672-a20b-43e2-ba59-cd1028580916">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6Njc0NTI5NzViNDFkNDVhZTk4ZWFmZjZhZDRjNmE2ZjkvdGFibGVyYW5nZTo2NzQ1Mjk3NWI0MWQ0NWFlOThlYWZmNmFkNGM2YTZmOV8wLTItMS0xLTU4NDMw_2277f2a4-7e28-4dbe-a6a5-4cdf4141dbd6">98-1341933</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYy_3473b9f4-2da0-45d1-b830-7a21dcf52dd0">10 Earlsfort Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU5_bc464c76-66fe-4f34-9db8-861476ca46a7">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYw_7a9c145b-e3b2-4e8c-b5cc-b77f1bc18a2f">D02 T380</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU0_9c7ccda2-be47-4338-ad83-2ac4f179c738">IE</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjYz_d398e860-970a-4b87-94b9-42c312a37c90">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU4_fc1913a8-c094-4ea1-9a68-38501eb9364e">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU1_b82bfabb-86c1-4051-b374-1693520b040d">901-5201</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTAtMS0xLTU4NDMw_e2d8444d-f91d-4a9d-a4c2-ab80b80f3b5a">American Depositary Shares*</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTEtMS0xLTU4NDMw_05f5dd1a-5f25-429a-8d09-4997503ac0d8">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib1caf3780b724a7ba878c82b0bee36bd_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8xLTItMS0xLTU4NDMw_78a1a9c8-2c22-406f-b67d-7bf412625534">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6ZmM3ZjI2MmUwMzI1NDU3NGFlZGJmM2Y1YmYwMzc1OTUvdGFibGVyYW5nZTpmYzdmMjYyZTAzMjU0NTc0YWVkYmYzZjViZjAzNzU5NV8yLTAtMS0xLTU4NDMw_080e74b4-aa66-4f6b-8b25-09841f139e3e">Ordinary Shares, nominal value $0.01 per share**</dei:Security12bTitle>
    <dei:EntityCurrentReportingStatus
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjU2_eb313c03-bce1-4b98-a8d8-e5053c721277">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY0_d640d1cc-108a-406c-b803-9e14533790bb">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8xLTAtMS0xLTU4NDMw_f47ce54f-a455-4437-9bc9-dc6d75d244c5">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8xLTMtMS0xLTU4NDMw_9f7c8998-e4b9-4b74-b7fd-4df306de5154">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGFibGU6N2M2MzMzYmYxNjJhNDdhYjg5NThkY2NiNzkxMDlmYTEvdGFibGVyYW5nZTo3YzYzMzNiZjE2MmE0N2FiODk1OGRjY2I3OTEwOWZhMV8yLTMtMS0xLTU4NDMw_a48a4b20-5ecd-4bbd-bcae-47fd6eb34f22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNjY2_5590c6a6-98c0-4969-9971-7b88f2cbafbf">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i2d88356afacb448386df09e27fc8201c_I20221107"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xL2ZyYWc6NzIwMmUyMWY3OTVlNDI0NmI0NTUxNTM5Yjk4MTlhM2UvdGV4dHJlZ2lvbjo3MjAyZTIxZjc5NWU0MjQ2YjQ1NTE1MzliOTgxOWEzZV8yNTc1_422fc479-b40d-4442-ad16-06a4f96883e0"
      unitRef="shares">61778732</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi0yLTEtMS01ODQzMA_ed3d4c16-a179-480f-b6a5-6971b51effaf"
      unitRef="usd">2933000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi00LTEtMS01ODQzMA_b72c6a06-6062-48f2-8e84-95a855253c0f"
      unitRef="usd">4380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi02LTEtMS01ODQzMA_9d5a87d8-0fbf-4a67-84b4-3240797fbb89"
      unitRef="usd">14465000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNi04LTEtMS01ODQzMA_1bd25ef8-1cfb-4102-8083-92e40d25b47e"
      unitRef="usd">14994000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy0yLTEtMS01ODQzMA_cca9d908-c14f-49b5-b551-18e201f358d9"
      unitRef="usd">14096000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy00LTEtMS01ODQzMA_e359ce81-091e-466a-a662-f48cbc687ea6"
      unitRef="usd">21283000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy02LTEtMS01ODQzMA_ccf09d59-1bec-47d3-b15c-98c5ee75589e"
      unitRef="usd">57535000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfNy04LTEtMS01ODQzMA_c0326f93-cde3-403a-b097-4047e34dd6dd"
      unitRef="usd">47469000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC0yLTEtMS01ODQzMA_351c564b-e649-4795-aef2-38a6439924ff"
      unitRef="usd">-69000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC00LTEtMS01ODQzMA_2f782438-a75c-48e2-9932-a6ccd5ce23ce"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC02LTEtMS01ODQzMA_86cc86d2-286c-440a-869e-ec949cac63fe"
      unitRef="usd">3523000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOC04LTEtMS01ODQzMA_cd9f1d6f-63fe-4641-a2b8-7d36c5c13edd"
      unitRef="usd">-53000</us-gaap:RestructuringCharges>
    <us-gaap:CostsAndExpenses
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS0yLTEtMS01ODQzMA_21153cfd-38e3-4c18-84ed-9c8d9438c35d"
      unitRef="usd">16960000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS00LTEtMS01ODQzMA_c111c815-cb99-46aa-8ae1-3d22a72255de"
      unitRef="usd">25663000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS02LTEtMS01ODQzMA_67ea13d7-7757-40b1-952f-b4d37bc53a8c"
      unitRef="usd">75523000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfOS04LTEtMS01ODQzMA_567a3efe-437f-40f9-83a4-9335bcf79ea4"
      unitRef="usd">62410000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtMi0xLTEtNTg0MzA_e911a61b-6280-4e49-9b18-3037393c663d"
      unitRef="usd">-16960000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtNC0xLTEtNTg0MzA_1dfd1ea2-20e8-4392-a0d9-506c1fe68505"
      unitRef="usd">-25663000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtNi0xLTEtNTg0MzA_c1b18afa-45bc-4f57-aa96-cf6b0576ff2d"
      unitRef="usd">-75523000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTAtOC0xLTEtNTg0MzA_20b10da4-8d6d-4bc7-ad8f-fae278c50951"
      unitRef="usd">-62410000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtMi0xLTEtNTg0MzA_81ff3e9b-d888-4556-9b7e-1aedcc322b82"
      unitRef="usd">448000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtNC0xLTEtNTg0MzA_14c5b23e-3cac-43cf-ab34-d29f1424643c"
      unitRef="usd">489000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtNi0xLTEtNTg0MzA_465c1c74-712f-4308-a79e-1bcaf7201954"
      unitRef="usd">503000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTEtOC0xLTEtNTg0MzA_a50f7c7a-2712-4203-b767-f596ca0203f1"
      unitRef="usd">1531000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpenseDebt
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItMi0xLTEtNTg0MzA_766a9d44-3453-452f-a0fa-444c5cbaea16"
      unitRef="usd">3564000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItNC0xLTEtNTg0MzA_e84dc8b5-fdcb-4d1d-8633-41540dbeeca6"
      unitRef="usd">1929000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItNi0xLTEtNTg0MzA_3af55798-d089-4397-b469-9dd4571d1b36"
      unitRef="usd">9087000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTItOC0xLTEtNTg0MzA_69fc2645-b9aa-4995-b4f9-6814016ec58b"
      unitRef="usd">5788000</us-gaap:InterestExpenseDebt>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtMi0xLTEtNTg0MzA_ce11fa99-832e-4496-b993-41412d97a33c"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtNC0xLTEtNTg0MzA_fc779af2-6e8a-40f0-bce5-347f1378144a"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtNi0xLTEtNTg0MzA_7a5e83f3-1b8d-48de-89f1-676520e11061"
      unitRef="usd">33000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTMtOC0xLTEtNTg0MzA_9ad6683e-cd7b-4146-a791-3bd33f05ef57"
      unitRef="usd">166000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtMi0xLTEtNTg0MzA_13d5cd17-ae82-4aa4-8a55-0fddabd4045e"
      unitRef="usd">-20076000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtNC0xLTEtNTg0MzA_3d41fb9f-9dd1-48b4-907a-d18b5134561b"
      unitRef="usd">-27103000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtNi0xLTEtNTg0MzA_b0bbad5b-b4f8-45fa-98fa-1298002fc34d"
      unitRef="usd">-84074000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTQtOC0xLTEtNTg0MzA_a64d4656-f4c6-4d2f-854e-a6509cf1b9ea"
      unitRef="usd">-66501000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtMi0xLTEtNTg0MzA_dba8bea4-e4a1-4309-a49b-6cdb9c71e061"
      unitRef="usd">70000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtNC0xLTEtNTg0MzA_905af191-07a2-4de6-9ee1-ce63a7463c80"
      unitRef="usd">-5101000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtNi0xLTEtNTg0MzA_93750112-5f66-4538-b3b9-4c50a03dfee4"
      unitRef="usd">25940000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTUtOC0xLTEtNTg0MzA_1855921f-1b4c-4c65-94ed-30912df71709"
      unitRef="usd">-11473000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtMi0xLTEtNTg0MzA_903d5fb5-9beb-4051-b36a-90f776890e42"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtNC0xLTEtNTg0MzA_19d713e7-4fa4-455d-8759-4d5ff9639e9d"
      unitRef="usd">-22002000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtNi0xLTEtNTg0MzA_e1f63364-a1f2-4302-ba07-5ff86e55c293"
      unitRef="usd">-110014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTYtOC0xLTEtNTg0MzA_11a39f9c-9520-4507-9150-2cbc60dbd66f"
      unitRef="usd">-55028000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtMi0xLTEtNTg0MzA_82690241-96d0-4b81-9712-7de7292652f3"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtNC0xLTEtNTg0MzA_c422033e-525a-4cc8-896c-93d48b8eb233"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtNi0xLTEtNTg0MzA_f757de9c-78e8-4697-8822-44b480e44327"
      unitRef="usdPerShare">-1.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTgtOC0xLTEtNTg0MzA_63486003-c2e1-4ba8-af24-d8b2ab7b172d"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktMi0xLTEtNTg0MzA_0d221755-f5eb-4748-842f-15474be5b480"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktNC0xLTEtNTg0MzA_92651a70-cd01-416e-b57b-3bb97a982bd1"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktNi0xLTEtNTg0MzA_4829d901-ffd9-4030-8436-1c8ac48d4db8"
      unitRef="usdPerShare">-1.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMTktOC0xLTEtNTg0MzA_2bdf75f7-8792-48d9-8a4c-ca899d4985e8"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtMi0xLTEtNTg0MzA_6d7996a3-e498-4727-a147-583f80ad582c"
      unitRef="shares">60201000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtNC0xLTEtNTg0MzA_bcfefc46-a178-4b65-a665-35b82650a27f"
      unitRef="shares">58585000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtNi0xLTEtNTg0MzA_dd0645d3-8967-4e1c-8e0e-127dc6c262f6"
      unitRef="shares">59359000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjEtOC0xLTEtNTg0MzA_5f8762af-dc62-40fd-b0b5-5abb9589d062"
      unitRef="shares">58506000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItMi0xLTEtNTg0MzA_3e8b95e6-ba0a-45c4-84c3-3063a437b849"
      unitRef="shares">60201000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItNC0xLTEtNTg0MzA_27bc8362-3680-469f-9a5d-22856ab6148f"
      unitRef="shares">58585000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItNi0xLTEtNTg0MzA_d8c84f23-eb7a-4e21-82c5-b80010113a57"
      unitRef="shares">59359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xOS9mcmFnOjI5OGNhYjMxYjlmNjQzZmZiNzcyMmYyZWY0NjM5YWFlL3RhYmxlOjA2NDE3MzFlN2U4ZjRmZDk4Njg3ZTMxNzRiYzBhMWZhL3RhYmxlcmFuZ2U6MDY0MTczMWU3ZThmNGZkOTg2ODdlMzE3NGJjMGExZmFfMjItOC0xLTEtNTg0MzA_47a3ea22-f367-419e-8a18-f3efc071e2ae"
      unitRef="shares">58506000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy0yLTEtMS01ODQzMA_903d5fb5-9beb-4051-b36a-90f776890e42"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy00LTEtMS01ODQzMA_19d713e7-4fa4-455d-8759-4d5ff9639e9d"
      unitRef="usd">-22002000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy02LTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293"
      unitRef="usd">-110014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfMy04LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f"
      unitRef="usd">-55028000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS0yLTEtMS01ODQzMA_b8b25f15-e641-4f94-b0f5-3ebaea30cc13"
      unitRef="usd">-647000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS00LTEtMS01ODQzMA_2cece5d6-1f63-4051-ae3a-7fd06d21fe6a"
      unitRef="usd">-237000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS02LTEtMS01ODQzMA_9d7c6981-d85a-4236-9176-7ba94405cf01"
      unitRef="usd">-1489000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNS04LTEtMS01ODQzMA_1e7f330c-87fa-4866-95a6-07eeea529c07"
      unitRef="usd">-839000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzYz_b201427a-793e-4a64-9171-366534267c91"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzY3_e39ccbc7-3d58-4131-8d8d-52d768c9f358"
      unitRef="usd">-59000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzcx_1512047c-dacb-4f0b-9a6f-25657ff86c65"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjY3YjY3OTliNTViMTQ2Yjc5ZTlhZWQ4Y2I2ODY1NDFmXzc4_c3456c5f-7771-4f1b-ab34-5a7389dfa6c8"
      unitRef="usd">-220000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi0yLTEtMS01ODQzMA_352c6d22-fd6d-44dd-b0f7-a27082344d40"
      unitRef="usd">-934000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi00LTEtMS01ODQzMA_7c49ef5c-256c-4b9c-ab70-39689b7c4518"
      unitRef="usd">-157000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi02LTEtMS01ODQzMA_264826b8-76a8-4ee4-bbfc-a21f8dd92be3"
      unitRef="usd">-2480000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNi04LTEtMS01ODQzMA_bacde1e9-e8f8-4078-8087-d407cfdc1300"
      unitRef="usd">-854000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy0yLTEtMS01ODQzMA_631b7037-f991-44cb-ba77-1a32e7ba7123"
      unitRef="usd">-1581000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy00LTEtMS01ODQzMA_6945a9ac-4038-439b-967d-10de72f3c069"
      unitRef="usd">-394000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy02LTEtMS01ODQzMA_51c3c1a9-fc0d-438a-b61d-8cf842132c2e"
      unitRef="usd">-3969000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfNy04LTEtMS01ODQzMA_6bc3404e-ce8e-46ec-b5ba-c154a829b287"
      unitRef="usd">-1693000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC0yLTEtMS01ODQzMA_989918fb-de49-4576-a998-f76b0aeef66c"
      unitRef="usd">-21727000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC00LTEtMS01ODQzMA_710b1685-89bd-45f1-a5c3-8dc3089c940d"
      unitRef="usd">-22396000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC02LTEtMS01ODQzMA_22cdded2-4e15-4426-b3c7-cca96a594d60"
      unitRef="usd">-113983000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yMi9mcmFnOjkzZDQwMDc1ZTFhZjQ1YTZiYTE5ODA4ODU5ZTk1ZTZhL3RhYmxlOmIxZGEzMjE1MzM5MzQ5ODI4YWVhZTE1MGNkMThkNDc5L3RhYmxlcmFuZ2U6YjFkYTMyMTUzMzkzNDk4MjhhZWFlMTUwY2QxOGQ0NzlfOC04LTEtMS01ODQzMA_9fffbabf-62e2-4f09-b1be-4d4f86546fa4"
      unitRef="usd">-56721000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNC0yLTEtMS01ODQzMA_3a5c846d-ceea-44b0-bfe2-5c63ffa8e6c8"
      unitRef="usd">60715000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNC00LTEtMS01ODQzMA_c3ae9ecf-fbac-4742-a5a3-d36105470090"
      unitRef="usd">50708000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNS0yLTEtMS01ODQzMA_58b7c1e8-2ab9-4b11-83ec-81fda2930bb9"
      unitRef="usd">45760000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNS00LTEtMS01ODQzMA_3280870e-13ba-4c61-a38d-1f8af278f11c"
      unitRef="usd">106513000</us-gaap:MarketableSecuritiesCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOC0yLTEtMS01ODQzMA_2fb33d47-6bfa-425b-acf0-acf0be51e9c6"
      unitRef="usd">2077000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOC00LTEtMS01ODQzMA_7bf4c56d-21c2-489d-9f32-28decadbddb5"
      unitRef="usd">2443000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOS0yLTEtMS01ODQzMA_044c0afe-a239-4b3c-adf5-0331d36a4a18"
      unitRef="usd">4670000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfOS00LTEtMS01ODQzMA_bf9984f1-9b26-46ec-8bbb-b459bc4d21b5"
      unitRef="usd">32826000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTAtMi0xLTEtNTg0MzA_263f5f3e-556c-49af-8628-8f19b8702e08"
      unitRef="usd">113222000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTAtNC0xLTEtNTg0MzA_e516cb1c-6311-401b-be5e-b18514f2cb86"
      unitRef="usd">192490000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTEtMi0xLTEtNTg0MzA_1cc72610-4f34-44ce-828b-397706ee44c0"
      unitRef="usd">896000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTEtNC0xLTEtNTg0MzA_292cf438-f33b-4fef-a831-68829098aeb8"
      unitRef="usd">285000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTItMi0xLTEtNTg0MzA_35e65504-75d0-4343-9e5a-fbf55753ccab"
      unitRef="usd">1947000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTItNC0xLTEtNTg0MzA_1861b2c0-74d2-405e-b8e7-dd030524551c"
      unitRef="usd">2652000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTMtMi0xLTEtNTg0MzA_d132e929-026f-4b5e-89cb-146258aa95a0"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTMtNC0xLTEtNTg0MzA_5f78c6aa-d047-4356-a62f-32668f7cac15"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTUtMi0xLTEtNTg0MzA_e2026978-6f4b-4352-8d63-633331034dff"
      unitRef="usd">1137000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTUtNC0xLTEtNTg0MzA_a0806649-fdfe-4b5f-b1c0-4e6aa8c3d704"
      unitRef="usd">1225000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTYtMi0xLTEtNTg0MzA_a0ee94e8-8890-4f3f-a5aa-3b3aa2d50c09"
      unitRef="usd">11720000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTYtNC0xLTEtNTg0MzA_3f8a6277-bef3-47c6-8abc-3e9a23ed1e5d"
      unitRef="usd">33777000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTctMi0xLTEtNTg0MzA_9d409163-5780-4c71-831c-a7e2e5a24a91"
      unitRef="usd">145758000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMTctNC0xLTEtNTg0MzA_67a21723-9ce3-4621-a8c0-d3f37d956282"
      unitRef="usd">247265000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjEtMi0xLTEtNTg0MzA_8fca55c2-e6db-4b11-a1d3-e74d75dd3af3"
      unitRef="usd">26299000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjEtNC0xLTEtNTg0MzA_c9f5a092-6f65-4d75-91b5-a5f836a6e74c"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjItMi0xLTEtNTg0MzA_54715860-fe6b-4cc8-a590-b194c86f42df"
      unitRef="usd">1011000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjItNC0xLTEtNTg0MzA_6297ad04-3610-4c8f-ac95-fdf7288c6f0a"
      unitRef="usd">900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjMtMi0xLTEtNTg0MzA_6a5f8a09-6c88-4d9a-9a06-29b5d14eb87b"
      unitRef="usd">2479000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjMtNC0xLTEtNTg0MzA_6799bb5b-6f60-4950-adbc-fc2c120ff535"
      unitRef="usd">7679000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjQtMi0xLTEtNTg0MzA_b02c62f8-88ed-455f-a6bf-198cc02d9331"
      unitRef="usd">7965000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjQtNC0xLTEtNTg0MzA_62dd8b40-bf09-4dd2-9025-1ea550f03e30"
      unitRef="usd">7151000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjYtMi0xLTEtNTg0MzA_014f7f40-9c88-49f3-a65f-7e8d9f5975ee"
      unitRef="usd">3757000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjYtNC0xLTEtNTg0MzA_a262c229-a9bf-4d2f-81d7-05caa31bbce5"
      unitRef="usd">5270000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjctMi0xLTEtNTg0MzA_07653bb1-bc12-4fc4-9cc4-bac259708d40"
      unitRef="usd">41511000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjctNC0xLTEtNTg0MzA_6cbb5a00-3f45-4da9-b81c-b384d8992b02"
      unitRef="usd">21000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjgtMi0xLTEtNTg0MzA_f62922af-1b3e-4376-a116-ba316b39ad2c"
      unitRef="usd">109934000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMjgtNC0xLTEtNTg0MzA_2f4c0b92-30f1-4e70-a81e-ba724e896f10"
      unitRef="usd">142397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzAtMi0xLTEtNTg0MzA_0db76a5b-1669-41c3-94cb-c16db2c23183"
      unitRef="usd">1026000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzAtNC0xLTEtNTg0MzA_853f40b4-b202-4821-85b1-87258f5293e9"
      unitRef="usd">1707000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzEtMi0xLTEtNTg0MzA_34d3c43d-6512-4573-bf1b-4b0775b0956c"
      unitRef="usd">5727000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzEtNC0xLTEtNTg0MzA_1086a814-b892-4bca-a97d-1ae9fceeff11"
      unitRef="usd">3917000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzItMi0xLTEtNTg0MzA_8884871b-13e3-43a9-b166-375856e0f56c"
      unitRef="usd">158198000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzItNC0xLTEtNTg0MzA_1dbe956d-79d3-42fd-8f78-3a0c99371701"
      unitRef="usd">169021000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8zOQ_d8c79000-0058-4243-a584-c10e9f76d57e"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8zOQ_eeda4697-bc9f-4862-a3e0-44b96006d15d"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl81Mw_0ad17c2b-ce9e-4c04-8818-0febde6a5268"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl81Mw_b700340d-4a75-4890-8236-52dc844212be"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl83NQ_20c0f78c-2c98-4beb-8f20-d2e8c658fd07"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl83NQ_6b171e2e-8dbf-4a39-a3e2-5077daf1ad23"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8xMTE_6e2d9803-31ce-4bbb-832f-22ea8c88ba82"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjpjNmEzNTdhMzQ0Mzg0NTA2YmYwZDA0MDFmMTcyYmY1Zl8xMTE_ede60972-a577-4e39-b24c-2818a9f5d3e0"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtMi0xLTEtNTg0MzA_95bea75b-6003-4d99-ad74-460edb6e63a0"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzUtNC0xLTEtNTg0MzA_a55d2f5e-ac5b-4983-94e1-a503bfe4be67"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8zOA_857e75bd-9f1e-4596-9bce-c2c40417cd7f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8zOA_99c1214c-5f54-407c-bb4f-6744fa389960"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF81Mg_379a65ca-e398-45c0-94cb-9bd1ffd161e7"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF81Mg_6b108d25-c35c-43e2-9fbf-9148eb995f52"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF83NA_16c7f8fa-8446-4953-bd0a-fe37eaaf82f0"
      unitRef="shares">60885000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF83NA_1812fc92-dd20-4156-869b-3e2e46ca3d72"
      unitRef="shares">60885000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8xMTA_5100ed86-c1b1-4569-b1ff-9ea7eb860ffc"
      unitRef="shares">58620000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjo4MzE1Mjg0YTJlY2Y0ODk3ODI5YmEwZTdiYjkzNjFlOF8xMTA_c266d3a8-3797-45ef-8233-dbe656087d35"
      unitRef="shares">58620000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtMi0xLTEtNTg0MzA_de117961-50ed-4123-b659-27f7db6c73b3"
      unitRef="usd">608000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzYtNC0xLTEtNTg0MzA_5fd92022-83dd-49b9-98b4-c01d13a140d5"
      unitRef="usd">586000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzctMi0xLTEtNTg0MzA_bc86b898-4f7e-45d7-b4b5-f7cd86473252"
      unitRef="usd">572626000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzctNC0xLTEtNTg0MzA_d9bc4acd-3380-4836-b201-8b81daf16c78"
      unitRef="usd">549349000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzgtMi0xLTEtNTg0MzA_6e5542cf-ddda-4ea7-a41a-dc6df822f012"
      unitRef="usd">-557770000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzgtNC0xLTEtNTg0MzA_0506a02b-e243-4b8f-87eb-d68512d1ca0d"
      unitRef="usd">-447756000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzktMi0xLTEtNTg0MzA_fa273ecf-99f8-4c34-af7d-58eb8262b9f8"
      unitRef="usd">-27909000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfMzktNC0xLTEtNTg0MzA_adc88539-9b35-4aea-b2a9-5c6333a41b69"
      unitRef="usd">-23940000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDAtMi0xLTEtNTg0MzA_c1ef058d-054a-466e-9eb4-9513a849edcf"
      unitRef="usd">-12440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDAtNC0xLTEtNTg0MzA_ece596a2-278a-4a89-ab38-192b57730fcd"
      unitRef="usd">78244000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDEtMi0xLTEtNTg0MzA_2b6c650d-8614-43b5-b956-7d3345367929"
      unitRef="usd">145758000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yNS9mcmFnOjYyOWM2Y2VmYWUxMDQyMThhNTU3ZDYzNzc2NmU1Y2ZlL3RhYmxlOjMyMTlkYmQxZDY0NzQ2MTI4Nzk3YjUwMzhkOTY1MGVhL3RhYmxlcmFuZ2U6MzIxOWRiZDFkNjQ3NDYxMjg3OTdiNTAzOGQ5NjUwZWFfNDEtNC0xLTEtNTg0MzA_033224c4-da73-4e04-9b43-b0a5b909f47b"
      unitRef="usd">247265000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i5f43b68471384987a8e508240d806954_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0yLTEtMS01ODQzMA_af3e2a59-2879-4ac7-a8fc-0d3d1ac4ecd4"
      unitRef="shares">58620000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5f43b68471384987a8e508240d806954_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi00LTEtMS01ODQzMA_b362858f-c42d-44ea-bddd-b0c00a67507f"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ie8cb34e98b804bc2a8b68791f13f017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi02LTEtMS01ODQzMA_3bddcbf9-dfe4-4b2d-973e-f09905350317"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie8cb34e98b804bc2a8b68791f13f017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi04LTEtMS01ODQzMA_65ef7ee6-179e-4db6-bf8b-96f4d68cef52"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b1249cde8f3412792b6a31c6aea2f32_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xMC0xLTEtNTg0MzA_0493e84b-304f-4646-ac64-8bfec5f4d309"
      unitRef="usd">549349000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibb305ae339da4b9e9da20b480077e5d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xMi0xLTEtNTg0MzA_64ce5756-9f39-423b-90de-6cb3cfff7de3"
      unitRef="usd">-447756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc69325a19a142a89fc302cf9e4c995e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xNC0xLTEtNTg0MzA_a52a51fa-4297-4d8a-95bc-b785cf898a35"
      unitRef="usd">-23940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMi0xNi0xLTEtNTg0MzA_38e10be4-4451-4002-ba05-0cd0536cbb78"
      unitRef="usd">78244000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3f5b47363bca4f2d8091e56f790a6b0a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMy0xMi0xLTEtNTg0MzA_d5faacd9-1bb4-4804-a04c-e2fa9baaccb3"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMy0xNi0xLTEtNTg0MzA_0dd133b0-8b7c-4e55-82c7-2d6e2aa364fc"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i226c75787e2147c1b17dd3071938941f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNC0xNC0xLTEtNTg0MzA_2e4a21cb-d57e-4714-ba78-066947ccfae7"
      unitRef="usd">-1102000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNC0xNi0xLTEtNTg0MzA_472eac97-f4fb-485f-a24e-f7b915078130"
      unitRef="usd">-1102000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0yLTEtMS01ODQzMA_fee18769-f05a-4c14-a4bb-068497a059f9"
      unitRef="shares">275000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS00LTEtMS01ODQzMA_e136b878-77fd-41fc-b21d-91cbde39b21d"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0xMC0xLTEtNTg0MzA_11b0cc14-01cd-417a-953b-aa34a4b361fe"
      unitRef="usd">1903000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNS0xNi0xLTEtNTg0MzA_77cf30b8-370c-4138-b52d-88ab90dacde4"
      unitRef="usd">1906000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0yLTEtMS01ODQzMA_3ab19343-afeb-45fa-b592-0b4163c0018d"
      unitRef="shares">119000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi00LTEtMS01ODQzMA_a7081b52-9072-4821-a445-1dcfec55d841"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0xMC0xLTEtNTg0MzA_ec33642b-68b2-4ab4-9e9b-8a03c8adb544"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNi0xNi0xLTEtNTg0MzA_8d5ade6b-e6f4-4830-9eca-490dce1ef0bf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i15e4cd964924474395cd0baba766d16f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0yLTEtMS01ODQzMA_f97d1b6d-7536-48f7-b38c-9c4c8141457a"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0xMC0xLTEtNTg0MzA_e87588fc-be24-43a6-860a-6dbf61ea32ce"
      unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfNy0xNi0xLTEtNTg0MzA_2477821c-3e88-4163-b883-2602c63dc62f"
      unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i432dbcdc9aae432797d9078759a71608_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOC0xMC0xLTEtNTg0MzA_a0b28142-474e-4f1b-b93d-57cc6c43a4a5"
      unitRef="usd">2505000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie18ac08f254b4ce79d4a668d0d54f802_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOC0xNi0xLTEtNTg0MzA_2b8ae660-cc21-4f96-a9ee-804e21945dec"
      unitRef="usd">2505000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i35d6eab9188e4c6ba7d964585d71fe15_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0yLTEtMS01ODQzMA_b4050420-54ca-4844-93f8-97bfb8c439eb"
      unitRef="shares">59032000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i35d6eab9188e4c6ba7d964585d71fe15_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS00LTEtMS01ODQzMA_30d1a0df-7101-406e-acb7-141bbf470525"
      unitRef="usd">590000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS02LTEtMS01ODQzMA_c5e5a11e-2fdb-4156-b917-35dc9c2a23f4"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1e51b275e35a45cfb2f0cbdfaca62516_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS04LTEtMS01ODQzMA_6ca8e629-4b39-4fc1-8a73-e00e57404ebf"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87ed9d20b39a413c9890b8202a0e2d68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xMC0xLTEtNTg0MzA_a45ed289-3f59-4431-bffa-fbedf0ebf283"
      unitRef="usd">553859000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idf0dcb690e5547d78e784e45c6a81bf8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xMi0xLTEtNTg0MzA_1bad55aa-059b-44aa-b931-51d33864205c"
      unitRef="usd">-474180000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4406995bd3d645db88eae94e1a61ee22_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xNC0xLTEtNTg0MzA_ae5149e0-9f4b-4d75-9a08-eb565fc0f87a"
      unitRef="usd">-25042000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i597de771574f44ecbf7bdca7363c74a3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfOS0xNi0xLTEtNTg0MzA_919ad3b0-32e8-4789-b2a8-da25c903f543"
      unitRef="usd">55232000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i352fb45f049d4e20be6533e5330bed51_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTAtMTItMS0xLTU4NDMw_685cc4ab-a819-4042-9eea-f9e4a3364b20"
      unitRef="usd">-63444000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTAtMTYtMS0xLTU4NDMw_1b1cd9d0-18df-4268-9d6d-637c8b3f2882"
      unitRef="usd">-63444000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i858c6029c86f470f8ea195b51df7fd90_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTEtMTQtMS0xLTU4NDMw_d6bec324-54df-4414-89ed-83ac287e5fde"
      unitRef="usd">-1286000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTEtMTYtMS0xLTU4NDMw_3e3fd4e4-982f-4935-9943-f81059b49ae5"
      unitRef="usd">-1286000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i0235c181696c43e685632d5e23836a0a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTItMi0xLTEtNTg0MzA_7d615f47-91bb-4f35-981f-c442e8b06e71"
      unitRef="shares">6000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
      contextRef="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTMtMTAtMS0xLTU4NDMw_0ed9ebc4-8da7-4c5e-a688-f90bbd37cf53"
      unitRef="usd">5508000</avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature>
    <avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
      contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTMtMTYtMS0xLTU4NDMw_f85bfe12-e9ff-44ab-a100-cf6812e77fa4"
      unitRef="usd">5508000</avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i402459cd682e41f3b64c8a4d3fdae521_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTQtMTAtMS0xLTU4NDMw_5762ca12-2c9a-46ab-b9bc-f5b39d4827f7"
      unitRef="usd">658000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i14278672f928497e983673bb3cd6ae4f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTQtMTYtMS0xLTU4NDMw_81edb6c2-6102-45ce-acf6-cb53627d49d2"
      unitRef="usd">658000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i1bf80f97883a4000a3b2582adeac9a34_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMi0xLTEtNTg0MzA_0d58c91f-8bc8-491e-a479-a8a055208f01"
      unitRef="shares">59038000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1bf80f97883a4000a3b2582adeac9a34_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtNC0xLTEtNTg0MzA_932b0ebc-0f6e-4ea7-a34a-1047ced17d38"
      unitRef="usd">590000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i2f1c927f07094257b38758d27969490b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtNi0xLTEtNTg0MzA_901aee4c-523c-4e5e-8f6b-146a974e2b06"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2f1c927f07094257b38758d27969490b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtOC0xLTEtNTg0MzA_edc335bf-0362-4eb2-8c4a-f13eb5fa6f59"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38e1032982cc4ef596e29fa5bd65b3d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTAtMS0xLTU4NDMw_ac5865fb-9e25-4204-b4ae-2045f7880c0c"
      unitRef="usd">560025000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i406e727d4c7940eab3bce49cfe84a5b4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTItMS0xLTU4NDMw_e61bd89b-254a-4039-97d2-1490ebbe6c4f"
      unitRef="usd">-537624000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7333adc928c34207b1ae3ea0580e1a34_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTQtMS0xLTU4NDMw_dc28153e-7eee-495a-a778-46d18b7196cb"
      unitRef="usd">-26328000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fde74b73c43497f867e979065e4f089_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTUtMTYtMS0xLTU4NDMw_de0a3c1e-3e11-4a84-a6f9-ff7173b44c62"
      unitRef="usd">-3332000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTItMS0xLTU4NDMw_bc8c892a-c6e2-4e49-818f-58efa4357525"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iffe46ad702824dcb88c5439257e2e20d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTItMS0xLTU4NDMw_c815109f-d319-4ac2-916c-880804fd4f61"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTYtMTYtMS0xLTU4NDMw_bb9fdd5d-32dd-48e0-a67d-ce4c854db365"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8dcd418f53514c1bbf7914a6f2125336_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTctMTQtMS0xLTU4NDMw_1dda69bb-4fa8-43dc-951f-606674e9a060"
      unitRef="usd">-1581000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTctMTYtMS0xLTU4NDMw_c2441024-5a5a-4a13-a42f-a5f421ed38b9"
      unitRef="usd">-1581000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMi0xLTEtNTg0MzA_0394a28d-e4fa-4ded-977a-ff84c06e21d1"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMTAtMS0xLTU4NDMw_5917d262-1ccb-4171-8ca1-4e75f1fe7e94"
      unitRef="usd">64000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTgtMTYtMS0xLTU4NDMw_1a078466-4e99-4219-a752-1eb90c01376f"
      unitRef="usd">64000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTktMi0xLTEtNTg0MzA_023b7bd8-ea5a-400e-ba3d-17d8c9bc4788"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMTktMTYtMS0xLTU4NDMw_630cf886-5c7f-4496-bdb8-9b073201b1c2"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMi0xLTEtNTk5OTY_498016c8-a20e-4d3e-a977-05fb2f8eda25"
      unitRef="shares">1768000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtNC0xLTEtNTk5OTY_68fa9f11-0f2d-40c8-a585-a7fca4497788"
      unitRef="usd">17000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTAtMS0xLTU5OTk2_4bce4ef5-8b89-430f-b77a-e3a59020a404"
      unitRef="usd">10515000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTYtMS0xLTU5OTk2_1bf7bb6e-ade7-477b-8da3-830d38e96f68"
      unitRef="usd">10532000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTAtMS0xLTU5OTk2_56634905-0b8e-45a6-bf2c-a11ce35bec9b"
      unitRef="usd">19000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTYtMS0xLTU5OTk2_96f79d6c-a77b-468b-bc1c-2f7c72e6e73d"
      unitRef="usd">19000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMi0xLTEtNTg0MzA_22633752-ff4f-4ad7-9576-c14e0f730251"
      unitRef="shares">57000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib560163bfb7049c3a18c5d907c380de8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNC0xLTEtNTk5OTY_1892ec2b-52b5-44e8-9001-a7b6d74d0253"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTAtMS0xLTU4NDMw_252f8385-1ed4-480a-9e04-604db0ec1c2f"
      unitRef="usd">118000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjAtMTYtMS0xLTU4NDMw_293ce521-9879-4f33-b9e2-aa9cf37004c3"
      unitRef="usd">119000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4d7afdac62a940f5b2e98016fb4d3eed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTAtMS0xLTU4NDMw_c226e912-abdb-410c-a518-b689e024d01c"
      unitRef="usd">1923000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjEtMTYtMS0xLTU4NDMw_043b2387-1bca-45ac-9c18-526c654c8bde"
      unitRef="usd">1923000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i052fb6f4421c4d4f9984b955980c6583_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMi0xLTEtNTg0MzA_4b7d8c4e-562b-466a-981e-223683eb3489"
      unitRef="shares">60885000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i052fb6f4421c4d4f9984b955980c6583_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNC0xLTEtNTg0MzA_d3ec25c5-5add-45ba-809b-3c533863263c"
      unitRef="usd">608000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iea88b7ed2ea84e5ab764b998327d144e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItNi0xLTEtNTg0MzA_ac2df73d-c462-4af6-8721-b4e68f25f8f4"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iea88b7ed2ea84e5ab764b998327d144e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItOC0xLTEtNTg0MzA_6a9375ac-efa4-438f-a46e-0d484a9501a5"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92a1264cc8b9472daa169711675defb7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTAtMS0xLTU4NDMw_fb959912-b4de-4d5c-a448-109cad95d8d8"
      unitRef="usd">572626000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b3f5f57fc524b96b5cfe506a4c5fea0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTItMS0xLTU4NDMw_902cff71-3692-4f09-b29d-c161483e8fba"
      unitRef="usd">-557770000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83a69202d1114ffc970a48ee40981389_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTQtMS0xLTU4NDMw_6673e493-19f8-421f-a22d-47b9c15e8359"
      unitRef="usd">-27909000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOjk4NDA1YzA1NzA4YTQ2YTE5NmM5ZmFlYjVjOTM0ODY0L3RhYmxlcmFuZ2U6OTg0MDVjMDU3MDhhNDZhMTk2YzlmYWViNWM5MzQ4NjRfMjItMTYtMS0xLTU4NDMw_24fa64f9-7465-4faf-87ae-b3d3a16fc4ec"
      unitRef="usd">-12440000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i34a108c684b944f1949cff98177a2d4d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0yLTEtMS01ODQzMA_be45cffe-972d-44b3-ba76-1715c5d119d7"
      unitRef="shares">58396000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i34a108c684b944f1949cff98177a2d4d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi00LTEtMS01ODQzMA_c5396975-3a57-4f2d-9008-5221d7377dec"
      unitRef="usd">583000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi02LTEtMS01ODQzMA_15e86e2f-1f96-4cef-8abf-c424ba1bc030"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7b2ae393eb7c4f519bbd113e9bdcec7e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi04LTEtMS01ODQzMA_f982784e-02d4-4d4a-b24b-47982163a51d"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66b3fac2f2f8404794c0c0c3cb9dc2b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xMC0xLTEtNTg0MzA_0bdc29bd-af22-47a0-ac7a-d555e0088dd7"
      unitRef="usd">566916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id39750e42b8c4306aad61fee7e83a5eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xMi0xLTEtNTg0MzA_f3f57471-133b-4a14-b569-463d8b14fe9e"
      unitRef="usd">-384187000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief0230fccabc48f5a6ef37bc48d526f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xNC0xLTEtNTg0MzA_be1758ae-3da1-4b7c-9160-cf5df57689b2"
      unitRef="usd">-21051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id3c35d690609413bbeb5dca96b91b6b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMi0xNi0xLTEtNTg0MzA_9fd91b1c-7f67-4458-bebd-86f91bcf6c45"
      unitRef="usd">162266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i52a5be02a4754c908aea2eb24daf8a58_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xMC0xLTEtNTg0MzA_944524d5-e058-4eb0-aa50-290e4d038eb6"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2113f33399c94c20b59358750f55db61_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xMi0xLTEtNTg0MzA_6edff9cc-3463-4d42-a08e-826b7672602d"
      unitRef="usd">13760000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia2bd8f8d15554ccaa1b7314e61a0bda1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMy0xNi0xLTEtNTg0MzA_e12156be-c8f7-42ed-be5e-212ac3267cec"
      unitRef="usd">-12939000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1daef32fcaaf4e3198268352bfe614c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNC0xMi0xLTEtNTg0MzA_b83f3e2e-de5b-49df-b0a2-e9e04798613f"
      unitRef="usd">-13445000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNC0xNi0xLTEtNTg0MzA_9249e1e0-6e1b-47ba-8dea-847cbf4aa2aa"
      unitRef="usd">-13445000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5d3b32370a14fc9ac68416910db95b4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNS0xNC0xLTEtNTg0MzA_c4a3518c-426e-46b7-bf84-572181372427"
      unitRef="usd">-1255000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNS0xNi0xLTEtNTg0MzA_196ed89f-b38f-4e1d-91f4-fd11e70debeb"
      unitRef="usd">-1255000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0yLTEtMS01ODQzMA_86442aa4-0bff-4cc1-b586-b128d31d1d13"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0xMC0xLTEtNTg0MzA_1f10466f-4d75-4d64-9f94-d5c3fee09a4c"
      unitRef="usd">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNi0xNi0xLTEtNTg0MzA_597f306c-c684-4890-8556-4539253ee0a5"
      unitRef="usd">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0yLTEtMS01ODQzMA_3597ace2-97c5-432e-9d78-397cc8057df3"
      unitRef="shares">61000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy00LTEtMS01ODQzMA_34fd7a87-73b0-486c-b41c-7301114afb84"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0xMC0xLTEtNTg0MzA_f199f54a-c8b2-4179-9d87-4b20ef8eb908"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfNy0xNi0xLTEtNTg0MzA_a481e356-cc8c-475a-af7b-4b47e39f3060"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i86dc9f4502a44d60978454055a5b3d3b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0yLTEtMS01ODQzMA_1b36070d-a7ce-4b55-837e-e1d39b74c6ca"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0xMC0xLTEtNTg0MzA_0120d0d5-2a5e-41f5-925a-bea9dbee3a82"
      unitRef="usd">43000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOC0xNi0xLTEtNTg0MzA_f888cee3-9cb6-489a-af00-2f4263197abb"
      unitRef="usd">43000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie4cf707f13404cdcbf11b99f54f8bb13_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOS0xMC0xLTEtNTg0MzA_3ba7e1d0-4c4e-4240-a248-98ca1813c4c9"
      unitRef="usd">1728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0dc46a9b9766447aae358fb24aaee96e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfOS0xNi0xLTEtNTg0MzA_dad6b14e-1b98-470c-bd7f-916cddccbea5"
      unitRef="usd">1728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="id1abc68c06e44c02a69a0e3b81539a1b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMi0xLTEtNTg0MzA_cd23a916-6105-4f8d-9d20-860314c1c9e0"
      unitRef="shares">58488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id1abc68c06e44c02a69a0e3b81539a1b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtNC0xLTEtNTg0MzA_7030058f-46bd-40b2-86a5-316c28dca53b"
      unitRef="usd">584000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i213fec939ca94d28a184d48147f2f980_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtNi0xLTEtNTg0MzA_7c5c5b16-9d4c-47ca-a7ab-c7ec188a9ced"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i213fec939ca94d28a184d48147f2f980_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtOC0xLTEtNTg0MzA_11699e07-ba11-4562-942c-b32d27d15a71"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94d53876fb534cecadcfeab8814f3dc8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTAtMS0xLTU4NDMw_1fc3ab27-9e8a-4888-a515-5aa1bc617813"
      unitRef="usd">542093000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i229da85b4f654c07be3b461a8a726d99_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTItMS0xLTU4NDMw_a2f4b0e5-05fc-47b2-9ad8-ed9be0e0d240"
      unitRef="usd">-383872000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i58d09c1dffe3407b993cb0bf2c8894ab_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTQtMS0xLTU4NDMw_11cde0d4-7330-417c-9502-506f0b09d55b"
      unitRef="usd">-22306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia1168117551d4a9a8647ed266ee1d21c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTAtMTYtMS0xLTU4NDMw_b962ff0f-324d-41da-8c99-5c4f566b55d0"
      unitRef="usd">136504000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i441ab67fef8d46f69ad115a28d4e47b2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTEtMTItMS0xLTU4NDMw_06c95d2c-9d59-4d5e-8b71-fb31081dacd5"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTEtMTYtMS0xLTU4NDMw_46afd006-32fc-4785-9df1-806b48046ea6"
      unitRef="usd">-19581000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4916497bce934c388a6e76aef6e5f8b2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTItMTQtMS0xLTU4NDMw_ac535442-a9d7-4a73-9856-a9fae5a12d69"
      unitRef="usd">-44000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTItMTYtMS0xLTU4NDMw_af09e456-3485-4df6-8778-edf9970a33df"
      unitRef="usd">-44000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1fb5fe8401174459933a0141de1de360_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTMtMTAtMS0xLTU4NDMw_aae81a1c-e520-4e9d-a76e-4596929cc7c7"
      unitRef="usd">2001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6ac94c15a9e942a185aeecc84c9f5f16_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTMtMTYtMS0xLTU4NDMw_3bbc1f05-f3dd-4373-a239-5c98c4a5a181"
      unitRef="usd">2001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMi0xLTEtNTg0MzA_a9b878da-ccb4-4db2-809f-c746ed85e5b4"
      unitRef="shares">58488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibd86e067d9ab49cf8bbe0f7c0f2171e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtNC0xLTEtNTg0MzA_06e10c00-dad3-428b-b0e9-1e3944dcd1b5"
      unitRef="usd">584000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i1f8355061a09422faca4bfc446a9317f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtNi0xLTEtNTg0MzA_a9691d7d-c7ee-471a-9483-0258bc0bd8ff"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1f8355061a09422faca4bfc446a9317f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtOC0xLTEtNTg0MzA_b3cd09a3-7fbc-4196-afe5-4741679b7cf8"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i78a7bb9eb70c43868a690dbac0c7d90c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTAtMS0xLTU4NDMw_62fb8f1d-fd0f-4c81-ad50-e4a2b7031bf7"
      unitRef="usd">544094000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id909d7fef83b4684a532a146f36cc21e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTItMS0xLTU4NDMw_da49a035-eeed-4221-9c4a-5bbd39bcb795"
      unitRef="usd">-403453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c237b4e52b04e4190505ebcd87c3c0f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTQtMS0xLTU4NDMw_b4c4178d-9a2a-402a-933c-66f391db0f6a"
      unitRef="usd">-22350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67aab025ab13460f81e69e191c346f26_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTQtMTYtMS0xLTU4NDMw_ae1f8741-2911-4ca5-8f99-a803b915ab95"
      unitRef="usd">118880000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie15da54ef7274b76b422a70b1c736327_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTUtMTItMS0xLTYwMDA3_b9a23a0f-cb79-4a10-a999-da7b16103e86"
      unitRef="usd">-22002000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTUtMTYtMS0xLTYwMDA3_afe2b98f-37d3-4345-ad61-0394bb45fed6"
      unitRef="usd">-22002000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia8f0906d79e940ad870b539d8791c365_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTYtMTQtMS0xLTYwMDA3_05e19b65-49fc-4997-bcf8-bfd21de52972"
      unitRef="usd">-394000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTYtMTYtMS0xLTYwMDA3_5be4fbdb-6d62-4dd4-8914-528eed7d896e"
      unitRef="usd">-394000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMi0xLTEtNjAwMDc_8ba68f61-0f9a-41c3-9b61-fbf3946e008d"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctNC0xLTEtNjAwMDc_17977fb8-2ced-46ab-8477-f806bcc2ce5f"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMTAtMS0xLTYwMDA3_1c302f0b-06ca-4012-a50f-67c19bcf89e8"
      unitRef="usd">62000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTctMTYtMS0xLTYwMDA3_afe8cb33-a40c-4456-8166-36d7a2126769"
      unitRef="usd">63000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMi0xLTEtNjAwMDc_015e3a14-2d14-4629-a4af-b0f7abe9d869"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtNC0xLTEtNjAwMDc_b44b0f2f-9a6d-41bd-9a19-aa786a94f401"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMTAtMS0xLTYwMDA3_d326fcec-65f3-4854-8c28-7c46eb1e7b26"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTgtMTYtMS0xLTYwMDA5_11838fbb-40c8-44bf-86ce-6c6d090adcb3"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ib6d7c4d2a63e42f7a48c500ff1a0e9a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMi0xLTEtNjAwMDc_6ee7e0ce-6e6a-4883-8edb-ae075dd61bfe"
      unitRef="shares">9000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMTAtMS0xLTYwMDA3_8067fa11-e7a6-4299-b29e-e0bbb2c3da81"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMTktMTYtMS0xLTYwMDA3_23615bbe-58cb-4e46-a235-593b918cfe9d"
      unitRef="usd">51000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i858bb564a22c494cb368931091b853d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjAtMTAtMS0xLTYwMDA3_f491a711-91f8-44ef-b2c6-a6550e0b5059"
      unitRef="usd">2359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjAtMTYtMS0xLTYwMDA3_94758a9b-3f81-45a3-90c1-8957bfa7da76"
      unitRef="usd">2359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMi0xLTEtNjAwMDc_be952a09-9a56-4ef7-9d4c-425dd94674a1"
      unitRef="shares">58616000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i89d0cfd2e5ac4bb89e86dbdc52d74753_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtNC0xLTEtNjAwMDc_d964e8e4-e0f8-4c05-ba7e-a58d2734c4e1"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i35e8617f6b8b4839961ae2d42367307e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtNi0xLTEtNjAwMDc_a1d26d0c-4b2b-4d65-a611-a4d173fe62c1"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i35e8617f6b8b4839961ae2d42367307e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtOC0xLTEtNjAwMDc_dddff24e-4324-4626-9cd9-df1356736387"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i006e36115c06446280acc29186452555_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTAtMS0xLTYwMDA3_3d346d9d-0a63-4dd2-b04e-9cbe55bcf585"
      unitRef="usd">546565000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if21be33b2a2f4c259a0dc8988e8c8bbb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTItMS0xLTYwMDA3_d8bf8487-0279-4c9a-9b0a-43f905105675"
      unitRef="usd">-425455000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTQtMS0xLTYwMDA3_806611d9-01ea-4fa7-8357-70b727cf3320"
      unitRef="usd">-22744000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i407de99cf96a455d8396a71ae495f64b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8yOC9mcmFnOmViNjZmMDg1MjA0MzQ0YzFhOTAzZWJhNTQ0YWQ5ZmQ0L3RhYmxlOmVkNmFkODMxZTA0YzQyMDM5ZDRjODhhZWNhYTdhMGQ0L3RhYmxlcmFuZ2U6ZWQ2YWQ4MzFlMDRjNDIwMzlkNGM4OGFlY2FhN2EwZDRfMjEtMTYtMS0xLTYwMDA3_12d3b78d-fd5e-491b-ab81-6ffaa68d11a8"
      unitRef="usd">98957000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNC0yLTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293"
      unitRef="usd">-110014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNC00LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f"
      unitRef="usd">-55028000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNi0yLTEtMS01ODQzMA_e98b5d6f-fb8f-40a9-ad9b-05aaaa6dbc9f"
      unitRef="usd">907000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNi00LTEtMS01ODQzMA_e683d50a-9b46-4611-adbb-3050492f0fa8"
      unitRef="usd">614000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNy0yLTEtMS01ODQzMA_522245e0-ecca-4696-bef0-e414b9182554"
      unitRef="usd">4147000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNy00LTEtMS01ODQzMA_0a680d76-6bce-4789-9ad2-8dc98ba8023f"
      unitRef="usd">937000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOC0yLTEtMS01ODQzMA_ae8a7edb-b20d-4280-9b8b-a8d2371e90f6"
      unitRef="usd">25916000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOC00LTEtMS01ODQzMA_cd5b57d0-c121-4467-828e-38b99411a90c"
      unitRef="usd">-11322000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOS0yLTEtMS01ODQzMA_7f01498f-6a15-4221-a9d5-8a8359aa7cce"
      unitRef="usd">5086000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfOS00LTEtMS01ODQzMA_7dae11db-a4ea-497c-a66f-f5a2a25873cd"
      unitRef="usd">6088000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTAtMi0xLTEtNTg0MzA_ea75529c-7d84-4e16-9642-f343f1f05ed2"
      unitRef="usd">33000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTAtNC0xLTEtNTg0MzA_35df11ff-9045-4a56-b554-b28eee7c4114"
      unitRef="usd">166000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTEtMi0xLTEtNTg0MzA_0cb69e76-5be0-4340-85a5-42919202db72"
      unitRef="usd">1539000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTEtNC0xLTEtNTg0MzA_3b242792-01c4-4601-87f0-10633252ca97"
      unitRef="usd">1056000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTUtMi0xLTEtNTg0MzA_19c4fac0-87c7-4956-9ece-e5731bc2d735"
      unitRef="usd">-27948000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTUtNC0xLTEtNTg0MzA_d984b427-13e6-4d97-b012-43bbc5a27eee"
      unitRef="usd">54000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTYtMi0xLTEtNTg0MzA_a2b2c5a6-c2a3-476e-8171-2f02170516b3"
      unitRef="usd">-27000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTYtNC0xLTEtNTg0MzA_9f58230a-116e-4471-b4ed-0efdad1075ab"
      unitRef="usd">-3079000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTctMi0xLTEtNTg0MzA_19410b53-9332-4fa2-9985-8397b72ce0b0"
      unitRef="usd">-11629000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTctNC0xLTEtNTg0MzA_34b1c1d4-a576-42a8-8a73-0da78e8b1963"
      unitRef="usd">-201000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTgtMi0xLTEtNTg0MzA_28f35528-e4ec-474c-97e0-359aa5837c42"
      unitRef="usd">4277000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTgtNC0xLTEtNTg0MzA_2af457a4-8ef2-44c9-890b-ead237720d8e"
      unitRef="usd">2421000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTktMi0xLTEtNTg0MzA_550f410f-947c-4e70-aef0-97aacf1ba770"
      unitRef="usd">3109000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMTktNC0xLTEtNTg0MzA_82780ef0-423b-4cb2-bf3a-875e08532fd9"
      unitRef="usd">2228000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjAtMi0xLTEtNTg0MzA_8a46fa6b-d2f4-48ef-94bd-944e62310cdf"
      unitRef="usd">-54938000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjAtNC0xLTEtNTg0MzA_19e691d7-280e-468b-b4fd-58e7690fbb64"
      unitRef="usd">-54804000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjMtMi0xLTEtNTg0MzA_0dd1a518-39b4-4a50-a15d-cfbcbd50631a"
      unitRef="usd">716000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjMtNC0xLTEtNTg0MzA_ad6d7785-e52b-435b-930f-8518d0af7545"
      unitRef="usd">26000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjQtMi0xLTEtNTg0MzA_802167f0-b82f-423b-852a-1d306b520112"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjQtNC0xLTEtNTg0MzA_a3929248-ad8f-4c03-8875-7475fbd48c82"
      unitRef="usd">16500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjUtMi0xLTEtNTg0MzA_477bcd30-7a4a-42a4-9bec-1e995a70146d"
      unitRef="usd">59873000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjUtNC0xLTEtNTg0MzA_6c44c2b3-eada-4924-a0e6-d25c5c2b0bd7"
      unitRef="usd">83726000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjYtMi0xLTEtNTg0MzA_31fb9460-cfed-4b51-91aa-bec796efd593"
      unitRef="usd">2334000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjYtNC0xLTEtNTg0MzA_caddb341-58c6-4b8e-865b-c9bf3c5bd886"
      unitRef="usd">58591000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjctMi0xLTEtNTg0MzA_8e8e4a30-4c1b-4066-9bb0-9c3080be3a35"
      unitRef="usd">56823000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMjctNC0xLTEtNTg0MzA_4b5c651c-bb69-4bd7-8052-eb44f7db470e"
      unitRef="usd">41609000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzAtMi0xLTEtNTg0MzA_abd131a7-0ffd-42f9-98a2-9c501519c3ad"
      unitRef="usd">4803000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzAtNC0xLTEtNTg0MzA_32561011-9568-44f4-a850-faa78e6078e5"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItMi0xLTEtNjE3MTA_d8ca61b5-6f0b-4fd7-a2b7-3ef39fd98ed1"
      unitRef="usd">10532000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItNC0xLTEtNjI0NTE_4700b936-8d62-4225-b54b-e87c81881aad"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzEtMi0xLTEtNTg0MzA_ea8ae94c-29b5-40c3-8a4d-c0a06710aa42"
      unitRef="usd">2192000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzEtNC0xLTEtNTg0MzA_94b6118e-32f3-4bb6-a229-2ae2871010fe"
      unitRef="usd">263000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItMi0xLTEtNTg0MzA_0e84e78e-6b51-48eb-9141-a77d6eb5c5e1"
      unitRef="usd">7921000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzItNC0xLTEtNTg0MzA_89812c38-5c24-46c4-be4e-ba298dd5b563"
      unitRef="usd">263000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzQtMi0xLTEtNTg0MzA_06692972-cd04-466d-b65d-f61a63050387"
      unitRef="usd">201000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzQtNC0xLTEtNTg0MzA_3723982e-5bed-4174-b6a1-8597f0d701f5"
      unitRef="usd">-621000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzYtMi0xLTEtNTg0MzA_82ce2b92-360e-4689-943f-44c0061fdda2"
      unitRef="usd">10007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzYtNC0xLTEtNTg0MzA_11187b13-3a28-4d7b-9474-9e3cc705f85b"
      unitRef="usd">-13553000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzctMi0xLTEtNTg0MzA_8d58280c-863b-4ba7-a63c-6d7a4947e720"
      unitRef="usd">50708000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id3c35d690609413bbeb5dca96b91b6b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzctNC0xLTEtNTg0MzA_3c5fc37c-80fa-464a-8118-7d45da6fe2be"
      unitRef="usd">71722000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzgtMi0xLTEtNTg0MzA_9bdfae84-c5d9-4be4-a59e-37d4be64cc12"
      unitRef="usd">60715000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i407de99cf96a455d8396a71ae495f64b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfMzgtNC0xLTEtNTg0MzA_4a357850-86d0-4468-b525-367404643035"
      unitRef="usd">58169000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDEtMi0xLTEtNTg0MzA_e93be031-589a-4a7f-9b72-142a6a0dd601"
      unitRef="usd">9660000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDEtNC0xLTEtNTg0MzA_e4886344-4350-452b-97f3-df9b2ceee03b"
      unitRef="usd">6469000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDItMi0xLTEtNTg0MzA_b0d8343b-f7a3-4ec0-a948-68c54d0b6b19"
      unitRef="usd">-32323000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zMS9mcmFnOmY4NDY0NzMwODc2ZjQ2ZTRhMGE0ZDVkMGRlNzc2MmM0L3RhYmxlOjY2Zjk1NTk4ZWRmYzRhNTU4NjliMTViNDhiOWE5ZTVmL3RhYmxlcmFuZ2U6NjZmOTU1OThlZGZjNGE1NTg2OWIxNWI0OGI5YTllNWZfNDItNC0xLTEtNTg0MzA_a13e5378-e6dd-4d0d-b88d-901cad5b1528"
      unitRef="usd">68000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM3OQ_db529e78-04c5-4a76-aa01-56a0188b8a58">Summary of Significant Accounting Policies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#x201c;U.S.&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#x201c;EDS&#x201d;) in adults with narcolepsy. On July 18, 2022, the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) granted tentative approval to LUMRYZ for this indication. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. The Company is primarily focused on obtaining final FDA approval of LUMRYZ. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#x201c;REMS Patent&#x201d;), which is listed in the FDA&#x2019;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#x2019;s Orange Book or a court earlier determines that patent is not infringed, invalid or otherwise unenforceable. The FDA&#x2019;s tentative approval can be subject to change based on new information that may come to the FDA&#x2019;s attention between such time as the tentative approval and potential final approval. The Company cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of the Company&#x2019;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any commercialized products in its portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#x2019; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $60,715 of cash and cash equivalents and $45,760 of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#x2019;s ability to generate revenue is expected to start following the launch of LUMRYZ, which is dependent, in part, on final approval of LUMRYZ by the FDA. As of September 30, 2022, the Company has $26,375 aggregate principal amount of its 4.50% exchangeable senior notes due February 2023 (the &#x201c;February 2023 Notes&#x201d;) and $117,375&#160;aggregate principal amount of its 4.50% exchangeable senior notes due October 2023 (the &#x201c;October 2023 Notes&#x201d;) (together, the &#x201c;2023 Notes&#x201d;). The Company does not currently have sufficient available liquidity to repay the outstanding balance of the October 2023 Notes. These conditions and events raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In response to these conditions and events, the Company is evaluating various financing strategies to obtain sufficient additional liquidity to meet its operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. The potential sources of financing that the Company is evaluating include one or any combination of royalty financing, secured or unsecured debt, convertible debt and equity. In addition, the Company&#x2019;s financing strategy could also include refinancing or negotiating new terms for the 2023 Notes. The Company also currently has authorized and available the use of its at-the-market offering program (&#x201c;ATM Program&#x201d;), described in more detail below, which could provide the Company up to approximately $135,000 (as of September 30, 2022), net of commissions, if fully utilized. While the Company has the ability to utilize the ATM Program, it intends to pursue the other financing strategies described above. Based on the Company&#x2019;s ability to raise funds through the ATM Program, the Company has determined that it is probable that such proceeds would provide sufficient additional capital to meet the Company&#x2019;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report. As a result, the Company has concluded that management&#x2019;s plans are probable of being achieved to alleviate the substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The sources of financing described above that could be available to the Company and the timing and probability of obtaining sufficient capital depends, in part, on obtaining final FDA approval of LUMRYZ, resolving any legal and regulatory matters that could preclude the Company from launching LUMRYZ and future capital market conditions. If the Company&#x2019;s current assumptions regarding timing of potential final approval, the timing of the launch of LUMRYZ or if there are any other changes or differences in our current assumptions that negatively impact our financing strategy, the Company may have to further &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;reduce expenditures or significantly delay, scale back or discontinue the development or commercialization of LUMRYZ in order to extend its cash resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;At-the-Market Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On February 5, 2020, the Company entered into an Open Market Sale Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;SM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (the &#x201c;Sales Agreement&#x201d;) with Jefferies LLC (&#x201c;Jefferies&#x201d;) with respect to an ATM Program under which the Company may offer and sell its American Depositary Shares (&#x201c;ADSs&#x201d;, and such ADSs sold under the ATM Program, &#x201c;ATM ADSs&#x201d;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#x2019;s Registration Statement on Form S-3 (File No. 333-236258) (the &#x201c;2020 Prospectus&#x201d;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#x2019;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#x201c;2022 Prospectus&#x201d;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2022, the Company had issued and sold 1,768 ADSs, resulting in net proceeds to the Company of approximately $10,532, pursuant to the 2020 Prospectus. The Company may offer and sell up to an additional $39,142 of ADSs under the ATM Program that remain available for sale pursuant to the 2020 Prospectus and also up to $100,000 of ADSs available for sale under the ATM Program pursuant to the 2022 Prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of September&#160;30, 2022, which is derived from the prior year 2021 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 16, 2022.&lt;/span&gt;&lt;/div&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <avdl:NatureOfBusinessPolicyPolicyTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM4NQ_5c185e66-9d4c-44e0-be5b-906a5c766090">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#x201c;U.S.&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product candidate, LUMRYZ, also known as FT218, is an investigational once-at-bedtime, extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness (&#x201c;EDS&#x201d;) in adults with narcolepsy. On July 18, 2022, the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) granted tentative approval to LUMRYZ for this indication. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. The Company is primarily focused on obtaining final FDA approval of LUMRYZ. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A decision on final FDA approval of LUMRYZ is pending disposition of U.S. Patent No. 8731963 (the &#x201c;REMS Patent&#x201d;), which is listed in the FDA&#x2019;s Orange Book. The decision on final FDA approval could occur on or about the expiration of the REMS Patent on June 17, 2023 or sooner if the patent is earlier removed from the FDA&#x2019;s Orange Book or a court earlier determines that patent is not infringed, invalid or otherwise unenforceable. The FDA&#x2019;s tentative approval can be subject to change based on new information that may come to the FDA&#x2019;s attention between such time as the tentative approval and potential final approval. The Company cannot legally market LUMRYZ in the U.S. until final approval is granted by the FDA.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of the Company&#x2019;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any commercialized products in its portfolio.&lt;/span&gt;&lt;/div&gt;</avdl:NatureOfBusinessPolicyPolicyTextBlock>
    <avdl:LiquidityAndGoingConcernPolicyTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzgxNQ_0382b492-b86f-4bfb-b152-16dc282a7baa">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/div&gt;</avdl:LiquidityAndGoingConcernPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY3MQ_7a9ca94f-76cf-4d45-aebb-37ab8a208178"
      unitRef="usd">60715000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY2Mg_9d528860-536a-467d-9ef8-de265b1ee6b8"
      unitRef="usd">45760000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY4MA_f2e536ba-7e6b-4881-9960-c996c77db66f"
      unitRef="usd">26375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY4OQ_b2271afc-4d19-4949-ae4f-ffa3d4541698"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzY5Ng_5cd36913-c384-48fc-b6e0-ff5db2cad224"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcwNg_72bcc6d2-c028-4869-ade1-5a27357397bb"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="ic846f79390da411baf672e11138d8640_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcxMw_94b70368-5295-4e26-9b39-ebaa7050d170"
      unitRef="usd">135000000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <avdl:SaleOfStockCommissionPercentage
      contextRef="idf727c0cbc0d4d77aecbe73f9e0c4cbb_I20200205"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcyMw_b7153947-5e83-48cb-8c41-ddeecc24ed29"
      unitRef="number">0.030</avdl:SaleOfStockCommissionPercentage>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="iaa1afa74539c4902922f142c1210083f_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzcyOQ_db3b7f1c-ace8-4cc7-93b1-6f928fee48f1"
      unitRef="usd">50000000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="if65bfb99cbf2433ab28b9b155376252c_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzczOA_71b12196-b610-4e16-9192-58bfdc423b45"
      unitRef="usd">100000000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc2OQ_fbfc6a88-8021-4584-abea-d577c8c721f0"
      unitRef="shares">1768000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i1bb3943b3eaa4946836d9a560bfabee2_D20220930-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc3Ng_16a10e95-790b-4e2a-951d-e2b5344f7b74"
      unitRef="usd">10532000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount
      contextRef="icf4ca9e79bab4ceda5ce5f8750665f49_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc4NQ_11a0f526-7674-422d-897f-81791202bed8"
      unitRef="usd">39142000</avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount>
    <avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount
      contextRef="i2b516ef9e5224745a478640fa35c9afe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfOTM0NTg0ODkxNzc5NA_b6a3cfd7-1ac2-4d16-becf-2513e429aeb7"
      unitRef="usd">100000000</avdl:RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8zNy9mcmFnOjUxMmM4MmFkNDRkNDQyZjhhOTBkODg0M2UwMjViZTI1L3RleHRyZWdpb246NTEyYzgyYWQ0NGQ0NDJmOGE5MGQ4ODQzZTAyNWJlMjVfMzM4OA_b8220f98-87db-4e08-b819-7f8b8f2f0601">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of September&#160;30, 2022, which is derived from the prior year 2021 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 16, 2022.&lt;/span&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzc0OA_323dabbf-2652-4557-be23-87abd59f8d6c">Fair Value Measurement&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - Quoted prices for identical assets or liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - Unobservable inputs that reflect estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended September&#160;30, 2022 and December&#160;31, 2021, respectively, there were no transfers in and out of&#160;Level 3. During the three and nine months ended September&#160;30, 2022 and 2021, respectively, the Company did not recognize any allowances for credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of its $26,375 aggregate principal amount of its February 2023 Notes and its $117,375&#160;aggregate principal amount of its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair values of the February 2023 Notes and the October 2023 Notes at September&#160;30, 2022 are $25,584 and $101,970, respectively. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding the Company&#x2019;s debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzc1NA_1ad5366e-73ea-431c-a3b1-1283dae6b9ed">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9034e3eea5954251b56209f67d99c46b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0yLTEtMS01ODQzMA_e48644fa-f1dc-4c0b-bd50-55f3768fa1e3"
      unitRef="usd">31481000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42d21dc155e64f37a446b0e84d4976b3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC00LTEtMS01ODQzMA_dd99bda9-ca30-4508-8caf-e50d70e006ed"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9be88a5186547af9bac2db96c0d314c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC02LTEtMS01ODQzMA_9bb7d8a3-299d-4177-9e8d-a9d3a620d4f5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f5b4e9bf4294ad3855eba74063db7bf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC04LTEtMS01ODQzMA_278aa762-2a35-4999-b99f-135d005842c9"
      unitRef="usd">78098000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6b1fbf65244d44e5b30d39291b2fee91_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0xMC0xLTEtNTg0MzA_9f202913-bdeb-4bea-8764-e94aa0890359"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7732fc52cd52433585e6e3881ca0de58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNC0xMi0xLTEtNTg0MzA_d7ae94e9-e929-4c09-a2b6-e723b12ce825"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a3773002d244c34aea4fe21b68c31f8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0yLTEtMS01ODQzMA_35c1ec9a-0fec-45ff-9773-9ab683c40fc8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52a16e746e11428a8a70889cb36973ac_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS00LTEtMS01ODQzMA_5eb0fd40-4fb7-47cb-90fd-573f6598f29c"
      unitRef="usd">9178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4659da3e5e6e4b81ac8a8c5d5408d5ed_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS02LTEtMS01ODQzMA_733b48b7-24fa-45e1-b144-1e4e649bff65"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3d3636fc86bf4e418c691cc2e41b6d3e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS04LTEtMS01ODQzMA_0c7aec3d-3318-488e-9e02-5892a5625889"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47dcccfa7c50438eb45d7d48956a6b42_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0xMC0xLTEtNTg0MzA_9d236f06-fe53-44ee-ab1c-174e92c068ae"
      unitRef="usd">16479000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie39a1b6970aa4db987b72e4f7b8b1e55_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNS0xMi0xLTEtNTg0MzA_9b82ad07-d36f-458d-8271-7ffd758e2de7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d3a19c47255496184d2a49062a6a184_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0yLTEtMS01ODQzMA_75788527-bcad-4fe5-bed4-02a28d335f60"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if37b82ee9ff1453bb386fd75f1d28653_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi00LTEtMS01ODQzMA_4eb49393-be1a-4ee0-9405-2934ddcf9809"
      unitRef="usd">3458000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04f623a32e9c42a78b39d8b1336e8ed0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi02LTEtMS01ODQzMA_7d65675a-89ff-4711-8e55-b437c2a04051"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6eadf013ec464baa8c05eace10107933_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi04LTEtMS01ODQzMA_3934feb6-b599-421e-af42-3992936711d2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52a672b4236141ea87f8252cc44a0803_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0xMC0xLTEtNTg0MzA_6044d4a6-f7dc-462d-b194-89124f990c69"
      unitRef="usd">9471000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id83b8410c35f458bb9cc1c09bfed7f76_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNi0xMi0xLTEtNTg0MzA_968c0310-206d-4185-b75a-5d01fc9f2522"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iead5d1bc954d49df81b5bdb5758886e6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0yLTEtMS01ODQzMA_bf419443-222e-448a-a127-2bfd9ba0370d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iabde77903698481883f2e97de186f6c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy00LTEtMS01ODQzMA_4af04b7a-aa75-4dee-95d3-1ee63c6c4aa5"
      unitRef="usd">1643000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b1fb3c05c2d4391aac196e02ae0db2d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy02LTEtMS01ODQzMA_20f67808-9012-485f-9b13-975922511de0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie64cc03ea55a4af785d07e9c36ed47f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy04LTEtMS01ODQzMA_95973544-3d6a-4fb1-93c0-543396369fd2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8ba686307084b878761e39792b65749_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0xMC0xLTEtNTg0MzA_5c934bdf-a631-4378-ae8c-c656d7591d10"
      unitRef="usd">2465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i42c8ac8d5610497498f8d8ff97b74668_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfNy0xMi0xLTEtNTg0MzA_4687cbda-a732-4005-83f7-b33ceb0a4ce0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i43f7d3853b624df8b8d498a70765a7d3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0yLTEtMS01ODQzMA_4aee4237-2f42-4024-a3c8-719bbb12dc56"
      unitRef="usd">31481000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i29b635783cf44814ab114c3ec2777bbc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC00LTEtMS01ODQzMA_c346d251-f1a0-430f-9972-b8c272f8cce2"
      unitRef="usd">14279000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i33c84835d749403fad63d02da1c19f19_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC02LTEtMS01ODQzMA_52789878-768e-4331-9cb3-321f50b7933c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i008389be6902419a89fb4467f69d8cf5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC04LTEtMS01ODQzMA_3777b7b8-b801-48d4-a798-bb059770937e"
      unitRef="usd">78098000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idc7fd82afc824c2d809f04c9d1209c92_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0xMC0xLTEtNTg0MzA_177a1933-60ef-478c-a195-6ea19e16b022"
      unitRef="usd">28415000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie24d32544eb3492583f742640967b39f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RhYmxlOmNhZWNkODMxYzNjYjRkOTZhMzFkMmQ4OWQzOTUyYTc0L3RhYmxlcmFuZ2U6Y2FlY2Q4MzFjM2NiNGQ5NmEzMWQyZDg5ZDM5NTJhNzRfOC0xMi0xLTEtNTg0MzA_1d33094e-9c0d-4ef3-a805-41faeaa84312"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzA4NQ_c7b6e8b2-7adc-4540-92da-319612bec1d1"
      unitRef="usd">26375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzIwNQ_b8717319-70a0-4461-ac99-8c76205d83ad"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzYzOA_f592ac45-364d-4ae1-bb4d-146ec1cc53fa"
      unitRef="usd">25584000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80MC9mcmFnOmNhNWYzMDA0ZTQ0MTQ5ZTA5ZTBmYzQ0Yjk2N2FhYmU0L3RleHRyZWdpb246Y2E1ZjMwMDRlNDQxNDllMDllMGZjNDRiOTY3YWFiZTRfMzY0NQ_e2063ec6-0e5c-449f-9bc8-5510d49640e8"
      unitRef="usd">101970000</us-gaap:LongTermDebtFairValue>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyMQ_86061546-2a6f-48d7-8c1d-4e32c091980c">Marketable Securities&#160;The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#x2019; (deficit) equity, net of income tax effects. As of September&#160;30, 2022, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;September&#160;30, 2022 and December&#160;31, 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income, net in the accompanying unaudited condensed consolidated statements of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized gross realized gains of $64 and $22 for the three months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $61 and $66 for the three months ended September&#160;30, 2022 and 2021, respectively. We recognized gross realized gains of $372 and $74 for the nine months ended September&#160;30, 2022 and 2021, respectively. These realized gains were offset by gross realized losses of $1,092 and $173 for the nine months ended September&#160;30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of the Company&#x2019;s investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its investment in available-for-sale marketable debt securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#x2019;s investment portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the gross unrealized losses and fair value of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2022. The unrealized losses in the table below are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNw_e4762f22-85ba-4b62-a7d0-e2b7c0fb244b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;September&#160;30, 2022 and December&#160;31, 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy0yLTEtMS01ODQzMA_5dcbd74b-8179-4aa9-b702-d76f9619d124"
      unitRef="usd">32922000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy00LTEtMS01ODQzMA_6e37d21c-5ebf-42d2-835b-766bf46a530e"
      unitRef="usd">220000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy02LTEtMS01ODQzMA_d4f33cdf-32b2-423d-ad71-885975fe2393"
      unitRef="usd">1661000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d8c5d3f7d8f408cb1189d0ba1317e86_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfMy04LTEtMS01ODQzMA_09414653-4f48-431e-a831-ad7ed734b9cb"
      unitRef="usd">31481000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC0yLTEtMS01ODQzMA_a5249c1e-bda6-4b2f-a028-e53d7c6686c9"
      unitRef="usd">9885000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC00LTEtMS01ODQzMA_0b8adcfb-1787-4772-b817-25ba4af0dc72"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC02LTEtMS01ODQzMA_0a8b64ca-27b1-4be1-ad26-f8fb9f1bf1bc"
      unitRef="usd">707000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNC04LTEtMS01ODQzMA_a41ea72d-3b26-4052-a7da-1a95feebae16"
      unitRef="usd">9178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS0yLTEtMS01ODQzMA_e5917d5d-7cee-4f01-9268-e0c19e43cfb8"
      unitRef="usd">3827000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS00LTEtMS01ODQzMA_ba473c94-d458-47c7-96da-604f42fba973"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS02LTEtMS01ODQzMA_b78c451b-fa02-46ef-9b7f-4acfda79d29f"
      unitRef="usd">369000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNS04LTEtMS01ODQzMA_4c2b4c09-259a-4287-aea4-91b17d973981"
      unitRef="usd">3458000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi0yLTEtMS01ODQzMA_8c5a22f9-d9e7-4f4c-a590-8dbec01992ce"
      unitRef="usd">1691000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi00LTEtMS01ODQzMA_0ffa03dd-61d2-4075-9c8d-04ead0196136"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi02LTEtMS01ODQzMA_f557ad00-dbb0-49c3-8189-6f578f0bcbe4"
      unitRef="usd">48000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNi04LTEtMS01ODQzMA_8d8d3860-26e5-4860-ba4c-30d57e812bf0"
      unitRef="usd">1643000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy0yLTEtMS01ODQzMA_b78135a7-bf9c-4f39-b43b-91a99e1ee2d8"
      unitRef="usd">48325000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy00LTEtMS01ODQzMA_16a3b001-fd5c-4689-a54c-2534b059ba0d"
      unitRef="usd">220000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy02LTEtMS01ODQzMA_024438dd-38be-4b46-8dd2-5895615f258b"
      unitRef="usd">2785000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjU1OGI3MTRlYjc5MTQxZTNiYmU4MTE2YTkzZmRiMTBhL3RhYmxlcmFuZ2U6NTU4YjcxNGViNzkxNDFlM2JiZTgxMTZhOTNmZGIxMGFfNy04LTEtMS01ODQzMA_9f17740c-be75-464e-838f-e072e99e654e"
      unitRef="usd">45760000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy0yLTEtMS01ODQzMA_407eb824-a75d-46d0-99da-157eefbdcf79"
      unitRef="usd">78331000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy00LTEtMS01ODQzMA_5dc314c5-d9d6-4f57-80c1-332fa072f239"
      unitRef="usd">813000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy02LTEtMS01ODQzMA_c7c14e1b-6dfb-4cbf-94f2-0cf18e52e192"
      unitRef="usd">1046000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib25efd41b0a8497088a128e71d6d5557_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfMy04LTEtMS01ODQzMA_38e821a6-1770-40a6-ad58-ec0b7effdc06"
      unitRef="usd">78098000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC0yLTEtMS01ODQzMA_fd082326-e471-4511-9403-aa900baa1e8b"
      unitRef="usd">16478000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC00LTEtMS01ODQzMA_e8c3c791-5dc2-49f3-a7a3-22ea5d68628e"
      unitRef="usd">94000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC02LTEtMS01ODQzMA_7d59fcca-046a-4b61-9fb4-0f0dcf4074c7"
      unitRef="usd">93000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25fb303f345248a9a4f13e49293b295b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNC04LTEtMS01ODQzMA_3ea54996-62d6-4914-b8e5-9c68386a9dad"
      unitRef="usd">16479000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id9f88e70592e4720b210f17465179f02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS0yLTEtMS01ODQzMA_2a9a5cde-be20-4049-88ff-f708f325e311"
      unitRef="usd">9530000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id9f88e70592e4720b210f17465179f02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS00LTEtMS01ODQzMA_624d0180-2f09-4a55-a264-21b594ae2c8e"
      unitRef="usd">39000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id9f88e70592e4720b210f17465179f02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS02LTEtMS01ODQzMA_8c57f6a4-7b3f-470e-88c2-1e068ebff926"
      unitRef="usd">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9f88e70592e4720b210f17465179f02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNS04LTEtMS01ODQzMA_6a02cfe4-df02-4c6c-ae6c-01297255bbbc"
      unitRef="usd">9471000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibf8be616cca445759476d602725c21af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi0yLTEtMS01ODQzMA_017a3f96-0b86-4b11-a79a-d41046af104c"
      unitRef="usd">2473000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibf8be616cca445759476d602725c21af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi00LTEtMS01ODQzMA_67d69f31-5651-41ac-a3da-7f920a161413"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibf8be616cca445759476d602725c21af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi02LTEtMS01ODQzMA_d639c20e-f703-4ba3-9050-87c4ad15c686"
      unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf8be616cca445759476d602725c21af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNi04LTEtMS01ODQzMA_67825146-3355-461d-a6c1-f4458b219fb0"
      unitRef="usd">2465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy0yLTEtMS01ODQzMA_b72ba1a3-f866-4249-a970-86c75fd0a653"
      unitRef="usd">106812000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy00LTEtMS01ODQzMA_e5281349-099d-444a-a55a-5989fb9c95c3"
      unitRef="usd">948000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy02LTEtMS01ODQzMA_64c81456-36a1-4391-8f3e-96a8fc68403b"
      unitRef="usd">1247000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOjE0M2VhZTY1YWZjYzQ5NDc5OGYxYmY1YjJhMzhhZjMxL3RhYmxlcmFuZ2U6MTQzZWFlNjVhZmNjNDk0Nzk4ZjFiZjViMmEzOGFmMzFfNy04LTEtMS01ODQzMA_c98fe333-d4c6-4d27-b85e-48cc826a75f6"
      unitRef="usd">106513000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTA1MA_c6d66a7f-fd62-4df4-be82-6c2fed081414"
      unitRef="usd">64000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTA1Nw_18b1f306-05cf-45a1-8714-6968099d3142"
      unitRef="usd">22000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTE2OA_b911a47b-c83f-4f6b-b44e-0b09365024b7"
      unitRef="usd">61000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTE3NQ_6bfd57a3-d4ea-4fbc-9e42-d725db5e175c"
      unitRef="usd">66000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTI2OA_9b79447f-08e3-48f3-90ad-ecc37158bff3"
      unitRef="usd">372000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTI3NQ_a67421f8-0819-4529-874f-29cd246f28e6"
      unitRef="usd">74000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTM4Mg_c48a859a-c950-4008-b922-fd2bf1bdd9a7"
      unitRef="usd">1092000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMTM4OQ_4ed69d6d-5808-4fff-942b-87b50323db78"
      unitRef="usd">173000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNA_114e88e6-c5cc-4fbd-a73b-d13a568ad2a7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of the Company&#x2019;s investments in marketable debt securities, accounted for as available-for-sale debt securities and classified by the contractual maturity date of the securities as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy0yLTEtMS01ODQzMA_15032774-41c8-4f40-b458-190246baddf5"
      unitRef="usd">1602000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy00LTEtMS01ODQzMA_37cb7797-2345-46c6-af62-faa5dd2e2257"
      unitRef="usd">7576000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy02LTEtMS01ODQzMA_39629695-5789-4b15-a4c6-af66bd19a505"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy04LTEtMS01ODQzMA_5fbded90-2764-4662-8129-0dceb35f06fe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfMy0xMC0xLTEtNTg0MzA_a41ea72d-3b26-4052-a7da-1a95feebae16"
      unitRef="usd">9178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC0yLTEtMS01ODQzMA_e7c445df-bfd3-42c0-8934-3775645a9e6b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC00LTEtMS01ODQzMA_6576d64a-fdf3-4269-8e3f-9cdd07bfdeb4"
      unitRef="usd">1992000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC02LTEtMS01ODQzMA_52ee7af0-ca73-4a16-aa21-6945de567087"
      unitRef="usd">600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC04LTEtMS01ODQzMA_d3a0536c-253f-4503-8f17-2d059ee1c18f"
      unitRef="usd">866000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNC0xMC0xLTEtNTg0MzA_4c2b4c09-259a-4287-aea4-91b17d973981"
      unitRef="usd">3458000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi0yLTEtMS01ODQzMA_046d39b9-b197-451d-9c82-710aa4ca5412"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi00LTEtMS01ODQzMA_dbcc2cef-2525-47b7-a01e-dcc7321a6f2b"
      unitRef="usd">1451000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi02LTEtMS01ODQzMA_e3eea333-1847-4ebc-9d3c-758c39a52927"
      unitRef="usd">192000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi04LTEtMS01ODQzMA_51f109a6-8741-4735-b7a7-c69e7f7f4f1f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNi0xMC0xLTEtNTg0MzA_8d8d3860-26e5-4860-ba4c-30d57e812bf0"
      unitRef="usd">1643000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i92a02dd313384743b867f33cd4c52454_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy0yLTEtMS01ODQzMA_0fa25841-088c-4bb7-a108-5a2e674dcae7"
      unitRef="usd">1602000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i92a02dd313384743b867f33cd4c52454_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy00LTEtMS01ODQzMA_86b08b6c-72ed-4c43-878b-73bb090985a1"
      unitRef="usd">11019000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i92a02dd313384743b867f33cd4c52454_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy02LTEtMS01ODQzMA_2d80a4eb-90a4-4430-8d83-cdffaf0ae4a9"
      unitRef="usd">792000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i92a02dd313384743b867f33cd4c52454_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy04LTEtMS01ODQzMA_45f16ed8-d52c-45a9-9584-e9a7bc6f84f1"
      unitRef="usd">866000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i92a02dd313384743b867f33cd4c52454_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmNhOWU1MDliMTA5ZDQ2ZDZhN2Y5MGMwNDk0MmE2ZGQwL3RhYmxlcmFuZ2U6Y2E5ZTUwOWIxMDlkNDZkNmE3ZjkwYzA0OTQyYTZkZDBfNy0xMC0xLTEtNTg0MzA_d7a54ae6-b84a-4706-a86a-412a8df9274c"
      unitRef="usd">14279000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RleHRyZWdpb246MTFhMTkwYmU5NWUzNDA1NTk3MmIxY2E1OTBiY2E1YTNfMjQyNQ_603a3198-6ca0-41dd-97a9-b2d47bb58f31">The following table shows the gross unrealized losses and fair value of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2022. The unrealized losses in the table below are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0yLTEtMS01ODQzMA_dac16de3-2b69-4597-b453-b847592f234a"
      unitRef="usd">6264000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi00LTEtMS01ODQzMA_08afb0d5-cad7-47bb-8fa7-bb35df246460"
      unitRef="usd">440000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi02LTEtMS01ODQzMA_a857f2bd-1af9-4115-b03d-8871c7478855"
      unitRef="usd">2914000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi04LTEtMS01ODQzMA_dab9d372-45f3-49b3-a96e-99eccb055cec"
      unitRef="usd">267000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0xMC0xLTEtNTg0MzA_93186a9c-1d4c-47de-b836-c53b18481210"
      unitRef="usd">9178000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5cc5c4400683462b921d63ccb7ac42d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMi0xMi0xLTEtNTg0MzA_8b8073da-ab32-40c7-a907-8bfa77d2479a"
      unitRef="usd">707000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0yLTEtMS01ODQzMA_dbf9192a-0045-48e8-98e6-c10c3f69924c"
      unitRef="usd">1042000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy00LTEtMS01ODQzMA_096bb593-b4c9-4b60-b02d-81743158ea85"
      unitRef="usd">63000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy02LTEtMS01ODQzMA_f77d227e-fe60-467f-b5ef-9ef34d3a95ba"
      unitRef="usd">2416000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy04LTEtMS01ODQzMA_7f952f4d-337d-4340-992e-dd88abc8c02a"
      unitRef="usd">306000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0xMC0xLTEtNTg0MzA_321a453e-f5b9-4cb3-9904-e49f3ee1ae7b"
      unitRef="usd">3458000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i824eee128a3c45f7841f91d18b27b288_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfMy0xMi0xLTEtNTg0MzA_7255f266-f0f7-49bf-aaf4-43feb00a6463"
      unitRef="usd">369000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0yLTEtMS01ODQzMA_3c9b2103-46f1-4a45-8f32-c5cfb5d9c396"
      unitRef="usd">1065000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC00LTEtMS01ODQzMA_e1d2be1b-b171-4c7d-b410-8571c453d851"
      unitRef="usd">17000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC02LTEtMS01ODQzMA_44252b98-0857-43d9-bdb3-b3efc994d446"
      unitRef="usd">578000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC04LTEtMS01ODQzMA_d299dbec-3ec4-4c32-a8d1-570de6078f23"
      unitRef="usd">31000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0xMC0xLTEtNTg0MzA_6be43190-9b96-45fc-82e5-64ca5964d4fa"
      unitRef="usd">1643000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9cdc6a0bec0341349445b3e3db552d5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNC0xMi0xLTEtNTg0MzA_1f949a16-be8b-4ae0-875e-80be76261cd3"
      unitRef="usd">48000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0yLTEtMS01ODQzMA_f3bbe709-9589-43ff-b786-18cb54674210"
      unitRef="usd">8371000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS00LTEtMS01ODQzMA_b1813eb0-f1c9-41a7-bd4e-0aefd4e1c389"
      unitRef="usd">520000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS02LTEtMS01ODQzMA_5d730193-47a2-431b-896f-17a511150255"
      unitRef="usd">5908000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS04LTEtMS01ODQzMA_5f86da40-47fa-442c-9e34-069e38fddf5e"
      unitRef="usd">604000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0xMC0xLTEtNTg0MzA_4ac11457-215c-4258-a0b1-ab7963119138"
      unitRef="usd">14279000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80My9mcmFnOjExYTE5MGJlOTVlMzQwNTU5NzJiMWNhNTkwYmNhNWEzL3RhYmxlOmE5MzQxNDViMDY0YjRkYzlhOGViZWZhOGJhYjJmNmM3L3RhYmxlcmFuZ2U6YTkzNDE0NWIwNjRiNGRjOWE4ZWJlZmE4YmFiMmY2YzdfNS0xMi0xLTEtNTg0MzA_01c3b2ae-107c-4ff6-b5ce-a95d2ca44bbb"
      unitRef="usd">1124000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzI5ODUzNDg5NTE3Nw_cc54e30c-6aeb-41c4-9b7c-261e86e21749">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due October 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities, net of $76 unamortized debt discount and issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2022 and 2021, the total interest expense was $3,564 and $1,929, respectively, with coupon interest expense of $1,646 and $1,617 for each period, respectively, and the amortization of debt issuance costs and debt discount, totaling $1,918 and $312 for each period, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2022 and 2021, the total interest expense was $9,087 and $5,788, respectively, with coupon interest expense of $4,852 and $4,851 for each period, respectively, and the amortization of debt issuance costs and debt discount of $4,147 and $937 for each period, respectively. Current period interest expense also includes $88 of additional interest expense owed to be in compliance with certain terms of the February 2023 Notes indenture and is not applicable to future periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#x201c;Issuer&#x201d;), issued $125,000 aggregate principal amount of its February 2023 Notes in a private placement (the &#x201c;Offering&#x201d;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560. The February 2023 Notes are the Company&#x2019;s senior unsecured obligations and rank equally in right of payment with all of the Company&#x2019;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#x2019;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 5, 2022, the Issuer completed the exchange of $117,375 of its February 2023 Notes for a new series of its October 2023 Notes (the &#x201c;Exchange Transaction&#x201d;). The remaining $26,375 aggregate principal amount of the February 2023 Notes were not exchanged and maintain a maturity date of February 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $4,804 in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $5,450 in fees to third parties that were expensed as part of the completed Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $5,508, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $5,508 are amortized over the remaining term of the October 2023 Notes as a component of interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes (so long as the principal amount of such holder&#x2019;s 2023 Notes not exchanged is at least $200), which is equivalent to an initial exchange price of approximately $10.79 per ADS. Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#x2019;s election. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;February 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the February 2023 Notes may convert their February 2023 Notes, at their option, prior to the close of business on the business day immediately preceding the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;October 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the October 2023 Notes may convert their October 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding May 1, 2023, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after May 1, 2023 and prior to the close of business on the business day immediately preceding the maturity date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzc2Mg_386183ed-95c1-436b-a9e7-e1c14e3bde78"&gt;five&lt;/span&gt; business day period immediately after any &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfNzgwNw_508bcbe0-6ff0-45f0-850b-ee02e8547ae7"&gt;five&lt;/span&gt; consecutive trading day period (the &#x201c;Measurement Period&#x201d;) in which the trading price per $1 principal amount of October 2023 Notes, as determined following a request by a holder of the October 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding May 1, 2023, regardless of whether a holder of the October 2023 Notes has the right to require the Company to repurchase the October 2023 Notes, or if Avadel is a party to a merger event that occurs prior to the close of business on the business day immediately preceding May 1, 2023, all or any portion of a holder&#x2019;s October 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding May 1, 2023, a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If the Company calls the October 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding May 1, 2023, then a holder of the October 2023 Notes may surrender all or any portion of its October 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the October 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the October 2023 Notes may exchange its October 2023 Notes until the redemption price has been paid or duly provided for.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least 130% of the Exchange Price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considered the guidance in ASC 815-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Embedded Derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#x2019;s ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#x2019;s option. The Company has therefore applied the guidance provided by ASC 470-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;, as amended by ASU 2020-06.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTE3NTc_7fa33dab-7972-48ed-9dc2-4b692bd1299a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due October 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities, net of $76 unamortized debt discount and issuance costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjYyYmFlZjkyNGU5NzRiOTc4YTVhYTQ2ZWJkYjJiY2VmXzI0_2ac83b69-dff6-4138-bd11-792211db5099"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjYyYmFlZjkyNGU5NzRiOTc4YTVhYTQ2ZWJkYjJiY2VmXzI0_721eb78f-6b08-4a8f-b93b-553289c8aadf"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS0yLTEtMS01ODQzMA_c7b6e8b2-7adc-4540-92da-319612bec1d1"
      unitRef="usd">26375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia0be1e2e6aa34e60b94e4a63dccf861f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMS00LTEtMS01ODQzMA_645a23a2-755d-4f67-a9f4-8315573db4c6"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjUxMjNhZmFkYjJkMDRlOTdhNGM2YjE4OTQzYWJhYTVjXzI0_cd424f4a-e059-4bca-8159-ccfeda0c164e"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia5fad38fdfbb421d89768bb22556c4b0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi0yLTEtMS01ODQzMA_b8717319-70a0-4461-ac99-8c76205d83ad"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7728b1ad8844b9c8acb4b0a1e2a5eee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMi00LTEtMS01ODQzMA_fa8210c4-d3a8-4dd9-9ba5-ad40458840c2"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMy0yLTEtMS01ODQzMA_277c228b-1953-47bc-b2fe-2c4fc286ed02"
      unitRef="usd">7517000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i99b46577c09a4108b4d6e3e1474da619_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfMy00LTEtMS01ODQzMA_4bd012b5-7c46-4545-bb12-bdbd97958f45"
      unitRef="usd">1353000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i2ce417f2f23846bd8e35ba84f4fedf18_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNC0yLTEtMS01ODQzMA_24cb5f98-4caa-4794-81a5-a39948842c61"
      unitRef="usd">136233000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i99b46577c09a4108b4d6e3e1474da619_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNC00LTEtMS01ODQzMA_a69a8314-c8f8-428f-b153-7e6c5c41135a"
      unitRef="usd">142397000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy0wLTEtMS01ODQzMC90ZXh0cmVnaW9uOjM5ODRjODdiYjc4MzQ4YjE4YzZiMjhiNGQxNjYxNmI2XzM3_de69a0dc-3eea-4ad6-8b2d-03ab4883765a"
      unitRef="usd">76000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy0yLTEtMS01ODQzMA_72712c95-e81a-492d-aac5-a83458c36799"
      unitRef="usd">26299000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfNy00LTEtMS01ODQzMA_2c593174-1968-4ec0-b1e7-aaad83929b1e"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfOC0yLTEtMS01ODQzMA_c91c3f9d-f3ab-4a6f-8965-87a248cf0978"
      unitRef="usd">109934000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RhYmxlOmU0MGUzYWVjZmFjNTRlMjlhNzI2OGNlYzdjYzBhZTViL3RhYmxlcmFuZ2U6ZTQwZTNhZWNmYWM1NGUyOWE3MjY4Y2VjN2NjMGFlNWJfOC00LTEtMS01ODQzMA_57b79fc4-697f-4241-b393-7bea3c3158a8"
      unitRef="usd">142397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMxNw_75f48946-6750-4bef-ae68-61c99797fcab"
      unitRef="usd">3564000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMyNA_22d9482f-92a9-491e-bb1a-fdc9d5397503"
      unitRef="usd">1929000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMzMA_9db84af5-6160-46b9-81ff-49ba4ebf0408"
      unitRef="usd">1646000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzMzNQ_cb8bd59c-7164-4aed-b4c8-6301842c3015"
      unitRef="usd">1617000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM0MA_6a652e19-df69-467a-8478-a88f0f8fbcb0"
      unitRef="usd">1918000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM0NA_80c8d79f-2f47-4073-bc69-993ef4e61f01"
      unitRef="usd">312000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebt
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2MA_7b033d9a-e69f-4dea-b0eb-2a77acdf0ebd"
      unitRef="usd">9087000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2NA_1a0e7e3c-1af4-4b0e-b2db-129b6200d714"
      unitRef="usd">5788000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM2OA_0e03287d-0e94-4da2-8e83-079440e7a637"
      unitRef="usd">4852000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM3OQ_c053e954-3fdd-499c-97e6-59851eabaced"
      unitRef="usd">4851000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM4Mw_b25213d3-f2de-4934-9de5-26c30000cec5"
      unitRef="usd">4147000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM4Nw_31f601b0-0e8f-4061-8b3f-c67a52365026"
      unitRef="usd">937000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <avdl:AdditionalInterestExpenseDebt
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE5OTAyMzI2NzM5MQ_857918f7-6d43-42c1-8498-8676c82f9af7"
      unitRef="usd">88000</avdl:AdditionalInterestExpenseDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTk1_cc9782b5-2809-48a8-9997-3570fbe2e722"
      unitRef="usd">125000</us-gaap:DebtInstrumentFaceAmount>
    <avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm
      contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTE3NTY_f1399dac-cdff-4352-b987-b93b75f37a3c">P30D</avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm>
    <avdl:DebtInstrumentOptiontoIncreaseFaceAmount
      contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTMyNA_761eee2d-090f-456f-9290-84ca233fe976"
      unitRef="usd">18750000</avdl:DebtInstrumentOptiontoIncreaseFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTUyMw_d89b9194-d66f-4486-b5b9-c833e6226246"
      unitRef="usd">137560000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <avdl:DebtInstrumentExchangeAmount
      contextRef="i3ad36b5fcb3045a68356e8cc78da6a85_I20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTkyNQ_70ab392e-302e-4037-b440-cfc2416644e3"
      unitRef="usd">117375000</avdl:DebtInstrumentExchangeAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6c50635ba7df4b1f8f3cea8c28c4bd5b_I20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjE1Mw_2510b2fa-4836-4b1b-87ca-de947afc4a5d"
      unitRef="usd">26375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i700854cc6b274bb6aa14c33e39284fc2_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjM5Mg_cf214829-bfb3-4d7f-ab5e-2f7356b18030"
      unitRef="usd">4804000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i8f34651b6e804b898cbacfb584c9a8e9_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjU1MA_9ddba2c5-41cd-48e3-9fd2-60b1884678a2"
      unitRef="usd">5450000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
      contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjczNA_362e546c-0e7b-4526-a5c1-b5149617aa8f"
      unitRef="usd">5508000</avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease>
    <avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
      contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjczNA_7a6c379e-4e0f-4746-a003-9cabca02f3bb"
      unitRef="usd">5508000</avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature>
    <avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
      contextRef="i5a4fe972a2a84345ab6c92cb89a4daf1_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMjkwNQ_4f0d7ff9-b7ce-45ec-b7cb-9be73aac8550"
      unitRef="usd">5508000</avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease>
    <avdl:AmericanDepositorySharesConversionRatio
      contextRef="ibb4289596c9445e5b6b589951af85b2f_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzExMA_b05dade5-1c75-4a07-a584-13c26b2c6ac3"
      unitRef="rate">92.6956</avdl:AmericanDepositorySharesConversionRatio>
    <avdl:AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange
      contextRef="i5585700b61054faf8d529487860514d5_D20180216-20180216"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzI0Mw_81256930-468a-476a-bbad-e22fa7a3e397"
      unitRef="usd">200000</avdl:AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange>
    <avdl:AmericanDepositarySharesOptionPricePerShare
      contextRef="i0a57e70df4cf4e74b5f4a323a7cf7ac3_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMzMxNA_90b1840b-9db7-465d-b06e-934a58360ffb"
      unitRef="usdPerShare">10.79</avdl:AmericanDepositarySharesOptionPricePerShare>
    <avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay
      contextRef="iaa11a62b43844fdba38a32b1411c594b_D20220405-20220405"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfODA3Ng_34cad267-f692-4402-be1b-a76cd7d8ef3f"
      unitRef="number">0.98</avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i544add4877ba4985a689c57ae1698e30_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfODc3OA_6ebd89a1-e725-4353-a6e1-8e5fba1ae628"
      unitRef="day">95</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays
      contextRef="i544add4877ba4985a689c57ae1698e30_D20220405-20220405"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTAyNg_63cc3ca7-a1c7-4c05-a654-d7742601e1f8">P35D</avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTYwNw_34ccec0b-d1d8-4da4-aaba-2fbd396f87a9"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTY3Mw_556a047c-8aff-4753-a82f-d2bac2205054"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfOTgyMg_cc773291-7323-4a85-8e99-7baa8f3f154a"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA3OTQ_9f2077b0-a52d-4447-80e2-a1153261b275"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA4NDc_34ccec0b-d1d8-4da4-aaba-2fbd396f87a9"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="id04e24fb41ba4bee98d50ec341ee2e50_D20220405-20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80Ni9mcmFnOjM0YjBlNDNhYzVhZjRmM2M4NWZhYTM4M2FjZjdkODQyL3RleHRyZWdpb246MzRiMGU0M2FjNWFmNGYzYzg1ZmFhMzgzYWNmN2Q4NDJfMTA5MDM_556a047c-8aff-4753-a82f-d2bac2205054"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTk1MA_259d5db4-9a0d-4ad9-a876-70ee97268717">Income Taxes &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The income tax provision was $70 for the three months ended September&#160;30, 2022 resulting in an effective tax rate of (0.3)%. The income tax benefit was $5,101 for the three months ended September 30, 2021 resulting in an effective tax rate of 18.8%. The change in the effective income tax rate for the three months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the net operating losses during the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The income tax provision was $25,940 for the nine months ended September&#160;30, 2022 resulting in an effective tax rate of (30.9)%. The income tax benefit was $11,473 for the nine months ended September 30, 2021 resulting in an effective tax rate of 17.3%. The change in the effective income tax rate for the nine months ended September&#160;30, 2022, as compared to the prior period in 2021, is primarily due to the valuation allowances that were recorded against the deferred tax assets during the current period.       &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the nine months ended September&#160;30, 2022, the Company collected all of the outstanding receivables due to the Company related to net operating loss carrybacks under the Coronavirus Aid, Relief, and Economic Security Act for losses incurred during 2019, which were carried back to 2015.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNTg_dba8bea4-e4a1-4309-a49b-6cdb9c71e061"
      unitRef="usd">70000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTQw_8e90f840-91a5-4ead-aac9-27d58b64b764"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMTcx_905af191-07a2-4de6-9ee1-ce63a7463c80"
      unitRef="usd">-5101000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfMjUz_da1d2124-392f-409a-bfe2-01032e768710"
      unitRef="number">0.188</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNTI5_93750112-5f66-4538-b3b9-4c50a03dfee4"
      unitRef="usd">25940000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNjA5_5732e4fa-436b-431f-bcf6-9ed5a6bb61de"
      unitRef="number">-0.309</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNjQw_1855921f-1b4c-4c65-94ed-30912df71709"
      unitRef="usd">-11473000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF80OS9mcmFnOmU1ODc5ZWI2MDZhNzQ3MjM5OTNhMGEyNDhhMWQ4NDU4L3RleHRyZWdpb246ZTU4NzllYjYwNmE3NDcyMzk5M2EwYTI0OGExZDg0NThfNzIw_c17b7b24-4413-4b1a-96e8-cc648b19f481"
      unitRef="number">0.173</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTI4_c1aef7a9-20c2-478a-a418-5f6758bfd1f8">Other Assets and Liabilities&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsource contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTQ4_8321f539-fbb2-42d7-a3e7-93ad9b1217de">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMi0yLTEtMS01ODQzMA_cdefd497-627c-4d04-9fdd-6c4b521a6da0"
      unitRef="usd">3745000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMi00LTEtMS01ODQzMA_3abe7a6a-5ccb-403b-8693-587ce60ed654"
      unitRef="usd">3179000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMy0yLTEtMS01ODQzMA_bb911296-d581-435b-9d6a-797ee0931e1f"
      unitRef="usd">567000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfMy00LTEtMS01ODQzMA_b5dcc6d6-673a-4e1a-842b-3a3b198cb520"
      unitRef="usd">271000</us-gaap:OtherAssetsCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNC0yLTEtMS01ODQzMA_a9cb63bb-66f5-4625-b6dd-a293076096de"
      unitRef="usd">277000</avdl:GuaranteeCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNC00LTEtMS01ODQzMA_cfa8e126-d2b4-4ed5-9b60-ce51106c38ed"
      unitRef="usd">279000</avdl:GuaranteeCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNS0yLTEtMS01ODQzMA_783220f9-bf03-4fe4-a3d2-065c9627ebec"
      unitRef="usd">81000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNS00LTEtMS01ODQzMA_b13d7c2b-d9c8-4451-99e9-147132b1fe6b"
      unitRef="usd">29097000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNi0yLTEtMS01ODQzMA_494d5626-ce6c-446a-ab08-03245d1ff5de"
      unitRef="usd">4670000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjBlY2I3MGQ1MDg1YTRiMjZhNmY3MDk5YzNkNTYwNWVjL3RhYmxlcmFuZ2U6MGVjYjcwZDUwODVhNGIyNmE2ZjcwOTljM2Q1NjA1ZWNfNi00LTEtMS01ODQzMA_220c0467-f193-420e-81f0-9fbd9cfe1292"
      unitRef="usd">32826000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTM2_d945acb0-1177-47d4-b3e1-5b6737cb4dd3">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMi0yLTEtMS01ODQzMA_f3defa47-6263-4ccd-bfd1-d1a652cd4eaa"
      unitRef="usd">10979000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMi00LTEtMS01ODQzMA_d35f9973-28d7-4f0e-b5b0-6031ad37008a"
      unitRef="usd">8549000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMy0yLTEtMS01ODQzMA_4031b9b8-1ec5-4850-aa4b-85b7dbc3b492"
      unitRef="usd">564000</avdl:GuaranteeNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfMy00LTEtMS01ODQzMA_31549103-4f0d-4576-a4ba-757b69fe3076"
      unitRef="usd">771000</avdl:GuaranteeNoncurrent>
    <avdl:OtherNoncurrentReceivables
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNC0yLTEtMS01ODQzMA_184af210-dfc9-4a6e-a3d0-841a31833d1b"
      unitRef="usd">177000</avdl:OtherNoncurrentReceivables>
    <avdl:OtherNoncurrentReceivables
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNC00LTEtMS01ODQzMA_1438249d-a9af-4121-b524-5a9ee56a49c4"
      unitRef="usd">329000</avdl:OtherNoncurrentReceivables>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNS0yLTEtMS01ODQzMA_d7b6b62d-c1d6-45db-bd06-884e762c78b1"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNS00LTEtMS01ODQzMA_6e627fd6-0aa1-429d-970e-9666868bef90"
      unitRef="usd">24128000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNi0yLTEtMS01ODQzMA_37a8dc34-8a31-4ea9-a36f-a8fa72682ae8"
      unitRef="usd">11720000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM1NGZlYmI0MzRhMDRmZDM4ZjVhOTc4YThmNmY0YTMyL3RhYmxlcmFuZ2U6MzU0ZmViYjQzNGEwNGZkMzhmNWE5NzhhOGY2ZjRhMzJfNi00LTEtMS01ODQzMA_7670056d-989f-4e1f-bfff-24f299440176"
      unitRef="usd">33777000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTMw_f813fdb8-6ae7-43bb-9e04-98d9d35c80b0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsource contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMi0yLTEtMS01ODQzMA_f9a9271c-45b2-4335-8c1e-55ec2526963b"
      unitRef="usd">4419000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMi00LTEtMS01ODQzMA_10ba45d2-b66a-4461-a6dc-906713aaf208"
      unitRef="usd">2678000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMy0yLTEtMS01ODQzMA_c397dad1-fe93-4870-8513-a4268f0a49c9"
      unitRef="usd">1515000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfMy00LTEtMS01ODQzMA_f45c0c19-a0c0-48a7-b5dd-fde04e4c9902"
      unitRef="usd">41000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNC0yLTEtMS01ODQzMA_50780068-28a4-478d-8033-1d1b8ecf1fe0"
      unitRef="usd">1293000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNC00LTEtMS01ODQzMA_9c2e92b1-7b18-41b7-b137-4086c055d643"
      unitRef="usd">3167000</us-gaap:AccruedSalariesCurrent>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNS0yLTEtMS01ODQzMA_5c8ae02a-5826-4092-9ab5-77dd2d70fb3b"
      unitRef="usd">738000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNS00LTEtMS01ODQzMA_830558a9-c403-485b-9a72-b2e95735e37f"
      unitRef="usd">1048000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNi0yLTEtMS01ODQzMA_ccb871b6-c272-4ee2-8168-6871a87d1449"
      unitRef="usd">0</avdl:AccruedTradeDiscountsAndRebates>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNi00LTEtMS01ODQzMA_5b6decb3-b47b-439b-9155-354fa944a440"
      unitRef="usd">217000</avdl:AccruedTradeDiscountsAndRebates>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNy0yLTEtMS01ODQzMA_8134d770-0dfb-4ce3-9e7f-6bea5690deae"
      unitRef="usd">7965000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjM4OGI0YzhhOGUxZjQ2ZWNhNjBmZWYwM2JjNTkyODVhL3RhYmxlcmFuZ2U6Mzg4YjRjOGE4ZTFmNDZlY2E2MGZlZjAzYmM1OTI4NWFfNy00LTEtMS01ODQzMA_4a17971f-3b9a-44a7-9658-ad2e1e137d7f"
      unitRef="usd">7151000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTM4_afe4734b-0b6a-497a-a35e-a19c2fd8358e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi0yLTEtMS02MTgxNg_8d932ef2-ae27-4841-8adc-ad20c2b5e707"
      unitRef="usd">3265000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi00LTEtMS02MTgyNA_6b3f8445-24a0-41ae-ae10-eec548740f26"
      unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi0yLTEtMS01ODQzMA_2b2d7014-c6b5-4393-9741-aafd09ac32c9"
      unitRef="usd">278000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMi00LTEtMS01ODQzMA_cf7acc71-db7c-4f49-9971-5e002824f231"
      unitRef="usd">280000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:AccruedInterestCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMy0yLTEtMS01ODQzMA_2ce198d4-0a1a-42d5-b015-fe2d9cebe9c4"
      unitRef="usd">199000</avdl:AccruedInterestCurrent>
    <avdl:AccruedInterestCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfMy00LTEtMS01ODQzMA_11c467e0-0bc3-48b8-8e10-54a74551704f"
      unitRef="usd">4920000</avdl:AccruedInterestCurrent>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNC0yLTEtMS01ODQzMA_ec9e6e79-8c48-4aa6-ac61-7e8246cdc41c"
      unitRef="usd">15000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNC00LTEtMS01ODQzMA_92ed30ff-f80b-43e4-82e8-2ff0e758f24c"
      unitRef="usd">70000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNS0yLTEtMS01ODQzMA_ade9c414-1092-436b-baf3-da33ec140e01"
      unitRef="usd">3757000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOmU4MmQwYWNhY2JhYTRlZjZiNzExNmViNzkyZDIxMzdkL3RhYmxlcmFuZ2U6ZTgyZDBhY2FjYmFhNGVmNmI3MTE2ZWI3OTJkMjEzN2RfNS00LTEtMS01ODQzMA_0f7461f0-2964-4eac-bb2b-9e1682720bf7"
      unitRef="usd">5270000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RleHRyZWdpb246ZjAyOTAyMzlkNmEzNGNlYzgxMjM3NzVmODAwYmFlNGRfMTMy_ae6562a0-10b2-45fb-84aa-1c8581e12b86">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMi0yLTEtMS01ODQzMA_517a08ea-725d-4f06-8768-47133ceb1a54"
      unitRef="usd">5161000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMi00LTEtMS01ODQzMA_3476dadc-d86d-4c1d-a2c9-026deb9a62b5"
      unitRef="usd">3143000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMy0yLTEtMS01ODQzMA_ff2444e0-8727-4717-8cb5-f756e187ad09"
      unitRef="usd">566000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfMy00LTEtMS01ODQzMA_527a91e3-17c8-4447-99ff-14bdf16ab24f"
      unitRef="usd">774000</us-gaap:GuarantyLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfNC0yLTEtMS01ODQzMA_f5779c93-f6e8-4809-b069-0ff09aac6a46"
      unitRef="usd">5727000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81Mi9mcmFnOmYwMjkwMjM5ZDZhMzRjZWM4MTIzNzc1ZjgwMGJhZTRkL3RhYmxlOjUyY2I3NzUxNjJkYjQ1ZmZhN2M4ZDliMjY0YWMxYzQxL3RhYmxlcmFuZ2U6NTJjYjc3NTE2MmRiNDVmZmE3YzhkOWIyNjRhYzFjNDFfNC00LTEtMS01ODQzMA_23f22a0a-c7e2-4936-988b-21cd072676c7"
      unitRef="usd">3917000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njc0_34ceb8a7-34cd-4c45-9a83-76180df058dc">Share Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Performance-Based Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Board of Directors approved the grant of performance-based stock options to certain executive officers and employees. These performance-based stock options vest upon both the achievement of certain commercial milestones and specific service conditions. As of September&#160;30, 2022, 2,165 performance-based stock options were outstanding, none of which had vested. The weighted-average grant date fair value of the performance-based stock options was $3.71. The Company has not yet recognized any related share-based compensation expense as the commercial milestones have not been met; however, in the event that the performance conditions are met, $8,032 will be recognized by the Company for the performance-based stock options outstanding as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i95fb7b72db174d1c930b80d69d55059e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njc2_4431af2d-d03f-4a74-8c16-caa0408f11db"
      unitRef="shares">2165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i95fb7b72db174d1c930b80d69d55059e_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njgz_982d8f7a-e5c9-4e6d-9588-68a5ae8afdf1"
      unitRef="usdPerShare">3.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4bb2365318f346929309ffb2b2636041_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF8xMDkzL2ZyYWc6YzE5YjNiM2Q4ZGZhNGE2M2I0ZmE2OGViMjE1MzI0ZTUvdGV4dHJlZ2lvbjpjMTliM2IzZDhkZmE0YTYzYjRmYTY4ZWIyMTUzMjRlNV85MzQ1ODQ4ODM3Njkw_4e70d7eb-27b8-4dc1-8dc9-c02961f2e7b2"
      unitRef="usd">8032000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMjI5OA_592988dd-387a-4a9c-bd39-6b94169279ea">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#x2019;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#x2019;s Employee Share Purchase Plan (&#x201c;ESPP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a choice to settle the conversion obligations under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#x2019;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#x2019;s ESPP has been calculated using the treasury stock method. The dilutive effect of the performance share unit awards (&#x201c;PSUs&#x201d;) will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net loss per share, together with the related shares outstanding, in thousands, is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Loss Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Potential ordinary shares of&#160;18,722&#160;and&#160;15,684&#160;were excluded from the calculation of weighted average shares for the three months ended September&#160;30, 2022 and 2021, respectively, and potential ordinary shares of 18,925 and 15,497 were excluded from the calculation of weighted average shares for the nine months ended September&#160;30, 2022 and 2021 because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the three and nine months ended September&#160;30, 2022 and 2021, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMjMwNQ_94da0300-0ffc-4094-8ad1-ff413d8afb70">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net loss per share, together with the related shares outstanding, in thousands, is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Loss Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy0yLTEtMS01ODQzMA_903d5fb5-9beb-4051-b36a-90f776890e42"
      unitRef="usd">-20146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy00LTEtMS01ODQzMA_19d713e7-4fa4-455d-8759-4d5ff9639e9d"
      unitRef="usd">-22002000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy02LTEtMS01ODQzMA_e1f63364-a1f2-4302-ba07-5ff86e55c293"
      unitRef="usd">-110014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMy04LTEtMS01ODQzMA_11a39f9c-9520-4507-9150-2cbc60dbd66f"
      unitRef="usd">-55028000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC0yLTEtMS01ODQzMA_9969ad27-65f0-4216-8687-00dad41775a7"
      unitRef="shares">60201000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC00LTEtMS01ODQzMA_868aca26-ac2c-4100-9723-4daa35a5bb05"
      unitRef="shares">58585000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC02LTEtMS01ODQzMA_2ddcffea-e3e7-4dbd-8162-5695c996a7d8"
      unitRef="shares">59359000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOC04LTEtMS01ODQzMA_35a79509-4891-4fbb-9089-94de062fa2f7"
      unitRef="shares">58506000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS0yLTEtMS01ODQzMA_51d42b8c-848a-4ef4-a0d0-bf2c3ab0bd2f"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS00LTEtMS01ODQzMA_84e2859e-5a62-4dcc-9993-5fb3156a96bd"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS02LTEtMS01ODQzMA_24584410-f7bb-4f73-8adc-ab8630fd2d68"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfOS04LTEtMS01ODQzMA_b9e8c0e0-925e-4d0b-a086-3e2f5d5046d4"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtMi0xLTEtNTg0MzA_8181d0bf-3708-4af2-a56a-ba79195041b1"
      unitRef="shares">60201000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtNC0xLTEtNTg0MzA_b140e392-f162-4032-a86f-de62f331eea9"
      unitRef="shares">58585000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtNi0xLTEtNTg0MzA_0df80f58-b73e-4504-bd30-956093e6d12c"
      unitRef="shares">59359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTEtOC0xLTEtNTg0MzA_cacfc616-0c21-4ba5-b9de-1332613b09bd"
      unitRef="shares">58506000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtMi0xLTEtNTg0MzA_8f509a30-11eb-4aca-b5bf-f7308b9ffb2f"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtNC0xLTEtNTg0MzA_ff8bb5b9-1473-4164-b5ef-54c7fb17a758"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtNi0xLTEtNTg0MzA_1af93a8b-5631-467d-b2b3-917f2b375b53"
      unitRef="usdPerShare">-1.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTMtOC0xLTEtNTg0MzA_489a082f-b3f2-4956-bd78-29f8ea934ebb"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtMi0xLTEtNTg0MzA_3a101310-fe44-4855-9a5e-03b20d6bc3bd"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtNC0xLTEtNTg0MzA_6729ca7e-3683-48b0-8b23-466bd1480934"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtNi0xLTEtNTg0MzA_3a4738f5-732e-4bdc-949d-accfa4be8daa"
      unitRef="usdPerShare">-1.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RhYmxlOjE4YjQ4YTk3N2I1ZDQ4MGViYzg3ZWRhZmZkNThlYmRmL3RhYmxlcmFuZ2U6MThiNDhhOTc3YjVkNDgwZWJjODdlZGFmZmQ1OGViZGZfMTQtOC0xLTEtNTg0MzA_e69c0b4d-6858-42bd-bc73-db105d8368c8"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTY3Mg_5055dc51-cb83-41b8-ae33-195c084ffa42"
      unitRef="shares">18722000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTY3OQ_11558229-625b-44ae-8e54-f2866b90a7e4"
      unitRef="shares">15684000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTgyOQ_d49b34fb-9cd3-4906-a1de-66d94073fde8"
      unitRef="shares">18925000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81NS9mcmFnOjI3NjM5YWI3ZjdiZDRhNThiZDRlOTRhNzc4ZjNmM2MwL3RleHRyZWdpb246Mjc2MzlhYjdmN2JkNGE1OGJkNGU5NGE3NzhmM2YzYzBfMTgzNg_79342c7f-30b4-41f2-87cc-778d3ab8493e"
      unitRef="shares">15497000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RleHRyZWdpb246ZWRmN2FjMDc4ZjA0NDVhZWIwYmNhZTQ0MWM4ZjIxODVfMzkz_2755eb99-266f-4956-b29a-6f2eebd85623">Comprehensive Loss&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three and nine months ended September&#160;30, 2022 and 2021, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized (loss) gain on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss, net of income tax benefit of $&#x2014;, $59, $&#x2014; and $220, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect on the Company&#x2019;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RleHRyZWdpb246ZWRmN2FjMDc4ZjA0NDVhZWIwYmNhZTQ0MWM4ZjIxODVfMzky_1c17a86a-e2c6-4d36-ad8e-4118f8b889cb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three and nine months ended September&#160;30, 2022 and 2021, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.749%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized (loss) gain on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive loss, net of income tax benefit of $&#x2014;, $59, $&#x2014; and $220, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b395e51b07443339e8545ddcb926fec_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC0yLTEtMS01ODQzMA_f93d18e5-932e-4c7e-9f05-f830265db8a7"
      unitRef="usd">-24697000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6552bf81cec348cba10fdb3ad7a1af92_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC00LTEtMS01ODQzMA_59951ad1-bbac-48e4-b6ad-e79529d7a1eb"
      unitRef="usd">-23229000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i68fd68b84e214afeb6ac688372c7b9b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC02LTEtMS01ODQzMA_108f45ec-cfee-41f3-bcb7-103af50443fe"
      unitRef="usd">-23855000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifef4b6bda88f459a829bd244521b420f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNC04LTEtMS01ODQzMA_362c2f60-d69f-46d6-8e7b-418edbb388a9"
      unitRef="usd">-22627000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibfec458cab2647ec9baffeb95d1d2718_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS0yLTEtMS01ODQzMA_1aa8e094-79e2-45cd-8c8b-6ccc67641262"
      unitRef="usd">-647000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifa65319a9bbf4a30919b395ad1dce174_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS00LTEtMS01ODQzMA_6780d415-1c73-4a7f-9f7f-e349bedf18b7"
      unitRef="usd">-237000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia1c144896d5e4e3a83ac70f08d710d09_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS02LTEtMS01ODQzMA_b14ab056-c12f-4654-af08-53944523b901"
      unitRef="usd">-1489000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i76ffebca8fd84c3e8cfc2a78874bfac7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNS04LTEtMS01ODQzMA_dda0a731-1639-4ab1-a9fa-9039a2b55c1e"
      unitRef="usd">-839000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib91c2787e79e44ae873764654f563d0c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi0yLTEtMS01ODQzMA_1621cb09-44b4-48e5-89e5-ad2861775d07"
      unitRef="usd">-25344000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i124b04c0e92f4d0fb431541e53c91932_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi00LTEtMS01ODQzMA_71475570-ed55-4ecb-906c-cca22df55ac1"
      unitRef="usd">-23466000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib91c2787e79e44ae873764654f563d0c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi02LTEtMS01ODQzMA_83b15bb8-6500-4144-8e65-2d225be02d55"
      unitRef="usd">-25344000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i124b04c0e92f4d0fb431541e53c91932_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfNi04LTEtMS01ODQzMA_323c7797-ae6e-4ab2-8cc4-dae1ce43e06e"
      unitRef="usd">-23466000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iddd2203e3e99413c90a5be54a528a206_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS0yLTEtMS01ODQzMA_cfe2fa38-a5d6-4881-bf4d-f69a99d9d77d"
      unitRef="usd">-1631000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i15d9478444524a59af93cc2f7ef2a1e8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS00LTEtMS01ODQzMA_b5f62b40-694d-4d9e-a4d9-c8fe5578e4d1"
      unitRef="usd">879000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ida0df7aa69fe43dbb346fad573194ef4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS02LTEtMS01ODQzMA_3302523a-608f-439a-a072-601bbf97584a"
      unitRef="usd">-85000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i65b75dc6dfac4a31922574bf257cd0d3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfOS04LTEtMS01ODQzMA_d284d026-72ca-4b3c-a64a-037eb8121977"
      unitRef="usd">1576000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N182Mw_b201427a-793e-4a64-9171-366534267c91"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ib3d1905959484d72869a870dc88c4bef_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N182Nw_e39ccbc7-3d58-4131-8d8d-52d768c9f358"
      unitRef="usd">-59000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N183MQ_1512047c-dacb-4f0b-9a6f-25657ff86c65"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ic208098e61eb40778a8e62a88986aa66_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMC0xLTEtNTg0MzAvdGV4dHJlZ2lvbjowODg0OTU3ZjY4N2I0ODA4OWYzOTk0MTk5MzYyZjA3N183OA_c3456c5f-7771-4f1b-ab34-5a7389dfa6c8"
      unitRef="usd">-220000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8cd7da939b0f43d5bf4ee7d265fa9078_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtMi0xLTEtNTg0MzA_2d90fd4d-5836-435c-bf11-6ff7ebfe6f2c"
      unitRef="usd">-934000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8dd2ac44366649d6822cdcb681c75934_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtNC0xLTEtNTg0MzA_e2290844-178c-4913-8ba6-b0c640ea57e1"
      unitRef="usd">-157000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i531c84d42a854c188abebdccb7a5cbb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtNi0xLTEtNTg0MzA_d64df8bf-89c6-4c2f-905d-b24f99fe9e35"
      unitRef="usd">-2480000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4b6e419f0e784181bbd1f69a1ef3e998_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTAtOC0xLTEtNTg0MzA_c4dbc12b-ad53-48bc-8bdc-1ce51e279254"
      unitRef="usd">-854000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i89275b0e02ad490a9cea278805a53efe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtMi0xLTEtNTg0MzA_0d1b6dac-cda4-41b9-a7b2-24ac15d18ef4"
      unitRef="usd">-2565000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a81c1516d914bc5afcc186a3bb51380_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtNC0xLTEtNTg0MzA_4c7d2803-73cc-45a8-863c-2fb9baa2ab5d"
      unitRef="usd">722000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i89275b0e02ad490a9cea278805a53efe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtNi0xLTEtNTg0MzA_04604483-4f16-438d-b179-ba202fb44237"
      unitRef="usd">-2565000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a81c1516d914bc5afcc186a3bb51380_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTEtOC0xLTEtNTg0MzA_0e342bc7-a4d9-42c0-8d37-d123258c47a4"
      unitRef="usd">722000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i83a69202d1114ffc970a48ee40981389_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItMi0xLTEtNTg0MzA_ec40537c-6833-44c0-a7ca-2e56adc8558d"
      unitRef="usd">-27909000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItNC0xLTEtNTg0MzA_08141a9b-3dff-4a51-83dd-9b78da409bff"
      unitRef="usd">-22744000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i83a69202d1114ffc970a48ee40981389_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItNi0xLTEtNTg0MzA_0850fa76-0f9a-4ef1-83df-20ad7658b17d"
      unitRef="usd">-27909000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf73d3032e2b44d9a1bc3d11327639d6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF81OC9mcmFnOmVkZjdhYzA3OGYwNDQ1YWViMGJjYWU0NDFjOGYyMTg1L3RhYmxlOmUyNmM0NmI3Zjc5ZjQyYmQ4N2NlYmFmODRiNzNkMzZiL3RhYmxlcmFuZ2U6ZTI2YzQ2YjdmNzlmNDJiZDg3Y2ViYWY4NGI3M2QzNmJfMTItOC0xLTEtNTg0MzA_145fa84c-0cf3-498a-9084-e16383fe99df"
      unitRef="usd">-22744000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfMTA1Nzc_b9d69d83-e390-41e5-bb4a-9d7882625d6b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to potential liabilities generally incidental to the Company&#x2019;s business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At September 30, 2022 and December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations, cash flows or liquidity.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;First Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#x201c;Jazz&#x201d;) filed a formal complaint (the &#x201c;First Complaint&#x201d;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#x201c;Court&#x201d;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#x201c;Avadel Parties&#x201d;). In the First Complaint, Jazz alleges the sodium oxybate product (&#x201c;Proposed Product&#x201d;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#x201c;Avadel CNS&#x201d;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#x201c;patents-in-suit&#x201d;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Avadel Answer&#x201d;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 18, 2021, Jazz filed its Answer (&#x201c;Jazz Answer&#x201d;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#x2019;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#x2019;s action on Avadel CNS&#x2019;s NDA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#x2019; Counterclaims (&#x201c;the Jazz First Amended Answer&#x201d;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#x201c;REMS Patent&#x201d;) de-listed from the Orange Book and seeking to have the motion resolved concurrent with the parties&#x2019; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#x2019; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#x2019;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#x2019; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2022, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing was held on October 25, 2022. At the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#x2019; request and scheduled the hearing for November 15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Second Jazz Complaint &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 4, 2021, Jazz filed another formal complaint (the &#x201c;Second Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Second Avadel Answer&#x201d;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Third Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 10, 2021, Jazz filed another formal complaint (the &#x201c;Third Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#x201c;Third Avadel Answer&#x201d;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fourth Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 15, 2022, Jazz filed another formal complaint (the &#x201c;Fourth Complaint&#x201d;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the de-listing of the REMS Patent from the Orange Book, which is pending in response to the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On September 21, 2022, Jazz served the Fourth Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#x201c;Fourth Avadel Answer&#x201d;) with the Court in response to the Fourth Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) de-listing of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#x201c;Sherman Act&#x201d;); and v) attempted monopolization under the Sherman Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Avadel Complaint&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#x201c;Avadel Plaintiffs&#x201d;) filed a formal complaint (the &#x201c;Avadel Complaint&#x201d;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#x201c;Jazz Parties&#x201d;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#x2019; trade secrets. The Avadel Complaint further includes typical relief requests such as injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#x2019; scientists.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#x2019; response to that Motion was filed with the Court on July 29, 2022. Jazz&#x2019;s reply was filed with the Court on August 5, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Administrative Procedure Act&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#x201c;Federal Defendants&#x201d;) in the United States District Court for the District of Columbia (the &#x201c;DC Court&#x201d;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#x2019;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#x2019;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#x2019;s unopposed motion to intervene in the case to defend the FDA&#x2019;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#x2019;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#x2019;s and Jazz&#x2019;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#x2019;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#x2019;s motion and the Federal Defendants and Jazz&#x2019;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent de-listed from the FDA&#x2019;s Orange Book described above in the section regarding the First Jazz Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than commitments disclosed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 15: Contingent Liabilities and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to the Company's consolidated financial statements included in the 2021 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s guarantee to Deerfield Capital L.P. (&#x201c;Deerfield&#x201d;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deerfield Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s February 2018 divestiture of the Company&#x2019;s pediatric assets, the Company guaranteed to Deerfield the quarterly royalty payment of&#160;15%&#160;on net sales of the FSC products through February 6, 2026 (&#x201c;FSC Product Royalties&#x201d;), in an aggregate amount of up to approximately&#160;$10,300. Given the Company&#x2019;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $844 at September&#160;30, 2022. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Armistice Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, Inc., guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $841 at September&#160;30, 2022. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <avdl:PercentageOfRoyaltyPayableOnNetSales
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTQ3Nw_abfdafc8-1daf-4879-94db-a30ae9d98579"
      unitRef="number">0.15</avdl:PercentageOfRoyaltyPayableOnNetSales>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i0bb2f5402fe644e0bce0169c6c82e87e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTYxMQ_14d7827a-3737-4d3b-b5e6-bd1a25ad6d5a"
      unitRef="usd">10300000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfOTc3NQ_0a2f26b9-f6e4-4db4-b0cd-1c7a1641cb78"
      unitRef="usd">844000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <avdl:GuaranteeAssetCurrentCarryingValue
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82MS9mcmFnOjY4ZGU1Y2NmZDVhYjQyYWRhNjg0NjQ0MTJmODdiMWRiL3RleHRyZWdpb246NjhkZTVjY2ZkNWFiNDJhZGE2ODQ2NDQxMmY4N2IxZGJfMTAyNjc_e5cb90c6-89e7-4c67-b29a-13b2b5caa667"
      unitRef="usd">841000</avdl:GuaranteeAssetCurrentCarryingValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfODE3_5d82e005-1f3a-4c09-b256-ea96ac345da7">Restructuring Costs&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Corporate Restructuring Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost structure optimization efforts included a nearly 50% reduction in its workforce that was completed at the end of August 2022 (the &#x201c;2022 Corporate Restructuring Plan&#x201d;). Restructuring income of $69 associated with this plan, comprised primarily of adjustments to the estimate of severance related costs, were recorded in the three months ended September&#160;30, 2022. Restructuring charges of $3,523 associated with this plan, comprised primarily of severance related costs, were recorded in the nine months ended September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s 2022 Corporate Restructuring Plan obligations as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022 Corporate Restructuring Plan Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2022 Corporate Restructuring Plan liabilities of $1,480 are included in the unaudited condensed consolidated balance sheet in accrued expenses at September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
      contextRef="i143ad04a470f4af39f1d8a4f532972a0_D20220601-20220831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfMjk4_59c7c870-1d01-4693-a8f2-488fae3e75c7"
      unitRef="number">0.50</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringCharges
      contextRef="ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNDIy_351c564b-e649-4795-aef2-38a6439924ff"
      unitRef="usd">-69000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNTQ5NzU1ODE0ODg3_86cc86d2-286c-440a-869e-ec949cac63fe"
      unitRef="usd">3523000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfODE5_b32dd8fc-ebff-41cf-98dc-fa993f963da8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s 2022 Corporate Restructuring Plan obligations as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022 Corporate Restructuring Plan Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i56a91a73aa374140bd351a086c6c55a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfMi0yLTEtMS01ODQzMA_f3c74531-edaf-4104-bb63-e56eab6f9b7c"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <avdl:RestructuringChargesExcludingOtherAdjustments
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfMy0yLTEtMS01ODQzMA_e266a32a-74f1-464d-8cc0-4144719c4d4f"
      unitRef="usd">3592000</avdl:RestructuringChargesExcludingOtherAdjustments>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNC0yLTEtMS02MTExNQ_4c2d5db9-6a29-44f5-9141-8d431ec7ad66"
      unitRef="usd">2043000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNS0yLTEtMS02MTEzMA_2fe1b104-4454-490a-97fe-cb7da7f9f881"
      unitRef="usd">69000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RhYmxlOjRmYjAyM2FkZTZkNDQzMDM4M2U2OWI5NjFjYWMyNGNmL3RhYmxlcmFuZ2U6NGZiMDIzYWRlNmQ0NDMwMzgzZTY5Yjk2MWNhYzI0Y2ZfNC0yLTEtMS01ODQzMA_5cf3361c-6d35-47ee-af86-1db7a5010106"
      unitRef="usd">1480000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i26afda82b1a54595b97eea252e8036f3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82NC9mcmFnOjJjODc2MzllMTRkYTQ4MzA5MGNkYTdhNWIyOWExZjJkL3RleHRyZWdpb246MmM4NzYzOWUxNGRhNDgzMDkwY2RhN2E1YjI5YTFmMmRfNzE5_5cf3361c-6d35-47ee-af86-1db7a5010106"
      unitRef="usd">1480000</us-gaap:RestructuringReserve>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ie1bc53c913a440edab2127885e09eae4_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfMjE1Nw_8599cdcd-084a-4efa-8d6a-f38432ab89be">Subsequent EventsOn November 4, 2022, the Company repurchased $8,875 of its February 2023 Notes for $8,653 of cash consideration through an open market purchase.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i92ccb82c6cb44edb9963e6452b789279_I20221104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfOTM0NTg0ODg0MjUzNg_804be9ff-f45c-400b-82c0-a5b46e3d2cbd"
      unitRef="usd">8875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5643a43d090c46a387889dbf7fcfb224_D20221104-20221104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OTc0MjM1YThiYjQ1NmM4YTk3NzllNmY5OGI1YjZkL3NlYzpiNjk3NDIzNWE4YmI0NTZjOGE5Nzc5ZTZmOThiNWI2ZF82Ny9mcmFnOmZmZTZjN2E2YzJlNzRjZjViMjliYjhlOTgyNzRhZGI2L3RleHRyZWdpb246ZmZlNmM3YTZjMmU3NGNmNWIyOWJiOGU5ODI3NGFkYjZfOTM0NTg0ODg0MjU0NA_31034b83-de25-445b-8b2e-9f6ccbaef2a9"
      unitRef="usd">8653000</us-gaap:RepaymentsOfLongTermDebt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,!HPH3=0O\\XEYL%_0_*]W%Z_P-02P,$%     @ CTII528I"UYO!0  *A8
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MR(=<O0=9W6BQ:%XEW JM1=%<SCF#,&H _#\30C_=U&\G-F^CQO\!4$L#!!0
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M"5*YUDBNW3245NQI#S67ZR)'!JR@M!I*8U :A]($BJ8V!VG(!79'SJ$YD$V
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MP<!TDZAE940QHE^$NGE0&H/2.)0F4#15X-+Y"^S6W].6EP6FO4:N+]N7.[C
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M1^*-J;5+Q%OM')35B?A8L@P++SU\T=CRXV@Q:I3>+U<.N41E35:G7L"WF<Y
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M-LQE72*6VF[8ZUV9HK8(SE2I4<4I9=O>M*>/]FM1J $+BOEBB9[0#$;#I*=
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M]Y*[,<GBSF'$AV:U4C9 # , 6'3'%3^_%1?A7C>#9,JE5B\#YBB,)2LAWG)
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MNH-N\,A4+NF$+<7T 7R6?@KRNC:&.3>1'KFIPJ&E'8S/;8?M3A@PO1)Z,O&
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MQT8#\'ZEP4"\H06ZSZ<W_P!02P,$%     @ CTII50CVWTM2!P  ;A0  !D
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M;W)K<VAE971S+W-H965T,3,N>&ULW5I;;]M&%OXK S<M;("6J;N5BP'':=$
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M%Z@&0IEP;(/.*M3H'ETEI7A>I@"F1-89?D+$+OFMU+ZVQA.*X)4"->RE=E,
MJ=,6L/3P=1OI.'WVS5UY'Y!N;U%NW4X2Z9'G((&GT018U)+.;;1)L=0PCK(0
M;/=01+G+IZ<UTWW,]07"0-PVR$<]!.U826VZ<4_Y")J2RQXU1&G*5:Z OGQ0
M7RG)B858,4I:#V"0?1I?UXB(?*N2$/D]W;47E0@Z347:-RVH,J9B-"$O%Z<[
MZ=!.2= PU*64*+F@7\O#!6\/\63H2VHQY%:C@?->\.+^58_Z<"2CET6 D<,^
MQ[-KYXT&2BY5]^P#OQ*'4+0"OSHJ*?**I@XV0&)"5BU&@]EB.A.W;SY8:G(
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M?)Q$S#0O]&;B=!5>Q0OM\,8.PP(?-63\ >PO-1S>3KR"[C-I]@]02P,$%
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M&$O9@(<F<R4TO-?PH=48+ ?@*R3SNA%Z0UG4IM4%Y5! PZ;>@&F\K.5_")+
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M<ADH\Z&U!E!:B*+I!Q T&8V1^?L&/Q;$&[7LT&\9@&7'<JZYL7WE :7Y4%H
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M\18Q@(F'EF6%,,WR271SY5_%X/+>L41"<WLOEN9%0:<*(4*EB5AHKO,L38Q
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M_2M6UDVKU)(7SPZ06FBU2FV'RMI]F/;!A M83>+,=J#[][LV:48*A+6CTKZ
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M?!,O.XHGYEDYX@H?J:8YP^\($#H YR<<"U;6T2_5_,ND^QM02P,$%     @
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M'PFHS7 4P-!@IK$L'\SP 9[:&/<]DR6-<63'>!],H3:T_6!LP!32T$9V: _
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M</>BR#;5T^9NLZ+(DNK/M>"AD.4)ZOV[3$T"ZA=E@/U3&B_^!%!+ P04
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M3X!K!_4\94QN-SI \\,3_@%02P,$%     @ CTII52J?T*FW @  R0<  !D
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M;2Q:NV'<K.("I9YE&H?Q5\Q DFNE !6A?$D^,?K(<H8,%#DG]?07P<]GE93
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M'J0)P/VU$/IY8JZ3[M]#^A=02P,$%     @ CTII58T-!A"D @  E <  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULK95M;YLP%(7_BL6JJ96V\I(
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M";&O&.%W8XYCT\_\>?H-4PJ>$ &K'20(? +/*,19&"<Q+ 2)-^ >TC@$,(O
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MWE&Y9ER1'%)4Y5U>HZVRGD/U1HO2-MJ5T-BV[3+#T0W2".!]*H3>;XR"]L]
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M'J28D9*9>[GYA+M\(L>72*:K+VSJV"CR("FUD7P'M@XX%?6?/.W6X0 0AJ\
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M=PX>G$?QYIR*M[^=C'\#4$L#!!0    ( (]*:567BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ CTII56EK5?X[!
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MMKFGE2[J8SYK?X5//P%02P$"% ,4    " "/2FE5!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (]*
M:54[Z')C[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( (]*:5697)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ CTII507?/:AH
M!@  FR,  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( (]*:54F*0M>;P4  "H6   8              "
M@:L.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "/2FE5
MT28+ML@#  "V#0  &               @(%0%   >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ CTII54U8%OC< @  & @  !@
M     ("!3A@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M (]*:56&)@XH408  )D:   8              " @6 ;  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " "/2FE5'?[W!1 #  !Y"@  &
M            @('G(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ CTII5?!>R[OA$@  :_,  !@              ("!+24  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (]*:54@]#+]3 <  ',>
M   8              " @40X  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " "/2FE5EI33$WH"   T!0  &               @('&/P
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ CTII55V08K3!
M#0  Q24  !D              ("!=D(  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " "/2FE5C+(XQUX(  !*%0  &0
M@(%N4   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( (]*
M:54(]M]+4@<  &X4   9              " @0-9  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ CTII58QFSN\7#   M"4  !D
M         ("!C&   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " "/2FE50$[^Z(\$  !*#   &0              @(':;   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( (]*:56I&\1BW@,  %$)
M   9              " @:!Q  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ CTII567WJ35D P  ]0<  !D              ("!M74
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "/2FE53EX;
M? (%   R#0  &0              @(%0>0  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( (]*:56]@:^7V@,   H)   9
M  " @8E^  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MCTII51P263.R$@  ,D,  !D              ("!FH(  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " "/2FE5$;!,=Q $   2"@  &0
M            @(&#E0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( (]*:562RIJB40(  "T%   9              " @<J9  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ CTII5?_T]1F4!P
MPA(  !D              ("!4IP  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " "/2FE5H^##-H\#   ""   &0              @($=
MI   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( (]*:56%
M.55IN@4  *T/   9              " @>.G  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ CTII560T</+Z @  F 8  !D
M     ("!U*T  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M" "/2FE57B]'0D@$   '#   &0              @($%L0  >&PO=V]R:W-H
M965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (]*:57+YR\:-0,  %@'   9
M              " @82U  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L!
M A0#%     @ CTII57G6G4Z: P  :@@  !D              ("!\+@  'AL
M+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "/2FE5&E67_M4"
M  "8!@  &0              @('!O   >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;%!+ 0(4 Q0    ( (]*:57]<:6FM <  #9)   9              "
M@<V_  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ CTII
M56WT=GB+!@  9#X  !D              ("!N,<  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " "/2FE5T<*G%50#  "E#   &0
M        @(%ZS@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( (]*:55 F24QYP0  )<9   9              " @072  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ CTII56]K,XW/ @  X @
M !D              ("!(]<  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " "/2FE5WHL/GJ@$  #]&P  &0              @($IV@
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( (]*:56X4W)]
M200  .L4   9              " @0C?  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ CTII57+4=^WY P  3Q$  !D
M ("!B.,  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "/
M2FE5B+K._,H*  "Q<0  &0              @(&XYP  >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( (]*:55LZN8$WP(  /P(   9
M          " @;GR  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#
M%     @ CTII52J?T*FW @  R0<  !D              ("!S_4  'AL+W=O
M<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " "/2FE5+@BQS<H"  #'
M!P  &0              @(&]^   >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM
M;%!+ 0(4 Q0    ( (]*:568/WSNT0(  $D(   9              " @;[[
M  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ CTII58T-
M!A"D @  E <  !D              ("!QOX  'AL+W=O<FMS:&5E=',O<VAE
M970T,RYX;6Q02P$"% ,4    " "/2FE5*FI%GFT"  !R!@  &0
M    @(&A 0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M (]*:5754;KORP(  )0&   9              " @44$ 0!X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ CTII5?(^!:B;!   LQD  !D
M             ("!1P<! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " "/2FE5+J=8RL "   8"   &0              @($9# $ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( (]*:54/^9DL_00
M !H<   9              " @1 / 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ CTII51628[NO @  A0<  !D              ("!
M1!0! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "/2FE5
M%M;Z>HX#   H$@  &0              @($J%P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( (]*:55I4E+8M@(  .L&   9
M      " @>\: 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ CTII58R[U[S9 @   PL  !D              ("!W!T! 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " "/2FE5',4/H!X#  !($0
M#0              @ 'L( $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( (]*
M:567BKL<P    !,"   +              "  34D 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( (]*:55I:U7^.P0  -$B   /              "  1XE 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "/2FE5BC%V7\\!   S'P  &@
M            @ &&*0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "/2FE5,N&!X<<!   2'P  $P              @ &-*P$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     /  \ %L0  "%+0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>174</ContextCount>
  <ElementCount>232</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>35</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Other Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilities</Role>
      <ShortName>Other Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Share Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensation</Role>
      <ShortName>Share Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLoss</Role>
      <ShortName>Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Restructuring Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCosts</Role>
      <ShortName>Restructuring Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/FairValueMeasurement</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/MarketableSecurities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/LongTermDebt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Other Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesTables</Role>
      <ShortName>Other Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/OtherAssetsandLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveIncomeLossTables</Role>
      <ShortName>Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Restructuring Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsTables</Role>
      <ShortName>Restructuring Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/RestructuringCosts</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Fair Value Measurement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementNarrativeDetails</Role>
      <ShortName>Fair Value Measurement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails</Role>
      <ShortName>Marketable Securities - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Marketable Securities - Schedule of Unrealized Loss on Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails</Role>
      <ShortName>Marketable Securities - Schedule of Unrealized Loss on Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails</Role>
      <ShortName>Other Assets and Liabilities - Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Share Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationDetails</Role>
      <ShortName>Share Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ShareBasedCompensation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails</Role>
      <ShortName>Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Net Loss Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareNarrativeDetails</Role>
      <ShortName>Net Loss Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Comprehensive Income (Loss) - Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails</Role>
      <ShortName>Comprehensive Income (Loss) - Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ComprehensiveIncomeLossTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/CommitmentsandContingencies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Restructuring Costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsNarrativeDetails</Role>
      <ShortName>Restructuring Costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Restructuring Costs - Severance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails</Role>
      <ShortName>Restructuring Costs - Severance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="avdl-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SubsequentEvents</ParentRole>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted, avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays -  avdl-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="avdl-20220930.htm">avdl-20220930.htm</File>
    <File>avdl-20220930.xsd</File>
    <File>avdl-20220930_cal.xml</File>
    <File>avdl-20220930_def.xml</File>
    <File>avdl-20220930_lab.xml</File>
    <File>avdl-20220930_pre.xml</File>
    <File>exhibit101-divisemployment.htm</File>
    <File>exhibit102-mchughemploymen.htm</File>
    <File>exhibit103-kimemploymentag.htm</File>
    <File>exhibit311q32022.htm</File>
    <File>exhibit312q32022.htm</File>
    <File>exhibit321q32022.htm</File>
    <File>exhibit322q32022.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="665">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>73
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "avdl-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 15,
   "contextCount": 174,
   "dts": {
    "calculationLink": {
     "local": [
      "avdl-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "avdl-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "avdl-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "avdl-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avdl-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "avdl-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 363,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://www.avadel.com/20220930": 2,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 9
   },
   "keyCustom": 36,
   "keyStandard": 196,
   "memberCustom": 11,
   "memberStandard": 24,
   "nsprefix": "avdl",
   "nsuri": "http://www.avadel.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover page",
     "role": "http://www.avadel.com/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Fair Value Measurement",
     "role": "http://www.avadel.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Marketable Securities",
     "role": "http://www.avadel.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Long-Term Debt",
     "role": "http://www.avadel.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Income Taxes",
     "role": "http://www.avadel.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Other Assets and Liabilities",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilities",
     "shortName": "Other Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Share Based Compensation",
     "role": "http://www.avadel.com/role/ShareBasedCompensation",
     "shortName": "Share Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Net Loss Per Share",
     "role": "http://www.avadel.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Comprehensive Loss",
     "role": "http://www.avadel.com/role/ComprehensiveLoss",
     "shortName": "Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Commitments and Contingencies",
     "role": "http://www.avadel.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Restructuring Costs",
     "role": "http://www.avadel.com/role/RestructuringCosts",
     "shortName": "Restructuring Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Subsequent Events",
     "role": "http://www.avadel.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.avadel.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Marketable Securities (Tables)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.avadel.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Other Assets and Liabilities (Tables)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables",
     "shortName": "Other Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://www.avadel.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Comprehensive Income (Loss) (Tables)",
     "role": "http://www.avadel.com/role/ComprehensiveIncomeLossTables",
     "shortName": "Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Restructuring Costs (Tables)",
     "role": "http://www.avadel.com/role/RestructuringCostsTables",
     "shortName": "Restructuring Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "idf727c0cbc0d4d77aecbe73f9e0c4cbb_I20200205",
      "decimals": "3",
      "lang": "en-US",
      "name": "avdl:SaleOfStockCommissionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i43f7d3853b624df8b8d498a70765a7d3_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Fair Value Measurement - Narrative (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
     "shortName": "Fair Value Measurement - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Marketable Securities - Narrative (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails",
     "shortName": "Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Marketable Securities - Schedule of Maturities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
     "shortName": "Marketable Securities - Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i5cc5c4400683462b921d63ccb7ac42d0_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Marketable Securities - Schedule of Unrealized Loss on Investments (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
     "shortName": "Marketable Securities - Schedule of Unrealized Loss on Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Long-Term Debt - Schedule of Debt (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:CouponInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails",
     "shortName": "Other Assets and Liabilities - Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i95fb7b72db174d1c930b80d69d55059e_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Share Based Compensation (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationDetails",
     "shortName": "Share Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i95fb7b72db174d1c930b80d69d55059e_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details)",
     "role": "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails",
     "shortName": "Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Net Loss Per Share - Narrative (Details)",
     "role": "http://www.avadel.com/role/NetLossPerShareNarrativeDetails",
     "shortName": "Net Loss Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i56a91a73aa374140bd351a086c6c55a8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Comprehensive Income (Loss) - Components (Details)",
     "role": "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
     "shortName": "Comprehensive Income (Loss) - Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i3b395e51b07443339e8545ddcb926fec_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "avdl:PercentageOfRoyaltyPayableOnNetSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.avadel.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "avdl:PercentageOfRoyaltyPayableOnNetSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ifa7ec91468464d1094d4b09f51c2584a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Restructuring Costs - Narrative (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
     "shortName": "Restructuring Costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i143ad04a470f4af39f1d8a4f532972a0_D20220601-20220831",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i56a91a73aa374140bd351a086c6c55a8_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Restructuring Costs - Severance Obligation (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails",
     "shortName": "Restructuring Costs - Severance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:RestructuringChargesExcludingOtherAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i1acbbd1d1b1d403fa7e731b87fd898d5_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.avadel.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i92ccb82c6cb44edb9963e6452b789279_I20221104",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i26afda82b1a54595b97eea252e8036f3_I20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i34a108c684b944f1949cff98177a2d4d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "i1daef32fcaaf4e3198268352bfe614c0_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20220930.htm",
      "contextRef": "ie1bc53c913a440edab2127885e09eae4_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY (Parenthetical)",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 35,
   "tag": {
    "avdl_A2022CorporateRestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Corporate Restructuring Plan",
        "label": "2022 Corporate Restructuring Plan [Member]",
        "terseLabel": "2022 Corporate Restructuring Plan"
       }
      }
     },
     "localname": "A2022CorporateRestructuringPlanMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "4.50 Percent Exchangeable Senior Notes Due 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDue2023Member",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDueOctober2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.50 Percent Exchangeable Senior Notes Due October 2023",
        "label": "4.50 Percent Exchangeable Senior Notes Due October 2023 [Member]",
        "terseLabel": "4.50 Percent Exchangeable Senior Notes Due October 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDueOctober2023Member",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.50 Percent Exchangeable Senior Notes Due October 2 2023",
        "label": "4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due October 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDueOctober22023Member",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest, Current",
        "label": "Accrued Interest, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterestCurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedOutsourceContractCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Outsource Contract Costs",
        "label": "Accrued Outsource Contract Costs",
        "terseLabel": "Accrued outsource contract costs"
       }
      }
     },
     "localname": "AccruedOutsourceContractCosts",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedTradeDiscountsAndRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates",
        "label": "Accrued trade discounts and rebates",
        "terseLabel": "Customer allowances"
       }
      }
     },
     "localname": "AccruedTradeDiscountsAndRebates",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AdditionalInterestExpenseDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Interest Expense, Debt",
        "label": "Additional Interest Expense, Debt",
        "terseLabel": "Additional interest expense"
       }
      }
     },
     "localname": "AdditionalInterestExpenseDebt",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature",
        "label": "Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature",
        "terseLabel": "Change in fair value of October 2023 Notes conversion feature"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Minimum Amount Of Principal Amount For Exchange",
        "label": "American Depositary Shares, Minimum Amount Of Principal Amount For Exchange",
        "terseLabel": "ADS, minimum amount of principal amount for exchange"
       }
      }
     },
     "localname": "AmericanDepositarySharesMinimumAmountOfPrincipalAmountForExchange",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AmericanDepositarySharesOptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Option Price Per Share",
        "label": "American Depositary Shares, Option Price Per Share",
        "terseLabel": "ADS, option price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesOptionPricePerShare",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositorySharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares, Conversion Ratio",
        "label": "American Depository Shares, Conversion Ratio",
        "terseLabel": "ADSs, conversion ratio"
       }
      }
     },
     "localname": "AmericanDepositorySharesConversionRatio",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "avdl_AtTheMarketOfferingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Offering Program",
        "label": "At-The-Market Offering Program [Member]",
        "terseLabel": "At-The-Market Offering Program"
       }
      }
     },
     "localname": "AtTheMarketOfferingProgramMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CouponInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coupon Interest Expense",
        "label": "Coupon Interest Expense",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "CouponInterestExpense",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "label": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "terseLabel": "Number of business days (in days)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)",
        "label": "Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)",
        "terseLabel": "Increase in fair value of unseparated embedded conversion feature"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "label": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "terseLabel": "Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day(as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "label": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "terseLabel": "Scheduled threshold trading days (in days)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleScheduledThresholdTradingDays",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "terseLabel": "Consecutive business days (in days)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveBusinessDays",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentExchangeAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Exchange Amount",
        "label": "Debt Instrument, Exchange Amount",
        "terseLabel": "Debt instrument, exchange amount"
       }
      }
     },
     "localname": "DebtInstrumentExchangeAmount",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "label": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "terseLabel": "Option to purchase aggregate principal amount, term (in days)"
       }
      }
     },
     "localname": "DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentOptiontoIncreaseFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option to Increase Face Amount",
        "label": "Debt Instrument, Option to Increase Face Amount",
        "terseLabel": "Option to increase aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentOptiontoIncreaseFaceAmount",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Excluding Money Market Funds, Available For Sale [Member]",
        "label": "Debt Securities, Excluding Money Market Funds, Available For Sale [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due 2023"
       }
      }
     },
     "localname": "FourPointFiftyPercentExchangeableSeniorNotesDue2023Member",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_GuaranteeAssetCurrentCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Asset, Current Carrying Value",
        "label": "Guarantee Asset, Current Carrying Value",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeAssetCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Current",
        "label": "Guarantee, Current",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeCurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Noncurrent",
        "label": "Guarantee, Noncurrent",
        "verboseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeNoncurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in research and development tax credit receivable.",
        "label": "Increase (Decrease) In Research and Development Tax Credit Receivable",
        "negatedTerseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_LiquidityAndGoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity and Going Concern",
        "label": "Liquidity and Going Concern [Policy Text Block]",
        "terseLabel": "Liquidity and Going Concern"
       }
      }
     },
     "localname": "LiquidityAndGoingConcernPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "label": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "terseLabel": "Maximum aggregate offering price of ADS under shelf registration"
       }
      }
     },
     "localname": "MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MutualAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual And Money Market Funds",
        "label": "Mutual And Money Market Funds [Member]",
        "terseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "MutualAndMoneyMarketFundsMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_NatureOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for nature of business.",
        "label": "Nature Of Business Policy [Policy Text Block]",
        "verboseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_OpenMarketSalesAgreement2020ProspectusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Sales Agreement, 2020 Prospectus",
        "label": "Open Market Sales Agreement, 2020 Prospectus [Member]",
        "terseLabel": "Open Market Sales Agreement, 2020 Prospectus"
       }
      }
     },
     "localname": "OpenMarketSalesAgreement2020ProspectusMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_OpenMarketSalesAgreement2022ProspectusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Sales Agreement, 2022 Prospectus",
        "label": "Open Market Sales Agreement, 2022 Prospectus [Member]",
        "terseLabel": "Open Market Sales Agreement, 2022 Prospectus"
       }
      }
     },
     "localname": "OpenMarketSalesAgreement2022ProspectusMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "label": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "terseLabel": "Right of use assets at contract manufacturing organizations"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherGuarantorObligationsCurrentCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Guarantor Obligations, Current Carrying Value",
        "label": "Other Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "OtherGuarantorObligationsCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherLiabilitiesMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Miscellaneous, Current",
        "label": "Other Liabilities, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesMiscellaneousCurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherNoncurrentReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of other noncurrent receivables.",
        "label": "Other Noncurrent Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncurrentReceivables",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_PercentageOfRoyaltyPayableOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty that has to be paid by the company as per the royalty agreement.",
        "label": "Percentage Of Royalty Payable On Net Sales",
        "terseLabel": "Percentage of royalty payable on net sales"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPayableOnNetSales",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining American Depositary Shares Available For Sale Under Shelf Registration, Amount",
        "label": "Remaining American Depositary Shares Available For Sale Under Shelf Registration, Amount",
        "terseLabel": "Remaining value of ADSs available for sale"
       }
      }
     },
     "localname": "RemainingAmericanDepositarySharesAvailableForSaleUnderShelfRegistrationAmount",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Tax Credit Receivable, Current",
        "label": "Research And Development Tax Credit Receivable, Current",
        "terseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableCurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The non current portion of tax credit receivable on research and development as on the balance sheet date.",
        "label": "Research and Development Tax Credit Receivable Non Current",
        "verboseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableNonCurrent",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RestructuringChargesExcludingOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges, Excluding Other Adjustments",
        "label": "Restructuring Charges, Excluding Other Adjustments",
        "verboseLabel": "Charges for employee severance, benefits and other costs"
       }
      }
     },
     "localname": "RestructuringChargesExcludingOtherAdjustments",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_SaleOfStockCommissionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Commission Percentage",
        "label": "Sale Of Stock, Commission Percentage",
        "terseLabel": "Commission percentage"
       }
      }
     },
     "localname": "SaleOfStockCommissionPercentage",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.",
        "label": "Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Liabilities And Other Noncurrent Liabilities",
        "label": "Tax Liabilities And Other Noncurrent Liabilities",
        "verboseLabel": "Tax liabilities"
       }
      }
     },
     "localname": "TaxLiabilitiesAndOtherNoncurrentLiabilities",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ThirdPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Party",
        "label": "Third Party [Member]",
        "terseLabel": "Third Party"
       }
      }
     },
     "localname": "ThirdPartyMember",
     "nsuri": "http://www.avadel.com/20220930",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag",
        "terseLabel": "No Trading Symbol"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNMS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NASDAQ/NMS (GLOBAL MARKET) [Member]",
        "terseLabel": "NASDAQ/NMS (GLOBAL MARKET)"
       }
      }
     },
     "localname": "XNMS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r40",
      "r42",
      "r99",
      "r100",
      "r252",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r106",
      "r113",
      "r119",
      "r177",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r384",
      "r387",
      "r389",
      "r390",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r106",
      "r113",
      "r119",
      "r177",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r384",
      "r387",
      "r389",
      "r390",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r106",
      "r113",
      "r119",
      "r177",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r384",
      "r387",
      "r389",
      "r390",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r224",
      "r226",
      "r227",
      "r228",
      "r251",
      "r286",
      "r304",
      "r305",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r517",
      "r518",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r201",
      "r224",
      "r226",
      "r227",
      "r228",
      "r251",
      "r286",
      "r295",
      "r304",
      "r305",
      "r332",
      "r333",
      "r334",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r517",
      "r518",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r201",
      "r224",
      "r226",
      "r227",
      "r228",
      "r251",
      "r286",
      "r295",
      "r304",
      "r305",
      "r332",
      "r333",
      "r334",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r517",
      "r518",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r41",
      "r42",
      "r99",
      "r100",
      "r252",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Loss:"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r107",
      "r108",
      "r109",
      "r110",
      "r144",
      "r145",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r368",
      "r369",
      "r370",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r418",
      "r419",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITYParenthetical"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r16",
      "r479",
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r33"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r51",
      "r58",
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Unrealized (loss) gain on marketable debt securities, net"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r48",
      "r50",
      "r51",
      "r505",
      "r526",
      "r530"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r58",
      "r59",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r51",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r376",
      "r435",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r43",
      "r51",
      "r58",
      "r59",
      "r60",
      "r376",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r341",
      "r342",
      "r343",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r307",
      "r344",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r289",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Amortization of deferred issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r86",
      "r271",
      "r282",
      "r283",
      "r422"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r14",
      "r94",
      "r135",
      "r137",
      "r141",
      "r173",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r373",
      "r378",
      "r400",
      "r436",
      "r438",
      "r477",
      "r502"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r29",
      "r94",
      "r173",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r373",
      "r378",
      "r400",
      "r436",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r148",
      "r185"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Adjusted Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r152",
      "r156",
      "r496"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "5-10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r152",
      "r155",
      "r495"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "1-5 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r152",
      "r157",
      "r497"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than 10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r152",
      "r154",
      "r494"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than 1 Year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r146",
      "r149",
      "r185",
      "r482"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r11",
      "r88"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r82",
      "r88",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at September 30,",
        "periodStartLabel": "Cash and cash equivalents at January 1,"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r82",
      "r409"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r229",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, nominal value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 60,885 issued and outstanding at September\u00a030, 2022 and 58,620 issued and outstanding at December\u00a031, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r54",
      "r56",
      "r57",
      "r65",
      "r488",
      "r513"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Net other comprehensive loss",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r64",
      "r71",
      "r487",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r251",
      "r261",
      "r262",
      "r263",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r280",
      "r281",
      "r282",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r296",
      "r303",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expense"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r265",
      "r272",
      "r273",
      "r275",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r93",
      "r101",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r280",
      "r281",
      "r282",
      "r283",
      "r423",
      "r478",
      "r480",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r276",
      "r480",
      "r501"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Principle amount of exchangeable senior notes"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days (in days)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days (in days)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r248",
      "r280",
      "r281",
      "r421",
      "r423",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r36",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r37",
      "r93",
      "r101",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r280",
      "r281",
      "r282",
      "r283",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r37",
      "r93",
      "r101",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r280",
      "r281",
      "r282",
      "r283",
      "r290",
      "r291",
      "r292",
      "r293",
      "r420",
      "r421",
      "r423",
      "r424",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r261",
      "r277",
      "r280",
      "r281",
      "r422"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt discount and issuance costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r165",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair value, greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r165",
      "r189"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized losses, greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r165",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Fair value, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r165",
      "r189"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "terseLabel": "Unrealized losses, less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Marketable securities, realized gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Marketable securities, realized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r162",
      "r186",
      "r192"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r163",
      "r187"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Total unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r161",
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.",
        "label": "Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount",
        "negatedTerseLabel": "Gain from release of certain liabilities",
        "terseLabel": "Gain from release of certain liabilities"
       }
      }
     },
     "localname": "DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r86",
      "r95",
      "r355",
      "r360",
      "r361",
      "r362"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Change in deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r353"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r86",
      "r199"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r337",
      "r338",
      "r339",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r66",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r120",
      "r122",
      "r124",
      "r125",
      "r126",
      "r130",
      "r131",
      "r390",
      "r391",
      "r489",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic (in dollars per share)",
        "verboseLabel": "Net income (loss) per share \u2013 basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r66",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r122",
      "r124",
      "r125",
      "r126",
      "r130",
      "r131",
      "r390",
      "r391",
      "r489",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted (in dollars per share)",
        "verboseLabel": "Net income (loss) per share \u2013 diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign currency exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r133",
      "r177",
      "r289",
      "r294",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r389",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r435",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r393",
      "r394",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r263",
      "r280",
      "r281",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r394",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r263",
      "r296",
      "r297",
      "r302",
      "r303",
      "r394",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r263",
      "r280",
      "r281",
      "r296",
      "r297",
      "r302",
      "r303",
      "r394",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r263",
      "r280",
      "r281",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r394",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r263",
      "r280",
      "r281",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r397",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r170",
      "r171",
      "r172",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r188",
      "r190",
      "r191",
      "r192",
      "r274",
      "r288",
      "r380",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r296",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Other fixed-income securities"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r12",
      "r195",
      "r196",
      "r197",
      "r198",
      "r438",
      "r476"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee, liability"
       }
      }
     },
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r230",
      "r231",
      "r484",
      "r509"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r135",
      "r136",
      "r139",
      "r140",
      "r142",
      "r475",
      "r485",
      "r490",
      "r515"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r351",
      "r352",
      "r354",
      "r358",
      "r363",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r117",
      "r118",
      "r134",
      "r349",
      "r359",
      "r364",
      "r516"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes (refund) paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r20",
      "r483",
      "r510"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "verboseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable &amp; other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Net changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r70",
      "r269",
      "r279",
      "r282",
      "r283"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r80",
      "r83",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r69",
      "r70"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment and other income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturity Dates"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r94",
      "r138",
      "r173",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r374",
      "r378",
      "r379",
      "r400",
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r94",
      "r173",
      "r400",
      "r438",
      "r481",
      "r507"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 (deficit) equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r35",
      "r94",
      "r173",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r374",
      "r378",
      "r379",
      "r400",
      "r436",
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r262",
      "r278",
      "r280",
      "r281",
      "r480",
      "r504"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Net carrying amount of debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Less: current maturities, net"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r37",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r82",
      "r84",
      "r87"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r52",
      "r55",
      "r60",
      "r63",
      "r87",
      "r94",
      "r107",
      "r111",
      "r112",
      "r113",
      "r114",
      "r117",
      "r118",
      "r123",
      "r135",
      "r136",
      "r139",
      "r140",
      "r142",
      "r173",
      "r236",
      "r237",
      "r238",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r391",
      "r400",
      "r486",
      "r511"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r135",
      "r136",
      "r139",
      "r140",
      "r142"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r28",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Total",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Assets:"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r371",
      "r372",
      "r375"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r53",
      "r56",
      "r58",
      "r59",
      "r61",
      "r64",
      "r289",
      "r410",
      "r415",
      "r416",
      "r487",
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r53",
      "r56",
      "r371",
      "r372",
      "r375"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r44",
      "r48"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net other comprehensive loss, net of income tax benefit of $\u2014, $59, $\u2014 and $220, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r45",
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities, tax expense"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Current Liabilities:"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "verboseLabel": "Other Assets and Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Liabilities:"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Schedule Of Long Term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r81",
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments for debt issuance costs",
        "terseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units (PSUs)"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred shares"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, nominal value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at September\u00a030, 2022 and 488 issued and outstanding at December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "verboseLabel": "Prepaid Expenses and Other Current Assets:"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r7",
      "r27",
      "r193",
      "r194"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "verboseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from the disposition of the hospital products"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from sale of shares",
        "verboseLabel": "Proceeds from issuance of shares off the at-the-market offering program"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "verboseLabel": "Proceeds from loans or conditional grants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r76",
      "r340"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "verboseLabel": "Proceeds from stock option exercises and employee share purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r72",
      "r73",
      "r147"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "verboseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r200",
      "r438",
      "r498",
      "r508"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Cash consideration for repurchase of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r348",
      "r473",
      "r535"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r203",
      "r205",
      "r208",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "terseLabel": "Expected number of positions eliminated (as a percent)"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r86",
      "r202",
      "r211",
      "r214"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring (income) expense"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r205",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, ending balance",
        "periodStartLabel": "Restructuring reserve, beginning balance",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r16",
      "r205",
      "r215"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Accrued restructuring"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r205",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "negatedTerseLabel": "Other adjustments"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r294",
      "r438",
      "r506",
      "r525",
      "r530"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r177",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r389",
      "r521",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "verboseLabel": "Shares sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r51",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r153",
      "r158",
      "r164",
      "r165",
      "r166",
      "r168",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Capitalization, Long-Term Debt [Line Items]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the long-term debt component of the capitalization of the entity. The table may be detailed by subsidiary (legal entity) and include information by type of debt detailed by instrument.",
        "label": "Schedule of Capitalization, Long-Term Debt [Table]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r37",
      "r101",
      "r280",
      "r282",
      "r290",
      "r291",
      "r292",
      "r293",
      "r420",
      "r421",
      "r424",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Earnings Per Share Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r214",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r209",
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r306",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Shares outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of shares outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r91",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r39",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r133",
      "r177",
      "r289",
      "r294",
      "r341",
      "r342",
      "r343",
      "r356",
      "r357",
      "r389",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r435",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r133",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r18",
      "r19",
      "r289",
      "r294",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "Employee share purchase plan share issuance (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r289",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Vesting of restricted shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r289",
      "r294",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r18",
      "r19",
      "r289",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee share purchase plan share issuance"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r289",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Issuance of common stock under at-the-market offering program, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Vesting of restricted shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r289",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r24",
      "r25",
      "r94",
      "r143",
      "r173",
      "r400",
      "r438"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 (deficit) equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Shareholders\u2019 (deficit) equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r417",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r417",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r417",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r417",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r439",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "verboseLabel": "Schedule of Available-for-sale and Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r159",
      "r160",
      "r170",
      "r171",
      "r172",
      "r274",
      "r288",
      "r380",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r98",
      "r296",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government securities - U.S."
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofUnrealizedLossonInvestmentsDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r121",
      "r126"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r120",
      "r126"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedCalculationDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11019-110243"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11049-110243"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r536": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r537": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r538": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r539": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r540": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r541": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r542": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r543": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r544": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r545": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r546": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r547": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r548": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>74
<FILENAME>0001012477-22-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001012477-22-000014-xbrl.zip
M4$L#!!0    ( (]*:55.S "[M^D! *;#%@ 1    879D;"TR,#(R,#DS,"YH
M=&WLO6E?&TNR)_S^?HIZZ'EFSKE#X=P7G]/,T ;<]+6$#?+QA3?^Y0J%M=!:
MV#[]1%9)[-C8%MJL7K"DJLK*S-C^$1D9^>?_N6@UL[/0[16=]M]7\!I:R?[/
M^I__7Y[_]S_VWF6;'3=HA78_>],-IA]\=E[TC[-//O2^9+';:66?.MTOQ9G)
M\_*9-YW3RVYQ=-S/""+DWL7N:RF$EU&+7%*N<\:#RJV4.D?!<\28H,KZU:/7
M7B >4+1YD)'GS,J8:\=H'K&)WFO!"..K_K456C)"N5'6,BZ<,AH:"R)J9;D5
M/KWVN ^C@Q&V>Z\O;+?IB[^O'/?[IZ]?O4I?USK=HU<$(?&JNK@RO+6XZ%_?
M=WY^OG9];]%N%NV09N95OVO:O=CIMDP?9@Y:(2A'),?DNI%>AQ$L'V\(7DI?
M#>\8/1 NW/'=[O6"6SOJG+U*5](;KMM.5XNOM=SN]4W;A=']O>[-@*+IV?).
M^/%.HS"T+U]I,UVVIG?=YD7O;@_.Z>A>_.J_:^_VW7%HF?Q^3WPH'A\C7+C3
M&W/FFW?:-V?&A^::Z[3*^Y"F:'3OH)<?&7/Z<(C#"W?G[L$XASW'6NM7Y=7A
MK4_?E-CJ^N7][I.SIE_!U5M<E<-H[]P\&OW7& OS'*F<XIMVGGH?IK<:*F]_
MW33MH[^OA';^<7\%Q"$8O_YG*_1-EEK(P[\'Q=G?5]YTVGT0\KQQ>0J$<M6W
MOZ_TPT7_53G45^O_\1__\6>_Z#?#>B),/J+ GZ^J'_]\535M._YR_4]?G&6]
M_F4S_'W%%[W3IKE\W>ZT W2@N'B=;@S=ZF/A?6B7'^%Z'31-MW#5^R_Z>R'^
M?:4(V#I.G<;4, 9ZPEB"B50*%(0.)K#/FV57,,+Y#5>T32N].A2OM]K0O\LW
M,)RN:>ZT?;CXKW"YDA4>FO;TKTN[V3E[1_;.#FAMX$^VS@[?ZI/=U@[9;3A4
M.ZGA@\9Q<7#R ==;-7;0^$+K5\UFO77 =]_NX(.3PR_O:+UY<'5:U$_@VN;.
M5?W3%CMH[:!ZX_!D]^T6KU\Y?M@X;.U"._5/.^1P6Z%WY/#RX),3NXTCOMOX
MPG<WCT]J;_>*^N:7*_A\O/NV7M2O=NCNIX^7];=;K+99._-OMPO[]J.HM>JM
MP\:'\_KFQZN#1HW O^>UQA$[.#FXJGTZ_'+8."!P/_33#9_Y"][%VX>-SN4!
M.6S6-S>@;_7CVM4!_+MQ >^#OM<N#EM[S?K)P7GMRM$Z5E?O&EO]VCZZ>-?X
MR.J;M?//#D<AD3$PRP;EC%*1&^G2'^8CCIH);E;6$4J4($S*/U_=(>I+TOC-
MH-L% F\7/6>:!\%TM]I^$XS52E9)$;SAHO_:PR]Y"UY[G'NS9(%OL@!ZP )1
M$4FM<+GU!*RW,BHWG@!-N! ."4>\YROKF+RB>(+4'R&4&_)OPR^])8&_16#\
M4,:)U%B#N8D:R9PY%'/C(LD%T-OH0"U"?F4]$6%J]'T/[7?\DL+/HC!Y0&$B
ML B2A#P8'D&$J<RUM"R/2C%,:/"" X4_T G2=P.(ZTL"-\W1794=BXO@\VB:
M"70NB?UU8M,'Q.:@CP/' 3PH!W^\8KDVW.52D*@EUUQ9M[)>3N\$Z5WO-+K&
M%^VC_<N6[32?HGJ_.U@2_9M$9P^([H/2FG"2.T-8S@)8:L.4RS42D@NI/<-H
M9?U__@U<9_''=Y&=6O"_+8L(/'7F!)#=>X.<TEYI, TEV=&([  "D\-2D7WH
MA;W><*XS $ .M >?T)NN[WT\3;ALZP(<CEYAF^%=T>M/E^R7NV]TR[6VV[NM
MO^"YPU9M\PC73C90[>H#.KC:/MYM;%P=?OK7<;T!WS]]X(>M#^@=W3L^:%TT
MX9DO]=;VE]U-(%5C ^[_< EDYH>;>R>)90X_U8\/&OZX]O;F&7C7X)!\%(>?
M/A!HC]6NMILUN!_Z"V1N?JF_K;'=M]O- [)]7"=;Y]!6K%VB\R'I\>[FAZO:
MQF<!$-PG:XVYL3F+!.6*AI ;C@W&S@5&XLKZUQSDOSU)GY*RHA9:-G2_AV<,
MO-D(8AE5C$5O#56&$HL9=(AK9H>J@B&>CSZ,>"9YF:\W@^WOM'N@"Y*! "_U
M+'3[B4W^,>B!E]OK;9K+"A%L#KK0[4_'A3M.#[TQ[7^$X?W!3UF/U(LA0YW4
MT,')/T"V@0FN_CH^/-EKU4B-U3\= E/46(ULGQR>>&">#Y? ',WPS[W+PT_^
MU!(F:E=[1>WM1Y3NJ7_:;M7?'EP=7!WAP]8VZ(BCJX-/]5:=?  =\*\(?2"U
MH\]4"; *H$HU=Q@\-F%S '$R#]AA!M+L@U0KZ^_YYDQ0M''<#;WC3M/#;[W@
M!OWB[#:5IXWV)D_#H_,ZF' $-MH&E(L8P>OF\$=Q9/,0$ F*,VF"?)R&K^Z&
M5[HA!G"27>@]$A5*(:_7O3)>!U3.RA#8Z_[E*1"M5[1.FREX5_X&-(H5(:]-
M^]I%#Q#CGZ_NME&]_^:EPS[T.H-N^:V,7[X><E9%V1^!%:.&0AGE&7TK?/H>
MB]#-R@Z%1R-N;W;^ZVZ\XO[#ZZ.?[K9^6NJ;T;=>WW3[*=A0ND4Y= [AT7,W
MUZZ[Z6_=JO,4/KM[9?1]]))7=R;JT7FSV)E(I4)6$F:D-4HJIXA%-@20>3^%
M>1L./QPE&:^^>GC9Q6FS<$6_,B.9+UK)YJ=%AYM 73+_H,=[6Q?N&%@T;%P4
MO97U%/Y^_=_UVOZ?KQYMZWJ>KE\Y%Y0C7BG*A8G&60:^F!(^ J\3&8%^"+O/
M.^EU&",Y XQ>Q?'[U0Q@F*R;AH97GC<#@W91#;]W;$ A7(^L%4QOT WK0P*4
M%T=-C*Z-OJ<V'IW1:&0 #<*$8H)YC#3SS"(=.7:$*V:&LB!G6X?(27#B-1T&
MI?Z^.]'#A:G7'_<WOYL&EGJL$7B7FBGF)5%"@TI"WBGEF VQI $>T0#/(@WP
M\VF QZ8-'$$*:14$#I8A*96!S\0HI94P1HCAO.'9GK?G:M&?FK?;O OP?S\I
MB^NY\,49C.'VK24F,OU.]P?9_,'SZ<?-T.ZTBO9CS3Y7A=UIXM7=WG]+R@B8
M#6_ S&/#&0B;U3($ WY_4(B*2"O;,2-,<L=VW*'[]]F..S, AE-C(ZDQ5#+,
MD/44/%VDA!..<Z/*&<!E&&*F9@#GF.04CV,&(J,63)W$X(QI)4%A@+] &/(*
M"<W9Y&;@>P'?*""TWP>A3\]L_7N0EFD[K=-.&[[V*MPWN@U^;W7:^_V.^S**
M08P/![X(:8)REK*@E56(60=J' @E-8Z81H2E6QC2O"]]O&[P\T0=:F&ZM/-!
M1<K R=3$"D.Q$P94:*1D8:BSX7V1DDA,\[TI_$[[C3DM^J8Y)V2REB)N J7:
M&V9U@'\(LDPA0$>!>[XP9-H+?5.T@]\RW7;R?N>$/M$)30DW6!O,0,7IZ"@B
M+NK G-8\+ Q]-IP;M ;-E/^XVS\.W71?-QRGUL["3MMU6F%.2$8CMTQ20:TS
M+!( "AH'+J+4R B+S/U@$9U[VKV\;/U$((G>HNI/N(X!*^.0BH0SRUQ(BWS@
M,"J//&=1(3(%JL[%O!$BG.12R4 PDPY;++VG2&)-E68X+IXT3$6339_0F(-)
M2HGCFC F&=7<>62--2DA'8L%)/2+NDS3)RBCQ%OGG38FP&>II=<(!)EK([%
M:O$(.C$H/WWB4NY%,%9CI4!L!4AI$EVNN)<X!LR'L:WYI^FDXAKW2/,3^!'
M(K9$\D"Y8=Q%2R)RUD?CC" <BX4AS03C&N.C#@ 9KSWXR%0;AJG32B.KX!4&
M!>*%6ACJ3".N,3XR^8B\LT*CP#F37JH@%0L@3L(H;./BD&FB<8WQT8<Q)+3F
MUE,/9L=;,$,F:!:P$3@$0A:&/M..:XR/9!P 8) 2<\DB8\'9**UW)D4ZG&2&
M3HYDTYH!RDFT*4&,@?<?P 8$P2D-\'_XZ#F^3LP;(F(Q>VE ,Z==[D-A]GPH
M+,:3%( 9D4I($C513,N@%1626DN=%^#YQ"E0=2[F37'E!"+:*1&91!$T. :-
MSK&/,H*KN'C2,!.1G<D3&A'*'598:.$8#4)Q08GG@5"0%',=T%X@0D\TLC-Y
M@C)$&->@WA0)#$=J!7/*,$^C-X&3!;1C4XOL3,&<@7>#HI9*4<-@T@VUA"MB
M?#!.&\J&,&W^:3K!R(X83SH5B=AI(B.22#/"I:5*<N6)U$(SC>S"D&:RD9TQ
M48>J@!$E6A'G6(A<BT!T-."C"FZIUPM#G2E%=L9$)H;2[FKIF9.:H6 LM2XP
M[6)0#(BU./IMTI&=,=%'4DJ-!SVG'&4$28M-H,$@KE# BV1_9B"R,R:2B>B#
M9%92@/?@ 4?PAH.6&@D.[B]2$]1\TYJ!& ,3QDM$%&'>6:4<9U2#C0XD$.2G
ML*EE[K7+5+;<W(U0>.<95I%3CIG#UD:I,3,B$DPXI6+QJ#H3$8K)$]IR@;"@
M-EJ)  I0@T%^4[:"HPKYH!:/T!.-4$R>H,S+M/?&"6( Y$5N2= *2!PM\S2$
M!=3'4XM03)ZX*"VCB,@8P8YY%K56S&K.@<).<#7!?57S+*0OLN$K&*6L#)[
M!Q:XL5( :;2BX'!AQL+"D&:R$8HQ44<3@XE@SBFKF23>&"RTQ%A([@/8OH6A
MSI0B%./:-6EIY)'+Z#@!Z1&6NQ@X$H8Y'L$37A@R33I",2;Z*&J$AA8]QIC%
MZ+1$AJD0&-(*TVMW=_[I,P,1BC&1C#*#D7(B 07&(M8IX!>!7%(:XIDO2886
M8!O4I" #&MMV)VF)"5338*5CD6-M+0@6#=IZ%YP,"T.:"4*&\5%'"#!&QI%(
MHF*(2<T<@O]29[5WQ.J%H<XT(,/XR.2IEAP%1JQRC )4,%[@&((,8*QXL M#
MIHE"AO'1)T1$*(K.&>N8BMR($*E,GSTG(HJ%H<^T(<,X1<JE32X:":09IM8&
MR[TS ,<UMF+H+$V$9%-CVA^H)CO]J;@3GT+/WQMU;]Y^(C[%B>$V(&*8Y,QI
MI%+)BF )\R8JP]7L"GNOVW_]II)?$->M&(/K5[5;=^.&[YPF UG)^[/N]">#
M7C^]^ALBO[3E=[)\ /U&2JG6#M 6099KRA68]\BYMP(OV>>%V6=.,88AUJNH
M/.8<U(XS!EM),0L"&V2]6?+-K!(.>P-HD$0@662!8JV(4)03&X%VX&_=KRHX
M_YN:)IP\\'TU#\>T0QIYQX315DLA&)/&!-#B$5  ? I:A"E0=2[F+7)/+254
M(H-9=-JDJ!T6&B-O=<K/6SAIF'[2Q50(K81W.C*>@#+SX&5)Q3A#G)N4+DOM
MXA%Z<DD74R%H8"Y*)".F##'G'7B/V&H=4X$C:S%=/().)^EB*L3UV%C0Q Z)
MP "3$".T08%:A3G5 #6K0G(+0-/)%3(=U[9B OYB<)IJ9S3S1!FLF&<*,QE)
MU HM#&DF6LAT7-0!DG"JI(B64^:",][%8*P"^D3JG5H8ZDRGD.G8A(AH;Q3@
MRRC >T;2@FYCX#HK(XGP6B\,F29<R'1LU2.41]IA#RX_P L)N((ZBVPD3BG-
MS.+8GVFOH(R/9 9CH3"6G&//C#9*L)0:*$0(V)/AV2FSXOB^R PP!JA)R!BB
M\DQ$@$P>8VX(? M,6C)$Q&R$B.=_4]/D(SO/W2&-Q[9#6I@4F <ZZJ 9 ;3%
M30C.*0;N+(]83(&J<S%O3&/!M+0N:$!"5"DC@A0F1!$X>(@+* TS$=F9/*$Q
M8-VTG1:!\F>,@ZFF!F&&/>C]0 5:0$)/*Q P>>):KT1 0GIM;,JB5-8&%*5#
MD6")@QA:]?FGZ00# 6/:A8JCHIRCM. 'AHFDBI_,1L?2.@3%,BX,:28;"!C7
MQG9P):W5P4KD&%4"S)]&WAJ'7*J,[!:&.E,*!(R)3$ *[4O(G@( J28$!8P'
MZ)T*YP@."T.F20<"QD0?[0B5E@5.+ (O*IUCB'BPSBOI*%BAA:'/# 0"QE4?
M0AIC$>'&8LH$B@I@@@Y88P=?(YD@9)C6# 3,O>$L1$E2H0QAP3P;B2QVJ?PI
MD5,X<'/NM<M]*#SYXT"-BD@CX64*!" #&@A93K5/I\@Y*OCB474F'-K)$]H"
MC1WSQ @:&(G2,.4X0C$"T@[:J,4C]$13%29/4,7!;>6"&4(<T\Q9*A2X2$AC
MJWBJU;9P!)U:A&(*Q-4>N>A)X,8Q:Y4.2GCK'2=>,LGI$&[,/TTG&*$8USY<
M#K3 ,@JK+%-4:X%-()Z15#(;R; PI)ELA&),U$%(!"HPY@X)Q@11R(#+J[$2
MC!/.^<)09TH1BC&1*1)L Z66&!*9(UP;Y)W22@7EP*S9A2'3I",48Z*/C9)Z
MBB@)Q#+F4W:<HVE/.Y$"O .Q,/29@0C%F$C&D/1!:Q>U,(QS#Z9)& FVB6D>
M!9N@2$UK!K!QJ?""QQ9[AF@T,D@*:%A&#ZK%\]DO:O*NTS[JAVYK,]A^X_(T
MW.75_= N.MUZIQ^^I4:>_<+THAV8\>X@];1ZG3GSS=<;C*/WH>N2 %VX8],^
M"L8VPZTN; X"3">=W>HI@W91,49[D/IR3?-6,+U!-ZP/VX"/HP9&5T;?4PN/
M1TUX-)ZJZ*.UC&!@+RG ;!% & +P^AR4-YHS3MMU_0XT/-L,=X=%G&+IO&NJ
MD3<,8VNBD"1@,*'* QB= Q;9']A>X0O3O=PWS; ;2S?@-N'ZC>-0,]TOH;\;
MP5, >/.^VSGJFM:<D,BG4+9#SCKDF9?2!&?!8D0=D&-N"$(1_(_/EL5$.8))
MX&.8 6.P 3/).-6.:40T(1$SXC  !:1H',T 9O/*I+NGH5WQ:+K>VSCJAA(5
MIG$!M_9.@^L/7GI[-) +LW%X38+;: 'CV4@8I<829;7%G%,I""=NJ%/4#"<0
M_SBYR(3(!:*EQK0IVEJJ&;4T&,,T$XH*\*2X0#8:&P(95O %$S#[%7PG(6;C
M]NTF6B#ZMDWZ6HQX?#6$763.Z""U-9:YX UW*0E5<B0$CVP>:CC.OO(>']H@
MEF,1 %QP O/(N&$RX<!H*'?:Q'FH*SP7RGM<A88198&&8+CFC'!LN0#BQ)0T
M"EA)V-DGU[8ING^9YB#\X[)6.;:I@>UN^/<@M-WE75UY??.M6WM[P0VZ"=>/
M2W'?ZM+UQW_"($W7'5^^"V>A^42O=MJG@WZOO ./K3-%V[1=89J/NJ6U07]@
MFAMM7P/3<EFQ]?:@[>>%?QGQ!'L'X# (%JDT#)@6A;2M5DMAYZ#"_(+R+UGR
M[[-<4VV#4H9C)3B3)@+*<<1;+<!9IYBY)?].B7^_%8!;\N_P0#%N6= V,J)9
M"A:#(K9&,B2HM](.<WQGL939@O/O0N,'/+ZJV19'&P4G#! #"]Q2T+N::&Q)
M#$'C)?\N\<,L\Z^4J1PA)\[S%"OE"G!PH$IA9Y /PPJV2_Y=XH<9Y5]A*+ P
M0N#&,>8H,\&P& BV0CF*HUKBWX7%#S?QZ^YIIVOZ(:V=[Z>Y*/K%-U?D9P4
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MLQ0Q;H2B7 3EG%1@!HP:[?=B+W\RZ728:82E%HBI[N(%-I[S6X7C2"30)L%
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M+KXOR?:"9'L#JC'TJ[-VPD4Q@AT^I24/DZ7+I.AF\27EHIIN2L\<Y@M5@K;
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MBF8@SN\$Y[/Q#!.,R(Q#\KJLYXE1,"Q(\(94)BU&K[JL-Q//0)RW&>=W%<]
MG-\%SF<C&D([GAQCD'D5MZ0V@7'4E%]3#D33Q%QJ*J+1]/F@?T^<[Z?R;^Q]
M7/^?^D>C:*+D D[U)S[M3<JEA%\#C%4 FQF7B\N[N+!+MQI2U1"R:1JX\84?
MI-1Q(0Q/RM5\J:(C@^&D?-]D6#C"G<5>%54IY!"KSA/UH[I$F*N>SKV!&X2>
MZY>[*$^<E!L;/_GI$)Q_JV#3:-+I<-RK9M334>J[2>]C^NU3+TZ.+_CJTANG
MT^ I^?X6Y\M%%.;XZ5ON<+A_.;C0$1WX<40N_ZRNN*8PKZP6C$MGO!=2!>.L
MUC:I;(V77L6WC*U=O.GX6W;<::%2\*/D/H#+Y2:?NOXG]V6\]N\?QN*D-X"9
ML9\=MNG@K/^/'Y6W7G&UES_-C=Z5#ZQJ8=D?U[P[&FA]Y4!OO-[8VG[>>?''
MQI^[&YO;KPYW-C>>'W1>/-]L R1_>>F;^V4AV#O8WNJ41P?[SW>V-@[++P>'
MY9_=[;W#@\[^L_+2[HL_M_\H?[?S>KOS?/_@H WWM2#5_'-GT)D<#\_*I\;Q
MOU;Q!EY=4&(KKK[I!:E>6[^S;EWTKEQNWYV.T].+![_%WOBT[[X\[0WJ+ZW?
M]-LY+9Q3=<4Q,VMY_7W3E[_3SQ,RI:#S?8KS;SY_^4G]THS"F+[&[1/#Y4]?
M)D_H#5_C1MSHG;^Z6,J?<,WQ8I=PL64Y,V:%+M9>;\[^S=[= KG/?_NG=NY/
MK_!FIP1Q/^[LW)I9,\;A\:C(UMWR=\?CSG81I[%SD$Z+!*TV_3CI7F-C[Z$.
MS5YYYKHC<\V)M@*E6JYV2V\'GI^61B;SU9';/2>J8.QU]KJO<\./;> H3BJ<
M5,N=5%<?>N._.//6I 1HWE3XE;?^RL=U#.U6S3S_)D_UUKFI;1NLZU>EN^H.
M6[U+A8TY;[85]66W=[$5]>'KFZV7GW:W GUS^.SX3?F>H\,WO:/#;;F_M2'V
MMUZ5]WXHKWW?5BK7]OG-[]M?=]]OT]VONW+WZ\ORMSOBZ*_7QV\.RW._[WW8
M/3S^L+<5Y.Q6U-'[9Q^.#G>_[!Z^^KK[]</7O:T/8O?]\?&;OY[URW.?CMC+
MS_N_OR3E'O/N%_*EVH;:/2!T?^OEU]T[Z\O9ON1Y)*6'24K827/U2(G,D-(=
M-=)$4D)2PM:72$I7DQ*;(:6[ZGR)K(2LA+TJD96N9B4Q*Y7NIE4E'HN\(1[W
M)\=IU*ER^T;I. W&O8^ICK-U.X,TJ0Y'3MSGITL]!+GXT+::X*Z]S8@CAB.&
M(W9_(];D_@EE3UC+B?[9<%1^'73"V6B4!N%+9S(J'U;E51<1MJR=E6N=F%G9
M"B#MV(NH5_#-RPOX5-J>&WSSW-Z'E;FGU[DQB(??C;\1WY^-)U5F?E'%^_G0
M?7XQ'-4O3":CGC^KLS</AR]<^9@)RN$%Y/#>P=QVAC>>R4PE)"4HB&P%>)(E
M\.1=<IR$0(N3KH1NAQ9&&EB9Z#_20(MI8'8#@844DHP*JIC==%?3)>Y YTA4
M9#0GY=;6&4<:>)@TL+QX^QW3 $;.&N.(V7B^C3HH:RA$4S4J9ER!I5J!]LZ6
M22-#)G1MG7:%F3]JCRSQ$%AB>?%O% LM)H*Y$'K2F1?7 (S.A0B,*D0@G0*B
M4TI.,AN(7ELWO"4TL*03(Y<.)IY_!%1__Y32.O1R?UFIP[^+H/=J:%6!](Y/
M@Y1[];/_N-O@P?7P_VHP2F7<OZ;XQ[!?C?'OKC>H]LCV!P<IG(UZDUX:;XQZ
MX_+25OEU\.Y%&;=A+ 3PHQ;(O<\IPM<T&B+Z%T%_CWSZ ?V;EKSY?\<DG+P>
MN+_LV?[[(WY4_K]_V._M';[N[1Z^9$?OJWOME\][*8Y8&<.M([JW]>SD_WT]
M^OK6%Q$IF"Z>A>4)A%.B$A$4N%*2"Z9TF595=-04_?G;'']T%YJE=^_;WFJZ
MXK2\KVG)WR9N0_!! X_2@*"<@HDF@F11*Q-LYM)4=:1N.2,;+T:&O/D8)FCX
M_)9*RHC0 :(+'D0F'JQ3&9A44E<)54')G_-FQPWB0A/U[I4^4N=*SDSQ-O"J
M^H_,H+6N=A"H!^>Y .DT-S9FIX*I<H_)%=PY2N/3%*I*2OTO,T5\L$S>@]CT
MNRFL+]QXQ/9BV)[=W^.2!16KPGE111 B5JT L@;'-#&,ER<$65NW_#8)N%@8
ML[V(7QT?"!%_,\3/;N7I(&S*,E32,(#P-I3U6!/@5AGKRZN25HVOY6VV\A#Q
M[47\W6_EW1[QN&O7&!W,[MHQ)0Q3WH!6SH!(28#WN7 "H]G$:)E/O,CSKC#S
M AT)X2$0PNKX\B@!;H;YV0VZ,M%CHLE",KE@GF@#AA@-1>OKD&.@G!31;V1+
M1/_C*AQS.)RX_M]OTDW<Y_M.@+YV^:J'QYEW'RBIZ!$SG.Z2-^=KNRA.BZ?$
M-61K*0@1/'BG-5#'6=+E(675B>6N-//-P19.;5BD.-RJI#\]8L:X^T#+M1D#
M26$14IB-IR@KI+,N%!W%BYCBUH-5.@(E,6F6>2#*KJUSVT ) Z2$!T4)=Q^)
M01%Q]WPQ&W I$I$'ZBSD0&+A"^/ *QK!A&P$HYP%E@I?=*UJ(#\2&>-!,<;=
MAVJ0,>Z>,6;#-<H'+HA($)))(%0*X*5W$*@4SC#KF=&5VZ$L7P'&>%SE2J;1
MG/DXSC)J(?S=^\Y->][0AI<QC,.SJCW.Q2C<CEG;-O37+TK5_/@\F!5G>8&N
M*Q8;W/!K>C79WYPO4&RLI2;[,I["@I!:@;/60-;*$U?6 *7"VCJC7<T:2 %H
M#E/WO%^(Y(KDNCHQ0237NR'7N>0J2CQ51H*QOCCW,E-P,G P,7!B;+""3 LM
M<WN;ZN](KDBN2*[W%5U%<KT;<IU+56,AQA09B$0E",$4>!XTA."L<F41C8I4
M!:-YUYK;1$*079%=D5WO*Q*-['HW[#H;9;9EJGOG,RB66'6"U(*G/H&((ALE
MA<I.K*U+U=7L-MDMK2'7.@[][WH78_T:O<2GG]X;Q/+;4ZZ:+^"QO![H2[K,
M^A.OWVC^(*6."U4DW V^%.-U!L-)^;[)L-#,>0?ZBF+*^(ZGCVJ3N^KIW!NX
M0>BY?KF+\D15QF?\Y*=#</ZM@DTW!TZ'XUXU1Y^.4E4+Z&/ZWJO]__NQ3,OY
M9"3?W^)\N8BSR<_?<H?#_<O!A8[LP,P)V4L_JRNN.=$KJP7CTAGOJV.YQEFM
M;5+9&B^]BF^97+MXT_&W[IVG[ET"/TKN [A<;O*IZW]R7\9K__YA+$YZ Y@9
M^]EAFP[.^O_X47GK%5=[^=/<Z%WYP K_]JKNITL?Z+E&I_5 ;[S>V-I^WGGQ
MQ\:?NQN;VZ\.=S8WGA]T7CS?; ,D?WGIF_M[6]M[!]M;G?+H8/_YSM;&8?GE
M/QO/-_8VMSL'?VQO'QZTX2X6))9_[@PZD^/A6?G4..YVTN>0RI)PFLKT/7:C
MU"D<XOZU\'U=-4G_YFWU6O*=3.KUJPQ+WYV.T].+![_%WOBT[[X\[0WJ6ZG?
M]-OY;#]GH HZ,VM7_7W3E\]19>T3370%K//-U/,O/L?<DQIS,\OQ]#7%GPBJ
M?OHR>4)O^)KD_$;O_-7%4OG$$K-"%TM__O+EC[UFU;%FF_:N5$_I@P+C=.(+
MCCGI=J[9FONA#L96"N=C0>NQN++;=@M;:[=E<*^_IDQ=X5<7FG3.L[F#07L4
M;;.OGN<;!P>75<@R4@P7'[M61VUNT5L%1^S&O55^D92V KU5IO5R)QTW'J?)
M&-ME82NCEL/M%VL:DRU:U'X"-S<^KDOLA>I!^N]9[Z/K5T&L9;#V(F/XP/9K
M5JZYZ (;+DRY')UAGCHII)7>ZI0<DRP9PE7F;W>N5Q&TFHL;@UC]L_U](FY,
M-MUH5(5E7[O^65J-C9:]@XN-EJ,O^W_MLB/V^N3HKU>?=[=>?MD]/#[>.WS%
MWVP=?2WO97LGK^@1>]/_MM'ROMHHZ7\X.GGYN?P-V?OZDNT>[HB]KQ_XT?M7
MGW:_'G_8/SRBN[^_/I[=:-G]NO-Y_Z\_>V^VGGW8>_^R7._1Y]WW[_C^8>SM
M'6Y\W?_]I=PKG_'FKV=Y;SX!DSL9C%!EUA8#@A">@,^)@0R*YUSMHU4%$17I
M:BKG-EJN7GYNPIO8^QCIJ3EZDLI9ZC1WCFM!!?&12^I(57<V2.E,34^4,DZ1
MGMI%3[,IC(&[9%/(D'UUJ%D+!DXZ#I$K2J0H;KLE:^NRT!.9;X!\?_34I >W
M I)RUXT^I/,-AV\EDY;JE3S(.EGW(,"^6^Y[K:MS?QQYK3%>F^]D*8W7@28#
MS'D+PE,*AJ< AA:SLF(V[^W:NI!=K>8KW2W(:UCNKK4P;DJH((SO!L:S\H2S
MJE0=24"Y+]Y34!0<-Q%H-BXS;3*E86V=$M65=#X)^/YP_#?ZY"(KH%QL^C7T
MV_>7C_?6'EJ@\L\T3FX4IL'*F#ZF_O"TRK:K>X&%48J]26>40BI^62&^^ZX_
M^*#7J=O*3?<Q]I]>V+-XU%O?K7GH/F_6MOSSFREQY6IXY;KBX#7+GO,H-"A?
MM45DTH,+F=0_?)(TV:"J2LM$SY^[7OFP'^*Z(?V)N+YO7,^=^?59!*DB,!H8
M"&,CV,P9,%,&V$4?HY=U!75Q:SV*\;*;(O3%*)VZ7NRDSZ?5 8-QK7#.BRS_
MD R!,;06BYH+Y_O<FMM38Q86K,N7;=0&1,IKFO+F8VE$B$!<3N 8KV)I/("+
M60+AG$:NG'!5#QG151I#:0\7S4V%TA#-=XOF60'CL[5&9 K6,S6M+VB\]^ +
M1?L@(J.5@.&L:]A\T9+61M064D\KD+-Y7DGP]F(%2[&V2,D@RRV%Y78/-R:[
M/?*Y8KJ]PW=D]VO5Z8IGF7D"63>^LRZ#4<R R=1ZHPE+Q$S+A[#JJ%$CGEIK
M2H0@Z%LD>!#T2P/]WN:/H$^2JN!I ,4I!4%HD35))O#42"HR"]ZH GK+NL+>
MVE=9Q1+**Z!\7HR&I^5JOM0QFRI[OHYVUIVP[CM:\WBYL+E0SM2X+_IN,"F^
MW_:%??=2>UK3K ;[;<])'AJ"9HH2$)F+JF%5 L.,!VZU)BJE*HRSMFZNJ$5Y
M,[>N-7('(=XBN8,0;Q#BLP*'61:RX 8RY[[@/&5PAE-0QC!+K'')%Z^&F5L?
M);DKB#^RL,Y^@8:;5/6P^LF-4Z<>(1AF."N_M"/*\Z!)KBD=\\V.SRLS_EE=
MS'Y^-4ZUKX<^7G,4N#.G<KA,2DHB0,M8I X7'&R2#K+/4FK)0W"^ZH]C!2;6
M/%P@-Z56$,AW!N19+4.-HIX% EI459Y)%:<Q24.,A!/)A)15;C?K*ME4?!:C
M,0M#\O?A,'[J]?OW'7IYT&36E"JY,!;R5G.\M3LG0"+E+%EF@3"50?C"6\8&
M#U0H)HUS5KJJ,+WJ&MZF#70$;3L5"()V&:"=%1LR:Q.4<Q")T,5KD J<8ADX
M4\ID'5R@LH6@Q<-6#R7R@X>M6L/<=WO8:F\XP+W_QAG^U9PL2\5HRFH#*@M?
M,3P#$Q4'Q<O_*.$BYES%A2C'N-##Q?;='KA";"\'V[/JK1B0*"4LY)A3Y7)E
M\#00$*E(.A-XU$14V&:L3374'EFHJ,[C[Y2A!SQCM3):YEL<_/LAC$)J 4FM
M:5([FA,LCJ1D13)@C*US=G)5>LT!]V7U8E&20&R5H=S5#,]5/5P$-[:3A0A>
M-H)G90G/QBFF-?B4.0@=%!CG _!D'>,ITB3CVCKG77W[(@\M/4K5IAX3OSI)
MM;S<FN4>H&C;:"Y<__:!=$N]M\-BR.#-,7B8TV V"F*IXB"U*1HLZ*I,) W@
M=&)).B;*VEPT6%4G4C95_[8U:=-(;$AL]W<@#HFM26*;E:9*.T8UXV!#*M)4
M,0K.! *19ZZCE8H9MK;.A.XRU53,[*Z2Q2\NY&(>BYJV[K$OSVT^X]*@7=$7
M>X6O\J%Z&5=WLGN^L_&?G><[ASO;!YV-O:W.P1\;?V[_L?]\:_O/@__[?TS!
MXF^=?VYM/]O9W#G\5V?[Y:N=PZ,.MG'#QG?M[L2UVCL2%XWO^CWG>_VZ:#=V
MO\/N=RW'W&H7E;[ W.EP5/L3P]SI#P?O8))&)\4K\#<[Q(]MIA:YPU9#Y!XB
M:<_+!#PL\V^K3#_,UVC:^WP_7XG Y."D# R2BG[:?<71R"%I$;6,D;O,B_>I
MNLS:%B5L(!LA&RT__/6W;)1[GU.$KVDT1"):D(AFPV#!9NF(9:"RDE"1#UCJ
M)3B9#5=.%4(*E6HK#CK[K45,],CJ=5\A&H<SE1(N?+@OF$ZV HKKQV/5SR]L
MA^*K<<Z;+Y @A:;2* (YJ2*^0C"%[BP!3ZT(1F7!8IT(3RAM45(*(KF=:N7O
MD(Q@70BL<_MTS&H7B0!>%VX+)H,+5E:)[IH9$U0F;FW=DC9E@#ZRB-9&".5F
M)N/.J?N"9_-61(!<&.W%U&8H/!KGLOG""*KRJHJW!2H84YPMZ\ ZHH!9+R,5
MR1OMZ]9(^@$&?1#!36<)(8*7CN#YK"%KO9>^"I<4-6(E 1=]@!Q8H(SD++E<
M6]==U2H$/[)@20'&Z"Q];VZ& 9'5T".5T9Y_ST1 0FN<T%[.21)/6% L5V?L
M4@0A97&OE,] K0F!L&AY688*H=G;)T%B+*2U(&Y0DB"(EP_B^1A)C,8+ CX7
MYT+$R, 2)H$F)R7)A*?"O@7$5+8IH(FEFQY* &C_A\:QEY(),1*T LJKMAY2
M]C(I>[ZV :$BZUPHV]:A()MYT5U%?.EDHLW2:ID*F_"NEEB,Z>%"N-'2!@CA
MY4)XKN824RPP9L'9XC")R#(8&C40&8H]J?<AR;5UV66W[_K<TEC0"IQP^+%-
M[&VE28/^Y$_/ CYLQFLL8QG);HED-U\'@&@EN?<4?* ,1 ZB*)?RH\QO5M0*
M,5$4%U/0KFPL:>9Z"%FA$-(CA7QC:<$(^:5"?BZJ%+R7CA#@652IP<Z"-S2
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MI+'UHUPV+VT5+1!+;?>,.+CN^G&M6WY40[=Q,CP;7.<D\J,<'9Q8K9I8*S4
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M>Q_3S0.'#9Z?6#W:P\J<:"6T$EH)K8160BNAE=!*#\]*B[BV1IJ@"+/!J.K
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ME,Q+SZT56]ND(SFK*OU@59KD_@C,8^%IX,P0:STQ,F)J(PZ.UAT &ZK-BPD
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M=<KC!%?E;M&J;J25RR8A#7(6JK@*&09'.:/Q<:7;L,) C.8(0@OK-N1'BKG
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ML,5'(176N>P%GNV)4Y2Z*/5BO:E%D^^BR=->T\ L%DQZ1$4N8",P0SH1A6C
MPL#R>J+3RKJ>4]RD:'+1Y.)C?'*%GO$Q<D\=]]B 1AL+E%LK9*/ER!!'5#"*
M&4U6UMDJ%_?V,3Y>CZMQ@C ,-OX<!LHGE^F3KRND??&]T6\X]+O5%G;; \#G
MO(49'[RTV$6/&<\=1C@7CD46G! T"%]\Q\]G3YO3))W+P(PSR!&C@*22@(S7
M%"F"K>7>"D[H"S[:+UK^1%I>?,>/J?73ON/@O*<^)B"R5""N'!!93"(*WBM&
MB96)5EU+  ^*SA>=+[[CY53K:=]Q9#':W#:#: Z;><S5= /S2 GMF;&"&IH+
M$M[_0*@H=5'J$HG["!H^$XE+$L'&RESMEL#&S01RRBKDI8DJJ<03286N%RTO
M?N4E5NH9O[(..C M,:(R AW/KQP8WXCA(%34A+J$JY1LOJAF5\L6NTKH&EUR
M#^1LW9L%'9;=]+W2#/'1YN?%; _48AH"(XR!)<"9TU(EQGS@7E N>"GC\<PV
MC=DR'CC9W(&((*RU1]QE%P[!&@E+HU0\>!O5@LIX+%S/GC@ZH0!N =QG#KC%
M??Z8V#OM/M?28>VD1XK&@+CG#.QQ[9!BSF&#C1:6 /:254Q, =\"O@5\7Q[X
MEG.,Q>'K]#D&#1I;'EWNW,81YPPC'31#/J1D$[:16[.RKA:6V%+ M8!K =<E
M M>"J/=$U.ES(RX2D3%H% 3UN6NS049HCJ*QRGF9-$]DD;D(!5$+HA9$?4I$
M+6=W#P*L,V=W05G!;93(:6X15U@BJR6\(M3JD Q5W*^L$[Y*U<OQ!51'?[]5
M/8361]WJ?KO26_+ANMXM5+?OT-UPU**P<6 'D[T#V\/);H6Y6>&<_H/7]R_,
MC03A=3]_%ZX9ZWZ'HVZ$U;I5'1.=[=BNCXW!0<P?L8/I?H3=")\:]AHN7MZ_
M:HAX,HBKC79J]./_G+3[,:SF3Z63W !Q=-O><>S;+(V#JJ5Q'ZX _W5[N?_H
M$):R>JO1JT=5/4XO-?),3-Q^-.;KVS@VCGO]88+GZ2VHD^DRBLD#MU?]></>
M+]W^1,O>OWJ#=EZX"P)=NJU^VI.864:,1M);#  = C(*F+"C@2OGA$Z,U'MU
MNWL2PT;>,;$420L:J4B!4_BR3#(0K0#-@]?83'=GG=L(]:!W6FMLW0[\I#O=
M$#PW)+VY*^IM.IL.KVM*6BGWG%N/5+<>J8LP\$K_0[_]3^SFUJ@)]JI>'Q"@
MRL"J^B=Y )+VL-%O#[[7EQV#8^AE+.IE'!S&;H5(@]CI5'>8[.F:GQ<NT*X_
M?-2#&W;:WV/GK+Y^_B.\&.;/G+;A^RY> -BUUW0QY>OTH\]5QLY&DPAS:N'Z
MP^J1?6\P!"R%QUZ;V:^NH$M^<R0'%30N!*=&6,%IG6QW/%+1-_W8L;G+\ZC1
MZHA/3GQQM-'CRZ]8!WO#R?#ZK\QTD'HB2$0-PAIH:G(G_CVXZ!IU;/<C<B"=
MWY'-+H WMG-JSP8KOUUYKJ-V%TW-X_047+\6M]LYII:^1DHMM#?.,"D-\#F>
MNZY[!:"1:/3<Y.JG\[]W(WRL/W(;7YBG-5S/U5W[^%*SQK!YD)ZHMVM>>I?!
MFC4M'Z)_*YAL9:QEK,]FK ^D6THL6[MA\SR[#4]TEJ5 A+K#@]MDL[_4V;C:
MI;-,R/7--F^:B*7R)2]K'^KGU7CU_86!>)^^M0MI6ON\)N[2-=+X3V7T%O$J
MXE7$JXC7LYBXGXO7KU:!NO7D/)/Z4$O0\OBUGO3?^?%?RD'^HAK(_/Q@YVWM
M5.R=#.8?\60+<AOL)4*;E;7T&H[[X?/GGWZT-K^VFYL[>.?P\_>=\\[!UH>O
M[=UON_#SSX.=PS^/8+QLYKA_^_MY:_,=AG&<M@X_MUL?/A]NP7AWO_W9V3W*
MXW[?;A[MT)WSD)JSY;*"]42&R!!UTB NC,K-DUD^_%?"T$09MROK<I5*OJ!,
MW:4)E"KH6-#Q^:/CAO<G1R>='%61/U;P\&YX.)T)A;5-#@>!O TJ%Q)S2"<+
MH.B8"(ERR25>60<I*&A8T+"@X5.CX1@%M_K_Z77W8[]PQ05BXW06D]5")>H"
M(C8!5R1$((=90%HKDH,'M!9B99VN&E*X8D''@HY+AXZ%*]X+#V?ZH5AG E,4
MS.;<L,PXAJR1$1D38:6Q$#YZP$.I"AH6-"QH^-!H.!\#"R-<( +.) L91K2T
MQB,2N =S.43D-)/("^:(YII0@A?;I+J 8 '!Y7GN9P*"A?C=$_;:4_5-G<:*
M!8NL8T#_L%? _+!"VB6K5*!<&;NRKO"S87Z++'VZ_&?K'W)"3;=*XYM(-4*-
M+VM_K_W207OI'OBXW0/+ ?.28N5L6<_@8(4-M0ACGDM!1XV,CL 0"?8L26-H
ME4Z^BGGIZET4OYR=/B-5GSD[-=(Y81ARW!O$7:[ZCFE FBC.B-#1:K&R+N]=
M\KWH>='S<BKX5%H_?2J8LL%#540I@L)SJ1)R(B9D8F(\,&N$L_E4D)/2%[PH
M?CGP>D:J/GW@I9(1-/& &%,!<<8Q OX>40A:6^>UQQ14G>&BZ$71RUG.DBOW
MS%E.[I/*!8.-7#B@[]XQT&[,4>0F,5AR&Y4#[5[EXMYG.46_BWZ78XK%:_34
M,86B0B0J)4HXJ1R@DI"UB</.G:+#V$HN&6BT7%0=QR<YB?A) [CE/XG8JFJ0
MU>U$VUW?.YHL@O@0.7^WPKG2</+V#2?+4<1RXF'K[<Q1!//&48(9XC(1Q('L
M()T815[XY$0PGAE9'45(L41=*8OBOP;%+]3G7JH^?1012: N$H<<4:#J7@7D
M.,%("T6 UK*@16YHM:CXC*+G1<]O>Q11%/LNBCU]VL Y%=09C3"H,A@RP2 7
M'$.PLLD;PP/GL(>+A86;%LTNFEW.&AY!T6>2:Z@Q 988L>@Y[.# TZT.! F%
M0Y18Z42S[X(4/2]Z7HX:EENW9XX:I(N<$8.1<4;F]#F/-(T"2>ZM,!)V\62K
M7M_\WL%"1;^+?I>CAL5K]-11 TF&&TLD<E$[Q&T$6UN)B#0LKY)4$A]@N^;+
M1,L7F?- Z!I=\J.&V<K+R]!1\)9U&U]8$MPB9^:E[ 94VA2LIHY8P841SJ@8
M+5C[46,F$RL',L]\U_A[YD F,0>[ ZY:MYI\*IV04UHBHKT37"I>90_K5:;N
M;>8M4..><P/7 K<%;I<9;@LMOQ? 3A^#.:()BPZC1')&#LF%# ./"-N8X"?Q
M3)N5=4'O7<VPP&N!UP*O2P>O)1'J <%V^FA2!,4P,0QQ92FP6>*0-C(AHJP@
MA A,<WE$L6KPHN*G"]P6N"UPN[QP6]CLO0!V^DA8)"V#Y1@ -EG$.?7(1,81
MEO!#IQ"2B"OK$M^[^FR!UP*O!5X?'5[+2?R#0^K,23RWGA N%*)$>,2IT,AB
M1Y!URDA&B"%,KZP3ODK5HK*$"JP66"VP^M2P.L--"\HN$&6GHB,P\<Q1&Q'!
M"E V)8F<\!%9(P+UEG/G7(YW(O0E<-<JL.*WJA'R>O4XOK:;;/4\\_X2VO^L
M_Q_X9_Q8$_<[/!D,V^ELI,OK_\?U?UN_F(R+[U52Z:11G#)AM7-<2*^M4<I$
MF8QVPLFPET/#+[^T8'0@^*;NES3#0VMK^UV#OVF,8*)U<@37\5=Q(1+G!?.P
M]X)HX!BLHX3F]AH1FV@CW]NL<(%@@BX!8A82-ML#W^D-3OIQ&R[]1Z?GOS^Q
M_K;:8_UM@O[]T6EMM@YVSK\>[!Y^/FK2)F^!'NYL-WF3OC_</0S?P? [ UWL
MQ/_^?+;[+1P[RF7S_'.[^>$+SI]I?7M_U/JP<[YSOD]VC]X?-,_WSW>^M8Y:
M]!-O;?Z9FN<?Q=;F%]#=?=':?L=:IWO>"QX9]DC:Z! GGB/C0"FI)%'+2(GB
MIH9ID,\8-C(B:@;R)!R = A<6VJ(=-YYS1CA$:ZSTH@ D,=9</LG8()FZQ]M
MQ_Y1U0=\K-&CI9Z5WNM%>TI3ZL6[>3171V^Q94F"2.6"3)0&;3F#O0:D1T<#
M5O/%EO50LOBW/XCAI!.W4IZ.C]T!S%(NOCIXM6*917';[ZED&8,91<KD+A(Z
M!F2"I[ETGJ$N$&J,G9:MQT"N&6)3(5<EU<,LU2%WMV\/&H.3HR/;KSKYV@$0
MB$ZG=SK1ZWX:U>&S^^UNM>M,Q<K538KAX:I-XV)SJW<I>+Z./1[$-^,7OX?V
MX+ACS]ZTN]4HJR_]/KKZ:,?+-YC:I*K[U6__?MH.PX,WQJP)23)G&X4!CFY<
MOTO6*CHWM>/6[PF]QA2Y]FV\]JOO"<9_Z9L_&RS1:YQ=__82#O9V [HA@/,.
MG;5_X://HM7VW_%X&(]<[#<87FUD?%YL*_=G-1F;T8_F@E1S01;2=_PG4_!3
M8WWQ,'X[\_2O?KOKV\>VT[!'\#C#1B\UKC59P0YT^=3X"B,@UCO8G )Q)'#,
MDE51,>*T2D$;'<1\JY7/8ZB77.!CEI8X&'X&@_3O8;9*_XK]+$-V/UZ8GX@^
M3Z(PLC^!''SX D3@ZR&0@L/6]N=.\[!ST#J',7_(8PF'.^=_'.QN?VU/VY^[
MVY].=[=;![M (G:^-4GKPY<SL#]9\W"'[]"OARW:.FQ^>-]I?0-R\3<^O7)P
M\M;@W?][@/W1UZ[]9DZV#G?.P%[M[!Y^/X/KP'-^;L.<P1Q]A;%_HF#3?@<[
MN W7/?J_YQ_Q'K7 +7-WZ)#M5DZ81K#\!$@+I80$)[ Q/W%[S)6AG/5!(@6Z
M:AF05NP,C]Q*%KQ/6I)4R1 AE)$B0R]!AA0ET2F=D'18(V[AE3/,(2$8U08L
M=1O2RCI?$[.1:#-_^%^-^,,?V.Y^K,EB[+9[_4:W-P2,#">Q\3ZZ_HGMGV6,
M9U?):&GP4QK\/)@W]]?VQ?G>W$M0>VO[_3.8JXUJMWX>;MIG G'3Z0A>.1FU
MHTC9X!$7N;PM#18Q8B2A+GI8V]S/<96I116(*MW,"M@MSW/? >Q^C< 5L'LR
ML)M.#9!<6,HL@)T0 ?$D<PNSQ)%F1 C%@N,^%\/C;%7-(65+BG8+2NE]!4:\
M%<F&'#27G..4 $-14CM'J1#2<W=--\)B@#V6PK9O,L"^_&@>PK6.WF=#ZWMS
M\W-G:SL<M#XTZ<[A.[ZU_0G&^"<\Q]?#R@#S@5.>N$41B]R;QUND";P"N([!
M8D\DC]<88#?96UM^V,MNM7N:6Z5 ]RUWWE_2W++S/IDB3YL98!$2, P-4MAB
MQ+DDR'ICD/9*4BR"9C; SDO4(NR,4FE_:14Y*$6U(S9HS;G+3C#O0'\MT&HK
M8HR+I]!UG?'SV.\5';Z;#D^SYV0U)=AS%)C5B(=@D'%6(!LXY@(6%'NZ KH*
MGZ*_+Y$./_8IUQ-H8$XI?P-Z!\P8QI1C$ZIPA= >^(HJVVYHM >#$]OU$>9@
M,!RL-KIQV"C5]N\ZT_^Z2ZBKCYRH1!-EFDL7=&3"60V4%/AG(G=J*W()=E\N
M5WESM+Y_]>-1^^1HHQNJCXX6^FU>YU8LQ&9QH#C;ZI<JY2EL:8@8D;-@G4>.
MIHBHY\E3+6/  (IJ5<RIN_WO4M#O!6BY,8Y+ 6* C>4$:\>#C"P2KGBPDIA?
MHS1%RY]2RZ>I#W<!$^H$4I[GVIU<(.<(S66X@U%&Z,1%CF5G8K9VYY-H^6,[
M!9] 1T'F&WY$_"=<@J&*/EY\Q;^[F'#W.QE:.C1\ LJ3XVYS,'E&NH)LBT*V
M.?V!*/=.) /VG+<6^(OA2)-LU#%C.-ATU,O<-(3)5<H6U<1\:0Z B\HOHJ+Q
M@OA/4?D'4OEI,F.EL9H1CKQ.H/<TQZ41,%Y4E%YX3@@3N1 YIZO,W+M9T&.I
M_ V$9YP] 4\2?XX2R_?)U_MH+R8 O?;/^9-^'TR[!@#;*&VY]L(!:_VO)\J@
MOI?!66#X]C!\=M/9=E-L;7X^W-H,,#^>-\\_\7RFO7.^VVX>PK-^^/2C=;CS
MHP5S^7_/FVPO1$!Q''*KF B\S0:)M*,!868=\#:F9 9Q-=N5_DY>XH>+)'[9
M_J,GT.9)^O2V!IK"HA:HOM.&DZ**4&\$BF O(6Y ]ZSU8#AIQH7V3*J<(4+!
M;C+W+B)3W+]+J[Y"6D.L8M8RQ0G'+C!!+-;2 YD65O^*]3-7?<LY]J]J[K3]
M0[TPC"B.B)%@_T2/P?Z)"M37!LT,-?#;PLZQBT_W+HI73^YU_UY-QE^ZMB[X
M9T5F7GA.P.+GYZ5L$ _![UJ]KB\4;[$;Q=:L;]P;XEDR 24PJL#&DBD7MQ9(
M*TNY]@D;E>L$8K-JV*/4L+J3!CWG<H$%2@N4/@[7+E#Z(% ZS;F%<LHDSY$T
M*B%..4&.&8:4BY9Y1H2V^H'.')X02E^OYW[Y!EP>;:9*9>W4G2K4-[\BY46Q
MLI\5I+RID.5C%V][W^LWA@<1_NO'V#BJVA0T8C?$T+@H$E5#R[A25.4"SYO(
M:OW%W#ZTT1YE^#7BC^/8'<3&J1W<Z< F5T4 +LFEYI('X(L\<(=-$L13H;D=
ME1-45\H)_FP#&^<<OJL'].)/S'^]Z.#A.[&UO7'6A!VN==[\T3K=4R)Q;;A$
M4@F,N(L)V2@UDL0;HV!W\M:MK+-5(6<I?24>=UEYQP(Q&*P^PS4/BNI\]*YP
M\%K[?.MJY<EXY4E9^8=:^;/6QAZE 9:!)F2H-8@;$G,0IT4I>!,$\ Z!60[B
M-'368;_:@%D_CO#+/[%SMMHX;0\/8*E/CG.!TFE\N.-Y[L+@P?X3.F_>5H.:
MDI,B([>0D<Q337 PXTD '$A !^D,TB0!8S7.\N@2YCCSU%7)YYRL/ADZE(6_
MW\*W/NUYIUT0QB-%),^]W -RW,.VP##)49#PHXKPEG/R./(<-Z+U!XUC("J]
M, T662XRG1B=N]=EC4>ARE,'[M5GKYS*K]8L) <Y/RGGV)@8_%9ZW^["H&%0
M531(CA 9#?>9%-5_8HG#N1B)E8)&DDL,2MB.I+)(<Z61U3KAI)/S#E?;$9EM
MG??T1.3VXE!6O%IQ(" :>QV428@FKA#'BB'G8>V-83'Q*$G"!*@GH7=$F+7&
MW6VQYV;#=>&=)S3A?JDB?"'RB]<CFD-O'&8L&(NB!&7B(5KD<'2(6J6L#PE>
MAY5ULXKUG+WZKLCI*=;8:-#.Z$!EE;;PF@)(&RVME7*$G*28< ^]\H"@Q.*H
M(O.(V 0L#58=.1H<(M0X23$.BO#<;A8T\U%-N(7!0V'R]Y.1K8T]'#&C6@6$
MHP$9"98B'35#6)F\-LI*IE;6^:H6<_;9)T.'LO#W6GBV!28<%BP:P1%+(8#%
M#L:<45$B8;0@T3KK8Z@7GCRN"?=D:%)LMP<0-=X\W7-44,("0XF&"*+&.#(A
M"D2E9YD0^^A%%C7"EY&!%-OMCBO>.MUC)$E,'(9=10/GQ)(@[5A"'NQV09D4
MF$K@G.RNWJ&UQBC:=_3N+!6!1>S!7WWG),0G,EJJS6DCA*J)HNW,9;!%5+*H
MB.:G/2V4(3HI) -GB%,/HL*-1EHJZ35-QB8@(',8:MXG[,4LSR&EIV#V#GL-
M%^$]6.JCXTZ[VG=J*AO[0PM_SP&R@WRIO%]=Z0O0:%7U*]M@/G>')_TX2OC)
M92T;]A@NYJMBEW"'=%*]7XODX"7[%[:ZEW-$9'8A$+W:V/C'AMAIU- 8&V_M
M&=RH\9_V47L808'M^"\?!QV8PP&L4#PZAK>J1;'=LVIF;;8K0KL/JMXX/>AU
M.F>H=]J%#PU.W* =VOF6HV5Z._K:O_(O.?*<XM]SOEUV;L OY/=_KU8L(]YM
MY\!6J*AP2-PG'A5W(G'+*+/*)["4J]A3HF'/D'?)%'P/1.HN)3/Q*X.$K>WO
M9,][HW2N&$-A[T8<]FQDC%&("863BS0J2E?6"16K(-]S.,+^?C_NVR'HX)RR
MQVU@F?,U&T03OO!/]<4.K%->KRM2M942*$IW?RQ76=O_YP0T,;5CWGQ %X<G
M(P!R)V>Q/V@<G_0SOQWFCWX^ 8 @G&^ V(58N^8NN_ V-OQPK?$Q8U.W&VOQ
MK+ I?VQ\Y]HO5TMW8[\/%XXUMVZ#(+?AMG _?V '^=8_03'[TVZB0@ *8^PD
MP8(GFW00U'"MM,2"\"#RUE=+/KI4@8G-[JK$;QWG1]GN_34:V<9X=2YJ4M?Z
MD(,*K^@$H))_$T[ZI[U^&,3N*U.$NN7CSEXBS)A@/?(A'Z4R09$S6E7=<)1(
M3%GF5]891L&>3<<C-7K5W&?9&\M%X^0X_PKP.K%9/B8L7BLAP]['KN]'&.-=
M,?+5T:;M*B1#@4T38TY;-A@D0\@<G&$P\"5O*6,I&I4+\NNY]?AO ,EK@&,5
M]N(VD/%\ I!.8%/.FW??MP> 0KTY9&"MD0M-'?=[/D;8Z6$WCT#<0\.=3>[<
MP D2$*^YKH"Q.05WCIET'</%?L#J#X'^WTEN?PG4?K:O_S5ZJO?]WM$XO7\K
MO9I"+/>0WB]GS=.]H(TSQ' 4) @NYSIW.'<&Y;;$8*%327/S;<+4JI"SXKO6
MV+YN:^O'2=FJ,A'5[X-Q%?H3L 5@Q\WRZH!!5V9\+6JPF7YOQ+R=@V0!&:A"
ME+,N' -=S4R@VHSAW2G>>7&'^*,-!"#74X.KC8R F;MF^\'!IMV-@_JV$7;V
MD3G;.#RI/EWA\S2]O>$VLU?/L0_5!4 %XJ56_V,[)W'\BQT,XG!0?SU?<G "
MRCUYD;47;;QL /1U&J(^^[Q"K2K[,([)U;B=P5U]D<P&)F&#](YA+JS43,BH
MO5<Z6&GUN,$7Q^+6>^6[T5#*_O@SA/E^UOJTI[!US-"(&(9_.&9 FCC'R"=/
M.9&2\\BN+YO_,U,A.Z5LHPMRF&4O#L:?G6QL,?KHI/DP7KO&-F#-H+[/V)2H
M :T?CRPP^3N&*TDOL,RE A6P,D>23LQ'JSW-X2E!N)O$;#&6ZJN3LL-W!/8Q
M*@AV-%DP4YE$,/T.:>4M3(_ARB;/K0C7]H#[-1964Z'L>!H#4Z@V@RP[E1?+
MCJLDG35"OC9<ZI*:56C'7C"P;T_XA*ROZ"-,4!K%PLS149L-XJ-> #/>V['!
M=,W<UWHZOORQ;=_-J00,5 ONO7043"<GK27< ^$!G-*YYO7(JPRJBFZGLW_5
MY&2PE6;*3!6UG:^V3='<W_.)$JZI02XYAGA0"5DG(J))P2;MP !@N#KOQ',R
M&4#%4@3! 3')78T:![U.F/"XS!&QX8$=5M3TLGQ4[Y^1"^@2]*OR#-=>9([H
M_;HY!'L$EX+D_I68.VVT=]8G)\!X-%9'4P3QX07Q"ZF"YH.SU O$B0^PB42&
M3 H420Q"J+E4VM(<E</G&?$3@C@\:/<#2$6_\B56\E9M$Z/SCY!1+K\[EJ]+
MACN/EJPU+D^L\A%^_D:R[?Y5\R&;-7!-6_GU<SAA")4;OPNB/<@"F**M[)/V
MR+-36?YWLMHMSWX,:JG5G &'=M(;ZD%@+0\VD5N+Z1PJ_;8:Y[#M.O'=:.QO
M+X;^OA[YV"6U&>N?193GB[(_;VWL,4FCX-(C')5#7%")K/ $['K"C23*6IWN
MEK.^T-7?")F75""UW;L4[[\ 2#]VW]KC]M!V)C[SL?L>!/YKEO>M-"$K59&I
M:3DI<O$3N5!6>J8,V& Q.RH5![G &'#.6^<MIHDYER%.X-ECW3F1B+4+LA_#
MB1_9YW,JV=<0=[%HHUBC"]VO.%_W^G*.HPA'"]?HYXB#7C?GLU_@6'58=.D_
MSWLQRJ?*M1#5&W6!N9<GSM]/6Y_V>,) %Q-01^5!ID7T^95#QL5<7L-K(?!U
MXGQ?#EC;*GGO[G5'3KWI2(>7''"0]6K2#FYW.CF@XTJ[42 ^>>Y&1U^CF1PS
M],S"NQ>'I1=^O?[(2KY69?,'IK."'*?:" .:RD$(A)/ GHT1Q"8M'$TW'"A\
M;+V_NCM51W:VNQF/>X/VL-<_^_L A&5PJ:N?LVWZ:@,#FN?O?N1>F%@$FZ,%
MB5? F2U6P#$T1X1Y"D:UE]:SE75#UZ01<[),-S;_'N3(G,9_D;D>ETG/W:#7
MZ/3RIC*H1&C>QRM_>2U;%_[YB4M<==&T*_'K +X.'_/D"O],S.Q8S)J@$T<G
M1[7#;RM-G<V_[_7'5L+K1?_SC[AYNJ<)%=*PG-^L<\\/:9%S-J!(:;+*9E>.
M6EFG<^)2_CVF+B (\7].VF!*Q3HP9!XD@;CY"I/N8./_%?O5:B[DR)[>2F[J
ML_N_\F O[_YJ(:KY ^BNR98[QT (@E,@)B(@AV5$AG& *B9Q2BY7OEM3LZ42
M*FP"D%IK?,FI-=.'3]GQ,WD:/W%B5>V%Q_:LT>L##ST9Q%&P8XB=-FP@5>3=
M8,26X<TC^*2+J_F7@]4:%JM##: 6KMV]"-'/;U>^Y?R)U?'>>AE=5Y](=N+(
M:?"LF4=UQ3>9P+?];9(K9YW#4Q7?86VS'K:[)[:V928>;'0I3M>4@ %42@6?
M>=./'9M/@W\_;8?AP;C,V\071Q6Y\.57K!OT.B?#Z[]R72FBQV9OJ$%X TU-
MTL2_!_WQB([M?D0.3)'OJ H->6,[I_9LL/+;E><Z:G?1U#Q.3\'U0G8_$9U:
MVAKG++8L2>)\3(Q3&K3ES A' %RC26&TK\-W8MC(IE441$6N?) 1<_B.CLIQ
M;1)5R6+"^;6K^+0D_+^O>KOG'5!E=!E9W_DS[?[\8"([?K<FZZMYTZOC'RJ<
MZO3J9$)W,FA7\1(C1+SX/<!MVD=',;3KS?$X!QA5AGK^V)4SL.=]WG5':)JU
M&V>>8ND>\2XB-\<NGI6XV0_-$;A>%\3F,AHW]3J=WFD6(-_N^Y.CP3 ?8@P6
M)Y=->W$"NSIQWZMWJP+?ZH"<RO"H$PD:@SC,;IGA 6S<,,HZ:"GNVW[H5(.X
M<'K5?BD81ASX?MMEKWO^0G[::I.O@NTF1E)=Z>%4[\VO"=^HAB3*Q6C?,'FU
M0NU('.L_U3D9;Q#151'=IQ#0*HQ#7E39?/PA_'YEN@A?$WDN_GH0N;4CD_<&
M=1Q4N5GY<U707+]BK\?9]55SRVLB9JJ,KS'GK?PU9XTA3-2D2ER9X!PGCMH_
MT$$[@!R\>37F!HR!-O?WF)9$LQB0R6<MG$F'K(D*1>()C\R%F MM)^"4(^F\
MNM[CS+F)9:\!(L][F>=JGO=/6Z=[ FOG7<1(I@36OX!_M  K+T9,HQ9<V:BN
MSC- <8ZLS'2^,>S;2I$FIGPR-*P9+:A+G7'R5_7V18Y)NSMR&U0564:7J;T#
M/W%DS=W]\I:0_<OM;A40,][K+&PC_W.27<CN[!;*O7J9E#GY5*//'TT\R>A!
M<[1XM44-0:FO][%V3W)!FBG?A;6$6$D=9YKS%)QEVC+J""?$"\/=#2<C]'8'
M(S#EV3("JR.[OGKAQ ^WTO9!_(\=P#@R9L7PM^W$RL]1O7.=/V2C&^#=L;/L
M,RC45O<=3-7?)_Y@NYZM37MVX2)!])7Y2+8V-U@+0(M[&ZA4*$E#$>>8(A<)
M()>2/JB@P1I**^MF]@#E?XWE[+A>IO&OG>Q5[8^6JC& R;WTH.7W*P_'N!#!
ME-^_6PMSY<R=D.A9DZ'PED?B+1\3X-#P,APELX?X3^4MS8$M&5BK5+LJE2T!
MC[99H0$ QZZR?A4#^3VBG#L:YW[$^Y/^0S'[J[3\]"#"1?JWX4T'(Q]=G7P
MP\K(W+Z:TE#_^2*AZSJ0AL=JIW$R;CY[J,)_JF_#W,3^?KPRIP\Z'_,)H)T^
M.KF&2+IXR25'D9QS"6+J]XXN#9P\SBKZM7H\F(!K-YZ0 ?GJD0OG()9<*^4L
M-SJ'[ALO8(<GTNC(\ V[SL39WOS8ZHFM9_L =HT\#Y>[P^#5>M"W-CW;VMB3
MT05M+$%149%S'AFR,A*DHTC.$ALE!4IKYL13#_Q!#">='!=R">134FV[PW:F
M2WFCN,B^N0B4'K&L"^3Y5Z^_FA6I ^_W:X][M/U.NU;C?_WX]ZQ"7,K?6&/W
MX0[5<>!H1QIO-1=WR3O3O\[J:\&?3O))T,S0IK_U;Q#A8;OS\US>7Y'DVU"F
MO\<S/5^ Y^3Q5FKVNL1Y>^,,R(YDWC-O%;+$*\0]S+65@J.@%*<2DT@2B#,3
M,^F[5V3X4JIN+2"-D>S.BELNBW+3+KHZ$J\Z/J53Z<N<C71B*ZH<K=<? MV+
M&1765;Q%O^ MRK_GO13$MI]K-?2'=78?R+"OWK_0JIE/Q3KF#V[?M"#@#49&
M15+_E=&Z\AR'B;3)Z>__NU*]6]LF54[9.#SD#E0E8!XI3XX3 '@7H]%!X.@9
M)S'2* I5>3!LW\E>(3!D??38H4""S@43.;+66423"\S(I)7-G8SGQ.Y? ?=_
MC6T$D((<-33A.OKW[%G 3T/5ED-$WEX^P(2TD-<L+JQYNB>$M)@KC[3-U3Q4
M9K:YJT:@SGJ8>H$%S]4\9L7E&F?BX!*FZD*+=;&SBU(Q%?;,<=/-!^X9# 2S
M:;\?;8V1MK;#<XI\WB7NYLA["B&<=.O]/>SY[Y7_;AN,Z_T\OE?K@]O>/\LI
M<%XI1@U!\"]#W&H!!I8Q""P%JQ-+1'";*S#,"N.%$VXZ6FWD29NLAS;A3RO,
M\+DRPX]7*ZV!WG0&UY&Y3&3Z,>2:;AD5)@M@;>1V?[D&EARSS(\7Y?0>QO$$
MW^D^%0.]W1,!J/< MJ^>R4U^<V(NLWVU6CGMQM1R7H; *#>\E_G$:7LP&QY?
MFX,PQ+7&QHC^YL (^,/J5>?CQ6,-#O*4Q!_'[7YE%HY.<RXE(L1D3SK#JHI:
MQ5-&-5-&,SXI#QDI5B]/M:IHQ%NNT,5XKEF*27OUZ@TKQRKL.MTZ;Q9F-YQ4
M4M/[IQUJG^(ONON7)D9F(CFX"G3)<S0.<\F3EZ<D'E7B6D=U7E:RF3.5-YDN
M_ZH.$U-UDCBJYG11&O/?5PR;BYF_V;HIQ&&YB4-S>X-M;7_:,XEBI1Q&5M"
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M:,TYR['6^-#.X;[Y(O78,^#TW.%%S\!_\K.VJ]#>@_9@V,M523IC&Z+.B+\
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M'L0WXQ>_A_;@N&//WK2[U8"K+_T.=]]O=]$HFBU'8561IT"N1Z2IXD_UVZ,
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M_SZP_?B''<3PEST[ @ <+$GTY(_FYO?S_]#=LYUO7NZ<OQ,[AZUVDW[BNQ\
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M,73<P/K;'= 3Q/;*%2V4Y5G  F$_%U<?RF0Q1@YP8_7W",:"3_,"89--\!D
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M7.HH^^\\ _OI8D?3MEJTK93KRP_M=5:4,^TO]O,G 1;$S&2VU?N_=+='$^V
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M+0MK@.\X S(1;U4O%>_,+GU4>^5+'O($:,$,6J)=X#U:T1+YFE)]?>QN(;+
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MH#@9M;40JQ6":^%A_6;368+:!9^.,F'(*A\\J1IJ04)TY6VSI?L(<CR21,:
M4G$Z5RM!E(?+ !\1+!+'@!/.1\ 8.;J4*N3JL6D%-M$!*M-EB6)$>@( G_ )
MCE$R_%K\G,G(WR+^B ,92(=%I9;7Z&MY"GT7N&%&V8Q3>'3C\D!>OL#OMTX8
MJ!W938#W.+J*XZ&:.LW+&6 >)G4  .ND#K\)0J&>LY*"TYCS+G@/ P/JG/RL
MDN/TX+X*W$,^(E)5]KM2B"FEI@??)>#K2*]LAOD*%4LC8282K"<4X!()WPW9
MCL!=1Q6LG(92-U/>0GQ,K<$1U52'&2PR>NE"7L+'U:))N1..&A&(JE:-*SC,
MSP1!FNY2-GV[N>)/.V4JW(:4J2M3H#HI4X85)U[*@R *8L=@8>@;/MB3S(E,
M@_N.]W I4VORHF..Y1N=A)SMSDBZIC[C+ G<L8E((;LTW4:";+U\&^FJE6;N
MHA^FRA_I/GU) DDW0^3ZF2$WR?0P3<,'[ Z%FZ>[O#X7X\'PN%8KPSM(R) '
M?=.\C"Z>M+#G5_,S%FGD(1(T[B\_8_&=ZZ=G+#[C<5-'I3Y:UXS!8]RNBLO5
M\9-RJ")F,45:&FY@I5\B5ZL,.D%H>3OQ\W&#^L;V[>V!95/4J9-A5G2UJ>WW
M -7FDG%3I4D YHYTIL[#-T!E,AW?#RPA]#JKVVR-"5=;18Y'HVOSO1+E7QYG
MY#VHU ,1#\07=$4V7!\!5CUNQEB5;2U+!*NB^'!T9QGB9@57Y20A\ T4[!",
M'5R",P3E2%(/LM4EJ3^=E)\Z#/.H0:_2)_PE49J62MS(U;Q<(1:@OZD^W#FX
M)F?X56UX@?OURO!ERO"?<V"= ,"8RT+6IZ@=;X#*M@7.L==(S<-'H\Z95B,7
MU5R>-'0-54Y"Y5=TN9H9UW53G:?>NQ+7B4&H4#!2@^!F]6N6%IV\AG>+/.Y6
M8**1S@EJ*SLMV'2HO?U'BS&;/J5DT'S24G*7+*+Q.(Q*SR>)J'.=\7*VF*2*
M(NWV@S)+DVC4 K%RGHO4JB7"CU0];5GIITSR; 7597*JB-I4$ 7,S&)29'![
MEX!2IF\(H4!O(V8F#K"[)U@L U$T19'!5<9IFH]&^3GNA5)7IU+LL)E<A#SO
M#L)NN%Z_U7R[%V<W8O0U6.IL)9EA5YQ):NBB\<[=A*6M:ZWYK@/U5P&L<AHN
M2^ZZF=D@X7OC^L;^>.3+&SSWE^L[%W2-K3"94$S?AKGT9%'HEDU$0!M\XJ+6
MU+YLJ>+T0LO._D"A#BKM*/O)9#?5A M-['A(N@"@^"R;%>BWV15M&,P@--IQ
M.G5EW2G@!>$3/!Y[)XVGB)Q7ORC><HMW3=-.\?6N5?<@R5A]WZ4KDH@L8\.2
MB&Y*'$N3CZY,)NHD'[EP:>B8H6$RP_%,@UD\L9TDC3A/N.4'&]JO"5-OID4V
M6IY]WR@+6U*;UNX<LJP="U%QEJ951Y;K]<[I\H$;.#.$GT(9F]W%OT7*A!__
MGB4[E_0_$?>NZ"G3760[T:/:N726J BVK*Q2B2!(%AA@(',9;J'"<FH?2 6_
M57]445-8M]$<9R6;8M%W(8([ZG8IZY;"'TW160$_@.X5%WQ6MOIR_(+)?.N&
M\0"?>LY'(_Q;^:2I^E!6GY)> ,#(BW*834DIDP @Z,I>'8-&MX,%R$L7TSFH
MJ?@,JHJ7.R;D! "LA&(99WA"L.SM%L_7JSAK&:FB-D^:J5W4D0CUBWTP&GXH
M4M0E%IZQ(EME SR"@@[R_P9+BZ^NY2[L%LUA]^U7HJFW+$'&DCMX!'8&08ZR
MT!ID/L4R]DMZ@S39Q2)1M(UD8'9RV>CJ$3OI&-95T5:H@I^="B\LWKGL;AD\
M79XM_LA(\8DZT]8U(-K=)]]AGD2"R Z6U&7&1(+_=Z\K?72AJZ7>N:KJ_;*#
MT4B+:P9;7N_M"O2F')X]C 3,E$/@/YR-9&.;_\S12#[FQ5D6H](@LU +H7E<
M=FU5PD7MR8%P0%TAW\[K/!<Y'7O%_+3C,P0]'A,3]U#F), 1RX9:*E:[;OO&
M5V#JC:.,M=ZS]ZKN$T1/;_1[5N$T?-C?'P\^?/ZB_=[N7/B'3!82,*WB=*P"
M;,5?<>A**6JJ59^CI0$RH4QUXCE8?LV+B>H0THS>4&Q.M#"F]M,,=-182.Y)
M(KM1%U3P"0J\=+)]%]J!VCK^>,:P1\KJ55/9;Z$\)ACG0_BP[YS:OXX:C4KP
M=PDL;%!2U1NW:YBJ=ZLRII8PFD_RJ0ASRB)ATA9GZ+&?5,VOB1G##Z25)"N7
M+N1H]3ZP1_)F]Y"ZI"LJ0 @CB*L<I-/\3$)]2?>5<:TFK.@+DU/7**F(P0LG
M1(T#0);QF#4<;W6)XP+2UXU@)AT0$8"RJAJ<<$XNB0X9M(4XFPIKI<C+4A<_
M"@]J=P7-HF(S;)[3(AG69EXSGQXLRRA#<=A9UST [IK;:P2"5K).T9-![D1H
M1+".<@Y[*F8J[GK;ZZ\AIGC.VCLRG9N<F2CV+SM;E.=YO26H8)&_E+:QW+#3
M!H!:0J]&BI6$L(0"6DNDU50YNO;2Y<B4=SS#? KR$1,#.1P/RLI.3S]$"6#K
M&-M TW.FFON!UJ^T]=I_O/MN%_3VF,U%!WXZ]C-0^QN.<WCH?^>D_=?XH![4
M=*@ CF![(63\(_2.R-_00E;HU^H9TNS9T90*2]I^-'ECLP5(G4 B4A3D*TMI
M_'=Z4RW)7WBD*N_RF1P'JE%Z<]+*5@/@<E.(7%/4J#!N;%AZRD0VT&85EA_F
M0&6F^[P>?3/3_FZ,@Q"1ZFHK#QKS: \L^?]7]M5O# _K]KC$C&IM=S+!N2(?
MN.#A$]"K@5^8AOZ_W1D9U4 1@<3-,\WGLQ+[X4D.-E$>X\7!(EN-[FO2^YLY
M(P6UGIZTE;N^<OA.RD#HG[$1#HF1&- =^G"J0(%XN\=YD6;8<^(5FR(TM;]W
MWM4-_*N?Z\;X4K+73Q$]$46>8N-]0F+M@E0N*=M-/?^ E=A)\37(W8&()(Q
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ME*;ZOR6I'0\Y@'>WH&!*RYN\N0K$Y>H"6:DK<*IM!ZAY+2+Y;4)..%WQH)(
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M>:$'G!.!R:?MUJ;>NR)/A94-EQ%2:\?P&Y<IN]HW9-K  ]KW+^'*XMX#GH!
MG? *O\77V#*!$D?%LR^ZA'S\]_[^.REN:W04L1!#L70$-H&GZ@YP%3^IA4Z3
M&KHJ ;"&&$U4Q% <U34?X:<Y(CL F4BXH>^<7$QA416Y'YZ8=7IL(7ZU&K]:
MM7[6MC%8=_6@K)5#H+:D%58D#U/',J_Y=Y0G&% H$1T2_F,9V=26%\:N:_[
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M@S^ZVI6!2Y8+J'6I5@=E88-@F"DAM&M:Q=VU'_/I3"3@@Q4A;UY</-KLZV_
M\\UP<0/6D@U05^R\(-03@R]P&*XZ$)!Y=")9:R]T.-(X:)SD8ZXG%H/EZR.S
MC4%]WE@*+L8&22<M4+,Y\+V (*5<4\(BA .=U50$0)R+3HMH)_W(T,D%JB#
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M1CZC%P(/?N7:0B"E_RT5 J:U8VVX%/C 2\Z*6"1>-WND*J%P(WKMP*1+)^O
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MU>5AE%9M=0??]X9A5.1B^!1(H_M^5VYWV@$Z#I,"FX(K2EARH>;;';X3GH!
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M:'L8PTY/>"E&J><M,_//E#\IC&_!("'7"#J'A/?$$GQ-71&]05ZK^<X[)5#
M1 <$3M5&#W!_]SU+%+YDJP@I;GX^G%(&;2ST490"+(^HT:RJF73>U(PF\ZCV
M,9GX7>M(I8R%%/!XMX^?//E5L@"[?7WVV>LT6(;,__FW;R=?KL^O3Z[/_W[F
MG7SYX,$'G]2_/YQ?G7ZZN/IV>7;EG?QV\>W:^WQR^9]GU][E^=5_-EZ2Z79
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M\NTEKU@Z%; <=<>0R<#DPXJ'4F<,!Y9V2>^*(EG&89%Y2:4D-+Y)>X:M J3
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M?-G$:.F*>]%J;V$\N[4PGOWI[/>33QS(/OMP_N7WC8YDKT[E+1+\I3 12JU
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M%B[YU5C.](&C1F&^A*? "B#"R:1LR908H<\<<ST><X$>0%A[=GE1F2E9CY<
MZ+H<.\BE*=;YT=A^S8>VXU0RH;\><U+LPHH],*B]TI%4LQY6$95-HT.N5LD&
MAE5]@#/MY 4H5Z+N*Q[2L= CLM"<&D*:@P7:QFVXHP3.*"27%.F:J#/"?SD-
MB:IY6,HC;M6\ZF*;8@L5$#2.^E$R^*XPX+GL-(FE1>6_Q \061FF2NB<ET53
MP\G(2B0Z+X)G*I_.#) G"R:E1"K55Y BOUG]="N:E>/,Q^-,R8*SLAI4:W6K
MXBRTY9:=SBC(=+B/189F=E6]5.X[][^^PPHA)).P+&@E[VY^N$77GMO]Q]M]
MPL-R.3Z\/R(M5_3U@\U6"'.']Q.V#4$0 VG$1J)QP_";5#4WAM_KB"".D@KR
MO5"#7CT*I]/"8VX_'W$_6>@N<_7@81N!*D">3NI53^Z)4D"5%-.8O>@4(M'J
M![D[C<"VNN%)56(J4C+&4*6A%O49-CV>PG_VS:_*NHUC@,=C -5;PL93*3 ,
M-QY,ICGY.BU@S'OXQNW!HQJCZB"2UA1@7C+<:++7IU(!51%6@IEIQ!&Y";-0
M0[:D :JQ &NZ=I>DNKU2_%#/X8>>S)5^AH9G:/NUPTQ; B;PCJ>$G>*L/)A[
M!QF>M44;)B1C9^QDP1=)T]?")MT%:4PN%74/J2ZZZO!)N]K\T@;D8/QK'U.!
MB@D?U#D<(_]6@9N";($)@Q75I>LX,V:1AI728"5X'QN"[,!!0(Y5DD =?MOF
MJ\4<VQHV0:"HF, ,J\ZSD\IXITBQQWP-,R5X9$7 X=:SI\*9SP&E+ Q %4#,
MA2%DY0&%6]!50K##<)0):O! <4")8Y?*\="W$+/(^<1C42Y+)VKW7\E\E[<V
MAQE\N;6,0<[4A*4QS*Y*.Y9A1RB5-6[\C:AWLY<00THESS5A=;7'2GFCY%TE
M@="RC#8[#5"/-!PJ9R,K;%IGV'R'?BA\"[M,N<X3;@[#>V5"G"_CMJ66$2H&
M0TXN*WY/H?%4J+;/<6)J<6:^-T[NX'I-5R)SV5N+P599J:7Z('HH<BK$(GTB
M_ O5QL8$V1?[7I0O1X,Z5&1I 3J=@[.69C__2@6P"^*2_T?C ,C84BO8X0-N
M$)DV+6T B!&%"\*O&%V/E7R<&92)K@W#RIO>< FHD'& NF$19!+/2E?!K (N
MH4 Q=S&4O\JXL/X?8J#OF%*,(=)7IBVP-"L9\2[O3F8% N%3<+D&@&_-79I]
MTJUL<"H!_#'+&%=/E7Y]DAE^G8>[#!%6;FQK$!JB4H%V&(Y($.05?WJF'>I6
M$7O?3DZT0[;<E]3"Y\MRM-8%6H7@$YH*%.L;(2W7*A[$S+'V".[$H5HC2]$4
MW?VJ.D%0QF$PQ=P]>-K$)C8D.7;-S,)O"J--,MA.5L+]MT >J+%1!Q%S3+ ^
MDR][HIDS*3/9R),J%3/V>J+#T[C.\'[!9K_XH&J_(_LIQR&YZ%'K2P/J+%7"
MJR0%EH4B<&!ECKIE!O5_8P0S%CX2:5QC(&XJ>];+_$K[)<]4C;_3?<OL^MMU
MC>QD'SNMR?\(,?\9M*I?6NU&UX-91XK#*]\?-!N'^GO5YY@D7UW#XU^ZO<:1
M_7AMN^R*%E%D=,-@;U=F$--CA0?B(V>' SE+%6^&.Q'=ZHH\"BNGFWW5U"ZP
M:NE@[3(NDZ8Z;,OJ9O2F7UK=CK68X.8&121U%],-N75^U>J,31?K")W$PP)4
MZE-8)EY&<8X%0X-^A@)[5*1THE0?M'(Q>K(S,SI8.88@Z*@\PDE1E>=1/:#4
M=8ZP:HIJI6Y!&8EZ>I=K102I[,D]W)[<]N6V5D"07%3_PXQN9^ &;O]$\E2U
M:<.61L@^5&91M5^7%0:L1C5T]UC;)=\D=.=,A#*#:3^05Q5L0)I7LA:CH(A!
M';8Z^+"U$F8R65&6W*>F&3YUCUH$SK:S,W%FIL)(+0^8"@NRU=#0*AF/ILMD
M:K"G2LE<QI'* (MAU\MG?8Y2RUYCKYQUQ,JI4$FFJU]Q)2 5_"Y%&Q.G6DP'
M"3E9Y+TG(X@K"PC0G$<$JI<VJ5+ ,3L\DA[7\NI*MRT>+A6<*'>TLO9)D744
M9JB[JCH5^-)JH0K9G"05J@KG2+881 >0&C.F2+I$#U5F9_):T*9&LB,'D6H>
M2(%O:I+"9%?<T5CE('/>+F/G[,)I=6!?NAJ17@.A![<&9$&*BK&Z<]"+8$*Z
M#)"["0<8XZ-:E@A>95F-D29.AL#D,YY.OYS)G GQG3N8&WLVI8P#WA5R= VP
MF6&?"MG?<EN;&&5\B=TT=%LY^XI,NDG"&#X X4)^!_J08Y\C?>E%B.4L&-V+
MV3?$W#5>MS)_$SP(=UN6<QT%MTFJ.+-8N[_6QEL ESIXM/DK6[^B")?P$*7\
M^CK#7A:&1DZARC>*3>)@(MVW]7T$99=HLL+#B)JOIQ+F;]6L)G8GQTTI^=P<
M7-7K;BE*?^.V8[DN#S1!ZG$?O1P;RM !6N).TT4W^*C7YWC=YV*##2Y[Y>]D
M54XB.0DF_6)V!$02[0L/THL-&!R-0?1M@C <"M3O\1<AR4;"9*EY?;OZ>GUA
MNQKA_;F$<^F"%&7/O,H$LE"B"Q9$F=*FCH-TW')>G2J-7<^W9:QJI1:[N8E&
MU/(P'O&]QLA("0&S7F9F_)@[@)\D)HV*CZ >U&1"4_/(<E5H?J*4&,HGB7J*
M8M7= 0$4,%!+FL93<!#//5.3-T"GVNV0KZA<EAS(1],VHJJG=!W2XA:?%.4N
MIXP\[P8,$<Q=6^S3),-30?:87MR)^)YQJ+TX,J!-$9L@NH**_"TRW4C'";6&
MMVB)G$-,*D24R#E*M+22R>)'R.EAYA26G*8C:DR&3O':$C4U!*> 8;DT42F!
M3]4F(F^O+$I$2<(*8!=0EBW1ML2N3'U:#;<'G4FCP  >K55@IJQ?2JB4B:!R
MO5*S49@\%_VO1/\/MC#Z_]RWL.J?3/63!#K/Q#2O9H[>(Q"-Y,>PG\XI17N#
M7B>&6NC52I5Z-(NO<[X_LDG.4Y/V7%"2H>7W4K5JZC.)J]/9IG.&?367E(*Z
M4AP4L2)"OPBQ!:^-R^FGE'1*ISU7H4JTE>:GDEKG>5D&LG),2%''6815J[Y:
M66Y'"\?5EPF=,TR0 O!/;J0 E\XU"<&OS-";KQRO61S_>E&JKW)LP:VJ$M0K
MK&X\5WY9@69;&6X[Y0!(TIL@5N^VRM18_;PQ:A<.BDAI0M37B=UME"*?W.5C
MQ<PRBR_,TF*:5_S96VR^T'Y\K%9'PQ8B%D0/5(E"*_AW2?J="A[H8XY^'%TT
M)%0U150H@]V:M#GPWF16B41T>AZ(H6B?4OGY"2&]90K9DC$3V,D9)38HC6$8
M8/ZU%$UF+?16-CY=RHCLC+2Z?1%,4AK8L)$")'* /$'R.R6="C4Q'3X@Y(O*
MM_<"PH*09YB@YK/]/-D?HFU<;NW!Y21)3!O?OWDI+8G049I;,6S [&J]2U\!
ME:J>&C_#HCO0JAA0+K-VW?"WVFGV36$,FQA!]@NQVSZ,T@ LQH*R*/Q2?Q,L
M5(55^7QRG>,8NA)F0AF+14RS-M]K9I"Q<^!!8V5P?@_7G4O%1*(G+/[!G=,>
M=4D;/L-*8M@JL7(,LK8<YMQ(5VK4<J?K*GKR;BH#DLPC7SH_,IFB5JXM:53O
M.COGG"EO]Y?+K.N[9N?P<26H$KGD.)/X";"(,1E?,%Z>L/&*)/Z<DU0,$J#'
MOX1"#>);57@BLSV?O _SA;_4+'5+O)*+1WE99[PUTLMK:&H#\&M\N&6%P;HG
MJJ+!U^4C12Y*%*/K@N,%Y3!)9:@:*I//BV?,Q'Y-N@ENUV]J%Y&XY_&PP*IS
M+T>#(?[?LZHL\F0R7U&<0QUMJ^XKV N#<0QSO)$ 5>4G\'1+<X0QICX?2-,Z
M.4'#(<M4V@F=5"S-29"^)9Y<:VC;*Y"IBCQP0(>)KV8N#Y E;V?*1!B"DAZ'
MV5A0=2.!.CM>9371W"WD\WJEYU1NI54G93H.0 (-1)'KG/9^F.A-I2H(Q/G<
M&R&GWGBR9H\=O55REROL2%%D^QKO&X>JW\9TA^_N!EQS IZ\SUGOD(8G,[&-
M$%0'C-L7&HKZY8B6TL\9H$0_@8/@+[\PV$Z=BRQF02065S&HE+=1C6@+UGR,
M3BJ56 3"P(YK :)=ZN6T4P4R" =>?A<.Q'Z,!(,Y9<DP+$#5^#'KRVRXB4J#
M N4L82<^1G/Q"&<BS^45;*6KZE1F5=>*37^3K$!9"FG#^TOX?1)X7TM,FE5Y
M7*(1 EV7^5^H9\FY(R55<;=ERP"JJ0)OLAB;+V]HBL7'NKKY($P'Q23+97"6
M_<$H3^6!,OY]OJ4UF6]%10C/];[D=4\CW)W'I:12FX.(,2$<=68H"<][GG29
MIHF)E2BJV@<#'CGP+;K1V_OPO'3"+B#<;V*6Q&8PU4+C<2AI5U75E0@M\FZ[
MF6R%5:3PR*B6H%()3(FU2BV#.KRVO*%)]YQ[W JMS544P.U#WP@7:K2&QV$T
M7MBJ@E#.7T(CC"\[A7^516-5A2D;L;^X/,.2.<I2<6Q3FEH,<FY4^A%9\42;
M0HB0$S(#Z[Y1:TM":+< ]0'718EU>7J++E3=CY0H TLOT4I%OG(95+(K\%5E
MM\*LR\N:Y8*>C#XMNL0)?&C6]N7#"<L$@QTOYV8562G((JTL1#=BA5-V@@0R
ML[F\X]N&WEC8(%<'&6V]6Z5"*==(A.G= B%"QIST+55\@/\LU6CPS>:K9NY4
M&4=B]+EP@/3$:.N]W,;#\B*JG/-A4D$-!0-$[9@-E8L@N)-B&=C#""M 5W5"
M\P2+61&/V3=<)H8" NO)P;FBAN P"AZK*NVDNJ],=;D^_SX;X\;4BI)@*PDU
M"RT;AVR:-)B&0V7"U/'@-JFO:T)P+HC8&=9\EBXP#UO+3Y1?479\*2$5%OI6
M%WE4E</%^.%,F5[05X);3)CSM:M+/90G.7%5EAO^)3^1MDS5&2JYB:0SI>KZ
M_DG<SBN-X1ZZ&.[].E8U?&#.P:*SPG9C@-#T7A.O^@'G8<UU$U[A;)9\YK %
MZ&WT&94:$6Q4^PT)^FR=/%WVCD\,CL1GT7C\5Q@?DP?H]L8,+KB)0"FR@U0Z
MXP[3*V)]2.E8VP!CXS*6:U >?GZ^TG?<U$^JGSL#A=7$Z=*TX@/D@*>\-LZB
MU1Y=K<U(!0;OG8J-C:"9?RAL+:N?"^ ]^!6GG"=LX9 >:[G3#3MH+I&YB-;$
M[4A+R6*OW-RK[I;VGI%H#'EZE=A@V4^ 7]9.E87L+!01@NMMSAJH5!+*#E;!
MA2#/4Z9NGVTZ,+%BS$X&M6@TLM[L:W?4<"[@68E#53)TE*M?A\^ .$%45YIC
MBV]N9=G="1W9(]92N3KS_$,TM5HM637$:*MBR1A289>![&W7QI<(YE5/"XDC
M9"GZQ3]U0A'ES1AI8JDF$DV_CN"7U0R&=DV_09"F(4T4X[4UQP]?:_5M:1W7
M1GY-[;"UF(4"SH,QU\PQ LN6LWXI)\A^2,8E<30QU"BCN:":K\H:2"].D2*>
M"(3/J?0#E6>6 :4",(DSE7.@UXD<' XY$]N*E9K"[1PR)S8W:#V)O#+22>8I
M*O/MS,Z*N>*LF"^4-H?WG=TQI^/MX0A4KJCYOOP-_8*^:;U_6U->_!8TP9CP
M2OT@_HX2>3!3E2_ SCJY#>#V]*[@$H3K"4YKU</YZ=.IMR='KCZEAIWC% ML
M6::,18( */Q'0LFRU#NI/L^P9K$DHU/*M (>NDW"(77B& 6HU9L4K'/*@*+H
M9 (7+.T3[43-*^%\C,-(Z'8VB]HU21<?+4>Y"6OJ5=CXVX6=GVRFEP*R=/O*
MVATX8TVUU':QE+@,O;29*,M:"_0*C"&S$TP6!",D:B4UZR93"G3GB")BE2?X
M7IGY@GO !@?)O$'=@EAJ.S+.IR+-.DO07]@CU I&&YIB89PBS0JQ(*R^U9;V
M^HG\YW;2TU>9]+3Y=^R:+@79(,X4_N%#/U\^5[HI,XF#(Y4=6UXK);JFC4MM
M1R7=T<@X'G4C#W5(V![@=(RTA$)=%<BY<=MR;Z,-J_G.'??;N&=#)";W(]S;
M*7;T29*A[WU(BQM?MKC.)@+N'>\$2*4NG8\?3D_,_3;_3E5,*5]4VYUS%70O
M*Y4DF%>:#>@KJU1]&QO&9 L+?WLUE><75UE2^HC_V'66&MY)V8?N";)UL\K+
M2->4OP&Y22T<!8*1<]2Q"NG!K)N&KIRCTL#GYJ +KZQ:M*J^*V2PL.STMA\8
MU,S*@0[F@]I><6QILFRG+AB9\I?C3_X2Y(/Q_C^"'S I[P1$U)!#L+A?LXJS
M6S8',UN)F;.B4F->UAM;5$[,/B;+-\EGAE!Y3=0VT]09KS)^F)6R<E2?SSJ*
MD'*$Q[S,YZ:03\#=>%22#;\#/0BW0E<.LJ:B\L%DG+?FE_+A4)=BXQ,C-^A$
MK1JE%UZU[.XGEQH&XH,I:=#>F=45X$RGWY$O>C))8J"?[MV)PUA-V4P7SQ(%
MU3$S5,1\M*RN>W0I5[[<70[+7JB2P<14J#S*E=^S2S(=K]+QL,R^J@HDTSU,
M.6UO9*IJ !.*6WRYHC;5RC"MY$H-Y/ #[>_J"]-]3B&>+;B(3Q%"3 @+(BWF
MU>VK^KS)JX(N??E(;7@5#%X%HO$K3R'SF7[S-1#L4L#7)CVE.-;RF-V1KV;O
MJ3?BAK3??(PFF:X[YN+NF#4=#RT _H)^E-7;MZ8[935'ZM6TH+Q>:*O/>=2K
ME2Q6DG=HK$ZE/+& T37YM$;%PMSF4B[Q K5Y^S4?E4F#E%E"1EWKP]H"WZJ#
MB2))NE7L'9)MPD@*#H0^:;5=?U$*LCN%JV%)SKZ+$>/W33N/%FA8)8V-?D33
M17ESC^G(Y:48?*,]43QA4D66_YJR?2)91P*8K=O#"(76!^T)Z<.%WD2]6/VI
MU895DFN/F!&+J^(PJ'*F;[%#*IQK2A3R$9"7H/8WD.)I-'>0+=^,72R]?%WB
MQ<M"C_"E;&7HJ@94_7G(QZ/35$7.BI@@X'*!V*/D1IZX3!4)HNN3:K2HF94X
M#.F6JE::NAL.P:T4W(QO2EAJ1766'@(N 43@+BM=O)QY9*$'='_)<I*+B_N7
MX_Y'+NY_K^"TM?2ZLD5H/F "<\F%97.IK$-C!)UU@OJJF6Y=X03M0"ZE& VY
MM -W5-[R2ZG2#[HLJFQ=0.OVK-!7[,P%/;;64NQUG,I4%J:L]7*;+5E1AF/?
M]S?<\LEUQ))N:!6;053!?#DMF6A6L@OM"$7%QX6/@.I;J(9UE1:+LG&)UOE*
M:[6# WW9K=I4ZS?0JC*84?I;$1C,44,E5VO0>;6KU5V+I&96P9RRP\4FB=3[
M,+M?D8&>K%726F_+^?WS/0VHWC$FTF58?0'KEBWK.VI;K8IC=#V$0B;8,)T&
M ?[;G/1*-#6K5*=6YJ$*92ZF2[4/>"UY@GE*J(::Y:_^>.N=D!8P\LV]6_78
M+@0ZFWD;D'FY/'H9":TL_3* %-4,7<15HE)4=K%E:@2E>C:<UF17L!\1@H9<
M_2H:7]9V9'%VXD-J/2O+<W-F+IWPS+<:9SR@#D0I!K8;"5'UP9[?"0 0>1CO
M\CXR);>N"'7S4")A=802 ?H2[85.&^#1-!$@!I,)J-E&P)=*NH,Q3UT_1I$\
M$[JP;THL@8R,8CBBUE&,]<-(:(A%A!59'I<6[0?28@O04DNUA[\C4*3(*OLF
M#[J4K;55.?MVSK#$$!),<*Z^P"+@H,T25LG\Y6R!7G LPUS#8O1]42J0;G+U
MT2W,,R3OD;K058H735&E1.D72JWG)DKZF#*EE\!8^0S;Z@S8%5?/JQQDDMVZ
MQT!UJDFJER<+_&+7P4SU_[:A!KKTL*JIR-.1!:7_7U:3+F/9:GY-[0LN\&M5
M&_OT[?-_7_Z/MV<5.GO+=+8@CN<C,VNKJJ[D$?+;EM7UR"I.4.(5NL?GBA.H
M5&O"3\@-F893+(PJ9 WF.PIQJ%B$24I@W5X1JH0\/2\QCR_U-[@UAU;O6)@D
M]IJ4&ZIY^3;!U4;V@Q*JI9Z4)P/5,GDH\"E--74*2J>DMG"M+EHK;7^&]F+%
M5M^NN61#A6IJKC>\*T[8BJQ"XTM.M)FRFI"<L(VB(;8.1:IJ9=BIK%RA1'U0
MT:LU2&99O5%-;).4:&6Q5\MA/[:5MNAWX? _WH3]@^/#;KO3"X[Z_6[O8' 4
M'!\>'HN#T?%1O]<_&/YOJW7TYCDNYN6PUNNSSUZ[L:CIW[<OEV>_GU]=GUV>
M??"N3CZ=77D7'[VSOWT[O_YO[^KL]-OE^?4Y? C*K/?MZ@R__'IY<7IV]N'J
MB>[857L9XNQW00^L7]\7,$T?$<ZU(L.V6QO"L)V&MXAC/YQ]//GVZ?K*^_;U
MX@NPZ)?SBTN+4QL+..-E=.8'[/'C;&1W0S:RNU#R?#[_<@82Y^,9")H/YU>G
MGRZNOEV>;:14V4C>R2V_W%-QT>&&<%%O(1==7/_E[-([__+QXO+SR?7YQ1?'
M/T\F>UYW!.=X601GC4/5:>I#];)Q'Z#%8!_HFX)V_BXK)F"TS-[#'S<PBMRJ
M5O<9FE4O.?<'"\_]V7_]Y?RW\^N-O"[T=I5HR:24_;+4@4!C;9_Z@DPS\4[]
MY3V6DXR"V;LPID'I1Y6MP<W'DH1H3\D30H>%OS9\T6@R;^0I_/]0C2R_;M!7
MO^;#FN_:C7:SN_#K9J/UP.\.#@\?],MEDSWJ-@Y;QRN]]E<B!!,#Z(U;]Q]O
M.F_,0:2>[N_:TQ]>J]S.'=N\5TG.U'[^(T)[>O9C'/;#W/N2&$DNE[]D94U<
MUYN5'MT&(GP0V2 -IZ5^+M8^5RZM#A_"VE7+TY@GTW>P: ]NIG#HJ04\@'HK
M/+K^D(_+OC#P\U^HM&TM.).4YM![_V^;P;S+5+'1Z,E(P?,;BD'"3KIW%'#%
MIV!.0>U=+?C<OW_Q"7KC5(S^XXV<3ZO9V@<BAAGGBJ-WN3'.@;0?L2*3@96A
M5_!,/^*=J)IJU(\7@:R5IICM(X5V[8O\#LLAR"S.SR9E]31)IW)^Y#'\/14W
M&"/_*P)>84K__FM058=V[#2UW6G:L=/4WI\,QL7-6!^G%SM-UV-8=N9=-;S/
M@[_ C';_-'7<:=JQT]39_P[CZH,2W+S8:;H,!^,@'7K_&4YV_"!U6HV6.T&[
M<8(ZK=8_.\CJ?&Y.2]D&"HFNJUJ<_1"#@E )%UAMB,N18/=:.F&7122\5B?8
M;W7W D82\$>]H?QHFB:3(KH)3'8UOE^5$,&$Z=T_.FUW=';EZ+37.#H?-8#(
M'9V''9TVW#KN[.S(V6D_WK73.J(4V%-35J/5Z35]RMO'?IU8?,!Z7#UTW#Q0
M(UT%:3^(1;9_\2,2,ZK; =^TF\WV[I^IMCM3.W.F'N\^<F?J)]P,K<;5Z5\V
MY%2]! 7.*;SI_==OEY^\Z^ '@E!G(,,IAPB8Y&HP%I/ ^Y ,"C2DZ\([.\$$
MIR>?'!,L8H+3(!K(+C?>IS#^3NT;=YXE/IQ]="RQB"4^B%$8AZ^,(SZ=_.8X
M8A%'? KZ(GI%S/#U\LPQPR)F^(I%\ZEG^\\*" G/4&"X$D+C_18Q3/<5,\LI
MY@)Z7[&#*^5Z!=QM\P/FIW_$0C9[7.Q/1G="B[=4*R=5_"!7O"8TK]FE @<P
M%\[/"V-/8K,R#X_KO[WUYMGN5T+UW0L;/'X&!&8]NO'?%F$O/U)M'JPPA11:
ME'"Q<<M9N)Y5_OQ8I+(WZGWK?ID,71FO7IAL4:KN3MX)*N:*;:'BC.M)8/,(
M2B9,J7X'X7<>AA!__BVOQQ!?G?_^Y>0:LTJV!B6,B&M;GKYL%MI7RW7#V=M4
M$X.KH"C_C1@4*;=3L8,,^'7KN-/UY0]OL.Z@*O$[+*@C0Y%1\40J;L755+BZ
M#RP<.S5P!=2^& ?12)5Z))^6?(#JF18QY@;C^TPCS;5%DL)6(Q"S5]X G7;P
MO,CMX^/&4:_S$.!VM]DX;B_^^J$0ZVZCTWI\X':OU>@>='87N%VODU38LZIH
M'6SXHNJ!V"=_/_EP]LG[^I>3R\\GIV??KL]/3SY=>5\_G3[$#%NHA6XZ<>IW
M?.]2"\"W3VB5;C)7NT5M\J)VB _!M!/OO"]@]Q%$3Y9LWK$M_&WV;OM61&^L
MJYI4O\9?LU]K@/R[R;2O1<ZLF0>UKI?M19?K>-4M:M-EZND8&U/,X:0<J[I%
MK8:P>F9^W?N KIT3[=JI,NQ+T)]0MT\\@37)M 0"^;;L!EL[ -%JO4#A N?^
M<NZO!<Z@^L3^5F])9O\#G$I/F'2_R;1WB]KD1>T0'SHGS::NZ %.FOG\\-UD
MVM<B9W;92>-XU2UJTV7JE8BQE>G?L5\9HAG#H:H^S^Z;N90<Q\1N4<Y]LPON
M&W.T<9;8GP_[<,4W#_?F/&>YUMJ2HIM3P[7;7%;#]==^,IS!?\;Y)/KS_P=0
M2P,$%     @ CTII59O.^^3W#0  V9,  !$   !A=F1L+3(P,C(P.3,P+GAS
M9.U=;7/B.!+^/K]"QU5=S5:= R%OD]QDM@B0':J2D -F9^_3EK!ET(VQ&%EF
MDOOU)\EV;/PFF9!;WYKYD &L?B3UTY*Z6[+]\>>GE0,VB'J8N->MXZ-."R#7
M)!9V%]>M+[-;XT/KYT_OWGW\BV'\=C.Y P-B^BOD,M"G"#)D@1^8+<%7"WG?
M@$W)"GPE]!O>0,/X)(7Z9/U,\6+)0+?3[::OTJN+\W/KPKX\-RY.SBZ-TS/T
MP9A?7%P:'62==4Y/ST\^S*V_+ZZL\\X9ZMAS UW89\;I_,(V+LW3$\,^AK9E
M79Z?=D_/).B3=^692[2"@'?,]:Z>O.O6DK'U5;O]X\>/HQ\G1X0NVMU.Y[C]
MV_W=5!9MA64=['[;*OTTITY4_J0M+L^AAZ+B<&,Y6\7A!EK(.3+)JBTZV[D\
MZ41E!1(NP<:NQZ!KOF!;C!KL>8V\?!E^N2TNBWHZ1N?8Z!ZW &2,XKG/T"VA
MJP&RH>^PZY;O?O>A@VV,+$ZM@P1Y6P42EQFD"\0>X IY:V@B9><^O0- :!RO
MUH0RX&8$;>C-98,]RJ18"P3LW!$3,FERHJ3'B\J^9<JWD<,\\<T0WXZ>/*O5
MUJ_5]XP%A.M*-2=E@MK#7ZJT(&%JQY>7E^TG83OY+<@U!UG>$!^-XZYQ<ERA
MVB*[TJ^;?S,BN7VT(1XWU=H0R;VR#;ECI<@65)+RNZ?9# GD(?-H039M"V$=
M.TP7%Q^J6-X6"'HREU4J?2DO/^54"UV7,(D@?@E_6Z^Q:Y/@!_Z3H.TJXFZ"
M[&@&S,RN.0-$_G<%J4F)HQA-[34E:T091EYR9I8 2XKLZY:8GXUHKOK=@?,C
MWI*H2*:";0,4E]M<!#EW<4\B66$#URV/<^"@0#=U[OB:HJH=YR(>7R8DT?_W
M_3>A4[7_7,3TG3]']RUD5^T^%\$NWJ'W0GK&KP-L7;?ZA+N5:[C@K1._?YF,
MBOP)66E</,*,4./F?.K(?\? B/U0 TA)($0_MM,"*2C?0];8_20_IXT\% Z+
ME BFK$-;;ENMN6+ACY$>R[0[?A@,'Z;# ?\P'=^-!KW9<#"=\;_WPX?9='Q[
M-YY.-36O!:5DI<NIF')UHHB6"!8D<4$,#,:W0$ ?6(M5W1_?/TZ&GWF9T:_#
M/5*8Q57R>;(+GUOU'-A5L? (*>_N$C',._!65&]7HN3]=#^\@_=;]?[4=#NX
MZ=WU'OK#Z>?A</::4;V-HV3S3(_-$!4$L >N$CK>UQ@M 56R>+X+BX<16#Q)
M3C_W^'0UOAL,)]/!\';4'\V&__PRFOUK3Y-P,;Z2ZXM=YM]D?7_[ZX?N\<4_
MP/NPXI] 4/6!_\0BV9M^YG[MU[WY5R]X2GX_[+2^<GP@*SBPJ#'*WL*OTJQ,
MR?_E6XWO!L_W4W^U@O29V%.\<+'-N^^RGFD2WV7873P2!YL8>7J&H(FEXOFX
M([(4V#,=XOD4"=(#8$!LD( &,3:(P!O$W"W$]%?H^.@>0:$G,2CT>,J55+)R
MG&9%P ") Q) #6+@'M)OB,&Y@Z;(]"EFVB,E5U+)0#?-0 P#8IP&$7!'W,4,
MB1W9N:;I;TDH%7Z25K@0-X0\$  -TO3(Y2I$,_BD:^%) :6>3]-Z#J2!%&^0
MEL?< Z$]ST/,@ZYUA^$<.Q5FE6)Q)0-G:08D%@C  $<#";@&,3)=<L?P!G+I
M/EFMD>O)]FBZ0_FR2B[.,^Z/  (2"22A&L3# V)WQ/,>$97*T",@+:34_$5:
M\QP!" C ,0(:&J1S86H4+;FUX0T26M#=CDR+*?7^(:WW+0S)0+/TOL),^-)B
M&N\3&>$@5S\.*P-0<G&9PT6$)A>"+;P&T3)!'J.^R;B;[2[ZQ&.:;.3(J4CH
M9B+@+1 @41JD^JD_]]!WGW=@N!%VJ)N.2$DIU9X)<6,($& T2NDZV9RWR!!I
M9XJZF8A8/U,$WD>?FI3NRTO]S$0"09/ $GDE69EH.C^!!-X'@$VB)2\?5(66
M$GDE+9G@.S>KU$16DLFB*FSDR"E9R 3@VZFF)JJ_,)U1A0L5B)*83#1>EAEI
M(DVI*+L*.?FB2DHTPO0F$K$5- <95*&4*H240RB)4<3Q85;WO8#\J8D,94/!
M*N042BMYR<3T.>%D$_G0"T<>(*6\H1LTX%X1=O8:ZF2P55R>O&)S7,R447W@
M?5ACD_C.BU["CQ9Q)\+9%0/B!GK8JT3V+L!*IC4WW(7''E8%B M>*@.RM@//
MH9IV&\5:2$HF,VF*0B:;/3[SPMB7>33O8B4N=T97\IO);.2'T%MS=4&4?6!=
M*F*WT:J%I&13,R%R&*PYP\E<(LMWD!A/;&]CM 14268FKU(X-,-:@K')#@.R
MB(0O+D70P?]!EHCCB#MR-SR:D/N#>Z1:HQ8E]YG4C0[W<<5!2H&[5(FZ&VD/
MR7QFS)#X5HEP-8R2T4SF)Y4EW:8R2)PVG+#=5M)2!"5-F3Q0AJ9F+YV)PY&[
MT5,&H&0GDPU*GK9L/#>%&P:/%*TAMH9/XOP=$A=ET3Z/MGEO XE*).ZE)A7;
MIYE\4>G^A0'"RD%4NRP2R(0-B&0/UI'0G+SP0-PW,(=2:"7_F2R2@O_@,J_.
M.-!=3'?/-*F/7H;H?H@N %52G$DO*2@.ZXF'^(':]' +;3_Q\Q['<C&XDNI,
MIDEK-$<C>6NG^L!YX13[-K27XBN9SV2E*L_C36<__WZ,:IMZI1!*#C/)J*([
M.QK)3^HTR 29Q#6YP<IF$5ML9YG<S@?8\1DG(&YR)0I?78N2Y4S:*>=XBMB"
M3U8LTA6R:CF2P\I!HO:#15"T6ZRL E'RJ7/<J.E1<\'!(?$S<2NGAK71E-Q5
M.I$47 UJ:"J+13<.5>5/A:-DKMI]2(VD*WL@;+<94@-'1=>9SAU+C9\ELXJ>
MH@VBXG'AX[F#%]6]F4J(2A(SN:)\$E^J '$=C>0S?8=9Q0."^<)*EG)N>DK=
MI?9G)^-C>_OIZ<'WK2>LB^>KA^]LD%2)1SO_WF.S)0HV@<>VC811/U*RH'!U
MCU9S1%L SKG!0Y-=M[C=HY9\3/QU2RWG8L<1^\J1G'QKQ=6:%R763#[WV?)I
M^.P C]/%,//%MU\H\=?7K: X9FC5 L%CHE]>8W%ED17$[HA?$T#Q$^4SO1-;
M:R-7#%CQ.U\>-^)AU[Q1W$TU!:\+-+9YNRT^H,<V[]$=]-@$B<?A(VL*>3F*
M^;0AKO16O.4\#!KPJQYFD#Y+-]?KN1:_.GPREY"OO!/(T-@=0G,Y]<WEC$+Q
M[I,!?$ZJT8:.]Z+'&K7P#0E;!YW18"Q,Q(IV(3&BQ8%=T8,)FO.&>X5Z5,JI
M>Q>\IH)%E^;0$1/Z=<NDR,),L\_!+RON,0L"-#H<Y<',("7%8V"$-^$1^(*^
MEHGLWDT+S=^XEXELVSVG"/&6NHCX7IB-*^^O4KBV!/,F0.&6WR'Q\'OQ^J*Q
M_<5#,DTI/';1XWOH^C8,O8J8VF*5O JTID;RBP^Y#\50V(N@M7WN'C_S]LNC
MP87ZT!&M::]G2TRM1TC9<_F*FRU7EQ4V/CC&%QG'%PO*/>__<^ >W/JNY?4V
MW/<2;;TE5*Q:Y5U])6@=]/(@SDOR=?G&]["+O. &_N?@[PP]L1N'F-\*S5E3
M^@T[RJ):-/H:'3 3CLK6,8U>WC$->4^56@6O ZV)9GK6O_WPF.2,]"Q+.O;0
M>>3=&;E]N.9>FI,H,W)?;JX8VPE?4(R'X*MXL]XMDM91[ J]::55-/L_76<+
M/>G9DCO!2^*(K)O'9Q61:XD&%G=\B_VL5R#NW?Z"7R(A#77<$I\^$NRR6VRS
MYS":B(* X(BQBPEW([EW//!1M],]*9^47P%8APE9+!!C>\KXP)5I4T]8=1QD
M%<]#*KD*;L6;14U]CB4.A#/$#9.%,V5AEPI*OV)DOZF#U#L]Z^S!?BO#U,%J
MY4H7.K>$QKE%KY)W7!&EKI%4X7P<^0K6R\0<YS5VF-X5<'_\W-X3+V3K$[HF
M7 1M9:0?.1.*<: G7 ?KWV8H&K6]E4CN:-*:%JJK;2?3?1/R#!V^Q,)GT=*Q
M^X"86(6*+5E/N!;YO3%?;((03K:JMZ!(EA!O17VDQ%LC;HM>N057PZB?(8_7
M I^1D<MM"GKH%IK5C+H,H*X&SB<:!*FYY.'; &V00];!@]*>^K+:.(D9GPDL
MU,9.6#5-_]SA[S[FC7[FG?F%R"U+7BEU=5,%VO(U"8DG2(P9WL["[8I45N>+
M:XES2LBQ)VB!A0Y$JQ3C9<^UU'5011/   7_CUSMH5&HNE=AUC8[D+(#$ME!
MG.&8B&85)U5TY=_(.US[%&DEG*)T3RJ\"]X'49@Q*I6J:V!8Z, /^<IO6>)$
M<BI]E;;MZK%!!>C:CH67S1+5.ILM6--%5'N&VIMG47>-O%"GL9F86[:F_;KW
MF0\=3D]Z,Z@\9%"*U35*F)%'G]LCGU!Z"Q[G+'C(_LA#=1.O>7>D=R+N(:\4
M-^A"UB#/4>"\!?V0)U_BUU_H+=SE&&^:RY5U["O?.389X8:[I[1G#EH=!@2?
M=Y/W@H8;?_$LM?4ZH +^*V'4U<^O1.*>;:)N1E'HFB5VX!YEBP8RJ?EUB<VE
MW,R$[@T*RR.KNNM7%?^/GS^WCT+SZ6>1.$T1W)D9[P.7^4154.H:+80G!*,(
M1^4)%A6OZQ1Q#Y_PRE^]+.GQJ5R^PA&[:!G,SWL4:F7/M=15F249YNX>LM0Y
M&'6868O8N\>N)%WZAN(\SI:S>$MHM(A4=L(J(-<VF@XGBK'//,+]:A2=O@S?
MAU0^O11)_>$#0]X_X)E+M(*?WOT74$L#!!0    ( (]*:54Q\UI^FAP  .,1
M 0 5    879D;"TR,#(R,#DS,%]C86PN>&ULY7U;<ULYDN9[_PJO]W51QOU2
MT=43LFQ7.\)E.6S7U.P3(P$D+$Y1I/>05-GSZS=!W2B)DB@11SKN]H-,4M1!
M7C[D!4@D_OX?WXXFSXZQFX]GTU^>BY_X\V<X3;,\GG[YY?GOG]\P__P__O&W
MO_W]?S'V7R\_OGOV:I:61SA=/-OO$!:8G_TU7AP^^R/C_,]GI9L=/?MCUOTY
M/@;&_K'ZH_W9U^_=^,OAXIGD4E[];?>SLS:[$BQSR@2F#7H6G0N,8S9<:ZM\
MS/_GR\_9<H.\1(:N&*:C*RPDK5@14'(.5DMM5@^=C*=__EQ_1)CC,V)N.E^]
M_>7YX6+Q]><7+_[ZZZ^?OL5N\M.L^_)"<JY>G'W[^>G7OUW[_E]J]6T10GBQ
M^NWY5^?C35^DQXH7__7;NT_I$(^ C:?S!4Q3'6 ^_GF^^O#=+,%B)?,[Z7IV
MXS?J.W;V-58_8D(R)7[Z-L_/__&W9\].Q-'-)O@1R[/Z_^\?WUX:$HXAX^2G
M-#MZ47_]8O_@_:O7[S^]?D4O/AV\>_MJ[_/K5Y\^T\_?7K___.G@S;N#3Y^(
MD=6#%]^_XB_/Y^.CKQ,\^^RPP_++<SC.$U8USH/BE9S_O=V#7UQ0G6"2EI.5
MD-[1^]/'5R);,X#?%CC->"*RL^$GLW3I2Y.JL%EW]I<3B#A9?3I:SMD7@*^C
M][AX2U/G"-_-YO-1#"7$C(&A1<<THF8!=6(RE&*RXLH*>5EFE:DY<;72<8%Y
M7"GZ].DOJC!?X&0Q/_MD)=Z5:#<2<"+*AW-S\:0W-*WW9]/%>+HDJW#P%;N5
M4N8OL<PZ//G>9_B&\]??%AW,.K(=T'U_N\"C^?L9_7:Z(,70,%_>3A?8X7PQ
MXJ!T"(*3," R#28RD#8RGV)16IL(KC2638_L7);T&FSWNO2,_AX[,JS/G_V%
MU0R>VM@3WJ!+U_!\>8:??N/%?'ETM'HF&Q,A9W]?#6XK#"YFP]3_"5Y)#FT
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M9<YBIA_6>26X4Q&R;;Y^M0O%6T%2_HM!\A&5_!15SE%J8;TQ+""9;NU"8L$
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M;%G!6 L;1-UTX(8YH86)WAK1O%]A [*'90JNRM0FA)"C8,'95(M% HL<$@M
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MTEGU[,EA>%$@<&*2<9$IB1;1L\#1L&!MT$5R;Z[V#[T-#ML..Z1LI1]<]**
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MGA[4H/O-;"#.,BV"XSGY&BMWZ>!'HNCV@EVB\%81J6L"7L#EY1Q.X"F",HH
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MP>5 J;5:V^0%96B#]5J,N]UZG(S(N?>?>].7B<7.NK45*>C@A3*$AX"^%TM
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M7TH9F)4Q\=J5'7=)@B<L@UUQ8!,I=Q$_N#V9KH\D1@6X%!6QTJ+](V0B/J=
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M\OE!_<M/Y?3^8:96G]T52A]N=E84.ZU:+:G5$F56RW\\)NS7,]0/I.]R7]<
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M,_L=!.6=4DL@C?KV+PL^F]Y6*I5@.C>T4=ANN"L6C[=W=OIOGK0=\<">+<<
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M8DZ9BF+CAW,-L:88LCR2$&-B9B6N!4N%S_;.$3ECFV":%?N2_0 /=K5D8[/
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MWOT@W#,G6'"K-.[76^"^L9H;B'\&:^7!Y6F8NZ0E\$0L7,X"5\%#)S3P!.1
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MN30NJXTLR(7Y)XVL(XLUE&:AH%B24)WS<W9K0Z _;"'&GH VBR[&2:(AU9F
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M/(4HSK"9]@F+%/+*_N8J>6R#=KLNVJ[J%V!3V+H*!*BK</DF<G/N$L>U01]
M][UF.(7QC3/&_DL*7[Q"+36<Y0Z[!/&%8V]IXMW P!DN;3SJ\OG3W!:_K<+E
MJRO3-W=L?O5@FRB_+*K0#B7_JJ:W=[8B[I,JV*WZBVEZ^9XMU=HYFF@1"Y4B
M94]C%,12I\9UX?8?K%,J$GMQ9Y <F0&-&AL!KQ0&K-88W%J5@30Z VUOLCQ5
M-UD,=32GQHL75Q/E8C9C10D>5%$_TF67YK6_:1X;0_^-OC]#[$6=D^[S M3
M@"UDFC0:2X,-:,"Y &MX+L#Z^]H@!"J(@,4(;&Y>C2!W: ]]_MK91T.:]-\C
M?VD/G1@L VH?NG5S%JS3<:":_21+&2-8QU#S!$$<I1H2QA)(N)9QC"2+,N(S
M?Q^1,[8I==>G]IL-CT'I-D$% *CG.:-:96Q4- L.AZ+*WJ1] H= /'I,RJ#4
M=L+4EVQSZO&.JX7I[7RJI\+PRJ40=D?%YA-9S*9BJLK-ESCF0@N:9#!6-L,R
M2G-("$(PUC0A6!"52Z=8#S^Q8Z.';X_W]ZQXMB[UE@%@8P%8F>#I2+MU@J.K
M&QS:OIW1=BA[(AH_F$+Y;VY"A_6PO(#8\X'\WN[NI6R\I7?6.2J64UL_W/1+
M>;>8R9N"V67M>_9<3G**XX1(!HF0$<29%)!F7$&E$$DYY4HHYNN[.$L?&V6M
M=03+6DD@C9;U\M_\X+GB]^L(=\^G%WB'\(<VBE^ +=4OP ;W1GM@U0_K)WFC
M%M![<I<]N$_E#<LA3\N_D0ZE?3^:+^/U8CI??ISJY?.U,M_,^?+##W%G%Y!V
M*_B;FD\7Q9?%4I7O'Y7IB*2Y7YI&@M-,)A"E53*1G$&:Q[;0;YHKC&7"L-/1
M\'EJC(WL\"]I]#_ MN:@5AU4N@.C/+#:>U2=[=Y%[>PW'/ ]TZ"U 51&@,H*
MT)CAT VG;_Z&[ ^/<L"#],M =8%[[1^_(L%GP]I:+;A[Z\.5#3X;@9WZP>>W
MUODBR)V:S9I[#Q,54T+CJ+J0*2&V:?I(G#"(M(Q2G9%(9;GG/9"MYL<VQZPN
M.E@5.U_]V(:O?9XX'Y2>^=\+CR[W/@Z8?<ZUC^WFAK[U<<"4 Y<^#CW5==U<
M7[I<W];^\,,>4ZBW:J[T=#G)$I[R.%=0QB@V*^4LABR/8QBE6:23/,V2S+,*
MR0F)/M_;@9+1560)[')X=5FXRJ[@NRYN!]IU)1P,O-[7O@U6FY0+H%$6O&G4
M/;ZUT&&QZP1,L.5MN[2!%[1.IN\O8=U>ZYR+I5"L5.]5_=]/\Z8Z^><IX]-9
ME?)G(F(5"X00U)$VY&)#F%F::)AA@3'2.2>(^Y&+B]CQ,4RC(U!U#W@RBQ/4
M;O02&KZ>.6:E+GBS4OAG2],K.+>4#IKAQ1FB<#E?3HL<.@N,,P@'\L*XO]MA
MQZP*E/C+([-Q$(OBBL^FM]7Z>96/;S?Y:X1B0AF2D,4"0TPY@DS3%*(\XS22
M"1-1Y+Q+YB5Z;*N61F^EP'(!WBM5Z*F:.2:-Z@"\P]Y7;W#V3$MUD-M:<;"E
M^3K1IFL&WG-A]MC2Z@WN@;:Q0L+NMVO5";G6G2J_%H?;G>IDZ<Z.5+<6NCFA
ME:RM:>50[!6S%^ZU,K0OA((XY0P23 FD$9)*9BIA4>;G@SI('9\+6@^>.G%M
ME3;<Q7GJ#+J;-QH8R$%8?TO=_B/A/  *Y(JZ2!S4$_6 X*4CZO/J&?SSQ1A2
M4]N6K.H6SV8\B#BEFAKJ2;)80,R2#!*2"!CCB"(JI5D+>Y8_=Q4]/B9:7VB[
MTM4%-E %VYY'1RY]X,%)@7$=A)@V.N]P5'TG$/1'3QY8A>0H%['#$Y4'& ?9
MRN?]CME,IG,V%U,VVT2W7/Z8EA/&,4NITC"-;"8HEFG(,\PAPHAH'3%.B5,U
MOQ-RQK8H7JNY%<8%?K>:^J8L.8*K&^L$0*MGDND"E']>DG880N4B.2)EV/PC
M[:;NY1PY\;C_*7Z3F?\9Q?QFNIRI22PC'%,M8$3B#&(A4DB2E$"A=:JHHB)+
MG.I*'&I\;,.^4LK&\*/X#?]Y5:7 XQ!_#[WV<7XN)CT/;E\XO,[PC]G=Z01_
MK['!SN^/F;%]>G_TF:YS]8_5\=VFCL8J^C/1.LZQA&E.;<2-W=% *88D1CK2
M.4616\2-@ZRQ#=[:W]5683BM#Y\WE5U\9^WC"+O.W$%PZWWV_K$YJ=_HV4/=
M%0<\@DWCQR4-/)6?-'E_.C_]2L?+?(^\K%*1+3\\F7]6;*$S1&),(8H-1V L
M"&21R(V?S[)(Y3P7B5\NCD-2QL83&R5!I:7GA;R#0+J1PMGP]$P'+Y'I@0=:
M(0AUE>Z@C&%OSK69N7=1KO7A[L4/KE>I?6U:@ EAF,<JPS#B*8=8YSFD*:>0
M)U3CE# 4"Z>Q?E3"V,;YNB) K24P:E891?PK(^P">=JE/QN>GL>Y-S*=RB8<
MM/ZL^@F[+0Y>2.&@08<J*AQ^L',=2!LD\XW-6&&<@57UT2A#41K;X<ML'O$H
M19!*)B"G6$048S.Q>YX<'!8TOG."5927V$JLXEVR\1"D;G/X^3#U/+A7^*PT
M[*/&:RL&X4HE'A(R=$'$%D,/E#UL>[IC!?E%N2POY[*)TBTGD5G?QU@(*(1*
M($ZS'#+*F/DUI:F09HY'7D6;7PKPFL8'J]N\>% %JY(_-,&RGA7A7Z+H-MC/
MP:;G85ZI5D5L?#@5/>Q?S?V(V:$*M[]L?M@:[4>,VRO'?NRYCO.X_,_'NO9I
M>;.XE')JYRTVLR42/\V;M)]5!;2Z]IG]UQ;*J+28<)[D&HD$IBFSOCN+S42O
M**0L(HEB(N<DG\S5K:VXZCC;GZ&.TRB@]2C85JK'.>_>%ERJDZ;:_>KUA9UI
MH[?Q%DKO<N_G])BC,]%W+PSD<FS,L$'$&T.J4JLV-+^QY:(NM]B46;P *X/
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MN4 )IFE&L"\UG) Y2IK8Z'P!UEI#O2A@:?3N5LS%!7]W!@F(ZA!L<AS0;RZ
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MND--T$#Q;]\3%187QP"W,5;N)&"X^#D&#D<Q=90!6]ZW/8FU_L>3'>C]#T<
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M]+%YK@/ERUNJ(_5C4$:'S8U_@-4+X@.$6K' ;A5R!8,6,?CRESUX&!8,R[F
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MW.J@)0RPB&<MGH('/VX) ^3<B4O@".V<V'X][L75_G(*E2(:I@9(+FS00J$
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ME_W679DJ"HW)<9XAP'B16N^!"6"P$(!JD698&,Y(T![.6_+8PK*MXF7/S*,
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MR;UB:[831\ K]$*;6?G3?RV3";*_3))_S=ED]\_R&N=?LRR=)%;11UW&I//
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MSC0&A*#<'?X7@.4%!(9"7:0B*Q338>5*%R2-[753%^"X?O#'ZM8)\Z$%2Y<
M;GZ=1(6MYS=&:\1:U"Q=0:-#T=*ED0>N6KIBX&G9TK4'VG:K>7A8+LJ:@OID
M14&N(2E2@*"TN]6"84 +2 #F!8=I(3D40>=4)Q+&Y@AN5VJVX*OGNNPHM"O-
M2_PL/H8Q UT^-7?$UA (C@2 .,MX(0N,& F[3>V$X##7I96*5<515P#]]O>=
M0.G941ZBT4O'G@NF1^O2\W+\@3OS7##OM!O/I0_&K;AP6;3;--DORU79&>.
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M#4>]9 [;930$AI/6HD$/M^VA\-:*6/'YQX72/_^[?IY"E$N880V(TCG A69
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M?6!_AQ9SXQ>=]8MWSW[&\:J58&_5=SOJ-\Z"9+;XY6SR?B_=(]J#&"F,:J'
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MB-NJH2<NUFYM,+V'W00./1TG>\O!%>AX&G5KRC;'WY=S^_"ZTF*W*<N@A-Q
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M=D[LXT*N7(7P.UW]_^/BRTH_\IEZIXVV+E/5!0>[TX"R('ZJ<9ZRLH0ERP3
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M>YD-R!)L3$%(=*V;\MQ)R+@=2%H>2@>+N0NT;#B81!:"\\2Z*#&"BLC &R?
M&8^*1Y&\:NV[;%8>MR5(\]>)G03905#T:AKB]&3S^#_+Z[EKG^8G)/1E]=17
MW[Z+AB1C,=@$R"7600D1?%$2DBY9IN!M,JW?([:EK9LJFV%>1P=140=7-5?X
MNGE'(4TFF7A-@:$QH#Q#\*%P8";HP+RPJCPTJ.9 L'7U?CJ,]N^'V"&JZ.)
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M\V%=]Y R[IWB4.=8 [%W<(#=P4$042ME,WEU@6)881R$) J4H!BW1@K4 ]X
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M;_)'I&X'W3_.H\G RNS7]5R?)]>X?'NV2)](YFLFI4C%&X<@Q#IE7I-,O9!
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MGDV7:7Y&@I]XA3QJD0!UD75XM +ODP*GLF/2Z,1DZS!X6]K&-9S=H7,0E78
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M@F8\%":LR:W?3A^BYU"3<]=G7X(:HPCHC0-N;*$(-]'I[N@[7TI0ULHDL/5
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M*XO<@2O+LJ?X&$%:64<A"0>QH(;".)U2:,B/;6UK?DQ5DZD)=ZYPB7L=O,#
M/-%7<[J%=."+J]FI4?F<I"W-G; MR!K7 #7&RYUS#QJJI5=S=,],HGV>IQZ8
M;G3@<]06-+:*@KZK>5T$^GVQ=WA22X/7Q<AK<F(EYZ)B^3OB5!+"2&X!6>W2
MGHL#1Z<=>"4$>B.9;VZA#J/XX*AJV]5_N;KZE5  LS::20@UFTJ5:(%\AP1>
MQ""R=]R4UE?L!Y(\<I1V/'S>BN:.J.H^H[[7N*H#3=[B8LWG/D;RYD<TL(X/
M4M7(+#X/B]ET]O'[(I=/(3)%5/4(E$&!8DJ3J^\*_5AT#,9:UMS@W4?+P=67
M-S[W$KG.RB0Q(6#,N;[WVGK.*]!*.2E8YD6WOI^_EYAQS4\3'-RJ@FPB^%X=
MK&HJ%_BI)CE]6<]#VBL+\M:'M,AG?)BR9IF)-Q/*7L]7E\!1R ,RK\$:YD#I
M4(<P\PRU7HE0I(Q.S8LD'J3HX/>NJU+=W&;4C[\$M7!()/D,4=<V8179SD4)
M6=+93,)P++1.POP136-G'S9#R*W7JY;*Z-,IJ:UJIIMWP# C+VR=LX2S?9,,
M'_JX-C9G.VH;69\KZSVYL=X=%P8ZB6 +.<79UTQ])>K#A. @<Y$I2,\4:_T6
MM!.!#6S3CQ>[<OR&K!B/M"42.>MU#CDXX1.D'!G+04KOFQ?+[T3AN'9K.&S=
M8<:&TENO;M.Z8O0LK<X6=;3*NA?>'M;LCD]I8,1^1%LCVW5MF741[3K0OJ.=
M#AV!H:S[C:;H*:RW"ES4K)YGSJ#(2@7;>*-N3=RA-NN'"]VU U@I/G,5:Q.4
M>M>0,@15$&@+6MIK)"X\ND"ZLU_#X.NF[1I<?WVZ9>_/XA+_?D8?]/S+NOA_
MGQOUFY_1I+3C(;I:Q7PW%KE\D9%%),,8"%DSYY.O)42%'/JDI.2HL^:MG]#O
MH^7P+@#7/_<2O%)J%NC_@<('!&4$[9M 3$K4*9ML",ZM*VWO)6;L2NT&.+A=
MY=]"\+U:C6T*KX8O(CM^,=E81659^R2B1?#:!E"::P@V)_!9*Z$L#ZKY]*[V
M167KB;ZOP_7Q+NL/_[;Y>KE'K)!)F"(@Q9+H $\&G+(6;/$A"Y&%L_Y'&-I^
MN6ZKQ'91^[6YR>VE/&HGU#5/KZ9_/YOF6NH[RW^9KV.:6<+%["973!I#A!>(
MT9!]394K9QB@-B(QXTHL92OL;+G@N-TBAD#/$)+NH-W(+V$Y7;XI-R1V:U<D
M@S%J'H#'0%P5VAI..P61%X$6'8^I=1K3=I2-VP.Z,= &5$J?3M-=Q:(?:FW*
M7@[2 Y\V4&'K7;0>H[S5:_*3LY9 1H6B^B@,U-FO(+Q-EB>.IKGK,V1YZ_OT
M"?-9G2GV?96[IB2?"SZ_F;VKI4OU5F*]4]9:N'*'FIV(: +8L+' &8)4#B3C
M)07'I;+-6Z6T9*#C\ME=<'<K^!M-R7W:OCL+\?:V?0]\VD"EMP/:OAT*))5!
M+8A8$#5G10FFP5FI0 2M=)1.\=CZH>MX!;@?%F$]J>'R@V?Y*2Y683H[_ZO-
M#KJR+2)&EIT!9CQY'3[8.G01@6NN4E1>B>:-*W<F<NSJET&P==/:#:NZ+D9P
M7)'DTY.P7$[+M,YTJ&^<57QGX>37&G&3;)^%%=ZPWRPEH54F82IVGA\68V$@
M,&@NL^.,MQ[6=0B]X\:S1\+LT13:0=Q;Y7A%?#=&V?XV6V XF?XWD57S<^?+
M:57U=[_E!NOK4I60+?!4%"A'7R+*#*6@$,E'3-DWQG)#\L>-H(\$[;'4W:?K
M>;4CP?XNYQV?TKA;PH NYCTU\]Q2=".S!PS& IDS#9%+"1(#TUHS7^(06[E]
MOMAEM+6>R#BK+_DWJCJPJ,PDH3='[FMVI@(G/0=O3.$NJVB;\_ICJKKLI+ +
M*NX/>YLHHD^#<F^]\?[6Y4<?.625](!V9XO:5X8*C30:#(\(2K$"L3Z(%\>5
MD,P6:5N[QL/52J_?3B[WP-L%?@[3_/QKK4%;!T7KI9^>+>KV/ ^)KA^WM!UD
MX44 H_AH<]R&D"1PBTHHSX2,_$=@.IB*[@NF=P'-M7>MH^FF Z?_DM<K6__U
M?)8V+%[RY6LCP#K:1#M)TN0N@<=$_F;.P1H7!>.M[]>WI6W<2'0@) ZJH*Z
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M&$IR1FR'MKU)Z.FJL07>CJ.+L1&W9R*%BEYR9@187+?]D@Z<XAD"]]$7H7/
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M0JT-IY\QS6=I>C7=?.V\$.=U2'5^-[U:UW1NN$KKJU.O;DY>L\'M3EN^&UT
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MU\FB'B%<;LH1'>HD/.VIS"EV+$AN7Q:<?E0J<J<HKFS=%W$_)4._[3Q5PZ]
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MZ90*@JF/DW4N$-'RJ"EF4"*E)!:NOB8AQ<#.@ZNAX @Y/ "<.@".<][1B H
M$J8$"G%%F6!/  8K'*^8QRM()H;0EJXRY.Y],K(#B\$]*14T<(&1O04ED,9:
MALUE^6^VT%W3M&Z8*L^Y8_YY^)P[?LX=?SWHN!&8N'3#0)-\!+"OD34#)>.@
MDQP'SII#HVPTJ8!^AENTPG/F;"!\JN@XGCN]MU7.@"5JE=!<31TSM:-P.\HH
M(SB+"Z@]I<P-@@W)Y-%K'&((,]51L8N/@WL^ EB7(%Y2Y5T;Q!L:JH:<#:L!
MD2)"C(G&RE 33V603G<'@#U:U,ED-QL#88Q1][''8=7"<0:;J2*@U';1T@B-
M.GOM9,S[]A+"!)@J:+&)Y$ L!?.!9K2!,0'OM87Y:)@N3C*1+H078IJT%M-\
M<=Z^M$0M&X0*=6JA>.F/P&UU,(IKN!9&:?*JPA*IB]9$]#RWGQ#=@&^^,V^S
M2:S[1M6GV),62MV971;:UG_6@'4;H)X+24^KBXX(,%<BU!CNC\P?.L>PHB48
MNX(\3;%MGO%T@JP&XRJ<3PYO8"%&M$ /X=X/W#-=;8NW():M!NA;)^S3+JCW
M=]<X!-RJ3UA47=S6 [%6+BP.N$5@- 03;1WKG +YI@S[Y];LA!Z,(:L_,VVK
MTS$T3)4N'!Q^*!0,&N0]M\VJU17D2'!2,RB77<QS JFG2B#":6I;$T.Q+L6[
MSZGOF MRC]34-JWBLA!ZDM7)-?[-G/M73<#,^/B8$T'J&/9$[);AU&2V$J:F
MEQI6L.2.+14.N4T)'-3A^FUZ)K^"NF"ZZOO";RU)CFM7[04RL=5!)1^/W#HZ
M-B)_2DT\D-:#M#/0$,:".M?ZO.B^3=U.GOS!-C5FZT5,QO4J^6:LR@+BF&'%
M@$\3UP&,EL$.>#X%AWQA+>M$PC><@H++=9CD>XIBXRKJD\*48YV/+KZOVY*%
MN1LRDYA#\CQ8K!6,3O)M;<AS?Y85^[-<Q='NN=VMMOF&')<15TIQ #-.L3GI
MPNIS5+O8'QI%K;5R(XZY$&==*PZ$KK@KAKO]Y7L*_VHS#GX/_)_-R2,X4:&T
M._N&J-,$OVO6]N5;G%H+ZT&=^9*$0]!\8@"0?H&[C<)F*/C!MWTO**$-UMV4
M=V>!I1\2A"CTOA?OHOX&I\]4FIC0]LD)^7868?T:T<Y*JFWEPAS6D:QF.?$W
M+:)YRU$*H0T'EEH6B52[J%#LW=,8,G2ORM$5F1H+I9)*[M[Z<[A1,:ELG'-^
M!XH?_\4EY,N5*TZ1W)<,=&TMP<.;?V-3?V>>,%E:58#%%W* );&\<13#K)PT
MK6P.-,78"05G_3]0Y2"<X.Z*M#&4:EZY6(0 [(JJY@E;N,84@![N/VS>[F@'
M;IJK[:[;>4FJ_]P68\1FTS7]%P5;S:G=+U!Y"4^;4!DX[UCHB$$.^RTR<UF-
M.1U7(#\O)XPK';*I:[NKUZRY&9TU F5:9O.=OOC@F@'A<DC;DMQV8,I%W[DH
MI6X )C>I/.BB&,KU1*KH?L3L[N:J9K?F@-2.TYS.6[#N4MVS;6;5X@+>M( U
MG:7;')6=ABB_MW".YZF>_\W1G>BWWN[_1F.+V35O +2PFQX]RX1X9)'MO86>
MN0K4> 30D)8=OAC+,7,,==$W<:0][,X%5G0<1[RQ!9Y@FP^[ I+9DKWU%K17
M]3./K"+P,'Q@/>;2IDHKH+8CPG0.LW*4@LJC".,2OW*,ACU$'MBLN7[.M/'/
MH^=,VW.F[9%GVK;>UEAJBN9X')*DUGUY;Y.BMPIUB[AW1=( JSWN 8A;GD@;
M+;CQ":-BKSFH>*6XSRPP/B]W@1)WKO/(TX3%UC!FO+_5M6W!A]3W7UG35J^%
M=EMUT7?,,)+GN:!]C0T4L,]=\K>_&%S,8(OCC6"+9VWTM;31!D-UZ_GHMPH$
M;+#I5M#5A EG6/ATF+34ATWC!G3,[V&! # 6E0+BKF))V^RX?G*NBHZ>$U*=
M03D]*(M6NG-[N%S?*MQRS=K92F:"776%:[P$8NJV0LG<6\4#RU(\.T@5 \NG
M0'6!("5_9NBO8E+,+^+2[.?2D+#?*J7;8!V#N0KH"H%F)9\?4 3Q>(\]:A#Z
M0VO!S.8G5J9AWD287.^ $M P7=^>9HKJ"!O5D1--L]*E!70IJI;M"J"C/[+(
MJ[90!MT&0S48,*0,+2-Y0\S))W" \9&5@ "OG2N?2$;<&X\G?>]TMS4RO!!U
M&\7*Y1= *E>E*D4?O,@GK* V>([ZVG#IAI-1(-J;+S^K*2,J F#SS;C/JI79
MB\]LGC\AE<TWG72*DO3T.R4#74?<(7*V,H'5#U"7:[-KH$[1'R/?0I(WQR"4
M,]_?A)?,]K4S:IBYJ['_)L8VN:6'%-X(.T26HX2NO0BR 2O4HDT*';C+)^ 6
MD<JB_276TE>;?=)T+A0&/EW]S\]XS)-GNR]VZ62[TDE&UV.<:T:GYP%#A9KZ
MU?'%5VXSVB^R#^^_=1N=N+D\7W/M>=G877<G!^[4P?=*!@!CSWRL.D%U6QSR
M"T8"'(%\.TGW,] D&JK*ZP%.PX(EI5:WEQ'!>AC'3]SUK\4)KD]5J2EJ-]T6
M9>Y>:66^V&X'F#L!X],/XDE9V-9;7PK)PY!9U9<M2JGO#%]6-#9YRJWY2I)G
MC]XFWEQT)*WL:]IS0MU5PC##'JUI*3Y.I%PJ#@^F2A]:#0OI>-<R-@;-B%'Z
MTQ4'4)9'SJ?@;ZXW32D?H,M'7CBD -*KO5DLT?[RUB+-YQ!DD2I$SPON(J5\
MFVC&4M7Z(R\<$.>RWF*16&D3O4LZH*Z[@';E?45Y&B[#8#J/]&?+H_P'7TA!
MBF05I?!7.L@T?IGOYU896X7E*TVE:UP_P]5H>0T=$$'[:*/0Z4GQ!!>CJ$O+
MM(3O)V!^DKK^WZ7.5@7-YTYA646HL;]8/ESK'G 'V^INN7(C+PO74/&QG:D9
MX0S[6"]CCF.QT7.YV9N#*VY[)1!%Z=PQ>4[C\,_CYS3.<QKGZZG3#6E/=S9L
MH4<DXZ>B>74)]CY@BPI#5%4_R_#I>H:IN2?*'C7L1-FS/*Q5=3<(9=0=+LNN
MJE&AI!/,>9<3F#/;'5\-!ECC)EUPS\)(33LM7 Z$#@A@HQ)99&[[)=K6!CHJ
M(G(^OAB/]"(#;5SLTC9GQZ-*3%RT*B>OJ]2\/(?AZK/EN5)WJKKYV2:+,\VG
ML4X=6ZWAWHW\W 'J'46C?2+''1\WC#GK]K.!2<1J)2I^Y2@*GG%,2V<=)J[!
M*ORETIY\2OA0ZXQ6Y3OU&?=-)L&T%(\J'TW")UK8IG[5AOO5\^<6;B;A<G*$
M=\5&'+>YA (0J3U1YH-.DC@SNO#'A@RJK&2YLP0,N'AZ''"UJS>*T66SG1,"
M[?'I$?2"E,>YG@/77!Y]T3 >[2WG08+;&6W3 5[#:FI[&B'G5^>T7&0/(<%(
M#X;2+!/:LNUXR,6&-G>:=\"G+07.JTRP5X4F7N26>7>PC-+67T<+A(9Z.TV9
M-P?22S00KQ1E*M6@45LZ&Q2C=^9SZ&L64SKYI2Q>2>SN2E,KQV 0DGQ8;?!P
M"QK99C26#*7+BC>5CW[!%UD+9E]7/9V^E%5>?6+<N,V]QA:A#Z0.;!M/^Q=^
MN1MI::'+QP-&L9-=2Y9[$"Q?%ZUM'-UXFD5HW:W1EUH73^%P-B2GWW]WTOG6
MI:'TQ%.-C:6]%8:4RX% K.\.N]]L8>C)X5HYCT6K6^\9??4'_8_Y[B^>??<F
M^^[(8MK_84O[<M _Z:A#WW_1.5*=#GQ\*4].P*8.C@[5\:M_'W6VFNCP-P12
M75Z)CY>]J^[=G?CXOGO;O7[7JD',KJ.:!38S,$(6I5;Y=UVR>NCP70"X7=^*
MS5-FN7:JH+/.R^/VRYDG'9VT-Q6 7GHVT_NN.+_^<'-V]?M7FMOCI=/6V[/?
MSBZZOX@/9U=G/W4_=*]Z0)O;F^O;L][E]54#Z;/&LPZ.9WE[=V,9D64,26T!
M$OHISJ(AV'?Q,<8C)1<9RJ_U<T4R=N::NFR,6W^<\GFC%3JMJ.DJ-52-F]EE
M:H]2%>(W#"[<@ =&6:;5Y>9X8X-?E_%@D@+5</=?W?-?>Y>_=;]DDFMJE2^Z
ML4D<(C88B5E1>_V$S:_,5/S<%A?Z'A#+TG_+N&,!=&TZ8W_KGT2W62JO#O/_
M=WW+E\^^99-]R[_=3?S*<9ROQ^;[,VS^LI;-N_]Z?_GC94^<K3'X+XQ=??,9
MU@MR+R8XM$B>[0ZC#]38A=S?<]LXL=3XJ+FS>V?B<.G\NA]N?KG^O;L8&#5F
M*AALL,CUWW7_FC^#NU]__+E[WN-)/.0K;4+:%_6C;RY)%U&Q-U*E?!%62<X?
MJ5 ]I(V//2N.6L--/.K>GL=8[O,38F,4JE<(I^6^7?V:HLZB5SH5='(BMSB8
M:Z!-DBXZG@LW/2XYSZ$XH@&'0;V<:H:Q[NZ+ABUCG3!\NU'\/:*W'@6NXB4\
M^KRPCW=A[Y2BDR,FCUQ$%_VLM=&K_WLFR#-!GBI!GI7?F=V!C75 (T5M(^W1
M!X]W56L@9QEIKGPDSV4)-=8=S//([<4S\U\!J']>O\>[?L_([8G:Y6>";(@@
MSWFDN9^OGO-(3<XC[?5C?PK_&Z5A\/:_4$L#!!0    ( (]*:55 \SD)[2,
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MJB<#)%[+DL&<@ (J8<Z&4"% "7[@[GAA/AK#KR/[_L-MD!/3=(:EDNC UY,
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MW!AJP[N8<5473(B<%AAE+H@"20!_N2?P2T[U'S$(=Z-5BG&]Q,KO>>_'?>/
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M,Q\#8))$W\4^.T%+,Q=H24< J?6RZ3B*8+:Q2?3VY!:2X.C8;S'IL-N47.\
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M1=%]GSHOT6R_D4.)7S4,.>OJRT#F8O80):.R-P1/(J:M$\.'<Z)*N\>I:*?
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MF42.BFIFTQ_6?VR:>!];G>%#5!A1X<XXC;#T%R8&O/RSHG!V#*B;AEEIT^?
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M%2LNJ/U/[6R6!2Y;-4 3,F/3;4&6O;O'*7J=9K]\W9+KW.%2Y'3>B,^I289
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M\V7*2KX_VIBF[!?)XN01M'#T:J+;T[MQ5O:5A46=A<G(3GQ)TD-0?**?BS[
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M+%K;PQW&TI1C[6(9U)";T3"QLMPV!+.UNSJI;/@07XQ'Z!!)&^?ML,V0\6@
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M0WL*Q>/=U0:5T]<TESXUY=S3&IO.3GGD\N(9^2] J7_>O\>[?\^:VQ.5R\\
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M/G"#@<*0)'-VEZJ9A' "91\Y[>,5*APQ54@I4"$7*>/IG.6IU3F@P4@R'-_
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M\YKN7%M](J/M(OXG%;) 1I9ZO\J^D_7>.[#ML[J1LW>#IW\"4$L! A0#%
M  @ CTII54[, +NWZ0$ IL,6 !$              ( !     &%V9&PM,C R
M,C Y,S N:'1M4$L! A0#%     @ CTII59O.^^3W#0  V9,  !$
M     ( !YND! &%V9&PM,C R,C Y,S N>'-D4$L! A0#%     @ CTII53'S
M6GZ:'   XQ$! !4              ( !#/@! &%V9&PM,C R,C Y,S!?8V%L
M+GAM;%!+ 0(4 Q0    ( (]*:55ZY!SAECT  ,*2 @ 5              "
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M;&]Y;65N="YH=&U02P$"% ,4    " "/2FE50/,Y">TC   AY@  '@
M        @ &JB , 97AH:6)I=#$P,BUM8VAU9VAE;7!L;WEM96XN:'1M4$L!
M A0#%     @ CTII5=W(#CV=(@  D^   !X              ( !TZP# &5X
M:&EB:70Q,#,M:VEM96UP;&]Y;65N=&%G+FAT;5!+ 0(4 Q0    ( (]*:56C
MA=X^&@@  %@J   4              "  :S/ P!E>&AI8FET,S$Q<3,R,#(R
M+FAT;5!+ 0(4 Q0    ( (]*:55\Z0/%( @  *0I   4              "
M ?C7 P!E>&AI8FET,S$R<3,R,#(R+FAT;5!+ 0(4 Q0    ( (]*:57/%0@?
MQP0  "\5   4              "  4K@ P!E>&AI8FET,S(Q<3,R,#(R+FAT
M;5!+ 0(4 Q0    ( (]*:56U+,'1T 0  '84   4              "  4/E
L P!E>&AI8FET,S(R<3,R,#(R+FAT;5!+!08     #0 - '8#  !%Z@,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
